data_2lov_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lov _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.776 0.322 . . . . 1.0 110.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.54 34.65 1.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.87 -20.11 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 1.0 110.547 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.39 -17.66 13.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.489 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.587 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -90.28 -39.69 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.166 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.5 Cg_endo -87.86 25.03 0.67 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.555 2.17 . . . . 1.0 112.291 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.85 6.75 5.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.534 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -139.66 -44.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.543 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.28 8.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.51 ' H ' ' C ' ' A' ' 34' ' ' ILE . 10.4 mmt -101.58 -63.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.58 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.2 15.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 36' ' ' MET . 88.9 t -130.92 -68.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.482 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -41.88 -43.51 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.567 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -103.89 52.83 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.542 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.1 tp -159.55 -62.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.95 9.93 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 1.0 110.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.735 0.302 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.92 38.61 0.11 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.1 -4.49 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.334 . . . . 1.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 -18.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.544 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.9 mm -80.77 -35.58 0.84 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.454 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.87 7.83 4.42 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.403 2.068 . . . . 1.0 112.196 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.31 -0.05 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.669 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.61 -35.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -82.46 30.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.613 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.504 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.9 mmt -134.21 -62.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.9 13.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.52 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.2 t -137.43 -28.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.512 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.02 27.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 38' ' ' VAL . 1.2 pp -173.66 13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -131.34 -48.46 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.442 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.61 42.63 1.87 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.328 . . . . 1.0 110.486 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.821 0.343 . . . . 1.0 110.606 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.82 34.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.58 17.51 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 1.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.02 -21.61 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -76.4 -35.88 1.65 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.3 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.8 Cg_endo -88.43 3.66 5.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.429 2.086 . . . . 1.0 112.283 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.58 5.05 36.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.825 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 mt -137.22 -35.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -86.45 22.19 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.572 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.3 mmt -136.06 -61.94 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.55 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 39.3 mt -60.6 -17.98 50.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.585 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -99.24 -51.2 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.611 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -43.5 -46.09 6.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.432 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.76 69.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.468 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.28 -58.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.452 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.61 14.62 50.75 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 1.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.812 0.339 . . . . 1.0 110.515 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.44 34.09 0.83 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.83 -31.89 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 1.0 110.657 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.2 -1.82 21.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.548 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -90.28 -39.65 0.41 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.293 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.19 24.16 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 1.0 112.145 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.22 5.15 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.568 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 36' ' ' MET . 29.1 pt -131.67 -31.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.666 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 16.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.499 ' C ' ' H ' ' A' ' 38' ' ' VAL . 19.4 mmm -117.2 -57.99 2.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.2 mt -72.48 13.52 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.591 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.6 t -137.9 -21.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.54 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 39' ' ' PHE . 44.5 t80 -91.49 26.77 2.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mt -138.5 -6.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -126.59 -50.16 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.493 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.98 -7.69 0.83 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 110.413 -0.218 . . . . 1.0 110.413 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.757 0.313 . . . . 1.0 110.545 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.43 40.04 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.36 -15.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 1.0 110.542 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.77 -17.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.498 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.621 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 4.0 mm -80.24 -35.62 0.91 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.459 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.4 Cg_endo -87.9 24.29 0.72 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.393 2.062 . . . . 1.0 112.282 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.07 1.69 6.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.521 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -36.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.516 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.81 2.85 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.576 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.43 ' C ' ' H ' ' A' ' 38' ' ' VAL . 10.6 mmt -101.61 -56.23 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.551 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.77 13.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.537 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.43 ' H ' ' C ' ' A' ' 36' ' ' MET . 17.4 t -137.15 -74.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.502 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -42.69 -40.38 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -102.19 43.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.597 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -163.5 -67.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.382 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.02 -15.19 0.34 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 C-N-CA 121.119 -0.232 . . . . 1.0 110.537 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 1.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.42 33.98 0.77 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.73 -11.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 1.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -1.41 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.591 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.73 -38.88 1.82 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.48 4.6 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.37 2.047 . . . . 1.0 112.202 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.97 3.95 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.549 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 36' ' ' MET . 2.3 mt -140.13 -41.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.446 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.6 m-85 -75.99 26.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.579 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.493 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.8 mmt -136.92 -51.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.54 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.22 16.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.549 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' A' ' 36' ' ' MET . 22.0 t -137.01 -56.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -42.2 -53.36 4.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mt -95.41 60.07 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.573 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -171.11 -62.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.367 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.52 -6.37 1.05 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.486 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 1.0 110.594 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.92 38.94 0.84 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.66 -29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 1.0 110.528 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -107.76 -12.64 15.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.587 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.98 -36.06 3.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.315 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.14 25.8 0.65 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.307 2.005 . . . . 1.0 112.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.74 2.12 4.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.558 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -142.83 -44.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.635 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.8 m-85 -79.75 26.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.582 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.4 mmt -137.43 -58.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.02 8.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 36' ' ' MET . 17.2 t -137.62 -53.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -53.1 -39.68 63.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 mt -101.48 42.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.496 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -159.21 -65.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.8 -13.85 0.34 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.527 0.203 . . . . 1.0 110.493 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 27' ' ' SER . 17.3 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.821 0.343 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.75 24.85 1.96 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.37 -0.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 1.0 110.483 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.78 -17.38 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.06 -36.7 4.33 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.235 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.3 Cg_endo -87.47 25.64 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.316 2.011 . . . . 1.0 112.169 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.56 -49.7 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.598 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 pt -99.25 -31.87 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.658 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.67 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.551 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 38' ' ' VAL . 3.2 mtp -136.44 -54.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.52 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.89 2.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 36' ' ' MET . 2.8 t -137.38 -23.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 39' ' ' PHE . 41.9 t80 -88.97 37.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.537 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -136.59 -9.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.2 mt -112.15 -41.96 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.07 39.5 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.558 0.218 . . . . 1.0 110.486 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.784 0.326 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.0 14.65 3.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.879 -0.889 . . . . 1.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.29 3.43 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.277 . . . . 1.0 110.613 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.75 -30.68 6.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.675 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -77.96 -35.98 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.369 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 76.1 Cg_endo -88.74 26.09 0.59 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.413 2.076 . . . . 1.0 112.217 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.44 13.75 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.481 ' C ' ' H ' ' A' ' 36' ' ' MET . 10.1 mt -145.51 -46.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.12 4.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.588 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.498 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.3 mmt -97.83 -60.38 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.569 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -56.39 -5.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.52 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 36' ' ' MET . 55.8 t -101.82 -56.06 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.451 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -41.83 -41.11 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.63 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mt -103.18 48.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.646 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 43' ' ' THR . 16.7 tp -166.64 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.75 13.85 2.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 41' ' ' LEU . 8.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 1.0 110.7 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.816 0.341 . . . . 1.0 110.511 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.53 24.44 0.58 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.22 -13.11 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.72 0.295 . . . . 1.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -127.51 -1.96 6.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.459 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -90.45 -39.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.215 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.2 Cg_endo -87.14 7.94 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.444 2.096 . . . . 1.0 112.159 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.39 4.31 41.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.86 -39.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.28 30.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.576 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.5 mmt -133.96 -58.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.543 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.85 20.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.547 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -139.3 -48.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -49.26 -45.66 45.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.5 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -102.55 62.92 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -137.29 -63.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.533 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.82 -8.34 0.58 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 41' ' ' LEU . 1.3 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.56 0.219 . . . . 1.0 110.474 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.67 28.67 2.73 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.51 -15.08 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 1.0 110.469 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -136.34 -9.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.636 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -78.39 -40.11 1.76 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.938 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.6 Cg_endo -86.94 25.07 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.444 2.096 . . . . 1.0 112.2 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.12 6.26 4.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.496 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -144.79 -40.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.512 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' ' SD ' ' A' ' 36' ' ' MET . 51.0 m-85 -76.6 26.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.492 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.496 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.0 mmt -136.66 -50.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.28 7.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.555 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.4 t -138.26 -54.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.603 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.59 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.364 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.55 64.22 8.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 1.0 110.064 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.9 tp -164.43 -39.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.272 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.38 17.87 58.1 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.716 0.293 . . . . 1.0 110.654 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 44.16 1.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.65 -11.66 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 1.0 110.567 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 pp -138.15 -10.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.632 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -72.72 -41.15 7.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.2 Cg_endo -87.49 25.14 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.504 2.136 . . . . 1.0 112.219 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.68 -48.58 1.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.464 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.0 OUTLIER -103.75 -51.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.615 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -46.71 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.464 ' H ' ' C ' ' A' ' 34' ' ' ILE . 2.8 mtp -77.44 -55.69 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.564 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -52.03 -13.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.486 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.4 t -103.21 -47.24 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -49.73 -11.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.676 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 38' ' ' VAL . 2.9 mt -133.2 40.16 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.523 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -164.85 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.25 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.2 -1.98 30.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 1.0 110.589 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.831 0.348 . . . . 1.0 110.498 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 35.13 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 -15.08 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.688 0.28 . . . . 1.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.24 -20.56 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -74.87 -34.73 1.81 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.526 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.9 Cg_endo -88.24 26.54 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.282 1.988 . . . . 1.0 112.01 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.54 -3.39 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.657 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.59 -61.16 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.572 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 39' ' ' PHE . 1.9 m-85 -49.1 -29.78 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 mmt -74.8 -23.97 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.662 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 3.8 mm? -85.03 -6.12 59.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.59 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.86 -67.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.656 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 3.6 t80 -40.75 -48.8 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.655 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mt -103.39 60.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.533 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -165.29 -62.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.34 10.16 2.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.904 -0.879 . . . . 1.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 1.0 110.589 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.734 0.302 . . . . 1.0 110.573 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.04 23.72 1.6 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.74 6.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 1.0 110.583 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.42 -28.0 7.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.53 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -81.92 -36.14 0.77 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.361 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.1 Cg_endo -87.35 10.12 3.65 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.274 1.983 . . . . 1.0 112.09 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.1 -2.76 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.595 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.464 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.5 -42.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.75 31.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.554 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.464 ' H ' ' C ' ' A' ' 34' ' ' ILE . 18.4 mmt -136.53 -59.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mt -83.82 17.54 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.63 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.17 -11.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.63 14.12 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.34 38.89 3.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.517 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.69 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.4 23.55 31.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 1.0 110.398 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.778 0.323 . . . . 1.0 110.647 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.31 41.77 0.75 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 -12.34 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 1.0 110.586 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.473 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 1.7 mp -113.03 -31.22 6.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.522 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.607 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -78.9 -36.26 1.15 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.377 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.2 Cg_endo -87.2 25.87 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.299 1.999 . . . . 1.0 112.162 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.96 11.52 3.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.583 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -140.0 -40.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.5 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -73.07 10.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.583 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.46 ' H ' ' C ' ' A' ' 34' ' ' ILE . 7.1 mmt -103.04 -64.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.23 -17.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.632 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.47 ' C ' ' N ' ' A' ' 40' ' ' LEU . 50.7 t -90.04 -57.28 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.09 -15.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.533 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 38' ' ' VAL . 60.5 mt -118.94 41.71 2.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.4 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.37 -44.79 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.2 -10.23 82.77 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 1.0 110.38 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.748 0.309 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.86 36.43 0.23 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.01 -3.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 1.0 110.532 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.41 -19.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.582 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -78.59 -41.17 1.8 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 64.1 Cg_endo -86.91 -16.92 3.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.426 2.084 . . . . 1.0 112.21 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -1.37 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -136.47 -51.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.443 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -53.03 -31.79 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.51 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 32' ' ' PRO . 11.9 mmt -60.61 -59.25 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.553 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mp -46.4 -22.25 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.558 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.7 t -93.38 -50.46 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.552 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.32 -15.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 38' ' ' VAL . 3.1 mt -124.85 37.45 4.4 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.358 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' VAL . 14.7 tp -168.57 -62.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.35 -13.39 43.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 121.132 -0.227 . . . . 1.0 110.773 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.831 0.348 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.96 41.87 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.06 -1.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.704 0.288 . . . . 1.0 110.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.34 -30.3 2.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.617 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -75.44 -34.52 1.61 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.4 Cg_endo -88.0 26.36 0.59 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.265 1.977 . . . . 1.0 112.167 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.48 -2.21 3.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.708 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.9 -33.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.571 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -95.76 25.76 4.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.1 mmt -131.16 -19.77 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.511 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -125.26 19.6 8.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.74 -43.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -54.9 -14.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.666 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.64 17.92 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.595 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 tp -138.55 -41.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.251 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.96 2.28 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 1.0 110.607 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.732 0.301 . . . . 1.0 110.572 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.58 4.47 3.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 -6.01 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.673 0.273 . . . . 1.0 110.556 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.69 -17.58 13.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.582 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.9 -39.95 3.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 66.4 Cg_endo -86.89 -0.81 7.99 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.454 2.102 . . . . 1.0 112.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.29 11.12 38.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.552 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.7 mt -137.72 -36.53 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.93 2.75 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.436 ' C ' ' H ' ' A' ' 38' ' ' VAL . 10.8 mmt -101.7 -54.67 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.621 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.78 16.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 36' ' ' MET . 40.8 t -137.89 -70.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.568 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -46.07 -46.03 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -100.54 50.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -173.54 -64.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.31 -14.02 0.49 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.449 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 1.0 110.607 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.831 0.348 . . . . 1.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.75 37.1 0.14 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.871 . . . . 1.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.64 6.51 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.3 -27.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.608 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -69.99 -41.19 14.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.1 Cg_endo -87.33 22.3 0.94 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.595 2.197 . . . . 1.0 112.226 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.47 -7.89 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.636 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 36' ' ' MET . 45.6 mt -104.59 -45.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.634 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -70.55 9.25 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 34' ' ' ILE . 13.0 mmt -97.27 -62.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.53 -9.08 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 40' ' ' LEU . 92.1 t -98.28 -44.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -78.96 30.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.604 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.7 mt -138.9 6.32 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.41 -40.5 4.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.551 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.73 -3.62 50.41 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.616 0.246 . . . . 1.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.826 0.346 . . . . 1.0 110.586 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.36 31.82 8.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.08 -8.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 1.0 110.55 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.6 mt -111.52 -30.3 7.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.57 -37.89 1.7 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.194 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.1 Cg_endo -88.1 -0.27 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.389 2.059 . . . . 1.0 112.119 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.87 6.91 36.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.653 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.41 -51.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.21 -29.8 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.59 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.431 ' C ' ' N ' ' A' ' 38' ' ' VAL . 23.3 mmt -63.59 -60.38 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.446 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.5 mp -46.92 -17.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.537 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.431 ' N ' ' C ' ' A' ' 36' ' ' MET . 6.5 t -97.81 -52.1 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -42.4 -26.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.504 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -115.83 73.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.09 -57.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 10.58 67.86 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 1.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.712 0.292 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.38 40.35 1.11 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.24 -9.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 1.0 110.544 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.51 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.624 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.4 mm -83.86 -36.02 0.63 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.445 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.0 Cg_endo -88.26 10.75 3.3 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.468 2.112 . . . . 1.0 112.266 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.93 -19.8 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.525 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -105.52 -44.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.627 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' O ' ' SD ' ' A' ' 36' ' ' MET . 30.0 m-85 -74.21 19.77 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.62 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.522 ' H ' ' C ' ' A' ' 34' ' ' ILE . 18.1 mmt -136.49 -50.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.622 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.86 0.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.8 t -137.43 -54.17 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -49.6 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -98.43 56.1 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -175.05 -64.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -17.33 0.88 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.522 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.33 . . . . 1.0 110.518 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.23 32.88 0.16 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.89 -18.01 0.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.717 0.294 . . . . 1.0 110.578 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.442 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 2.6 mp -112.0 -29.69 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.601 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -75.8 -37.81 2.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.19 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.3 Cg_endo -87.6 26.15 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.461 2.108 . . . . 1.0 112.174 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.25 7.82 3.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -145.32 -39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.609 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.493 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.2 m-85 -79.26 26.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.588 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 19.4 mmt -137.34 -67.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.566 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -47.02 -24.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.572 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.61 -51.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.587 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -41.54 -30.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.465 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.93 80.29 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.411 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 43' ' ' THR . 2.0 mt -159.36 -61.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.56 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.44 28.41 1.23 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 1.0 110.539 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.859 0.362 . . . . 1.0 110.332 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 29' ' ' ALA . . . 151.13 -11.1 0.78 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . 82.88 34.56 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.852 0.358 . . . . 1.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -110.74 -26.6 9.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.335 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -77.57 -41.01 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.854 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.5 Cg_endo -86.92 24.78 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.475 2.117 . . . . 1.0 112.168 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.8 5.19 5.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -146.26 -55.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.546 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -60.92 -0.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.9 mmt -96.97 -50.36 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.544 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 9.4 mp -78.82 13.21 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.582 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.4 t -141.31 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.564 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.5 -50.49 16.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mt -99.16 49.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.636 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 43' ' ' THR . 14.9 tp -175.19 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.334 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -49.57 -12.49 0.38 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.788 0.328 . . . . 1.0 110.592 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.58 49.21 0.89 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.19 -16.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 1.0 110.622 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.3 -18.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.54 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -68.68 -39.84 16.04 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.95 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.8 Cg_endo -87.11 25.75 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.126 . . . . 1.0 112.192 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.55 -49.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.496 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 pt -101.09 -32.5 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.602 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.504 ' CE2' ' CD1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -79.04 29.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.455 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.6 mtp -127.31 -61.13 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.558 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.97 16.74 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.24 -31.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.643 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 35' ' ' TYR . 30.4 t80 -77.82 -34.84 51.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.645 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.53 26.61 10.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.45 -61.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.176 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 -4.86 69.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 121.088 -0.245 . . . . 1.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.819 0.343 . . . . 1.0 110.594 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -157.03 34.68 0.56 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.58 -6.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.665 0.269 . . . . 1.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt -113.19 -26.73 8.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.623 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.609 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -85.87 -34.72 0.5 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.597 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.7 Cg_endo -87.68 25.48 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.258 1.972 . . . . 1.0 112.141 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.32 11.17 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.4 OUTLIER -150.75 -48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.498 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -73.19 12.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.501 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' VAL . 14.5 mmt -129.68 -38.12 1.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 10.8 mp -55.41 -6.68 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.618 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.96 -53.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.582 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -21.41 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.588 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mt -136.8 54.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 -46.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.15 34.7 4.9 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 1.0 110.53 179.951 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.772 0.32 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.87 45.84 0.86 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.59 -34.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.739 0.304 . . . . 1.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -106.4 -9.61 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.573 -179.994 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.77 -40.06 3.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.49 25.97 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.498 2.132 . . . . 1.0 112.164 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.8 2.59 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.51 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.43 -61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.594 179.918 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.92 -28.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 36' ' ' MET . 2.9 mmm -75.11 -47.3 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -54.76 -7.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.8 OUTLIER -119.72 -51.54 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.494 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -46.13 -17.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.621 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 38' ' ' VAL . 8.7 mt -136.77 52.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.6 tp -169.8 -59.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.29 40.9 2.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 1.0 110.589 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.839 0.352 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.89 31.62 0.61 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.55 5.9 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 1.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.45 -24.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.568 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -73.84 -41.07 5.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 63.3 Cg_endo -87.03 10.24 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.573 2.182 . . . . 1.0 112.251 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.32 3.63 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.564 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.06 -41.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -67.44 4.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.503 ' C ' ' H ' ' A' ' 38' ' ' VAL . 20.3 mmt -100.92 -72.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mt -52.09 -9.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 36' ' ' MET . 76.4 t -101.03 -36.47 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.578 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -93.03 33.98 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.597 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -136.92 0.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -112.29 -41.33 3.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.525 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.91 -3.61 44.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 1.0 110.482 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.877 0.37 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.93 20.34 0.87 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.78 -5.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 1.0 110.534 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.74 -38.05 5.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.598 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -82.0 -38.04 0.86 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.245 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.7 Cg_endo -87.31 19.4 1.38 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.402 2.068 . . . . 1.0 112.131 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.16 8.28 13.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.48 -44.0 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.567 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.56 3.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.517 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.3 mmt -100.63 -47.63 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.605 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.31 27.86 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -146.58 -18.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -96.23 -2.13 46.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.678 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.84 40.31 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.494 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.87 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.11 20.75 44.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.377 -1.089 . . . . 1.0 110.377 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 1.0 110.344 -179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -149.4 31.89 1.14 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.82 -9.09 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 1.0 110.497 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -130.85 -16.56 3.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.62 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -78.29 -34.79 1.09 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.395 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.2 Cg_endo -87.72 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.319 2.013 . . . . 1.0 112.16 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.35 10.55 2.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' C ' ' H ' ' A' ' 36' ' ' MET . 14.0 mt -142.93 -44.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 7.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.511 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.507 ' H ' ' C ' ' A' ' 34' ' ' ILE . 12.5 mmt -104.68 -55.18 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.561 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.75 18.01 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' C ' ' N ' ' A' ' 40' ' ' LEU . 57.9 t -135.43 -63.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -47.36 -17.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.566 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 38' ' ' VAL . 3.7 mt -135.72 46.4 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.572 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 43' ' ' THR . 14.9 tp -175.17 -62.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.389 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.42 -10.48 2.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 1.0 110.676 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 28' ' ' GLY . 13.6 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.673 0.273 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.55 ' N ' ' OG ' ' A' ' 27' ' ' SER . . . -130.95 -12.97 2.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . 81.19 48.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.941 0.4 . . . . 1.0 110.094 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -129.09 -27.7 2.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.491 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -80.42 -39.05 1.14 Allowed Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.974 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.7 Cg_endo -86.91 25.25 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.362 2.042 . . . . 1.0 112.175 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.5 -0.7 6.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.49 -45.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.592 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.4 27.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.504 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.2 mmt -135.76 -51.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.519 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mt -59.45 -2.48 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.569 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.1 t -140.32 -61.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -64.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.638 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -100.94 63.86 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -163.74 -65.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.29 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.46 -23.62 1.37 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 121.2 -0.2 . . . . 1.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.871 0.367 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.58 37.44 0.19 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.97 -15.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 1.0 110.561 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -136.83 -15.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.642 179.988 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -79.1 -40.29 1.52 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.1 Cg_endo -86.97 25.29 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.461 2.107 . . . . 1.0 112.203 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.07 6.48 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.497 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.463 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -143.96 -42.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 3.3 m-85 -74.94 15.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.528 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.502 ' C ' ' H ' ' A' ' 38' ' ' VAL . 15.1 mmt -132.64 -55.71 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.515 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.98 11.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 36' ' ' MET . 6.3 t -142.25 -56.86 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.584 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.7 -53.75 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.456 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt -105.0 44.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.314 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -162.88 -55.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.371 -179.875 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -73.23 20.22 1.23 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 1.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 29' ' ' ALA . 10.5 t . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.833 0.349 . . . . 1.0 110.602 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.23 13.23 2.06 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -133.04 -8.79 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 1.0 110.418 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.21 -19.78 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.575 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -91.33 -34.54 0.36 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.673 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.58 13.55 2.61 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.203 1.936 . . . . 1.0 112.403 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' C ' ' SD ' ' A' ' 36' ' ' MET . . . -115.44 6.29 14.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.619 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.6 ' N ' ' SD ' ' A' ' 36' ' ' MET . 1.5 pt -140.15 -26.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -71.47 16.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.622 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -127.21 -67.13 0.85 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.708 -179.944 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mt -47.38 -13.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 1.0 110.689 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.7 t -102.84 -57.34 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.02 37.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.792 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.9 mt -139.06 -8.44 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.608 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 43' ' ' THR . 28.4 mt -115.77 -41.14 3.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.453 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.54 24.04 3.29 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 C-N-CA 121.12 -0.232 . . . . 1.0 110.583 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 29' ' ' ALA . 52.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 1.0 110.652 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 19.17 1.53 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -114.23 -1.82 13.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 1.0 110.481 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.68 -25.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -66.74 -41.02 35.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.3 Cg_endo -87.18 16.16 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.549 2.166 . . . . 1.0 112.19 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.79 -36.87 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.549 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 mm -89.36 -31.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.387 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -71.71 13.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 38' ' ' VAL . 28.7 mmm -117.59 -52.61 2.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.434 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.73 12.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.425 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.1 t -134.69 -43.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.469 -179.936 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -63.09 -30.31 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.504 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mt -101.74 52.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.75 -43.94 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.59 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 -16.81 80.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 1.0 110.481 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.8 0.333 . . . . 1.0 110.603 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.51 29.7 2.47 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.54 -7.22 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 1.0 110.493 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -20.18 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -69.57 -39.94 13.04 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 69.5 Cg_endo -87.0 2.48 6.98 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.384 2.056 . . . . 1.0 112.28 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.68 -1.04 57.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.625 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.21 -57.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.69 179.962 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 3.4 m-85 -43.22 -31.59 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.495 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.5 mmt -71.52 -33.62 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.419 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 34' ' ' ILE . 6.6 mt -74.24 -4.26 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.668 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.95 -67.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.692 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' TYR . 9.7 t80 -40.89 -50.05 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.605 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mt -102.56 61.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.488 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -170.47 -61.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.265 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.49 27.49 1.05 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 1.0 110.53 179.991 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.044 0.449 . . . . 1.0 110.164 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 29' ' ' ALA . . . 127.81 10.02 3.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.38 -1.088 . . . . 1.0 110.38 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . 80.31 13.23 0.9 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.026 0.441 . . . . 1.0 109.988 -179.548 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 3.8 mm? -65.74 -27.86 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.23 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.445 ' N ' ' CD1' ' A' ' 31' ' ' ILE . 1.6 mp -75.29 -59.68 1.27 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.242 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.86 -13.55 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.732 1.621 . . . . 1.0 111.949 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.85 -3.67 54.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.745 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.98 -53.81 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.543 -179.974 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -42.55 -30.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 mmt -78.45 -32.77 48.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.667 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.6 mt -68.43 -3.53 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.705 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -59.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.629 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.447 ' C ' ' H ' ' A' ' 41' ' ' LEU . 62.7 t80 -44.99 -64.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.42 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.9 41.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.508 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' PHE . 31.6 tp -153.95 -40.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.526 -179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.3 -13.29 76.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.834 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.0 110.636 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.744 0.307 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.07 21.32 3.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.7 -6.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 1.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mt -102.73 -25.53 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.524 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -93.21 -42.89 0.33 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.266 179.982 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.9 Cg_endo -83.54 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.793 1.662 . . . . 1.0 112.459 -179.13 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.09 -1.31 7.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.322 179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -148.79 -61.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.544 -179.919 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -42.35 -26.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.616 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.404 ' C ' ' N ' ' A' ' 38' ' ' VAL . 1.9 mtp -74.41 -55.85 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.422 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.9 mp -48.61 -19.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' A' ' 36' ' ' MET . 2.2 t -97.76 -49.25 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.56 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -47.31 -43.13 22.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.84 52.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -166.87 -62.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.355 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.78 -15.54 4.8 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.336 . . . . 1.0 110.555 -179.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.79 0.329 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.1 24.85 0.33 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.54 -5.87 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 1.0 110.601 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -108.57 -29.84 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.291 179.96 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -91.63 -37.93 0.37 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.201 -179.941 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.9 Cg_endo -88.41 12.15 2.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.392 2.061 . . . . 1.0 112.203 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.2 -5.11 44.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.612 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -132.74 -46.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.444 179.912 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -54.87 -52.68 62.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.508 179.781 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.2 mmt -41.34 -54.65 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.03 -38.61 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.951 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 40' ' ' LEU . 1.6 t -83.25 -37.51 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.35 179.537 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.34 19.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.692 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 38' ' ' VAL . 11.3 mt -128.48 34.95 4.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pp -174.05 -42.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.729 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.7 14.55 41.34 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 179.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 1.0 110.416 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.807 0.337 . . . . 1.0 110.582 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.64 24.39 1.82 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.94 12.18 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 1.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -153.08 -19.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.58 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -82.65 -41.28 0.9 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.799 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 70.9 Cg_endo -87.33 24.99 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.58 2.187 . . . . 1.0 112.184 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 5.08 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -144.03 -41.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -75.6 26.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.519 ' H ' ' C ' ' A' ' 34' ' ' ILE . 20.7 mmt -135.02 -50.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.588 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.91 8.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.431 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 36' ' ' MET . 4.3 t -137.44 -54.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.548 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.71 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.472 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.24 65.43 9.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.947 0.403 . . . . 1.0 110.11 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -168.59 -47.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.367 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 11.97 56.58 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 1.0 110.702 -179.976 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 29' ' ' ALA . 5.8 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 1.0 110.407 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.64 16.24 1.91 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -135.39 -9.52 2.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.733 0.301 . . . . 1.0 110.519 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.5 mt -112.84 -27.01 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.554 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.59 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -72.89 -37.23 3.89 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.258 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.8 Cg_endo -87.36 23.41 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.384 2.056 . . . . 1.0 112.236 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.61 -21.49 4.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.689 -179.957 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 36' ' ' MET . 33.3 mt -104.46 -43.66 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.483 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -75.48 24.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.561 179.957 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.519 ' H ' ' C ' ' A' ' 34' ' ' ILE . 24.7 mmt -111.85 -40.43 4.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.562 179.989 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.77 -35.64 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.571 -179.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 40' ' ' LEU . 9.6 t -78.39 -54.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.554 -179.84 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -44.8 -18.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 1.5 mt -123.41 39.75 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' VAL . 15.1 tp -166.33 -62.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.313 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.45 -8.88 47.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.328 . . . . 1.0 110.625 -179.96 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.27 11.91 1.81 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.08 -1.208 . . . . 1.0 110.08 179.386 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.35 45.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.104 0.478 . . . . 1.0 109.979 -179.511 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 3.4 mm? -83.3 -42.91 16.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.421 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' ALA . 1.5 mp -68.8 -50.63 22.91 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.568 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.84 29.97 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.593 1.529 . . . . 1.0 112.023 179.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . -136.07 3.67 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.488 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -38.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.564 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 42.3 m-85 -82.09 25.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.506 ' C ' ' H ' ' A' ' 38' ' ' VAL . 16.7 mmt -137.44 -52.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.563 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -68.9 8.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.566 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.3 t -140.3 -52.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.77 -54.71 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.431 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -104.49 45.58 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.423 179.806 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -163.73 -55.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.427 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -71.62 15.91 1.51 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.521 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 1.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 50.79 69.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.9 -68.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.598 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 45.36 58.46 5.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.58 109.49 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.26 -78.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 1.0 110.574 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -139.15 47.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 19.4 t0 -139.04 44.14 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 10.4 m-80 -155.83 109.71 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.593 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.0 t80 44.88 20.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.619 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 9' ' ' ASN . 28.6 m-85 -96.22 70.8 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.01 -78.46 0.31 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -171.47 -85.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 1.0 110.555 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 2.8 t0 74.39 17.65 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.587 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 50.42 98.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.55 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.5 -35.8 17.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.02 17.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.582 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.479 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 1.9 tp10 -45.59 -62.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.607 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER 49.56 21.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.525 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.34 15.65 2.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.567 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -100.98 -28.44 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.623 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -138.67 18.58 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.588 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -125.38 -19.26 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.616 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 p-90 -53.83 -8.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.447 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -135.56 1.17 2.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.59 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 40.24 83.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.711 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -139.51 5.72 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.54 34.65 1.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.87 -20.11 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 1.0 110.547 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.39 -17.66 13.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.489 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.587 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -90.28 -39.69 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.166 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.5 Cg_endo -87.86 25.03 0.67 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.555 2.17 . . . . 1.0 112.291 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.85 6.75 5.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.534 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -139.66 -44.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.543 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.28 8.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.51 ' H ' ' C ' ' A' ' 34' ' ' ILE . 10.4 mmt -101.58 -63.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.58 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.2 15.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 36' ' ' MET . 88.9 t -130.92 -68.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.482 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -41.88 -43.51 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.567 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -103.89 52.83 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.542 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.1 tp -159.55 -62.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.95 9.93 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -163.97 -56.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 1.0 110.573 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p 58.41 3.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.587 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 89.49 7.25 69.56 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.649 HD21 ' N ' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -100.88 -9.47 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 1.0 110.564 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 51' ' ' TRP . . . -92.11 -34.01 7.41 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.18 26.2 7.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 1.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.87 -35.54 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.577 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' THR . 1.2 tp -96.49 -59.3 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.599 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -41.75 -27.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.617 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 15.2 t -56.59 -42.19 78.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.581 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' A' ' 55' ' ' ARG . 21.1 t -47.99 -42.35 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.25 14.62 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 53' ' ' VAL . 2.6 ttp180 -135.38 -34.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.14 -12.42 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -52.18 -31.52 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.544 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.5 79.18 0.08 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -41.75 -34.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 1.0 110.556 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.595 ' CD2' ' H ' ' A' ' 61' ' ' HIS . 2.1 p-80 -67.41 -93.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' H ' ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -154.54 113.09 3.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.622 ' CD2' ' H ' ' A' ' 63' ' ' HIS . 40.1 p-80 -83.67 -127.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.544 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.622 ' H ' ' CD2' ' A' ' 62' ' ' HIS . 13.7 t-80 43.44 42.22 3.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.005 -0.997 . . . . 1.0 110.592 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -84.85 -127.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -144.16 -89.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.26 81.19 1.41 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.27 131.07 10.45 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 10.9 p-10 -173.97 -37.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 1.0 110.575 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 61.57 53.46 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -149.94 54.45 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' C ' ' N ' ' A' ' 11' ' ' TYR . 2.0 m-80 -155.8 116.69 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.547 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.506 ' CD1' ' OD2' ' A' ' 14' ' ' ASP . 6.4 t80 44.78 19.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.571 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' N ' ' C ' ' A' ' 9' ' ' ASN . 20.5 m-85 -98.66 89.57 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.546 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.95 -57.7 0.51 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' C ' ' N ' ' A' ' 15' ' ' ASN . . . 175.38 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 1.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' OD2' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER 47.19 16.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.518 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.449 ' N ' ' C ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -79.24 -17.36 54.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.547 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.69 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -82.33 57.75 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.546 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 p -149.07 -47.12 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 42.93 -155.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.62 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER 73.4 32.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.574 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -50.39 -11.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' CYS . 5.2 m-85 -47.56 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.72 30.1 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.579 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.72 13.07 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -95.7 5.58 51.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.11 16.0 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.547 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.507 ' HG ' ' N ' ' A' ' 27' ' ' SER . 28.6 t -144.56 -99.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.507 ' N ' ' HG ' ' A' ' 26' ' ' SER . 26.0 m -73.23 44.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.522 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -174.92 38.61 0.11 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.1 -4.49 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.334 . . . . 1.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 -18.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.544 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.9 mm -80.77 -35.58 0.84 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.454 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.87 7.83 4.42 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.403 2.068 . . . . 1.0 112.196 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.31 -0.05 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.669 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.61 -35.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -82.46 30.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.613 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.504 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.9 mmt -134.21 -62.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.9 13.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.52 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.2 t -137.43 -28.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.512 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.02 27.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 38' ' ' VAL . 1.2 pp -173.66 13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -131.34 -48.46 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.442 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.61 42.63 1.87 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 45' ' ' GLY . 3.8 t -162.11 -26.97 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.328 . . . . 1.0 110.486 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 t -71.13 40.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.638 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 80.37 28.33 48.77 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -134.89 1.26 3.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 1.0 110.564 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.0 -40.33 2.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.48 21.59 11.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.765 0.317 . . . . 1.0 110.467 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.71 -38.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.545 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.69 -66.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.566 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -50.06 -28.31 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.554 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -66.25 -29.79 70.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.51 -22.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -0.86 36.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -100.67 -40.86 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.63 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.651 ' HZ3' ' NZ ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -62.85 -23.15 67.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.574 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.651 ' NZ ' ' HZ3' ' A' ' 56' ' ' LYS . 8.9 mmtm -61.72 -35.33 77.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.56 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.78 99.84 0.2 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.473 ' C ' ' H ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.4 -24.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 1.0 110.528 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.444 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 1.8 p-80 -75.64 17.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.473 ' H ' ' C ' ' A' ' 59' ' ' HIS . 1.7 m-70 56.23 105.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.564 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -84.34 48.08 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -147.33 93.59 2.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.595 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 35.4 mp0 -137.97 56.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -81.4 -37.04 28.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.551 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -148.51 65.83 0.4 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.91 89.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 4' ' ' GLY . 1.1 t70 73.03 37.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 1.0 110.578 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -147.28 41.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.55 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.0 41.31 3.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.541 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.43 ' CG ' ' H ' ' A' ' 10' ' ' TYR . 53.7 t-20 -138.57 -120.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.608 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -47.27 -19.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.5 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' N ' ' C ' ' A' ' 9' ' ' ASN . 96.4 m-85 -73.88 56.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.67 -65.79 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.08 82.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 1.0 110.514 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.597 ' N ' HE22 ' A' ' 16' ' ' GLN . 1.3 t70 -101.35 30.91 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.556 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 58.68 78.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.491 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.597 HE22 ' N ' ' A' ' 14' ' ' ASP . 10.9 mp0 -87.37 58.22 4.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.633 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 1.8 p 80.11 -19.71 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.388 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.1 tp10 41.36 -164.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.8 OUTLIER 76.7 3.95 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.614 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -98.42 21.12 11.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.624 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.419 ' O ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER -83.76 22.83 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.568 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 2.0 p 62.39 41.49 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.578 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.07 10.35 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.546 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.545 ' NE1' ' NZ ' ' A' ' 25' ' ' LYS . 21.9 p-90 -98.56 4.1 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' NZ ' ' NE1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -151.15 16.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.561 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -55.12 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 m -73.92 55.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.606 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.82 34.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.58 17.51 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 1.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.02 -21.61 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -76.4 -35.88 1.65 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.3 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.8 Cg_endo -88.43 3.66 5.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.429 2.086 . . . . 1.0 112.283 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.58 5.05 36.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.825 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 mt -137.22 -35.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -86.45 22.19 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.572 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.3 mmt -136.06 -61.94 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.55 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 39.3 mt -60.6 -17.98 50.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.585 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -99.24 -51.2 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.611 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -43.5 -46.09 6.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.432 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.76 69.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.468 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.28 -58.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.452 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.61 14.62 50.75 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -159.94 -49.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 1.0 110.554 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 42.98 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.575 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 102.5 -31.75 8.36 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -69.18 -4.62 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 1.0 110.594 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.89 -13.81 60.29 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.45 21.32 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.08 -42.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.522 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.06 -44.81 5.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.413 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.423 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -61.38 -24.54 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.57 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -76.22 -29.55 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.496 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 55' ' ' ARG . 58.0 t -54.28 -62.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -73.01 39.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 53' ' ' VAL . 5.3 ttt180 -148.91 -47.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.544 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -20.77 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.616 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' CB ' ' HE2' ' A' ' 61' ' ' HIS . 7.5 mttt -60.58 -22.05 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.546 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.39 69.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 11.7 m170 41.94 71.02 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 1.0 110.507 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 27.2 p80 40.57 35.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.706 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.504 ' HE2' ' CB ' ' A' ' 57' ' ' LYS . 21.3 m170 54.51 105.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.566 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -146.33 104.67 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.531 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -96.29 87.14 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.445 ' CD2' ' C ' ' A' ' 64' ' ' HIS . 3.2 t-160 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.53 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -100.87 68.73 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -96.82 -5.91 37.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.585 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.45 -138.66 3.68 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.74 108.52 3.55 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -90.7 21.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.805 0.336 . . . . 1.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 5.5 p90 -148.1 56.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.568 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.61 45.61 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.577 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.53 -71.89 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.621 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.481 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 72.2 t80 -146.8 9.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.4 p90 38.8 40.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -165.15 -56.9 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 163.47 -22.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.673 0.273 . . . . 1.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLN . 11.9 t70 66.68 60.28 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.397 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -40.69 91.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.587 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.604 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -78.25 14.74 1.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.545 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.42 ' OG ' ' OE1' ' A' ' 16' ' ' GLN . 30.7 m -138.38 -49.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.595 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -80.13 61.86 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.599 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -99.41 -9.81 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.519 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.0 -0.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.625 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.515 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -49.58 -53.55 23.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.561 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.84 15.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.57 10.48 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.629 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -84.73 4.11 34.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.58 15.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.65 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.62 13.18 2.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.01 29.83 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.515 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.44 34.09 0.83 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.83 -31.89 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 1.0 110.657 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.2 -1.82 21.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.548 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -90.28 -39.65 0.41 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.293 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.19 24.16 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 1.0 112.145 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.22 5.15 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.568 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 36' ' ' MET . 29.1 pt -131.67 -31.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.666 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 16.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.499 ' C ' ' H ' ' A' ' 38' ' ' VAL . 19.4 mmm -117.2 -57.99 2.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.2 mt -72.48 13.52 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.591 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.6 t -137.9 -21.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.54 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.472 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 44.5 t80 -91.49 26.77 2.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mt -138.5 -6.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -126.59 -50.16 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.493 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.98 -7.69 0.83 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.525 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -135.39 -105.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.413 -0.218 . . . . 1.0 110.413 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.525 ' H ' ' CG2' ' A' ' 43' ' ' THR . 4.5 t 33.27 48.87 0.18 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.98 -0.555 . . . . 1.0 111.234 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 104.16 -50.03 0.89 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 43' ' ' THR . 54.2 m-20 -51.93 -10.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 1.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -92.41 -34.86 6.82 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mt -82.09 17.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 1.0 110.476 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -137.21 -34.86 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.03 -59.12 1.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.694 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -62.02 -19.65 63.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.523 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -73.71 -31.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.18 -36.1 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.42 16.58 14.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.523 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -129.43 -40.24 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.371 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -8.85 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -54.48 -33.02 59.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.579 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.71 85.22 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.66 -22.38 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 1.0 110.576 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.479 ' C ' ' H ' ' A' ' 62' ' ' HIS . 0.2 OUTLIER -139.75 -36.39 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.537 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -71.94 42.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.557 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.479 ' H ' ' C ' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -47.4 -86.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.527 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -156.48 117.44 3.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.613 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.545 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.76 30.18 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.406 ' O ' ' OD2' ' A' ' 8' ' ' ASP . 2.7 mt-10 49.28 58.32 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.582 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.81 -71.03 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 42.79 -120.57 2.61 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.851 -0.899 . . . . 1.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.31 13.72 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 1.0 110.567 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -139.02 43.16 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.533 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD2' ' O ' ' A' ' 3' ' ' GLU . 31.4 t0 -147.14 55.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.605 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.2 -30.65 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.543 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 8.2 t80 -83.81 -11.91 56.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.571 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -63.43 77.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.564 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' TYR . . . 153.66 -76.12 0.22 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -161.68 -37.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 1.0 110.634 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 4.6 t0 75.18 14.19 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 48.71 90.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.561 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.704 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -66.49 -19.57 65.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.616 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.92 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' A' ' 20' ' ' GLU . 5.1 pt-20 -69.99 -167.73 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.619 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 54.49 8.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 18' ' ' GLU . 3.6 tt0 -95.8 60.52 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -138.58 12.89 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.589 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 76.56 37.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.522 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.85 17.46 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -101.13 6.34 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.54 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.68 16.18 1.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.593 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 27' ' ' SER . 1.1 p -137.97 -53.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.541 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -101.05 14.05 33.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.545 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.43 40.04 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.36 -15.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 1.0 110.542 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.77 -17.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.498 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.621 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 4.0 mm -80.24 -35.62 0.91 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.459 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.4 Cg_endo -87.9 24.29 0.72 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.393 2.062 . . . . 1.0 112.282 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.07 1.69 6.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.521 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -36.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.516 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.81 2.85 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.576 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.43 ' C ' ' H ' ' A' ' 38' ' ' VAL . 10.6 mmt -101.61 -56.23 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.551 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.77 13.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.537 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.43 ' H ' ' C ' ' A' ' 36' ' ' MET . 17.4 t -137.15 -74.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.502 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -42.69 -40.38 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -102.19 43.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.597 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -163.5 -67.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.382 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.02 -15.19 0.34 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.527 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -138.3 -95.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.119 -0.232 . . . . 1.0 110.537 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.527 ' H ' ' CG2' ' A' ' 43' ' ' THR . 4.7 t 33.59 48.73 0.21 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.226 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 104.7 -46.89 1.12 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.921 -0.871 . . . . 1.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' THR . 1.5 m-20 -74.88 23.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 1.0 110.559 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -138.11 -33.27 0.2 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -99.49 33.32 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 1.0 110.615 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -126.7 -60.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.724 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.88 -36.6 6.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.572 ' CZ2' ' CE1' ' A' ' 54' ' ' PHE . 76.2 t-105 -78.61 11.85 2.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.454 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -96.76 -26.46 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.534 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.88 -62.01 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.558 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.572 ' CE1' ' CZ2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -53.6 -26.67 22.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.584 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -86.28 -38.14 17.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.564 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -48.43 -22.0 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.573 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -68.02 -31.78 71.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.566 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . 138.01 115.21 1.33 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.545 ' HE2' ' CE1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -57.41 -7.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 1.0 110.605 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.545 ' CE1' ' HE2' ' A' ' 59' ' ' HIS . 41.5 m-70 -89.49 -0.96 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 47.85 88.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -102.21 91.34 4.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -159.29 79.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.558 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.094 -0.955 . . . . 1.0 110.543 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -51.19 -69.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.643 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -164.71 23.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.552 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.99 116.34 0.7 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.08 77.15 2.06 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.05 14.69 28.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.807 0.337 . . . . 1.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -153.76 48.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.602 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -149.54 44.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.636 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 11' ' ' TYR . 19.8 t-20 -154.47 115.78 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.57 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 t80 44.29 20.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.576 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' ASN . 2.2 m-85 -144.31 111.64 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.555 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.7 -42.47 1.98 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.7 30.75 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 1.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -137.64 4.07 2.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.546 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.568 ' N ' ' NE2' ' A' ' 16' ' ' GLN . 5.9 p30 -149.86 56.32 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.519 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.568 ' NE2' ' N ' ' A' ' 15' ' ' ASN . 2.7 mp0 -70.05 -49.65 49.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.588 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 m -157.01 20.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.599 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 20' ' ' GLU . 4.7 mt-10 -152.16 -178.44 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.578 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER 62.87 -0.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.587 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 18' ' ' GLU . 2.5 tt0 -83.24 43.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.549 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -149.42 95.3 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.568 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.501 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 72.1 p 47.84 31.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -124.66 -19.82 5.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.594 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -53.71 -8.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.445 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -135.97 1.82 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.652 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.2 p 40.07 66.61 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.768 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 p -146.8 21.82 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.611 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.42 33.98 0.77 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.73 -11.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 1.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -1.41 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.591 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.73 -38.88 1.82 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.48 4.6 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.37 2.047 . . . . 1.0 112.202 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.97 3.95 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.549 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 36' ' ' MET . 2.3 mt -140.13 -41.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.446 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.6 m-85 -75.99 26.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.579 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.493 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.8 mmt -136.92 -51.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.54 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.22 16.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.549 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' A' ' 36' ' ' MET . 22.0 t -137.01 -56.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -42.2 -53.36 4.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mt -95.41 60.07 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.573 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -171.11 -62.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.367 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.52 -6.37 1.05 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -143.47 -91.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 1.0 110.594 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.474 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.0 OUTLIER 54.11 7.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.565 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 85.38 27.13 33.92 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 3.22 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 1.0 110.581 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.63 -23.05 8.1 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -115.35 14.56 16.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.777 0.322 . . . . 1.0 110.56 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -132.1 -34.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.609 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -101.9 -67.64 0.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.574 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' O ' ' CD2' ' A' ' 51' ' ' TRP . 5.6 t-105 -51.03 -33.43 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.64 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -60.31 -20.55 59.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.522 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 96.2 t -60.13 -29.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.548 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.45 14.46 31.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.403 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.29 -54.44 3.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.63 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -62.74 -34.41 77.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.62 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -76.23 -21.74 56.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.72 92.18 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -19.4 62.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.0 110.626 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -74.03 -116.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.568 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.586 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 6.1 p-80 179.31 83.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 62' ' ' HIS . 79.0 t60 -96.7 10.75 37.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.542 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' HIS . 21.6 t-80 45.92 97.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.618 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.541 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.46 101.53 13.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.515 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -44.02 -56.94 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.565 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.15 -120.71 4.68 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.71 -157.8 7.36 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.33 -43.58 7.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 1.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 t80 56.73 46.5 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.634 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -148.22 56.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' TYR . 46.4 t30 -151.36 70.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.609 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER 41.08 21.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.736 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.2 OUTLIER 43.58 40.46 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.573 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.4 31.43 0.62 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.3 -81.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 1.0 110.583 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.7 t0 70.07 33.37 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.614 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -139.41 55.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.56 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.407 ' CD ' ' H ' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -82.66 -21.09 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.591 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -163.14 50.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.531 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -101.32 -56.55 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.588 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -101.68 -9.75 20.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.565 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -83.28 17.04 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.573 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.455 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -82.1 2.05 33.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.583 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 77.27 41.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.591 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 19.17 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.557 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -97.93 -8.09 28.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.591 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 10.79 40.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.566 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 28' ' ' GLY . 8.0 m -161.7 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 57.9 7.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.549 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -150.92 38.94 0.84 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.66 -29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 1.0 110.528 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -107.76 -12.64 15.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.587 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.98 -36.06 3.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.315 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.14 25.8 0.65 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.307 2.005 . . . . 1.0 112.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.74 2.12 4.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.558 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -142.83 -44.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.635 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.8 m-85 -79.75 26.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.582 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.4 mmt -137.43 -58.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.02 8.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 36' ' ' MET . 17.2 t -137.62 -53.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -53.1 -39.68 63.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 mt -101.48 42.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.496 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -159.21 -65.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.8 -13.85 0.34 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.516 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -139.43 -100.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.527 0.203 . . . . 1.0 110.493 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.516 ' H ' ' CG2' ' A' ' 43' ' ' THR . 4.7 t 33.43 47.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.202 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 101.96 -47.32 1.17 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' THR . 1.2 m-20 -60.19 -5.56 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 1.0 110.498 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -103.64 -61.63 0.69 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.55 44.19 0.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 1.0 110.548 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 25.2 t -138.34 -48.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.584 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 pp -101.68 -26.05 13.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.591 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.32 -18.54 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.606 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -70.73 -28.87 65.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.553 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t -61.51 -47.89 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -8.29 34.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.568 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -100.82 -47.03 4.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.574 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -47.71 -19.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -53.57 -22.8 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.575 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 142.26 53.6 0.04 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.931 -0.868 . . . . 1.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 14.7 m170 47.6 67.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 1.0 110.536 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 20.9 p80 40.96 25.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.658 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 63' ' ' HIS . 1.5 t-160 -148.28 104.41 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.635 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 8.2 m80 -75.14 33.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.529 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 30.6 p80 40.68 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.721 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.558 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtp . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.19 147.12 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.585 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -99.81 23.19 10.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.8 -60.02 0.65 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.5 -167.51 29.15 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.3 -33.43 10.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.815 0.34 . . . . 1.0 110.579 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -141.89 45.2 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.514 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 4.4 p-10 -122.24 41.18 3.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.598 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 8' ' ' ASP . 13.9 m120 -138.06 -82.44 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.581 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -72.99 14.67 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.624 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 9' ' ' ASN . 39.6 m-85 -147.48 86.33 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.67 -47.62 0.62 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 176.46 77.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 1.0 110.564 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.75 -62.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.616 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.588 ' H ' HE21 ' A' ' 16' ' ' GLN . 0.2 OUTLIER -179.23 69.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.576 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.588 HE21 ' H ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -89.05 12.89 14.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.614 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.8 OUTLIER 82.7 50.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.247 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 3.8 tt0 -130.72 58.89 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.479 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 71.29 -5.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.475 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLU . 2.0 mm-40 -84.69 50.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.513 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -155.43 54.85 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.48 ' C ' ' HZ1' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 69.61 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.555 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -159.44 20.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.589 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -101.47 -18.29 16.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.586 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HZ1' ' C ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -100.83 16.12 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.577 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 28' ' ' GLY . 34.0 t -165.21 -80.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.567 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 27' ' ' SER . 17.3 t -73.13 38.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.579 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -144.75 24.85 1.96 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.37 -0.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 1.0 110.483 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.78 -17.38 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.06 -36.7 4.33 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.235 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.3 Cg_endo -87.47 25.64 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.316 2.011 . . . . 1.0 112.169 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.56 -49.7 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.598 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 pt -99.25 -31.87 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.658 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.67 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.551 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 38' ' ' VAL . 3.2 mtp -136.44 -54.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.52 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.89 2.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 36' ' ' MET . 2.8 t -137.38 -23.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.471 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 41.9 t80 -88.97 37.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.537 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 44' ' ' THR . 2.3 mt -136.59 -9.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.54 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.2 mt -112.15 -41.96 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.07 39.5 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.51 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -137.93 -100.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.558 0.218 . . . . 1.0 110.486 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.51 ' H ' ' CG2' ' A' ' 43' ' ' THR . 4.9 t 33.72 37.92 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.211 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 141.63 -62.77 0.52 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 43' ' ' THR . 8.0 p-10 -75.84 10.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 1.0 110.527 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -102.26 3.98 51.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.83 7.01 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 1.0 110.554 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.9 t -95.72 -54.87 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.543 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -23.44 14.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.576 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.502 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 2.5 t-105 -77.25 -13.94 59.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.589 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.7 -20.41 64.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 t -79.71 -29.79 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.586 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -1.45 58.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -101.21 -49.11 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.551 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -51.22 -18.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -54.22 -38.07 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.554 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 170.67 63.52 0.04 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.1 m170 56.92 -79.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.798 0.332 . . . . 1.0 110.713 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 m-70 -98.79 -75.45 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.507 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -161.64 100.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.527 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -145.17 112.04 5.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.553 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.78 72.37 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.53 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.7 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 68.24 1.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.604 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.76 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.07 134.21 1.64 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.02 77.58 0.1 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 3.9 m-20 -139.74 31.41 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 1.0 110.549 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 6' ' ' ASP . 48.7 m-85 -161.96 57.03 0.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -138.64 41.71 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.539 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.42 ' O ' ' CE2' ' A' ' 11' ' ' TYR . 71.3 m-80 -102.4 -73.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.522 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.452 ' C ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 m-85 -93.63 0.98 56.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.479 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.452 ' CD2' ' C ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER 48.13 41.0 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.611 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.07 31.15 0.46 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.07 75.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 1.0 110.613 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.35 -40.46 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.538 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -78.33 104.08 8.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' O ' ' CB ' ' A' ' 17' ' ' SER . 6.5 mt-30 -93.58 50.23 1.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.561 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 79.51 19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.464 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -50.15 157.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.504 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.5 t 76.94 -15.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.565 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 18' ' ' GLU . 9.6 tt0 41.67 22.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 27.8 m-85 55.31 64.44 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 6.5 p 53.38 40.79 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.647 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.32 2.52 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.338 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -81.86 5.28 19.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -133.12 0.34 3.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 t -99.57 -48.36 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -86.33 29.53 0.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.59 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.0 14.65 3.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.879 -0.889 . . . . 1.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.29 3.43 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.277 . . . . 1.0 110.613 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.75 -30.68 6.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.675 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -77.96 -35.98 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.369 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 76.1 Cg_endo -88.74 26.09 0.59 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.413 2.076 . . . . 1.0 112.217 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.44 13.75 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.481 ' C ' ' H ' ' A' ' 36' ' ' MET . 10.1 mt -145.51 -46.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.12 4.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.588 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.498 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.3 mmt -97.83 -60.38 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.569 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -56.39 -5.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.52 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 36' ' ' MET . 55.8 t -101.82 -56.06 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.451 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -41.83 -41.11 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.63 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mt -103.18 48.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.646 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 43' ' ' THR . 16.7 tp -166.64 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.75 13.85 2.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 45' ' ' GLY . 8.9 t -171.19 -48.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 1.0 110.7 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.498 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER 50.68 10.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.497 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 91.76 -10.59 74.24 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.498 ' ND2' ' OG1' ' A' ' 44' ' ' THR . 78.5 m-20 -76.66 -11.28 59.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 1.0 110.514 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.18 -15.36 60.85 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -118.93 19.47 13.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 1.0 110.483 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.55 -57.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.809 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.26 -35.93 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.81 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -76.59 -42.24 43.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.519 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -45.85 -21.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.485 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' A' ' 51' ' ' TRP . 53.9 t -72.26 -50.47 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.588 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -67.59 -12.42 60.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -101.69 -35.33 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.599 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -50.76 -41.16 56.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.594 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -58.06 -17.99 21.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.55 76.6 0.21 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.0 110.609 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -150.57 -54.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.568 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' N ' ' CD2' ' A' ' 60' ' ' HIS . 1.5 t-80 -171.24 104.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.6 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.464 ' CE1' ' HE2' ' A' ' 64' ' ' HIS . 1.6 t-160 -67.68 -47.92 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.563 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 42.22 61.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.517 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.464 ' HE2' ' CE1' ' A' ' 62' ' ' HIS . 2.1 m-70 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.586 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mmm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.56 116.35 17.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.588 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -95.69 19.12 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.39 -77.31 0.33 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 7' ' ' PHE . . . 159.16 -97.62 0.16 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.68 -17.11 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 1.0 110.507 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 5' ' ' GLY . 4.3 m-85 62.72 42.25 8.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.566 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -153.81 58.4 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.595 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.37 -16.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -146.18 -9.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.42 76.37 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.82 -79.58 0.3 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 174.66 71.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 1.0 110.595 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.511 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 3.4 t70 -72.7 -52.18 16.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.527 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 17' ' ' SER . 2.2 p30 -172.08 54.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.549 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -67.41 6.75 0.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.588 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 80.62 45.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.488 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 2.4 tt0 -69.89 -165.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 23.1 m 56.82 43.26 25.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.561 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 22' ' ' THR . 2.2 mm-40 -85.66 10.44 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.523 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER 60.93 1.12 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.572 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.494 ' H ' ' C ' ' A' ' 20' ' ' GLU . 63.9 p -150.89 14.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.51 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 25' ' ' LYS . 48.1 t0 -134.15 -39.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -47.6 -15.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.371 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -133.95 0.67 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.38 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m 38.32 61.59 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.935 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.88 34.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.53 24.44 0.58 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.22 -13.11 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.72 0.295 . . . . 1.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -127.51 -1.96 6.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.459 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.4 OUTLIER -90.45 -39.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.215 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.2 Cg_endo -87.14 7.94 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.444 2.096 . . . . 1.0 112.159 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.39 4.31 41.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.86 -39.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.28 30.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.576 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.5 mmt -133.96 -58.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.543 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.85 20.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.547 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -139.3 -48.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -49.26 -45.66 45.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.5 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -102.55 62.92 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -137.29 -63.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.533 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.82 -8.34 0.58 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.546 ' CG2' ' H ' ' A' ' 44' ' ' THR . 1.3 t -135.97 -108.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.56 0.219 . . . . 1.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.546 ' H ' ' CG2' ' A' ' 43' ' ' THR . 4.8 t 33.7 40.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.22 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' C ' HD21 ' A' ' 46' ' ' ASN . . . 105.61 27.03 5.91 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.462 HD21 ' C ' ' A' ' 45' ' ' GLY . 1.8 m-80 -133.88 -32.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 1.0 110.631 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.35 -3.28 69.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.58 34.96 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 1.0 110.492 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.17 -53.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.602 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.98 -25.8 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.609 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.421 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -73.74 -25.73 60.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.519 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.4 t -67.65 -37.73 82.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.481 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.4 t -47.73 -61.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.596 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -72.77 54.65 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -163.21 -48.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -15.97 55.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -62.6 -35.04 78.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.548 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 155.56 58.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 56.01 -80.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 1.0 110.643 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 58' ' ' GLY . 7.5 m170 -99.83 -74.62 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -157.41 106.54 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.551 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -64.26 -18.81 64.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.563 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.507 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 2.0 t-80 -134.45 -147.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.133 0.492 . . . . 1.0 110.404 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.507 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 17.5 m-70 . . . . . 0 C--N 1.322 -0.609 0 CA-C-O 118.056 -0.973 . . . . 1.0 110.572 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' C ' ' H ' ' A' ' 3' ' ' GLU . 7.4 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.86 40.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.61 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 1' ' ' MET . 2.7 pt-20 -82.07 -14.61 55.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.543 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.72 -108.53 0.25 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.29 -79.53 0.07 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 7' ' ' PHE . 1.4 p-10 -101.31 -77.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.882 0.373 . . . . 1.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 57.8 m-85 54.53 42.84 31.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.625 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 t0 54.38 48.18 21.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.526 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.443 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 48.22 13.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.631 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.503 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -137.77 95.97 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.8 -53.43 0.72 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . -101.3 19.92 16.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 1.0 110.595 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -1.4 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.553 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 3.6 p-10 -144.97 70.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.56 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -84.58 -41.5 16.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.567 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 p -91.47 12.82 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.539 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -138.17 94.6 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.594 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.496 ' C ' ' H ' ' A' ' 21' ' ' TYR . 2.0 p -138.97 7.8 2.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -72.0 13.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.576 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.496 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -75.53 23.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.528 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER 76.37 36.37 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.579 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.59 19.42 2.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.584 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -99.26 7.58 45.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HZ1' ' C ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -139.27 13.01 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.579 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 28' ' ' GLY . 64.9 m -137.7 -89.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 p -76.19 26.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.57 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -137.67 28.67 2.73 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.51 -15.08 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 1.0 110.469 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -136.34 -9.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.636 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -78.39 -40.11 1.76 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.938 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.6 Cg_endo -86.94 25.07 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.444 2.096 . . . . 1.0 112.2 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.12 6.26 4.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.496 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -144.79 -40.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.512 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' ' SD ' ' A' ' 36' ' ' MET . 51.0 m-85 -76.6 26.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.492 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.496 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.0 mmt -136.66 -50.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.28 7.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.555 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.4 t -138.26 -54.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.603 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.59 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.364 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.55 64.22 8.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 1.0 110.064 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.9 tp -164.43 -39.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.272 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.38 17.87 58.1 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 46' ' ' ASN . 8.9 t -173.04 -52.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.716 0.293 . . . . 1.0 110.654 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.466 ' N ' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER 42.64 21.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.522 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 103.83 -32.73 7.23 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -66.23 -6.62 14.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 1.0 110.544 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.52 -14.6 59.71 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.81 45.93 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.585 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 51' ' ' TRP . 38.9 t -134.04 -64.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.403 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -56.91 -5.04 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.62 ' CH2' ' NE ' ' A' ' 55' ' ' ARG . 2.6 m95 -64.83 1.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.519 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.472 ' H ' ' C ' ' A' ' 50' ' ' LEU . 13.1 t -121.39 24.64 9.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.463 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.6 t -152.95 -44.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.92 13.96 31.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.647 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' NE ' ' CH2' ' A' ' 51' ' ' TRP . 4.8 tpt180 -134.73 -35.02 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.477 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -23.48 66.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 12.92 36.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.561 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.0 -56.96 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.474 ' C ' ' CD2' ' A' ' 60' ' ' HIS . 23.2 m170 54.24 36.1 24.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.66 0.267 . . . . 1.0 110.541 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' O ' ' ND1' ' A' ' 60' ' ' HIS . 20.6 p80 38.46 94.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.0 m170 45.23 74.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -60.81 -64.53 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.528 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -146.81 93.63 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.575 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' OXT' ' CG ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.583 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -63.75 137.28 58.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.599 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -89.39 -44.18 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.74 -83.01 0.56 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.439 ' C ' ' N ' ' A' ' 7' ' ' PHE . . . -171.88 -46.14 0.04 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 47.89 16.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 1.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' N ' ' C ' ' A' ' 5' ' ' GLY . 13.6 t80 -152.36 44.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.571 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.39 41.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.507 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -101.36 -89.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.482 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 1.1 t80 -88.43 1.4 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.482 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.5 p90 38.72 40.4 0.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.83 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.9 -65.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 170.85 -37.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 1.0 110.555 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 t0 74.3 24.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.51 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 17' ' ' SER . 27.2 m120 -142.68 18.06 2.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.565 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.63 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -72.43 13.47 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.534 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -100.92 -50.17 3.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.615 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 41.82 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.57 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' TYR . 6.3 t -168.18 60.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.58 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 21' ' ' TYR . 3.6 tp10 -72.06 43.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.477 ' H ' ' C ' ' A' ' 19' ' ' CYS . 31.2 m-85 54.63 108.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.515 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.3 -2.5 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.597 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 35.1 t0 -105.74 27.72 8.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -101.25 -4.52 26.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.91 10.91 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.541 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -98.14 -62.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.536 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.37 19.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.538 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -138.03 44.16 1.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.65 -11.66 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 1.0 110.567 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 pp -138.15 -10.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.632 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -72.72 -41.15 7.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.2 Cg_endo -87.49 25.14 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.504 2.136 . . . . 1.0 112.219 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.68 -48.58 1.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.464 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.0 OUTLIER -103.75 -51.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.615 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -46.71 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.464 ' H ' ' C ' ' A' ' 34' ' ' ILE . 2.8 mtp -77.44 -55.69 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.564 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -52.03 -13.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.486 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.4 t -103.21 -47.24 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -49.73 -11.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.676 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 38' ' ' VAL . 2.9 mt -133.2 40.16 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.523 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -164.85 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.25 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.2 -1.98 30.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -144.62 -59.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 1.0 110.589 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p 57.19 4.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.605 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 93.32 13.81 55.13 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.473 ' C ' ' ND2' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -103.92 -18.72 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.402 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.84 -16.01 22.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.926 -0.869 . . . . 1.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -96.89 20.22 11.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.737 0.303 . . . . 1.0 110.458 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 2.3 t -103.46 -64.13 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.752 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -112.61 -36.69 5.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.704 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.527 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 21.7 t-105 -67.14 -9.15 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.421 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -61.62 -30.67 70.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.568 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 55' ' ' ARG . 6.0 t -72.03 -45.88 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.556 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.39 13.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 53' ' ' VAL . 40.3 ttt-85 -137.56 -35.15 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.712 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -52.13 -12.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.607 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.8 mmtp -69.3 -15.71 63.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . 161.06 105.49 0.2 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.4 ' ND1' ' O ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -58.52 -4.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 1.0 110.571 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.497 ' H ' ' C ' ' A' ' 58' ' ' GLY . 42.3 m-70 -81.07 -92.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.561 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 98.9 m-70 -155.45 73.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -70.69 61.96 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.585 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -97.48 42.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.598 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 m170 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.06 -0.971 . . . . 1.0 110.609 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 54.44 93.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.587 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.14 14.25 32.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.558 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.02 -131.94 0.39 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.25 92.52 0.12 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -145.89 -57.29 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 1.0 110.488 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER 63.91 44.68 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.547 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -121.84 41.29 3.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -137.9 -74.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.557 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.472 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 24.1 m-85 -98.42 -18.48 18.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.532 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.4 p90 38.7 40.74 0.43 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.859 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.7 -53.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.491 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . -98.35 34.96 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 16' ' ' GLN . 0.5 OUTLIER -101.44 21.69 13.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.592 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.42 46.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.656 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 13' ' ' ALA . 2.1 mt-30 -131.54 34.73 3.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' GLU . 21.7 m -137.91 -43.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.535 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.479 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER 45.28 96.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.648 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 95.2 m -155.73 20.09 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.507 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -98.87 38.18 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.59 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.74 -64.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.55 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -158.82 34.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.11 17.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.565 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 24' ' ' TRP . 20.5 p-90 -99.5 -20.97 16.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.595 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.81 14.89 30.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.512 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.622 ' HG ' ' N ' ' A' ' 27' ' ' SER . 0.6 OUTLIER -147.93 -74.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.572 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.622 ' N ' ' HG ' ' A' ' 26' ' ' SER . 40.0 t -75.56 27.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.498 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -137.79 35.13 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 -15.08 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.688 0.28 . . . . 1.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.24 -20.56 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -74.87 -34.73 1.81 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.526 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.9 Cg_endo -88.24 26.54 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.282 1.988 . . . . 1.0 112.01 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.54 -3.39 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.657 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.59 -61.16 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.572 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 39' ' ' PHE . 1.9 m-85 -49.1 -29.78 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 mmt -74.8 -23.97 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.662 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 3.8 mm? -85.03 -6.12 59.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.59 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.86 -67.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.656 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 3.6 t80 -40.75 -48.8 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.655 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mt -103.39 60.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.533 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -165.29 -62.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.34 10.16 2.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.904 -0.879 . . . . 1.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -162.66 -64.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 1.0 110.589 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 43' ' ' THR . 1.8 p 63.84 -2.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.52 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 82.04 27.67 44.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -134.53 0.77 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 1.0 110.582 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.11 -40.56 2.25 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -99.29 21.35 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 1.0 110.446 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.56 -42.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.591 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 53' ' ' VAL . 38.7 tp -97.56 -68.74 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.453 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -46.0 -26.37 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.572 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -68.52 -35.31 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 50' ' ' LEU . 64.7 t -52.04 -69.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.574 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -72.0 59.56 0.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.01 -66.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.643 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HZ2' ' NZ ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -61.05 -14.6 24.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.639 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.491 ' NZ ' ' HZ2' ' A' ' 56' ' ' LYS . 10.6 mmtm -51.6 -38.61 55.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.566 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 154.78 31.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.511 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 9.7 m80 62.58 -71.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 1.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 58' ' ' GLY . 29.5 m170 -69.65 1.46 4.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 31.6 m170 50.21 90.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.566 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -154.09 55.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -99.65 89.61 4.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.502 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.4 t60 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.524 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ttm . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.44 -5.82 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.577 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 59.46 17.55 6.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.534 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.84 126.56 1.01 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.73 91.45 0.08 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -148.31 12.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 1.0 110.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 18.4 p90 -160.52 62.56 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.504 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -156.87 60.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.571 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.575 ' ND2' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -101.94 -108.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.412 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 46.0 m-85 -65.6 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.474 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER 59.22 41.76 19.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.606 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 166.31 -62.58 0.22 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 165.58 -63.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 1.0 110.612 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.82 51.05 6.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.569 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.08 -1.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.614 ' NE2' ' N ' ' A' ' 17' ' ' SER . 1.2 pm0 -49.22 -21.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.614 ' N ' ' NE2' ' A' ' 16' ' ' GLN . 1.9 m -167.68 64.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.586 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 21' ' ' TYR . 67.5 m 55.83 14.92 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -64.05 2.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.508 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -75.17 31.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.515 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 20' ' ' GLU . 2.5 p 61.64 44.56 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.573 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 7.8 p-10 -137.77 5.14 2.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.54 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -92.36 4.32 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.529 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 16.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.567 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 28' ' ' GLY . 6.9 t -138.68 -93.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.2 m -76.11 30.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -147.04 23.72 1.6 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.74 6.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 1.0 110.583 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.42 -28.0 7.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.53 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -81.92 -36.14 0.77 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.361 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.1 Cg_endo -87.35 10.12 3.65 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.274 1.983 . . . . 1.0 112.09 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.1 -2.76 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.595 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.464 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.5 -42.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.75 31.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.554 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.464 ' H ' ' C ' ' A' ' 34' ' ' ILE . 18.4 mmt -136.53 -59.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mt -83.82 17.54 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.63 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.17 -11.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.63 14.12 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.34 38.89 3.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.517 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.69 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.4 23.55 31.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -169.12 -84.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 1.0 110.398 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.52 ' HG1' ' ND2' ' A' ' 46' ' ' ASN . 0.6 OUTLIER 49.79 10.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.663 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 74.55 27.11 66.02 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.52 ' ND2' ' HG1' ' A' ' 44' ' ' THR . 57.5 p30 -138.76 4.98 2.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 1.0 110.551 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.6 -38.61 2.2 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -103.5 19.7 19.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 1.0 110.606 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.71 -64.34 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.697 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -110.64 -35.94 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 43.2 t-105 -68.66 -7.95 37.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.499 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -63.53 -36.78 84.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' ARG . 12.4 t -61.16 -71.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.559 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -42.58 -21.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.604 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.1 tpt180 -82.67 -53.47 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.573 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -63.03 -36.03 82.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.639 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -50.81 -37.14 40.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.535 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . -165.5 86.52 0.1 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.4 -10.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 1.0 110.612 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -98.0 -75.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.614 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -171.45 118.13 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.62 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -100.76 -65.85 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -135.75 -147.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.137 0.494 . . . . 1.0 110.452 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.566 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' C ' ' H ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 4' ' ' GLY . 5.6 tp10 65.0 -0.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' A' ' 1' ' ' MET . 20.3 mp0 54.03 12.28 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.587 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 2' ' ' GLU . . . 45.06 88.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.54 17.88 49.22 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -33.14 10.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 1.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.432 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 36.1 t80 -125.67 42.85 3.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.423 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.69 46.25 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.575 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' A' ' 11' ' ' TYR . 25.2 m120 -149.12 -57.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.62 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -73.56 14.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.642 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 9' ' ' ASN . 77.9 m-85 -137.84 94.41 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.84 30.97 37.15 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 9' ' ' ASN . . . -174.49 73.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 1.0 110.575 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 12.5 p-10 -163.75 59.9 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.583 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 2.0 m-20 52.29 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.582 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.74 44.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.623 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 t -96.84 -1.67 45.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.01 94.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.626 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 p -141.77 15.69 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.595 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.29 56.94 3.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.595 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.19 -37.22 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.578 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -139.12 12.03 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.567 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -138.23 26.37 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -100.22 -12.76 19.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.501 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.83 11.23 39.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.564 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 28' ' ' GLY . 30.9 t -142.36 -86.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.568 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.66 18.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -151.31 41.77 0.75 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 -12.34 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 1.0 110.586 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.473 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 1.7 mp -113.03 -31.22 6.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.522 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.607 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -78.9 -36.26 1.15 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.377 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.2 Cg_endo -87.2 25.87 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.299 1.999 . . . . 1.0 112.162 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.96 11.52 3.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.583 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -140.0 -40.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.5 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -73.07 10.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.583 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.46 ' H ' ' C ' ' A' ' 34' ' ' ILE . 7.1 mmt -103.04 -64.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.23 -17.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.632 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' C ' ' N ' ' A' ' 40' ' ' LEU . 50.7 t -90.04 -57.28 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.09 -15.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.533 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 38' ' ' VAL . 60.5 mt -118.94 41.71 2.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.4 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.37 -44.79 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.2 -10.23 82.77 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -133.94 -52.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 1.0 110.38 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 40.26 22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.804 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 98.81 31.24 6.4 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' THR . 44.9 m-80 -136.36 -34.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 1.0 110.507 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.75 -2.19 90.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.12 -26.48 16.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.578 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.508 ' C ' ' H ' ' A' ' 51' ' ' TRP . 4.5 t -74.63 -58.57 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.675 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.71 9.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.643 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.508 ' H ' ' C ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -85.86 -8.54 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -103.6 22.37 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.572 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.27 -55.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.538 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.02 47.03 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.547 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -145.9 -59.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.721 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.5 -48.74 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.614 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -62.15 -26.11 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.338 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 61' ' ' HIS . . . 135.66 107.25 0.88 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.618 ' NE2' ' CD2' ' A' ' 60' ' ' HIS . 3.5 p80 -41.2 -27.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 1.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.618 ' CD2' ' NE2' ' A' ' 59' ' ' HIS . 3.6 m-70 -81.25 -44.04 18.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.53 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' HIS . 5.7 t-80 78.22 41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.668 ' CG ' ' H ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -66.21 -112.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.488 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.668 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 6.6 m80 -113.02 -146.61 0.41 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.14 0.495 . . . . 1.0 110.462 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.491 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.14 111.42 5.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -42.53 -41.93 3.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.556 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.59 -83.91 0.24 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.98 -57.33 0.17 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 69.27 14.82 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.313 . . . . 1.0 110.52 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 t80 64.74 43.07 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.593 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.24 56.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 11' ' ' TYR . 3.0 t30 -158.7 120.34 3.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.58 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.4 t80 45.36 17.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.609 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.473 ' N ' ' C ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -103.57 92.06 4.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.471 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 101.65 -68.63 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.931 -0.868 . . . . 1.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 164.38 85.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.313 . . . . 1.0 110.551 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -99.83 -57.92 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.594 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -175.33 97.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.599 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.33 -29.78 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 p -178.51 56.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 4.9 mt-10 -154.37 -176.71 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.549 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 1.1 t 78.32 -15.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.578 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 18' ' ' GLU . 15.0 mt-10 -97.91 3.09 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.585 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.509 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 68.9 t80 -149.36 14.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.624 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.52 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 3.0 p -137.69 22.03 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.599 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -128.53 -8.63 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.686 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -66.22 -8.84 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -132.25 -3.08 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.575 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 t 40.12 60.55 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.761 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -150.78 34.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.86 36.43 0.23 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.01 -3.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 1.0 110.532 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.41 -19.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.582 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -78.59 -41.17 1.8 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 64.1 Cg_endo -86.91 -16.92 3.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.426 2.084 . . . . 1.0 112.21 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -1.37 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -136.47 -51.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.443 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -53.03 -31.79 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.51 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 32' ' ' PRO . 11.9 mmt -60.61 -59.25 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.553 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mp -46.4 -22.25 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.558 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.7 t -93.38 -50.46 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.552 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.32 -15.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 38' ' ' VAL . 3.1 mt -124.85 37.45 4.4 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.358 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' VAL . 14.7 tp -168.57 -62.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.35 -13.39 43.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 45' ' ' GLY . 5.5 t -150.17 -44.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.132 -0.227 . . . . 1.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER 33.02 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.304 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -45.02 -62.26 3.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.56 -2.16 8.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 1.0 110.127 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' THR . . . -89.85 -23.52 32.73 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.6 41.64 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 1.0 110.605 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.5 t -135.05 -61.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.538 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -101.39 -15.82 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.56 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -81.63 -32.02 32.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.537 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -49.27 -33.25 12.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 t -57.36 -55.98 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.499 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -79.46 47.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.555 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -152.87 -49.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.561 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -20.96 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.586 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -48.66 -20.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -170.19 30.77 0.14 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.48 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 1.0 110.668 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 11.7 m-70 -139.22 -44.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.603 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 0.6 OUTLIER 170.2 130.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.479 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.64 -97.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 44.31 43.58 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.039 -0.982 . . . . 1.0 110.589 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -140.13 -34.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.594 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -166.4 115.83 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.557 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.35 -127.26 1.04 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.45 85.66 0.04 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -165.38 34.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -154.11 56.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.574 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 43.3 t0 -155.26 53.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.521 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 8' ' ' ASP . 8.9 m120 -138.2 -62.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.604 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -77.18 3.81 11.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.578 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -76.45 68.13 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.587 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.33 -80.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -163.27 72.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 1.0 110.513 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 2.7 p-10 -86.93 -43.48 12.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.547 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -178.29 98.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.577 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -92.96 20.75 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.569 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 1.7 p 79.67 25.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.449 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.2 tt0 -70.24 155.32 40.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.595 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 69.19 -8.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.542 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 18' ' ' GLU . 10.7 tt0 -82.49 61.07 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.583 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -138.48 -66.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.593 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m -164.72 34.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.579 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 19' ' ' CYS . 19.8 p30 -139.73 12.45 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.557 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -101.06 5.32 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 16.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.585 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 27' ' ' SER . 11.8 t -155.99 -108.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.597 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 46.67 18.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.594 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 26' ' ' SER . . . -167.96 41.87 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.06 -1.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.704 0.288 . . . . 1.0 110.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.34 -30.3 2.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -75.44 -34.52 1.61 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.4 Cg_endo -88.0 26.36 0.59 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.265 1.977 . . . . 1.0 112.167 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.48 -2.21 3.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.708 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.9 -33.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.571 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -95.76 25.76 4.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.1 mmt -131.16 -19.77 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.511 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -125.26 19.6 8.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.74 -43.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -54.9 -14.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.666 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.64 17.92 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.595 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 tp -138.55 -41.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.251 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.96 2.28 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' GLY . 14.9 t -170.52 -31.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 1.0 110.607 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -42.55 -21.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.56 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 137.8 33.43 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -137.76 21.94 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 1.0 110.499 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.3 2.91 3.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.15 14.07 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.694 0.283 . . . . 1.0 110.569 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.5 t -132.28 -33.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 tp -98.14 -49.23 4.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.356 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CH2' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -62.25 -12.99 23.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.495 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 t -96.17 -15.29 22.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.639 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.434 ' C ' ' H ' ' A' ' 55' ' ' ARG . 42.5 t -72.57 -51.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.728 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.52 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 1.8 p90 -79.35 21.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.668 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.621 ' HE ' ' CE1' ' A' ' 59' ' ' HIS . 0.4 OUTLIER -123.96 -49.03 1.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.549 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -18.67 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.679 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -72.88 -19.12 61.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.579 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 158.68 94.5 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.621 ' CE1' ' HE ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -41.07 -23.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.78 0.324 . . . . 1.0 110.573 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -138.71 5.95 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.531 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 63.1 128.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.54 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -147.45 111.88 5.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.55 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.575 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 3.9 t-160 -134.57 -147.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 1.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.575 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 20.2 p-80 . . . . . 0 C--N 1.321 -0.64 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' C ' ' H ' ' A' ' 3' ' ' GLU . 1.8 mtm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 73.82 -46.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.576 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 1' ' ' MET . 3.0 mt-10 55.29 100.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.607 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.18 0.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 44.94 35.35 4.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.14 -65.25 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 1.0 110.567 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 53.35 41.82 32.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.49 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -122.19 41.14 3.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 11' ' ' TYR . 1.2 m120 -157.59 111.88 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.565 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 43.68 23.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.592 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' ASN . 1.9 m-85 -139.59 103.69 4.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.616 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 -34.72 2.01 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' ND2' ' A' ' 15' ' ' ASN . . . -178.51 -82.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.8 0.334 . . . . 1.0 110.535 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 49.99 24.59 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.546 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 11.4 p30 -142.81 59.44 1.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -62.36 -48.71 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.62 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.22 6.79 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.575 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -84.76 87.33 7.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.557 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p -178.19 57.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.0 -9.21 28.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.574 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -42.14 -66.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.588 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -146.43 12.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.59 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.6 15.92 27.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.614 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -91.35 4.22 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.524 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.87 15.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.579 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 -48.86 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.593 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.8 p -86.19 28.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.572 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.58 4.47 3.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 -6.01 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.673 0.273 . . . . 1.0 110.556 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.69 -17.58 13.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.582 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.9 -39.95 3.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 66.4 Cg_endo -86.89 -0.81 7.99 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.454 2.102 . . . . 1.0 112.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.29 11.12 38.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.552 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.7 mt -137.72 -36.53 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.93 2.75 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.436 ' C ' ' H ' ' A' ' 38' ' ' VAL . 10.8 mmt -101.7 -54.67 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.621 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.78 16.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 36' ' ' MET . 40.8 t -137.89 -70.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.568 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -46.07 -46.03 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -100.54 50.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -173.54 -64.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.31 -14.02 0.49 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -138.09 -98.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 1.0 110.607 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.504 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.3 p 58.66 3.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.621 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 136.83 -25.66 3.06 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.02 -12.93 52.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 1.0 110.559 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.37 -9.89 69.0 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -116.66 -6.69 11.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.749 0.309 . . . . 1.0 110.462 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.63 -45.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.639 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tt -93.16 -65.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.612 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.426 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 1.1 t-105 -44.74 -37.21 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.601 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -55.97 -33.61 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.598 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.08 -38.03 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.593 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -84.44 9.26 13.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.545 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.86 -68.6 0.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.519 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -53.96 -30.15 45.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -89.56 -9.73 48.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.82 97.7 0.17 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.657 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 4.6 p80 -171.81 -48.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 1.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.657 ' H ' ' CD2' ' A' ' 59' ' ' HIS . 4.8 m170 -101.61 -14.13 17.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.581 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 62' ' ' HIS . 4.7 t-80 -108.64 -148.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.563 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.57 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 26.1 t-80 44.1 95.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.537 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 64' ' ' HIS . 6.4 p-80 -110.35 -146.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.165 0.507 . . . . 1.0 110.514 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.549 ' N ' ' CG ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -85.01 14.52 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.508 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 42.55 65.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.538 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.01 92.19 0.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.81 96.38 0.26 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.02 -34.18 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 1.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 54.81 44.41 28.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.569 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.46 49.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.521 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.71 49.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.566 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' CD2' ' OD1' ' A' ' 14' ' ' ASP . 6.2 t80 43.18 29.96 0.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER 49.24 42.54 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.607 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 165.21 -64.19 0.23 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 163.64 -39.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 1.0 110.542 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.494 ' OD1' ' CD2' ' A' ' 10' ' ' TYR . 1.3 t70 76.86 -14.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.543 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 13' ' ' ALA . 7.8 m120 -92.53 75.39 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.528 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.66 -42.88 6.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.593 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 t -157.11 54.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.6 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -102.02 -21.94 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.578 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.512 ' C ' ' H ' ' A' ' 21' ' ' TYR . 6.2 t -165.39 65.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.436 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' C ' ' CG ' ' A' ' 21' ' ' TYR . 19.4 mt-10 -71.5 40.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER 69.35 -62.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.652 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.76 35.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.473 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 -5.61 4.5 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.62 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -65.43 -9.3 24.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.479 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 -3.72 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.54 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.8 p 40.22 72.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.654 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.8 p -158.82 25.08 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.614 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.75 37.1 0.14 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.871 . . . . 1.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.64 6.51 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.3 -27.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.608 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -69.99 -41.19 14.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.1 Cg_endo -87.33 22.3 0.94 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.595 2.197 . . . . 1.0 112.226 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.47 -7.89 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.636 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 36' ' ' MET . 45.6 mt -104.59 -45.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.634 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -70.55 9.25 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 34' ' ' ILE . 13.0 mmt -97.27 -62.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.53 -9.08 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 40' ' ' LEU . 92.1 t -98.28 -44.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -78.96 30.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.604 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.7 mt -138.9 6.32 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.41 -40.5 4.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.551 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.73 -3.62 50.41 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.529 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -137.66 -99.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.616 0.246 . . . . 1.0 110.565 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.529 ' H ' ' CG2' ' A' ' 43' ' ' THR . 4.6 t 33.48 49.01 0.21 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.3 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 104.87 -46.74 1.14 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' THR . 67.9 m-80 -75.12 23.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.816 0.341 . . . . 1.0 110.562 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -136.41 -34.32 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -96.86 15.49 21.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.338 . . . . 1.0 110.475 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.92 -34.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -75.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.315 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -48.79 -24.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 1.0 110.664 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 t -71.68 -29.19 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.7 t -50.66 -41.48 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.628 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.86 1.61 46.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.88 -44.57 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.599 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -28.76 69.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.61 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -54.45 -37.24 64.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.564 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.61 36.83 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 12.5 m-70 54.32 64.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 1.0 110.616 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 21.0 p80 40.93 25.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.718 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 59' ' ' HIS . 33.1 m170 54.72 107.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -53.18 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.563 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.544 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 3.0 t-160 -134.91 -147.32 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.181 0.515 . . . . 1.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.544 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 50.9 m-70 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.48 -79.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.566 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -153.34 95.4 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.18 -121.96 1.31 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' CD2' ' A' ' 7' ' ' PHE . . . 94.72 72.5 1.16 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t70 65.42 54.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 1.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' GLY . 66.7 m-85 -148.58 41.83 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.579 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -157.01 60.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.479 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.37 -45.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.526 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CZ ' ' CE1' ' A' ' 11' ' ' TYR . 45.0 p90 -98.4 15.22 25.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.575 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.535 ' CE1' ' CZ ' ' A' ' 10' ' ' TYR . 42.1 m-85 -89.18 55.84 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.569 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.64 -70.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 175.41 73.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 1.0 110.616 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.28 -69.63 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -164.78 50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.594 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.657 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -69.95 -16.72 63.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.61 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 174.13 73.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 20' ' ' GLU . 14.6 tt0 -87.59 130.8 34.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.499 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t 65.19 -3.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.514 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 18' ' ' GLU . 44.7 mt-10 -99.46 19.76 15.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.589 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.414 ' O ' ' OG1' ' A' ' 22' ' ' THR . 0.1 OUTLIER -85.71 25.26 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.583 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 4.7 p 58.69 42.54 20.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.641 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -138.13 5.04 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 45.8 p-90 -75.02 -25.67 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.47 5.15 44.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 28' ' ' GLY . 62.4 m -100.22 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 0.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -101.36 31.82 8.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -163.08 -8.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 1.0 110.55 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.6 mt -111.52 -30.3 7.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.57 -37.89 1.7 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.194 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.1 Cg_endo -88.1 -0.27 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.389 2.059 . . . . 1.0 112.119 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.87 6.91 36.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.653 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.41 -51.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.21 -29.8 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.59 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.431 ' C ' ' N ' ' A' ' 38' ' ' VAL . 23.3 mmt -63.59 -60.38 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.446 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.5 mp -46.92 -17.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.537 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.431 ' N ' ' C ' ' A' ' 36' ' ' MET . 6.5 t -97.81 -52.1 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -42.4 -26.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.504 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -115.83 73.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.09 -57.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 10.58 67.86 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -139.2 -73.87 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 1.0 110.542 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 41.65 22.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.56 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 102.76 29.24 5.94 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' THR . 66.2 m-80 -130.71 -30.91 1.81 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 1.0 110.583 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.463 ' O ' ' CE3' ' A' ' 51' ' ' TRP . . . -88.71 -11.7 65.44 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.94 31.88 5.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.824 0.345 . . . . 1.0 110.346 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.42 -54.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.594 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -101.8 -23.66 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.461 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.535 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -78.4 -10.79 59.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 53' ' ' VAL . 10.5 t -89.18 -42.81 11.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.704 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 52' ' ' THR . 55.6 t -49.01 -24.36 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.922 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -101.12 -21.1 15.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' C ' ' N ' ' A' ' 57' ' ' LYS . 2.0 tpt180 -88.24 -51.98 5.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.606 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.94 -15.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.699 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 55' ' ' ARG . 15.6 mtpp -64.23 -36.74 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.569 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . 134.02 64.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 22.3 p80 40.54 73.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 1.0 110.804 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 44.42 29.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.651 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.489 ' CD2' ' H ' ' A' ' 62' ' ' HIS . 2.1 t-160 -142.35 -150.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.072 0.463 . . . . 1.0 110.421 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.489 ' H ' ' CD2' ' A' ' 61' ' ' HIS . 65.4 m-70 -141.96 97.61 3.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.46 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.416 ' O ' ' OXT' ' A' ' 64' ' ' HIS . 7.5 t-160 -154.86 95.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.416 ' OXT' ' O ' ' A' ' 63' ' ' HIS . 3.6 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.929 -1.034 . . . . 1.0 110.564 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' GLU . 3.0 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER 49.12 99.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.504 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.78 -58.35 2.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.87 -57.34 0.65 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.01 -118.24 11.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.32 40.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 11' ' ' TYR . 4.1 t80 72.24 43.42 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' C ' HD21 ' A' ' 9' ' ' ASN . 64.3 m-20 -147.57 49.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.595 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.449 HD21 ' C ' ' A' ' 8' ' ' ASP . 2.6 m-80 -140.42 -100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.588 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.52 -20.23 65.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.519 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD2' ' CZ ' ' A' ' 7' ' ' PHE . 10.1 m-85 -74.92 77.58 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.478 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 143.08 -76.62 0.3 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.806 -0.918 . . . . 1.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 168.28 122.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.347 . . . . 1.0 110.621 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -133.52 -73.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.501 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.541 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 3.6 m120 -84.66 -99.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 15' ' ' ASN . 2.5 pp0? 19.36 48.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.07 0.856 . . . . 1.0 112.202 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ASN . 8.3 t -158.1 -64.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.566 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 42.73 50.97 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.546 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.43 6.07 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.43 64.22 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.416 ' O ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -140.0 -66.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.619 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 2.0 m -168.23 39.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.544 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -143.29 11.77 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.41 ' NE1' ' NZ ' ' A' ' 25' ' ' LYS . 20.0 p-90 -101.59 5.09 41.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.567 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' NZ ' ' NE1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -150.11 16.37 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.58 -179.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 28' ' ' GLY . 14.2 m -137.92 -39.27 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.591 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 p -80.04 23.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -145.38 40.35 1.11 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.24 -9.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 1.0 110.544 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.51 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.624 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.4 mm -83.86 -36.02 0.63 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.445 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.0 Cg_endo -88.26 10.75 3.3 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.468 2.112 . . . . 1.0 112.266 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.93 -19.8 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.525 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -105.52 -44.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.627 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' O ' ' SD ' ' A' ' 36' ' ' MET . 30.0 m-85 -74.21 19.77 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.62 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.522 ' H ' ' C ' ' A' ' 34' ' ' ILE . 18.1 mmt -136.49 -50.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.622 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.86 0.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.8 t -137.43 -54.17 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -49.6 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -98.43 56.1 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -175.05 -64.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -17.33 0.88 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.562 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.8 OUTLIER -138.07 -103.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.522 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.562 ' H ' ' CG2' ' A' ' 43' ' ' THR . 1.7 p 62.64 -1.05 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 88.83 25.64 29.11 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' A' ' 45' ' ' GLY . 1.2 m-80 -137.43 3.95 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.78 0.324 . . . . 1.0 110.534 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.0 -19.24 10.99 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.0 15.77 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.687 0.279 . . . . 1.0 110.453 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.23 -62.05 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.52 -36.36 10.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.441 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 27.2 t-105 -69.97 -15.57 63.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.467 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.457 ' OG1' ' CE ' ' A' ' 56' ' ' LYS . 2.6 t -78.81 -24.79 44.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.637 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.08 5.52 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.436 ' O ' ' NE2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -138.48 3.39 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.642 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 59' ' ' HIS . 3.2 tmt_? -101.72 -59.42 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' CE ' ' OG1' ' A' ' 52' ' ' THR . 21.5 mtmt -53.91 -45.71 71.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.595 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -52.89 -30.37 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.618 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . -101.06 -68.37 0.83 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER 71.62 -40.57 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 1.0 110.577 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.511 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -78.34 11.46 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 66.06 126.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.548 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.436 ' NE2' ' O ' ' A' ' 54' ' ' PHE . 43.0 m-70 -83.0 78.73 9.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.506 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -89.61 84.51 6.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.589 179.935 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -138.04 8.46 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.563 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -140.4 63.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.22 -5.04 32.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.65 164.52 31.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -101.39 -78.12 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 1.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 t80 56.98 43.28 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.578 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -157.67 52.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.564 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -138.98 -20.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.553 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.488 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 t80 -153.21 0.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.617 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 14.9 p90 38.56 40.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.785 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.54 -50.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . 179.23 -58.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.585 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 4.9 t0 77.64 6.07 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.579 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.43 ' ND2' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 51.2 102.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.56 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.09 10.39 26.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.591 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 19' ' ' CYS . 5.0 m -134.66 0.38 2.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.633 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -57.74 -7.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 2.0 t -171.1 47.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.582 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -138.72 21.29 2.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.545 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 -52.03 3.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.6 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 p -140.15 31.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.86 3.51 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.568 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -81.58 5.87 16.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.39 16.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.591 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 28' ' ' GLY . 91.2 p -144.93 -109.17 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' ' OG ' ' A' ' 26' ' ' SER . 25.8 t -72.08 42.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.518 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -170.23 32.88 0.16 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.89 -18.01 0.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.717 0.294 . . . . 1.0 110.578 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.442 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 2.6 mp -112.0 -29.69 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.601 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -75.8 -37.81 2.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.19 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.3 Cg_endo -87.6 26.15 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.461 2.108 . . . . 1.0 112.174 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.25 7.82 3.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -145.32 -39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.609 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.2 m-85 -79.26 26.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.588 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 19.4 mmt -137.34 -67.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.566 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -47.02 -24.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.572 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.61 -51.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.587 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -41.54 -30.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.465 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.93 80.29 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.411 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 43' ' ' THR . 2.0 mt -159.36 -61.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.56 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.44 28.41 1.23 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.562 ' HG1' ' N ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -173.47 -86.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 1.0 110.539 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.562 ' N ' ' HG1' ' A' ' 43' ' ' THR . 0.6 OUTLIER 49.9 11.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.58 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 78.47 3.16 86.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.585 ' ND2' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -100.55 -20.92 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 1.0 110.531 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.585 ' N ' ' ND2' ' A' ' 46' ' ' ASN . . . -91.07 -35.07 7.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 50' ' ' LEU . 3.1 mt -89.98 -145.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 1.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 51' ' ' TRP . 2.8 t 62.64 -71.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.642 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 48' ' ' LEU . 1.2 pp -59.08 -4.06 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.7 -45.59 58.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.381 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.3 t -45.5 -12.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.289 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 51' ' ' TRP . 50.8 t -87.04 -31.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 51' ' ' TRP . 67.1 m-85 -124.09 4.81 8.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.869 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' NH2' ' CE1' ' A' ' 59' ' ' HIS . 2.4 tpt180 -90.33 -41.52 11.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 1.0 110.674 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 58' ' ' GLY . 3.5 mmtt -78.92 -52.69 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.463 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -62.63 0.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.557 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 56' ' ' LYS . . . 167.61 97.9 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.49 ' CE1' ' NH2' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -41.62 -28.24 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 1.0 110.528 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.601 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -138.7 -57.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.601 ' N ' ' CD2' ' A' ' 60' ' ' HIS . 0.7 OUTLIER 165.05 108.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.367 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.562 ' CG ' ' H ' ' A' ' 63' ' ' HIS . 4.7 t-160 -101.0 -138.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.582 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.562 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 2.1 m-70 -140.16 93.74 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.58 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.557 -179.997 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.23 71.54 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.534 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.43 86.77 5.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.55 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.13 -5.38 65.72 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.17 -144.11 2.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 t0 71.93 28.74 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 1.0 110.546 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 65.52 58.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.426 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -165.98 66.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.49 HD21 ' C ' ' A' ' 15' ' ' ASN . 37.5 m-20 -73.43 -34.86 65.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.403 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -152.09 -49.86 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -139.24 30.4 2.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.354 0.597 . . . . 1.0 110.489 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 117.24 27.08 2.76 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 86.4 93.89 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.998 0.428 . . . . 1.0 110.254 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -13.29 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 1.0 110.554 -179.633 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' A' ' 17' ' ' SER . 38.4 t-20 -150.37 96.79 2.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.452 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' O ' ' CB ' ' A' ' 17' ' ' SER . 5.5 mt-30 -74.77 22.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.599 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 80.56 43.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.335 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.497 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 5.4 tt0 -100.56 131.88 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.525 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 71.71 -8.41 1.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.579 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 18' ' ' GLU . 5.9 tt0 -80.69 45.82 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.578 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -102.17 -75.44 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.543 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.464 ' CG2' ' HZ3' ' A' ' 25' ' ' LYS . 2.1 m -166.69 28.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.511 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -141.07 28.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.48 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 19' ' ' CYS . 9.2 p-90 -128.83 1.63 5.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.486 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HZ3' ' CG2' ' A' ' 22' ' ' THR . 0.0 OUTLIER -151.8 19.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.521 179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.53 ' C ' ' H ' ' A' ' 28' ' ' GLY . 12.7 t -166.67 25.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.608 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.0 m -72.27 14.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.332 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 26' ' ' SER . . . 151.13 -11.1 0.78 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . 82.88 34.56 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.852 0.358 . . . . 1.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -110.74 -26.6 9.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.335 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -77.57 -41.01 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.854 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.5 Cg_endo -86.92 24.78 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.475 2.117 . . . . 1.0 112.168 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.8 5.19 5.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.503 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -146.26 -55.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.546 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -60.92 -0.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.503 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.9 mmt -96.97 -50.36 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.544 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 9.4 mp -78.82 13.21 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.582 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.4 t -141.31 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.564 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.5 -50.49 16.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mt -99.16 49.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.636 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 43' ' ' THR . 14.9 tp -175.19 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.334 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -49.57 -12.49 0.38 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.589 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -138.09 -98.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.589 ' H ' ' CG2' ' A' ' 43' ' ' THR . 0.8 OUTLIER 52.45 9.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.54 -179.981 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 83.53 26.55 42.44 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' C ' ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -134.77 1.16 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 1.0 110.59 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.78 3.63 42.1 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.23 3.03 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.37 . . . . 1.0 110.623 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.72 -58.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.573 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 pp -95.66 -34.32 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -55.46 -16.83 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.481 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 t -81.66 -17.74 47.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.548 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.96 -21.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.514 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.84 15.54 26.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.6 -71.8 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.687 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -33.49 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.69 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -60.15 -31.98 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.526 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.03 98.12 0.17 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -17.15 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 1.0 110.558 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -71.03 -86.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.515 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -175.09 92.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.616 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.521 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 15.8 p80 41.6 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.7 t-160 -70.41 66.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.572 179.991 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' O ' ' A' ' 2' ' ' GLU . 2.6 mmt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . 12.0 tp10 58.77 117.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.55 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -75.4 -85.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.529 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 -61.02 0.81 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.76 105.81 1.32 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -160.68 27.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 1.0 110.612 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -162.73 51.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.545 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -144.17 54.44 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.529 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' TYR . 6.7 p-10 -118.97 43.6 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.563 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.473 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 57.8 t80 48.2 12.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.801 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 39.89 36.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.711 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 40.27 22.4 0.04 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 11' ' ' TYR . . . 162.43 79.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 1.0 110.573 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.435 ' CG ' ' CE1' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.78 19.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.59 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.516 ' C ' HE21 ' A' ' 16' ' ' GLN . 1.2 m-80 69.93 125.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.591 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.516 HE21 ' C ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.78 -38.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.609 179.933 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -158.06 39.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -139.11 -17.61 1.04 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p -171.86 57.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.563 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -101.6 31.92 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.575 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -101.6 -81.5 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.575 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.32 29.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.519 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.15 -11.51 5.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.546 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -60.84 -8.48 3.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -0.84 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.55 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.3 p 40.04 79.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.666 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t -137.95 -35.43 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.592 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.58 49.21 0.89 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.19 -16.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 1.0 110.622 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.3 -18.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.54 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -68.68 -39.84 16.04 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.95 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.8 Cg_endo -87.11 25.75 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.126 . . . . 1.0 112.192 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.55 -49.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.496 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 pt -101.09 -32.5 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.602 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.504 ' CE2' ' CD1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -79.04 29.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.455 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.6 mtp -127.31 -61.13 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.558 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.97 16.74 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.24 -31.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.643 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 35' ' ' TYR . 30.4 t80 -77.82 -34.84 51.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.645 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.53 26.61 10.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.45 -61.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.176 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 -4.86 69.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -138.12 -61.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.088 -0.245 . . . . 1.0 110.65 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER 32.62 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.661 0.601 . . . . 1.0 111.301 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -143.62 17.53 2.23 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.77 21.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 1.0 110.012 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' TRP . . . -147.29 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.039 -0.825 . . . . 1.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -48.59 -13.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 1.0 110.217 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' H ' ' C ' ' A' ' 47' ' ' GLY . 79.7 t -82.04 -60.03 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.824 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -101.39 -36.51 8.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.692 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' GLY . 42.6 t-105 -60.3 -1.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.446 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.518 ' H ' ' C ' ' A' ' 50' ' ' LEU . 3.3 t -94.05 -31.33 14.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.67 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -72.74 -60.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.594 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -55.71 -14.56 2.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.624 -179.905 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 57' ' ' LYS . 2.2 ttm180 -98.1 -38.61 9.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.607 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -54.47 -7.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.62 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 55' ' ' ARG . 36.8 mmtm -78.67 -31.34 46.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.609 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.91 85.53 0.06 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.014 -0.834 . . . . 1.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.43 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -61.74 -12.37 16.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 1.0 110.636 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -98.26 -14.06 20.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.551 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' HE2' ' NH2' ' A' ' 55' ' ' ARG . 34.7 m80 50.71 41.63 26.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.58 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -7.59 26.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.56 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -147.14 99.65 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.633 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.554 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -101.43 -29.29 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -139.89 -100.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.579 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.49 -67.18 0.5 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.98 -74.56 0.29 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 -67.86 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 1.0 110.516 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.7 38.92 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 10.4 t70 56.13 50.44 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.546 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -118.09 49.48 1.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.358 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 48.45 27.29 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.4 33.99 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 1.0 110.337 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 44.7 65.58 1.71 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 169.49 115.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.774 0.321 . . . . 1.0 110.605 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 16' ' ' GLN . 27.2 t0 -168.8 45.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m120 56.52 5.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.58 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.619 ' NE2' ' N ' ' A' ' 17' ' ' SER . 1.2 pm0 -55.71 -22.78 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.599 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.619 ' N ' ' NE2' ' A' ' 16' ' ' GLN . 14.5 t -177.27 31.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.606 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -159.12 109.85 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.546 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.49 -71.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.569 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -82.78 51.66 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.423 ' O ' ' OG1' ' A' ' 22' ' ' THR . 71.3 m-85 -151.11 54.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.532 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.47 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 3.2 p 60.63 42.58 13.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 25' ' ' LYS . 1.1 t70 -124.65 -19.48 5.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.574 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -53.76 -8.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' NZ ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -135.27 0.86 2.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.5 p 40.16 62.2 1.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.418 ' H ' ' HZ2' ' A' ' 25' ' ' LYS . 9.2 p -152.6 27.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.523 ' N ' ' NZ ' ' A' ' 25' ' ' LYS . . . -157.03 34.68 0.56 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.58 -6.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.665 0.269 . . . . 1.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt -113.19 -26.73 8.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.623 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.609 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -85.87 -34.72 0.5 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.597 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.7 Cg_endo -87.68 25.48 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.258 1.972 . . . . 1.0 112.141 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.32 11.17 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.4 OUTLIER -150.75 -48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.498 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -73.19 12.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.501 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' VAL . 14.5 mmt -129.68 -38.12 1.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 10.8 mp -55.41 -6.68 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.618 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.96 -53.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.582 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -21.41 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.588 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mt -136.8 54.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 -46.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.15 34.7 4.9 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' GLY . 3.6 t -167.65 -30.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 1.0 110.53 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -41.91 -22.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 154.92 -0.54 0.17 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' ND2' ' C ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.31 -1.1 4.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 1.0 110.52 -179.972 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.92 48.34 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.12 23.8 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 1.0 110.539 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.9 t -137.87 -38.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.615 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.473 ' C ' ' N ' ' A' ' 52' ' ' THR . 2.9 tt -101.34 -52.76 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.57 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.486 ' O ' ' CD2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -45.89 -16.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.594 179.992 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 50' ' ' LEU . 8.3 t -62.24 -35.77 79.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 t -51.17 -32.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.575 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.71 15.77 6.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.59 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 58' ' ' GLY . 39.7 ttt-85 -135.56 -35.97 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' C ' ' H ' ' A' ' 58' ' ' GLY . 4.2 mtmt -51.6 -42.64 62.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.596 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -54.26 -10.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.511 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 56' ' ' LYS . . . -172.19 112.08 0.42 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.63 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 2.2 p80 -172.22 -41.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 1.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.63 ' H ' ' CD2' ' A' ' 59' ' ' HIS . 80.9 m-70 -157.1 44.48 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.612 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 42.24 76.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.576 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -154.42 115.19 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.636 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 4.8 t-160 -134.7 -147.29 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.495 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.636 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.541 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtp . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 49.8 66.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.607 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -101.38 3.74 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.23 43.53 1.9 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.53 169.0 21.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -87.26 -3.51 59.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.674 0.273 . . . . 1.0 110.572 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 4.1 t80 81.41 72.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 1.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 t70 65.3 61.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.587 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.43 -46.32 10.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.41 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -135.93 -76.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.504 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.8 27.61 7.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 1.0 110.458 179.891 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 123.42 -6.97 9.14 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.319 -0.855 . . . . 1.0 111.208 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 164.27 -35.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.006 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.5 t70 79.74 69.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 1.0 110.51 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 17' ' ' SER . 2.2 p-10 -42.02 100.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.618 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -77.14 34.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.628 179.952 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER 79.93 39.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.444 -179.913 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.06 21.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.578 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' H ' ' C ' ' A' ' 17' ' ' SER . 5.5 t -156.19 56.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.38 23.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.543 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 55.31 84.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.655 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.69 27.92 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.655 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.33 13.67 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.585 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -87.66 -16.53 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.546 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.81 11.01 40.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.563 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 28' ' ' GLY . 18.4 p -138.54 -64.95 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.542 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.1 t -77.91 15.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.574 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -143.87 45.84 0.86 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.59 -34.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.739 0.304 . . . . 1.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -106.4 -9.61 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.573 -179.994 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.77 -40.06 3.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.49 25.97 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.498 2.132 . . . . 1.0 112.164 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.8 2.59 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.51 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.43 -61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.594 179.918 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.92 -28.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 36' ' ' MET . 2.9 mmm -75.11 -47.3 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -54.76 -7.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.8 OUTLIER -119.72 -51.54 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.494 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -46.13 -17.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.621 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 38' ' ' VAL . 8.7 mt -136.77 52.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 16.6 tp -169.8 -59.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' CA ' HD22 ' A' ' 46' ' ' ASN . . . -97.29 40.9 2.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.473 ' N ' HD22 ' A' ' 46' ' ' ASN . 1.5 t -171.55 -23.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 1.0 110.589 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -41.55 -36.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.58 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . -161.41 -3.07 0.05 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 41' ' ' LEU . 7.5 p30 -101.58 18.96 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.739 0.304 . . . . 1.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.73 3.88 3.24 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.25 55.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 1.0 110.574 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 72.8 t -142.46 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 pp -97.68 -26.4 14.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -15.06 58.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.575 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.3 t -80.41 -19.91 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.535 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.0 t -66.08 -64.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.625 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -53.46 -16.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.566 -179.971 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -84.51 -46.31 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.514 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -47.8 -28.49 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.609 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -55.16 -14.14 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.519 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.04 90.15 0.07 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.412 ' CD2' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -57.58 -23.44 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 1.0 110.59 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 61' ' ' HIS . 13.6 p80 -91.76 -37.13 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.621 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 60' ' ' HIS . 9.7 t-160 -89.48 41.83 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.521 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -56.13 -5.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.566 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.519 ' H ' ' C ' ' A' ' 61' ' ' HIS . 10.8 t-80 42.8 78.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.583 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 p80 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.572 -179.989 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -61.38 103.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.551 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -88.55 -97.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.28 -68.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.72 179.72 3.54 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.27 -64.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 1.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 56.37 41.83 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.598 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -141.11 42.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.608 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 11' ' ' TYR . 46.4 t30 -153.5 82.45 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.558 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.479 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 1.2 t80 43.51 21.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.611 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.5 p90 38.76 40.28 0.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -169.27 -58.4 0.03 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . 167.21 -24.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 1.0 110.607 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.9 t70 78.37 -0.66 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.499 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.518 ' C ' HD21 ' A' ' 15' ' ' ASN . 0.1 OUTLIER -90.13 58.3 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.548 179.966 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 17' ' ' SER . 2.3 mp0 -98.91 59.99 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.582 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 80.98 54.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.149 0.5 . . . . 1.0 110.318 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.07 108.68 5.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.478 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 t 65.2 64.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.762 -0.458 . . . . 1.0 109.762 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' THR . 1.8 tp10 -69.3 58.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.63 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 58.99 -69.66 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.237 179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . 29.8 p -157.81 56.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.1 -35.55 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.616 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.406 ' C ' ' H ' ' A' ' 26' ' ' SER . 3.7 p-90 -61.74 -30.95 71.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.811 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -70.69 3.85 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.898 -179.682 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -137.55 -77.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.604 179.962 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.64 8.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.596 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -155.89 31.62 0.61 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.55 5.9 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 1.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.45 -24.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.568 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -73.84 -41.07 5.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 63.3 Cg_endo -87.03 10.24 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.573 2.182 . . . . 1.0 112.251 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.32 3.63 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.564 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.06 -41.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -67.44 4.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.503 ' C ' ' H ' ' A' ' 38' ' ' VAL . 20.3 mmt -100.92 -72.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mt -52.09 -9.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 36' ' ' MET . 76.4 t -101.03 -36.47 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.578 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -93.03 33.98 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.597 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.2 mt -136.92 0.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.535 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 28.1 mt -112.29 -41.33 3.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.525 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' C ' HD22 ' A' ' 46' ' ' ASN . . . -69.91 -3.61 44.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -137.46 -100.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 1.0 110.482 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.504 ' H ' ' CG2' ' A' ' 43' ' ' THR . 4.8 t 33.54 44.35 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 108.15 -49.41 0.86 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -71.08 10.53 0.54 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.914 0.387 . . . . 1.0 110.62 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -96.61 -5.85 58.67 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.17 -10.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 1.0 110.572 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.68 -46.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.556 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tt -95.76 -57.21 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.576 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -45.19 -36.77 4.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.471 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 8.9 t -57.62 -36.51 71.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.519 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -52.15 -48.48 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.586 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.1 -11.85 59.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.642 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.41 HH21 ' CB ' ' A' ' 59' ' ' HIS . 9.1 ttm180 -99.08 -33.63 10.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.592 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -55.08 -21.29 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.571 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -88.86 -11.81 43.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.525 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.41 93.02 2.22 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.41 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -54.76 -18.13 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 1.0 110.556 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' HIS . 4.1 p80 -95.67 -21.35 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.554 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' HIS . 1.4 t-80 60.39 125.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -74.71 -37.59 62.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.513 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 44.4 41.8 4.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.586 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.941 -1.028 . . . . 1.0 110.578 179.998 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.5 mtp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.64 114.0 20.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.534 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.18 -33.35 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.541 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.9 133.56 5.67 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.89 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.25 -46.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.707 0.289 . . . . 1.0 110.511 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 t80 61.5 43.32 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -140.58 42.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.581 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 11' ' ' TYR . 4.8 t-20 -157.48 108.25 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.469 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER 69.02 -38.47 0.4 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.089 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.537 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER 38.63 93.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.855 0.36 . . . . 1.0 110.826 179.902 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.53 -64.23 0.43 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.009 -0.836 . . . . 1.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -165.33 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 1.0 110.52 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.32 -0.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.626 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 13' ' ' ALA . 27.8 m120 -148.98 77.67 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.572 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.73 -39.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.679 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -90.72 -3.69 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.58 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -102.19 10.55 39.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -157.8 -36.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.552 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' C ' ' CG ' ' A' ' 21' ' ' TYR . 4.3 tt0 41.81 28.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.435 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 20' ' ' GLU . 1.2 m-85 71.74 -59.48 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.87 40.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.579 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.83 -1.73 3.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.6 p-90 -70.31 -10.59 59.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HZ3' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -134.0 0.38 3.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.609 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.4 p 39.8 79.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.522 ' C ' ' HZ3' ' A' ' 25' ' ' LYS . 3.4 t -161.84 21.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.621 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.93 20.34 0.87 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.78 -5.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 1.0 110.534 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.74 -38.05 5.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.598 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -82.0 -38.04 0.86 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.245 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.7 Cg_endo -87.31 19.4 1.38 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.402 2.068 . . . . 1.0 112.131 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.16 8.28 13.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.48 -44.0 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.567 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.56 3.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.517 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.3 mmt -100.63 -47.63 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.605 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.31 27.86 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -146.58 -18.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -96.23 -2.13 46.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.678 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.84 40.31 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.494 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.87 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.11 20.75 44.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.377 -1.089 . . . . 1.0 110.377 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -163.96 -83.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 1.0 110.344 -179.749 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.683 ' HG1' HD21 ' A' ' 46' ' ' ASN . 0.1 OUTLIER 42.85 19.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 60.57 12.12 25.15 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.683 HD21 ' HG1' ' A' ' 44' ' ' THR . 0.0 OUTLIER -127.89 -6.05 5.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 1.0 110.396 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.517 ' O ' ' CE3' ' A' ' 51' ' ' TRP . . . -88.5 -30.79 14.89 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -119.08 22.85 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.703 0.287 . . . . 1.0 110.511 179.911 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.4 t -128.58 -55.06 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.622 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.9 tt -95.87 -49.97 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.517 ' CE3' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -18.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.595 179.904 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 50' ' ' LEU . 3.5 t -79.29 19.02 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 51' ' ' TRP . 34.2 t -124.89 -29.94 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.504 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.492 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -102.81 -5.07 24.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.492 179.943 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -102.41 -43.59 5.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.623 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.47 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.529 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -58.93 -14.67 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.579 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.29 -107.13 0.72 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 72.82 -53.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 1.0 110.551 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -62.28 -25.59 67.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.554 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 48.91 89.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -99.89 70.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.583 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 56.8 t60 -99.86 84.72 2.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 m80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.61 179.966 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 69.03 117.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.529 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.6 mp0 -93.35 -64.89 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.87 -81.59 0.04 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.17 -50.21 0.75 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 7' ' ' PHE . 1.2 p-10 -100.87 -78.95 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 1.0 110.539 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 12.1 t80 65.57 58.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.613 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t70 53.12 45.28 29.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.546 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' TYR . 41.6 m-20 -136.78 109.01 7.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.478 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.0 t80 47.76 13.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.643 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' ASN . 14.4 m-85 -154.89 117.07 4.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.558 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 -29.26 11.6 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -160.2 -43.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 1.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 2.1 t70 78.48 -1.1 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.592 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER 60.53 125.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.52 179.973 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.49 -34.78 10.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 t -162.0 32.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.07 -47.91 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.555 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' C ' ' H ' ' A' ' 21' ' ' TYR . 4.3 t 65.92 46.79 2.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.77 15.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.594 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.36 -9.75 19.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.604 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.52 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 9.0 m -152.29 -36.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.721 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -87.47 23.3 1.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -90.41 -0.9 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.535 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -136.3 18.32 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 28' ' ' GLY . 27.3 t -135.75 -106.88 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -75.18 30.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -149.4 31.89 1.14 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.82 -9.09 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 1.0 110.497 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -130.85 -16.56 3.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.62 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -78.29 -34.79 1.09 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.395 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.2 Cg_endo -87.72 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.319 2.013 . . . . 1.0 112.16 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.35 10.55 2.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' C ' ' H ' ' A' ' 36' ' ' MET . 14.0 mt -142.93 -44.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 7.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.511 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.507 ' H ' ' C ' ' A' ' 34' ' ' ILE . 12.5 mmt -104.68 -55.18 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.561 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.75 18.01 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' C ' ' N ' ' A' ' 40' ' ' LEU . 57.9 t -135.43 -63.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -47.36 -17.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.566 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 38' ' ' VAL . 3.7 mt -135.72 46.4 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.572 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 43' ' ' THR . 14.9 tp -175.17 -62.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.389 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.42 -10.48 2.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.593 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -146.35 -101.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 1.0 110.676 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.593 ' H ' ' CG2' ' A' ' 43' ' ' THR . 1.7 p 64.44 -3.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.572 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 96.72 5.4 58.73 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 43' ' ' THR . 6.3 p30 -96.15 -42.11 8.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.319 . . . . 1.0 110.236 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.17 -16.33 79.72 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.708 -1.357 . . . . 1.0 109.708 179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -108.52 -169.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.386 -0.407 . . . . 1.0 109.982 179.517 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 t 62.1 -70.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.675 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' VAL . 3.1 tt -66.86 -37.66 84.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.606 ' CE2' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -41.09 -32.1 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.95 -179.573 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 t -70.86 11.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.605 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' LEU . 60.2 t -126.3 -19.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.99 -2.0 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.526 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.606 ' NH1' ' CE2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -103.0 -70.93 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.652 -179.895 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -48.49 79.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 1.0 110.577 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -81.43 -11.56 59.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.625 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . -104.47 -93.02 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.35 6.6 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.797 0.332 . . . . 1.0 110.538 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.65 ' HE2' ' CG ' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -136.04 -34.06 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.603 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.13 103.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.614 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.65 ' CG ' ' HE2' ' A' ' 60' ' ' HIS . 2.4 t-80 -91.59 27.43 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.62 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.495 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 0.4 OUTLIER -89.59 43.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.66 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.506 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 5.7 t-160 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.579 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.49 53.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.549 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.74 80.82 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.575 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.51 -134.21 1.08 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -165.84 -4.22 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER 172.82 76.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.386 0.612 . . . . 1.0 109.775 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -154.65 59.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.541 -179.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -148.45 53.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' TYR . 40.8 m-20 -137.39 50.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.588 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' C ' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER 41.54 20.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.708 179.903 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.2 OUTLIER 42.59 40.23 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.622 179.841 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 40.49 28.79 0.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 163.51 101.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 1.0 110.623 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.74 31.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.523 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 16' ' ' GLN . 20.9 p30 -141.3 -31.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.651 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.655 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -87.82 18.86 3.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.558 179.961 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' GLU . 10.1 t -147.24 -37.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.547 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 17' ' ' SER . 1.2 tp10 44.0 99.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.019 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -107.66 9.84 29.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.517 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 21' ' ' TYR . 24.6 tt0 45.91 15.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' A' ' 19' ' ' CYS . 2.5 t80 73.7 40.77 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 1.8 p 63.64 47.24 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.492 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -134.95 1.91 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.493 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -84.44 4.64 30.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.602 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.552 ' CD ' ' HG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -150.62 18.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.571 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.552 ' HG ' ' CD ' ' A' ' 25' ' ' LYS . 1.8 p -160.65 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.64 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 28' ' ' GLY . 13.6 p 63.27 -68.83 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.579 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.55 ' N ' ' OG ' ' A' ' 27' ' ' SER . . . -130.95 -12.97 2.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . 81.19 48.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.941 0.4 . . . . 1.0 110.094 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -129.09 -27.7 2.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.491 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -80.42 -39.05 1.14 Allowed Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.974 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.7 Cg_endo -86.91 25.25 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.362 2.042 . . . . 1.0 112.175 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.5 -0.7 6.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.49 -45.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.592 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.4 27.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.504 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.2 mmt -135.76 -51.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.519 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mt -59.45 -2.48 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.569 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.1 t -140.32 -61.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -64.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.638 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -100.94 63.86 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -163.74 -65.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.29 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.46 -23.62 1.37 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.595 ' CG2' ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -135.78 -97.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.2 -0.2 . . . . 1.0 110.65 179.894 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.595 ' H ' ' CG2' ' A' ' 43' ' ' THR . 6.1 t 36.01 32.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.481 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 77.68 -14.53 9.58 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -60.8 -4.35 0.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 1.0 110.538 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -91.88 -15.13 55.27 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.85 26.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 1.0 110.544 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.9 t -138.31 -35.83 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.599 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 52' ' ' THR . 2.0 tp -98.43 -56.75 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -53.34 -9.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.534 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 50' ' ' LEU . 4.2 t -102.3 -24.16 13.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.602 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.23 -31.31 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.587 -179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.519 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -99.28 15.92 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 -179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -128.5 -48.84 1.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -56.78 -33.1 66.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.585 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 2.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.568 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 56' ' ' LYS . . . -146.03 -61.71 0.02 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.91 -63.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 1.0 110.555 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -143.01 9.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.606 -179.969 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.48 114.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.594 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -44.39 -26.77 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.6 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.654 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 3.8 t-80 -117.68 -146.87 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.441 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.654 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 117.968 -1.015 . . . . 1.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' H3 ' ' H ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 3.3 tt0 50.65 89.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.561 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 4.7 pm0 -50.07 -15.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.606 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 2' ' ' GLU . . . 103.9 69.85 0.8 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.15 145.07 24.14 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.3 t0 48.3 33.4 3.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 1.0 110.463 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -158.21 53.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.494 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 10' ' ' TYR . 60.8 m-20 -128.15 40.87 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.491 -179.91 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.8 t-20 79.17 -28.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.0 109.895 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CE1' ' OE1' ' A' ' 16' ' ' GLN . 72.4 m-85 -89.95 -3.74 57.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.641 -0.708 . . . . 1.0 109.445 178.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 14.9 p90 38.18 40.71 0.34 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.848 179.985 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.42 -69.44 0.52 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -164.52 -36.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.814 0.34 . . . . 1.0 110.545 -179.962 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 10.0 t0 64.88 2.52 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.59 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 13' ' ' ALA . 10.1 t30 46.47 94.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.482 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' OE1' ' CE1' ' A' ' 10' ' ' TYR . 1.7 mt-30 -102.68 -47.76 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.618 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 p -130.76 -31.05 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.676 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 45.77 -148.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.535 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.48 11.11 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.78 12.41 28.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.53 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' ' OG1' ' A' ' 22' ' ' THR . 24.4 m-85 -67.8 -84.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.533 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 2.4 m -167.98 43.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.56 6.73 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.554 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -101.66 3.29 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.605 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 9.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.634 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 27' ' ' SER . 0.1 OUTLIER -134.2 -73.58 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.559 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.431 ' N ' ' OG ' ' A' ' 26' ' ' SER . 83.7 p -85.87 41.2 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.549 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.58 37.44 0.19 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.97 -15.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 1.0 110.561 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -136.83 -15.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.642 179.988 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -79.1 -40.29 1.52 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.1 Cg_endo -86.97 25.29 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.461 2.107 . . . . 1.0 112.203 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.07 6.48 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.497 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.463 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -143.96 -42.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 3.3 m-85 -74.94 15.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.528 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.502 ' C ' ' H ' ' A' ' 38' ' ' VAL . 15.1 mmt -132.64 -55.71 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.515 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.98 11.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 36' ' ' MET . 6.3 t -142.25 -56.86 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.584 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.7 -53.75 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.456 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt -105.0 44.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.314 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -162.88 -55.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.371 -179.875 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -73.23 20.22 1.23 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -170.69 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 1.0 110.571 -179.99 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.428 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.7 OUTLIER 50.14 11.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.551 179.985 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 75.44 7.0 82.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.92 -0.54 36.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 1.0 110.54 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.99 -43.4 2.84 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -98.38 29.07 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 1.0 110.512 -179.978 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 21.9 t -141.49 -47.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.434 ' C ' ' N ' ' A' ' 52' ' ' THR . 1.7 tp -97.14 -67.79 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.604 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.62 ' CZ3' ' NE2' ' A' ' 61' ' ' HIS . 46.7 t-105 -44.52 -21.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 50' ' ' LEU . 14.5 t -83.29 25.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.593 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.6 -57.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.605 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -78.61 -1.16 32.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.58 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -100.11 -40.87 7.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.467 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -85.29 -45.76 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.05 1.11 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.536 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.0 79.2 0.3 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -18.98 9.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 1.0 110.57 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -96.95 -29.9 13.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.631 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.62 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 50.9 t-80 59.46 62.19 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.58 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -82.49 60.11 4.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -156.6 76.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.591 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.568 -179.994 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' H2 ' ' H ' ' A' ' 2' ' ' GLU . 2.6 mtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.381 -0.599 . . . . 1.0 109.381 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 6.1 mt-10 55.85 104.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.559 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.64 -97.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.623 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.74 -96.28 0.2 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 45.09 94.1 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -138.91 28.53 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.0 110.617 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -138.9 47.49 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.567 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -120.68 41.68 3.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -139.52 -53.81 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.596 -179.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.82 -29.32 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.553 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.81 58.0 2.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.538 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.4 -37.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -175.98 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 1.0 110.522 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.95 5.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.539 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 13' ' ' ALA . 5.0 t30 -164.95 49.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.61 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -65.79 -31.69 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.965 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 16' ' ' GLN . 3.5 m 179.91 69.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.52 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.5 tt0 -100.16 60.13 1.04 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 1.4 t 76.12 -11.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.507 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 18' ' ' GLU . 1.6 mt-10 -99.18 50.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.494 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -132.8 -30.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.61 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -166.41 -33.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.722 -179.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.63 6.23 7.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.566 -179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -68.5 -12.63 61.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -134.7 1.17 3.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.589 179.953 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.1 t 39.74 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 29' ' ' ALA . 10.5 t -165.05 -38.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.602 -179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.23 13.23 2.06 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -133.04 -8.79 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 1.0 110.418 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.21 -19.78 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.575 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -91.33 -34.54 0.36 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.673 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.58 13.55 2.61 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.203 1.936 . . . . 1.0 112.403 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' C ' ' SD ' ' A' ' 36' ' ' MET . . . -115.44 6.29 14.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.619 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.6 ' N ' ' SD ' ' A' ' 36' ' ' MET . 1.5 pt -140.15 -26.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -71.47 16.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -127.21 -67.13 0.85 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.708 -179.944 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mt -47.38 -13.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 1.0 110.689 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.7 t -102.84 -57.34 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.02 37.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.792 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.9 mt -139.06 -8.44 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.608 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 43' ' ' THR . 28.4 mt -115.77 -41.14 3.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.453 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.54 24.04 3.29 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -166.53 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.12 -0.232 . . . . 1.0 110.583 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.496 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.0 OUTLIER 31.6 67.38 0.14 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.27 -179.998 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 102.35 -59.09 0.57 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 -179.967 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -58.8 -9.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 1.0 110.586 -179.985 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -95.35 -24.63 15.85 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -104.38 23.18 13.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 1.0 110.478 -179.943 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.49 -64.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.716 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -109.76 -35.91 6.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.659 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.515 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 74.5 t-105 -72.63 7.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.492 -179.958 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 50' ' ' LEU . 9.3 t -84.25 -16.85 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.503 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -80.01 -35.86 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.583 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -86.67 4.4 40.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' NH2' ' O ' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -101.59 -64.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.54 -179.948 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -54.49 -33.69 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.559 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -96.58 -5.89 38.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.538 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.31 75.38 0.19 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.006 -0.837 . . . . 1.0 111.006 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -28.52 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 1.0 110.596 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 25.7 m170 -76.23 -120.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.572 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' HIS . 1.2 p-80 -179.09 56.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.58 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 61' ' ' HIS . 27.8 t-80 43.96 94.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.623 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.521 ' CD2' ' H ' ' A' ' 64' ' ' HIS . 2.4 t-160 -134.59 -147.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 1.0 110.415 -180.0 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.521 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.61 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.1 67.62 5.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.551 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 5' ' ' GLY . 11.6 mt-10 -69.92 -76.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.57 3.98 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 3' ' ' GLU . . . 141.65 142.32 4.07 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.25 -61.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.318 . . . . 1.0 110.547 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 54.52 42.99 30.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.99 61.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.545 ' C ' ' H ' ' A' ' 11' ' ' TYR . 2.9 m-20 -166.17 130.74 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' A' ' 11' ' ' TYR . 5.6 t80 68.43 -36.18 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.118 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.545 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER 41.14 39.88 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 1.0 110.687 179.688 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.03 -46.25 3.6 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.96 -90.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 1.0 110.512 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.5 t0 55.4 32.17 18.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.595 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -90.93 11.95 21.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' O ' ' CB ' ' A' ' 17' ' ' SER . 25.6 mm-40 -91.56 4.3 52.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.542 -179.938 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER 164.5 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.584 179.973 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 42.03 35.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.509 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.562 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -141.07 19.31 2.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.592 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 21' ' ' TYR . 8.1 pt-20 36.42 25.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.0 t80 80.68 42.71 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.85 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' CYS . 12.0 p 53.8 29.85 10.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.35 -4.85 26.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.312 179.827 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.46 -9.79 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.383 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.596 ' NZ ' ' H ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -136.03 1.77 2.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.624 179.892 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.2 t 39.87 94.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.808 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.516 ' OG ' ' NZ ' ' A' ' 25' ' ' LYS . 52.8 p -162.94 -35.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.596 ' H ' ' NZ ' ' A' ' 25' ' ' LYS . . . -73.52 19.17 1.53 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -114.23 -1.82 13.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 1.0 110.481 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.68 -25.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -66.74 -41.02 35.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.3 Cg_endo -87.18 16.16 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.549 2.166 . . . . 1.0 112.19 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.79 -36.87 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.549 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 mm -89.36 -31.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.387 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -71.71 13.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 38' ' ' VAL . 28.7 mmm -117.59 -52.61 2.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.434 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.73 12.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.425 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.1 t -134.69 -43.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.469 -179.936 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -63.09 -30.31 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.504 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mt -101.74 52.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.75 -43.94 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.59 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 -16.81 80.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -139.04 -47.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 1.0 110.481 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 46.8 22.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.549 179.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 -12.23 52.7 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 43' ' ' THR . 4.0 m-80 -88.2 3.15 50.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 1.0 110.604 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.15 -39.7 2.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.19 30.58 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 1.0 110.604 -179.996 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.4 t -141.1 -48.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.572 179.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.424 ' C ' ' N ' ' A' ' 52' ' ' THR . 2.7 tt -98.32 -65.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.633 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.441 ' C ' ' H ' ' A' ' 53' ' ' VAL . 56.2 t-105 -46.6 -19.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.55 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.424 ' N ' ' C ' ' A' ' 50' ' ' LEU . 9.9 t -79.06 20.29 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.585 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' A' ' 51' ' ' TRP . 99.2 t -101.75 -64.57 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -83.62 57.27 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.471 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -161.95 -49.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -73.82 -22.57 59.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -70.75 -7.17 42.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.559 -179.985 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.78 96.12 0.11 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -24.05 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 1.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -134.07 -60.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.363 -179.924 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' N ' ' CD2' ' A' ' 60' ' ' HIS . 1.9 m-70 173.46 112.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.593 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 63' ' ' HIS . 10.6 p80 -97.71 -137.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.585 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.524 ' N ' ' CG ' ' A' ' 62' ' ' HIS . 20.6 m-70 -151.6 116.2 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.576 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.579 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 64.46 122.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -99.17 -58.64 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.597 179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.57 51.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.78 -157.84 28.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -138.2 -35.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.731 0.3 . . . . 1.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 11.0 p90 -138.7 50.75 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.555 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.63 62.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' C ' ' CG ' ' A' ' 10' ' ' TYR . 70.7 m-20 -161.01 51.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.241 179.91 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLY . 18.2 p90 36.05 41.82 0.14 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.327 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -34.59 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.259 179.617 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' TYR . . . 40.3 53.38 3.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.98 105.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 1.0 110.524 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 1.9 p-10 -175.62 54.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.511 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.474 ' CG ' ' H ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER -161.71 -113.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.486 179.926 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.638 ' NE2' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER 28.27 51.51 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.714 0.634 . . . . 1.0 111.613 179.952 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 82.19 44.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.184 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ASN . 4.5 tt0 -76.85 144.62 38.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.522 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.0 p -173.71 60.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.614 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -129.36 13.4 6.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.513 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.69 -39.85 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.613 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 24.88 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.511 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -136.96 5.06 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -83.36 6.63 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.14 17.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.593 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 28' ' ' GLY . 2.8 p -145.93 -93.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.583 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -73.57 16.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -139.51 29.7 2.47 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.54 -7.22 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 1.0 110.493 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -20.18 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -69.57 -39.94 13.04 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 69.5 Cg_endo -87.0 2.48 6.98 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.384 2.056 . . . . 1.0 112.28 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.68 -1.04 57.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.625 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.21 -57.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.69 179.962 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 3.4 m-85 -43.22 -31.59 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.495 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.5 mmt -71.52 -33.62 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.419 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 34' ' ' ILE . 6.6 mt -74.24 -4.26 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.668 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.95 -67.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.692 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' TYR . 9.7 t80 -40.89 -50.05 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.605 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mt -102.56 61.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.488 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -170.47 -61.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.265 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.49 27.49 1.05 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -166.49 -90.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 1.0 110.53 179.991 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.497 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER 41.3 22.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.661 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 135.1 -62.83 0.61 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.93 -15.21 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 1.0 110.677 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.72 -26.46 13.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -101.08 15.92 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.72 0.295 . . . . 1.0 110.602 -179.878 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 51' ' ' TRP . 93.3 t -101.9 -60.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.591 -179.969 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 52' ' ' THR . 2.0 pp -62.61 -4.46 2.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.541 -179.982 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.425 ' H ' ' C ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -73.11 16.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.507 179.991 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 50' ' ' LEU . 5.8 t -136.26 14.08 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.445 -179.974 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.3 t -140.65 -35.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.544 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.86 -9.53 18.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -101.95 -41.37 6.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.628 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -52.64 -35.39 54.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.593 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -68.37 -5.97 21.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.607 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.41 -106.37 0.81 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 68.04 -66.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.729 0.299 . . . . 1.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -142.09 9.47 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.63 -179.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' HIS . 7.4 m80 63.82 98.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 51.79 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.936 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.1 t-80 -136.09 -147.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.22 0.533 . . . . 1.0 110.397 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.538 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 9.2 t-160 . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.54 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -99.58 -65.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -170.31 125.33 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.555 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.29 -83.2 0.17 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.86 53.16 6.44 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.17 -16.14 59.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 1.0 110.531 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -138.06 42.19 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.596 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -142.72 45.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.592 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 11' ' ' TYR . 1.1 m-20 -162.38 110.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.421 179.997 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.468 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER 68.91 -38.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.118 179.669 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.526 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER 39.38 94.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 1.0 110.861 179.881 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.85 -64.15 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.78 -87.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.776 0.322 . . . . 1.0 110.496 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 t70 69.61 35.99 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.62 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -100.36 52.43 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 -23.51 38.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.552 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -173.67 27.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.531 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -90.58 96.69 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.624 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.2 t -173.56 -64.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.606 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -91.72 18.72 7.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.593 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -150.05 46.65 0.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.531 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.5 m -158.77 -36.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.643 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.63 26.67 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.573 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -104.91 1.98 29.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.545 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 19.31 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.584 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 28' ' ' GLY . 58.3 m -149.3 -82.26 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.51 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t 50.73 11.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.044 0.449 . . . . 1.0 110.164 -179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 26' ' ' SER . . . 127.81 10.02 3.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.38 -1.088 . . . . 1.0 110.38 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . 80.31 13.23 0.9 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.026 0.441 . . . . 1.0 109.988 -179.548 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 3.8 mm? -65.74 -27.86 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.23 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.445 ' N ' ' CD1' ' A' ' 31' ' ' ILE . 1.6 mp -75.29 -59.68 1.27 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.242 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.86 -13.55 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.732 1.621 . . . . 1.0 111.949 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.85 -3.67 54.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.745 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.98 -53.81 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.543 -179.974 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -42.55 -30.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 mmt -78.45 -32.77 48.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.667 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.6 mt -68.43 -3.53 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.705 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -59.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.629 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' C ' ' H ' ' A' ' 41' ' ' LEU . 62.7 t80 -44.99 -64.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.42 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.9 41.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.508 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 39' ' ' PHE . 31.6 tp -153.95 -40.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.526 -179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.3 -13.29 76.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.834 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -138.27 -46.78 0.52 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.0 110.636 -179.921 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 41.72 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 76.77 -7.38 34.33 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.026 -0.829 . . . . 1.0 111.026 179.907 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -101.6 6.69 42.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 1.0 110.644 179.978 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.63 -45.78 1.61 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.36 27.4 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 1.0 110.499 -179.983 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 4.9 t -141.66 -46.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.565 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tt -93.56 -63.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -53.14 -32.84 49.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -57.16 -30.69 64.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.568 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -53.72 -54.66 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -93.93 62.34 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.603 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.538 ' NH2' ' CD2' ' A' ' 59' ' ' HIS . 1.9 tpm_? -167.36 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.46 179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -17.25 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.536 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -57.9 -38.89 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.545 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 138.0 67.69 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.538 ' CD2' ' NH2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER 45.17 18.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.575 179.962 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 t-80 44.4 38.1 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.553 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.432 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -138.51 41.92 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.546 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -95.71 -52.89 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.555 179.978 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 30.6 p80 40.67 41.07 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.752 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.04 9.25 10.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.527 -179.944 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -169.66 -52.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.573 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.55 75.94 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.65 -155.97 2.03 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.27 9.62 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 1.0 110.574 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -143.18 42.62 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.549 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -148.68 50.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.51 -55.66 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.621 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.02 10.97 14.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.573 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.57 84.25 7.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.588 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.66 68.34 0.85 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . -177.97 -87.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.31 . . . . 1.0 110.604 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t0 52.0 10.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.608 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' ALA . 1.1 m-80 46.77 95.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.586 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -89.39 -43.87 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.523 -179.943 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -166.6 37.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.574 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' C ' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -70.11 169.71 12.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.577 -179.964 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m 47.29 18.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.621 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 18' ' ' GLU . 6.2 mm-40 -136.88 22.71 3.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 22' ' ' THR . 1.7 m-85 -97.27 11.12 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.551 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.434 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 76.55 31.08 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.567 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 p30 -140.59 19.32 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -93.75 -21.1 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.575 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 12.58 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.612 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 28' ' ' GLY . 51.4 m -135.81 -63.78 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.553 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 p -71.65 13.24 0.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.538 -179.97 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -134.07 21.32 3.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.7 -6.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 1.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mt -102.73 -25.53 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.458 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.524 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -93.21 -42.89 0.33 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.266 179.982 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.9 Cg_endo -83.54 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.793 1.662 . . . . 1.0 112.459 -179.13 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.09 -1.31 7.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.322 179.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -148.79 -61.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.544 -179.919 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.536 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -42.35 -26.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.616 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.404 ' C ' ' N ' ' A' ' 38' ' ' VAL . 1.9 mtp -74.41 -55.85 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.422 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.9 mp -48.61 -19.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' A' ' 36' ' ' MET . 2.2 t -97.76 -49.25 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.56 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -47.31 -43.13 22.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.84 52.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -166.87 -62.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.355 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.78 -15.54 4.8 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -139.12 -88.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.336 . . . . 1.0 110.555 -179.943 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.481 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.7 p 64.17 -2.78 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.566 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 84.32 28.72 32.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.22 7.5 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.58 15.55 6.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.1 16.65 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 1.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -143.9 -41.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.461 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.6 tp -94.33 -40.38 9.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.337 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -73.5 -30.11 62.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.263 179.796 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.613 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 9.2 t -82.23 33.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.556 -179.991 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 49' ' ' VAL . 2.5 t -129.4 -6.19 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.284 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.93 12.04 3.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.473 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -124.42 -20.95 5.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -103.06 -16.32 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.578 179.918 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -52.35 -32.07 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.627 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -135.33 -17.38 0.87 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.526 ' NE2' ' O ' ' A' ' 56' ' ' LYS . 10.8 m80 65.22 -68.64 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 1.0 110.533 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 58' ' ' GLY . 25.7 m-70 -142.35 22.02 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 m80 51.78 101.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 41.63 90.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.581 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.521 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.1 OUTLIER -68.37 75.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.595 -179.986 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.608 179.995 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.463 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER -63.43 -13.39 39.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.596 -179.993 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -74.44 52.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.536 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.35 57.33 0.62 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.55 -118.59 3.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.63 7.18 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.347 . . . . 1.0 110.539 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 t80 62.63 42.3 8.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.559 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -149.17 53.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.594 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -142.72 -42.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.54 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -101.12 8.84 42.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.519 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 40.7 40.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 97.42 41.53 3.41 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . 82.18 -28.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.765 0.317 . . . . 1.0 110.277 -179.904 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 59.58 2.14 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.732 179.654 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.509 ' H ' ' C ' ' A' ' 13' ' ' ALA . 10.2 m120 -138.38 78.0 1.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.51 52.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.36 -45.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.557 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 20' ' ' GLU . 21.3 tt0 41.74 56.36 3.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.605 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.8 -8.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.518 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 18' ' ' GLU . 1.8 tp10 -58.62 -22.11 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.555 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -101.31 13.0 36.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -142.18 11.0 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.605 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.04 16.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.573 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -96.04 -5.56 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.98 7.48 43.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.574 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.6 t -141.08 -67.36 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.545 179.939 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.4 p -77.01 52.16 0.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.604 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.1 24.85 0.33 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.54 -5.87 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 1.0 110.601 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -108.57 -29.84 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.291 179.96 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -91.63 -37.93 0.37 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.201 -179.941 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.9 Cg_endo -88.41 12.15 2.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.392 2.061 . . . . 1.0 112.203 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.2 -5.11 44.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.612 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -132.74 -46.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.444 179.912 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -54.87 -52.68 62.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.508 179.781 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.2 mmt -41.34 -54.65 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.03 -38.61 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.951 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 40' ' ' LEU . 1.6 t -83.25 -37.51 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.35 179.537 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.34 19.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.692 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 38' ' ' VAL . 11.3 mt -128.48 34.95 4.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.9 pp -174.05 -42.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.729 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.7 14.55 41.34 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 179.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -157.85 -85.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 1.0 110.416 -179.857 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.434 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER 41.04 22.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.572 179.808 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 136.23 -65.21 0.57 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -46.3 -24.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 1.0 110.563 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.94 -27.76 25.36 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -100.61 13.84 33.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 1.0 110.614 -179.947 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.6 t -101.82 -61.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.601 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.2 -0.52 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.475 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.4 ' CH2' ' CZ ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -80.51 -0.05 35.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.552 -179.962 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -113.81 27.69 9.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.551 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.83 -42.99 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.613 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -103.96 6.91 36.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.605 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.657 ' HE ' ' CE1' ' A' ' 59' ' ' HIS . 11.3 tpt180 -102.43 -63.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.584 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.57 -34.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.557 -179.917 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -62.96 -30.33 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . -175.59 96.52 0.11 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.657 ' CE1' ' HE ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -57.68 -6.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.312 . . . . 1.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.487 ' H ' ' C ' ' A' ' 58' ' ' GLY . 30.3 m-70 -143.37 -55.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' HIS . 35.5 m80 -146.64 113.6 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.58 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.483 ' ND1' ' N ' ' A' ' 62' ' ' HIS . 1.3 m-70 -58.32 79.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.586 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 61' ' ' HIS . 39.5 t-80 43.67 94.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.55 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.403 -0.592 . . . . 1.0 109.403 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 53.22 96.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.567 179.959 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -66.26 -62.34 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.583 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.5 33.29 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.91 -116.81 1.62 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.32 -44.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 1.0 110.592 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER 54.82 43.23 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.531 179.968 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -115.34 39.3 2.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.553 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.51 63.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.61 179.96 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.6 t80 43.93 39.28 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.639 -179.95 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.53 110.01 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.634 -179.977 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.51 0.96 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.877 -0.889 . . . . 1.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -171.95 -54.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 1.0 110.517 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 t70 59.52 51.36 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.497 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.53 127.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.568 179.945 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.66 -45.45 2.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.581 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.66 -22.06 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.79 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 49.15 49.99 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 1.0 110.606 179.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -36.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.522 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.5 51.92 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.547 179.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.48 ' C ' ' NZ ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -144.94 20.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.598 179.997 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 1.4 m -169.35 -33.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.543 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.3 10.43 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.788 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.663 ' HE1' ' NZ ' ' A' ' 25' ' ' LYS . 43.7 p-90 -97.47 -16.95 19.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.455 179.776 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.663 ' NZ ' ' HE1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -121.55 -30.36 4.23 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.411 179.406 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -40.75 -61.57 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.706 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t -87.23 41.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.582 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.64 24.39 1.82 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.94 12.18 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 1.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -153.08 -19.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.58 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -82.65 -41.28 0.9 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.799 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 70.9 Cg_endo -87.33 24.99 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.58 2.187 . . . . 1.0 112.184 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 5.08 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -144.03 -41.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -75.6 26.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.519 ' H ' ' C ' ' A' ' 34' ' ' ILE . 20.7 mmt -135.02 -50.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.588 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.91 8.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.431 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 36' ' ' MET . 4.3 t -137.44 -54.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.548 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.71 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.472 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.24 65.43 9.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.947 0.403 . . . . 1.0 110.11 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -168.59 -47.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.367 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 11.97 56.58 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 45' ' ' GLY . 8.6 t -172.91 -52.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 1.0 110.702 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.469 ' N ' ' CG2' ' A' ' 43' ' ' THR . 1.4 p 57.05 4.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.561 -179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 103.53 -14.61 53.93 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -0.72 57.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 1.0 110.545 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.08 -8.31 63.28 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.66 20.29 2.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.776 0.322 . . . . 1.0 110.597 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' O ' ' CG1' ' A' ' 49' ' ' VAL . 96.7 t -138.31 5.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 tp -133.31 -61.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.427 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -68.22 -8.82 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.424 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -92.08 -9.37 42.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.603 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.09 -43.56 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -84.1 0.85 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.659 -179.998 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.616 ' NH1' ' NE2' ' A' ' 59' ' ' HIS . 61.4 ttt-85 -100.58 -46.18 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.598 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -21.8 62.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.505 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 13.13 35.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.572 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -152.08 -62.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' NE2' ' NH1' ' A' ' 55' ' ' ARG . 0.3 OUTLIER 67.19 -67.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 1.0 110.627 -179.953 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLY . 92.4 m-70 -141.74 -36.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.542 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' O ' ' A' ' 63' ' ' HIS . 14.4 t-160 -98.27 82.47 2.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.577 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -44.7 -40.67 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.597 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.448 ' O ' ' NE2' ' A' ' 61' ' ' HIS . 9.7 m-70 -88.94 81.9 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.511 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.041 -0.98 . . . . 1.0 110.558 -179.978 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 51.5 68.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.559 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -70.83 -8.7 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.16 -84.26 1.49 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.1 14.91 2.23 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -87.29 13.15 10.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.333 . . . . 1.0 110.622 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 53.62 41.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.596 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -154.91 47.67 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.502 179.998 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.07 -17.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.598 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -154.03 9.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -93.2 75.11 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.36 56.91 6.0 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 15' ' ' ASN . . . -171.72 -53.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 1.0 110.547 179.964 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 47.32 16.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.583 -179.989 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.447 ' N ' ' C ' ' A' ' 13' ' ' ALA . 9.3 m120 48.2 96.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.594 -179.969 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 2.2 mp0 -56.36 -54.45 45.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.572 179.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 16' ' ' GLN . 58.8 m -169.74 26.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.595 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -158.29 120.87 3.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 20' ' ' GLU . 24.0 p -165.57 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.492 179.945 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.454 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 3.6 mm-40 -80.76 11.95 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.512 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.5 8.2 1.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.585 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.67 12.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.427 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -94.92 -37.45 11.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.65 -179.975 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -48.48 -14.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.409 -179.924 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -132.17 -1.97 3.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.393 179.687 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.31 107.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 29' ' ' ALA . 5.8 t -173.26 -41.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.407 179.897 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.64 16.24 1.91 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -135.39 -9.52 2.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.733 0.301 . . . . 1.0 110.519 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.5 mt -112.84 -27.01 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.554 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.59 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -72.89 -37.23 3.89 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.258 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.8 Cg_endo -87.36 23.41 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.384 2.056 . . . . 1.0 112.236 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.61 -21.49 4.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.689 -179.957 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 36' ' ' MET . 33.3 mt -104.46 -43.66 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.483 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -75.48 24.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.561 179.957 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.519 ' H ' ' C ' ' A' ' 34' ' ' ILE . 24.7 mmt -111.85 -40.43 4.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.562 179.989 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.77 -35.64 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.571 -179.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 40' ' ' LEU . 9.6 t -78.39 -54.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.554 -179.84 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -44.8 -18.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 1.5 mt -123.41 39.75 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' VAL . 15.1 tp -166.33 -62.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.313 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.45 -8.88 47.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 45' ' ' GLY . 9.9 t -144.64 -49.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.328 . . . . 1.0 110.625 -179.96 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.457 ' N ' ' CG2' ' A' ' 43' ' ' THR . 1.7 p 62.58 -0.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 81.34 20.15 65.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.98 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.412 ' ND2' ' OG1' ' A' ' 44' ' ' THR . 0.6 OUTLIER -118.82 -3.6 10.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.836 0.35 . . . . 1.0 110.468 179.945 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.26 -33.28 10.76 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -104.05 -115.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.661 0.267 . . . . 1.0 110.547 179.892 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.479 ' H ' ' CG ' ' A' ' 48' ' ' LEU . 58.7 t 55.58 -81.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.04 0.448 . . . . 1.0 110.514 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' LEU . 10.6 mt -48.95 -27.76 3.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.849 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.592 ' CH2' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -41.6 -39.33 1.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.639 179.94 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -73.58 18.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.3 t -138.2 -24.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.538 179.941 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -126.17 31.68 5.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.493 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.592 ' NH1' ' CH2' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -139.12 -59.34 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.51 179.957 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HZ2' ' CE ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -55.25 -29.75 58.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.562 -179.934 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' CE ' ' HZ2' ' A' ' 56' ' ' LYS . 1.4 mmtp -49.03 -27.96 3.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.543 179.964 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.13 82.75 0.04 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.563 ' CD2' ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -45.23 -31.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.728 0.299 . . . . 1.0 110.583 179.997 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.563 ' N ' ' CD2' ' A' ' 59' ' ' HIS . 14.4 p80 -56.51 -35.07 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.556 ' N ' ' ND1' ' A' ' 60' ' ' HIS . 19.9 m-70 46.14 62.93 2.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.562 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -154.86 83.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.528 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.6 102.82 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.555 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.607 179.965 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 . . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 1' ' ' MET . 14.3 mt-10 60.41 142.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.524 179.981 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.54 -98.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.495 -179.992 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.22 -108.86 0.21 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . 55.96 19.78 23.95 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER 60.83 3.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 1.0 110.608 179.962 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' A' ' 6' ' ' ASP . 23.5 p90 40.65 34.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.39 47.72 1.68 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.613 -0.722 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -162.21 -75.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.605 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.48 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 t80 -144.92 25.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.581 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.1 p90 38.58 40.84 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.69 -68.66 0.08 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -174.01 -96.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 1.0 110.598 -179.989 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.413 ' OD2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 t0 72.26 22.8 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.51 179.955 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.434 HD22 ' HG ' ' A' ' 19' ' ' CYS . 21.9 t-20 -164.3 66.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.59 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.402 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -70.82 -19.95 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.587 179.944 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 16' ' ' GLN . 1.3 m 168.4 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.585 179.978 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.98 135.41 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.52 179.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.513 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 175.87 73.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.573 -179.99 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.14 9.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.166 179.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 19' ' ' CYS . 3.4 m-85 66.93 92.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.559 179.853 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.2 m 51.21 25.36 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.398 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.86 15.34 2.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -129.84 -0.96 4.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.278 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -154.72 19.15 0.46 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.431 179.611 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.655 ' HG ' ' H ' ' A' ' 27' ' ' SER . 77.4 p -113.33 -108.67 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.655 ' H ' ' HG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER 63.6 -69.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 1.0 109.953 -179.664 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 26' ' ' SER . . . -145.27 11.91 1.81 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.08 -1.208 . . . . 1.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.35 45.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.104 0.478 . . . . 1.0 109.979 -179.511 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 3.4 mm? -83.3 -42.91 16.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.421 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' ALA . 1.5 mp -68.8 -50.63 22.91 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.568 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.84 29.97 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.593 1.529 . . . . 1.0 112.023 179.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.491 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . -136.07 3.67 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.488 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -38.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.564 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 42.3 m-85 -82.09 25.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.506 ' C ' ' H ' ' A' ' 38' ' ' VAL . 16.7 mmt -137.44 -52.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.563 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -68.9 8.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.566 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.3 t -140.3 -52.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.77 -54.71 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.431 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -104.49 45.58 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.423 179.806 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -163.73 -55.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.427 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -71.62 15.91 1.51 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.521 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -168.44 -83.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 1.0 110.599 -179.983 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.427 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.0 OUTLIER 54.33 7.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.564 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 81.55 21.91 61.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -133.83 11.01 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.802 0.334 . . . . 1.0 110.432 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.8 17.9 4.89 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.72 21.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.683 0.278 . . . . 1.0 110.519 -179.977 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.85 -51.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -101.57 -17.8 16.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.62 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -86.68 -11.32 51.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.618 179.913 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 6.4 t -84.64 -27.24 27.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.572 179.959 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -68.66 -23.66 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.9 15.57 23.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.553 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 57' ' ' LYS . 12.6 ttm180 -135.88 -46.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' CG ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -58.86 -5.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.596 179.945 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -100.95 -10.64 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.569 -179.983 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.48 86.89 0.07 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.05 -16.19 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 1.0 110.576 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -59.64 -114.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -138.06 89.14 2.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 101.96 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 2.0 t-80 -134.46 -147.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 1.0 110.415 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.524 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 10.8 t-160 . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.553 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.776 0.322 . . . . 1.0 110.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.54 34.65 1.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.643 ' C ' HD23 ' A' ' 30' ' ' LEU . . . -137.87 -20.11 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 1.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.752 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.39 -17.66 13.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.489 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.28 -39.69 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.166 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.5 Cg_endo -87.86 25.03 0.67 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.555 2.17 . . . . 1.0 112.291 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.85 6.75 5.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.534 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.734 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -139.66 -44.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.543 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.28 8.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.489 ' H ' ' C ' ' A' ' 34' ' ' ILE . 10.4 mmt -101.58 -63.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.58 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.2 15.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 36' ' ' MET . 88.9 t -130.92 -68.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.482 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -41.88 -43.51 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.567 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -103.89 52.83 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.542 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.1 tp -159.55 -62.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.95 9.93 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 1.0 110.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.735 0.302 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.92 38.61 0.11 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.1 -4.49 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.334 . . . . 1.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 -18.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.544 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.9 mm -80.77 -35.58 0.84 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.454 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.87 7.83 4.42 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.403 2.068 . . . . 1.0 112.196 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.31 -0.05 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.669 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.61 -35.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -82.46 30.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.613 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.9 mmt -134.21 -62.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 41' ' ' LEU . 15.2 mt -71.9 13.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.52 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.2 t -137.43 -28.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.512 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.02 27.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 38' ' ' VAL . 1.2 pp -173.66 13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 37' ' ' LEU . 96.1 mt -131.34 -48.46 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.442 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.61 42.63 1.87 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.328 . . . . 1.0 110.486 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.821 0.343 . . . . 1.0 110.606 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.82 34.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.58 17.51 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 1.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.02 -21.61 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -76.4 -35.88 1.65 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.3 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.8 Cg_endo -88.43 3.66 5.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.429 2.086 . . . . 1.0 112.283 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.58 5.05 36.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.825 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 mt -137.22 -35.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -86.45 22.19 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.572 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.3 mmt -136.06 -61.94 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.55 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 41' ' ' LEU . 39.3 mt -60.6 -17.98 50.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -99.24 -51.2 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.611 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -43.5 -46.09 6.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.432 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.76 69.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.468 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -142.28 -58.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.452 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.61 14.62 50.75 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 1.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.812 0.339 . . . . 1.0 110.515 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.44 34.09 0.83 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.83 -31.89 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 1.0 110.657 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.2 -1.82 21.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.548 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.696 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.28 -39.65 0.41 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.293 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.19 24.16 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 1.0 112.145 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.22 5.15 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.568 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 36' ' ' MET . 29.1 pt -131.67 -31.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.666 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 16.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.472 ' C ' ' H ' ' A' ' 38' ' ' VAL . 19.4 mmm -117.2 -57.99 2.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.2 mt -72.48 13.52 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.591 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.6 t -137.9 -21.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.54 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 39' ' ' PHE . 44.5 t80 -91.49 26.77 2.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mt -138.5 -6.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -126.59 -50.16 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.493 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.98 -7.69 0.83 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 110.413 -0.218 . . . . 1.0 110.413 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.757 0.313 . . . . 1.0 110.545 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.43 40.04 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -142.36 -15.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 1.0 110.542 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -137.77 -17.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.621 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 4.0 mm -80.24 -35.62 0.91 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.459 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.4 Cg_endo -87.9 24.29 0.72 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.393 2.062 . . . . 1.0 112.282 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.07 1.69 6.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.521 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -36.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.516 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.81 2.85 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.576 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.6 mmt -101.61 -56.23 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.551 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.77 13.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.537 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -137.15 -74.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.502 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -42.69 -40.38 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -102.19 43.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.597 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.449 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -163.5 -67.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.382 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.02 -15.19 0.34 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.449 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 C-N-CA 121.119 -0.232 . . . . 1.0 110.537 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 1.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.42 33.98 0.77 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.73 -11.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 1.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -1.41 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.591 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.73 -38.88 1.82 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.48 4.6 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.37 2.047 . . . . 1.0 112.202 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.97 3.95 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.549 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 36' ' ' MET . 2.3 mt -140.13 -41.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.446 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.6 m-85 -75.99 26.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.579 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.8 mmt -136.92 -51.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.54 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.22 16.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.549 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' MET . 22.0 t -137.01 -56.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -42.2 -53.36 4.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mt -95.41 60.07 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.573 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -171.11 -62.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.367 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.52 -6.37 1.05 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 1.0 110.594 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.92 38.94 0.84 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.66 -29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 1.0 110.528 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -107.76 -12.64 15.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.587 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.98 -36.06 3.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.315 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.14 25.8 0.65 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.307 2.005 . . . . 1.0 112.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.74 2.12 4.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.558 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -142.83 -44.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.635 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.8 m-85 -79.75 26.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.582 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 17.4 mmt -137.43 -58.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.02 8.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' A' ' 36' ' ' MET . 17.2 t -137.62 -53.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -53.1 -39.68 63.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 mt -101.48 42.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.496 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -159.21 -65.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.8 -13.85 0.34 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.527 0.203 . . . . 1.0 110.493 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.821 0.343 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.75 24.85 1.96 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.37 -0.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 1.0 110.483 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.78 -17.38 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.06 -36.7 4.33 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.235 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.3 Cg_endo -87.47 25.64 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.316 2.011 . . . . 1.0 112.169 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.56 -49.7 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.598 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -99.25 -31.87 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.67 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.551 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.474 ' C ' ' H ' ' A' ' 38' ' ' VAL . 3.2 mtp -136.44 -54.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.52 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.89 2.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 36' ' ' MET . 2.8 t -137.38 -23.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 39' ' ' PHE . 41.9 t80 -88.97 37.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.537 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -136.59 -9.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.2 mt -112.15 -41.96 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.07 39.5 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.558 0.218 . . . . 1.0 110.486 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.784 0.326 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.0 14.65 3.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.879 -0.889 . . . . 1.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.29 3.43 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.277 . . . . 1.0 110.613 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.75 -30.68 6.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.675 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -77.96 -35.98 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.369 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 76.1 Cg_endo -88.74 26.09 0.59 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.413 2.076 . . . . 1.0 112.217 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.44 13.75 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' C ' ' H ' ' A' ' 36' ' ' MET . 10.1 mt -145.51 -46.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.12 4.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.588 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.3 mmt -97.83 -60.38 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.569 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -56.39 -5.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.52 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' MET . 55.8 t -101.82 -56.06 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.451 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -41.83 -41.11 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.63 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mt -103.18 48.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.646 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' THR . 16.7 tp -166.64 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.75 13.85 2.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' LEU . 8.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 1.0 110.7 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.816 0.341 . . . . 1.0 110.511 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.53 24.44 0.58 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.22 -13.11 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.72 0.295 . . . . 1.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.44 ' C ' HD13 ' A' ' 31' ' ' ILE . 1.6 mp -127.51 -1.96 6.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.678 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.45 -39.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.215 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.2 Cg_endo -87.14 7.94 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.444 2.096 . . . . 1.0 112.159 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.39 4.31 41.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.86 -39.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.28 30.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.576 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.5 mmt -133.96 -58.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.543 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.85 20.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.547 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -139.3 -48.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -49.26 -45.66 45.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.5 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -102.55 62.92 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -137.29 -63.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.533 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.82 -8.34 0.58 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 41' ' ' LEU . 1.3 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.56 0.219 . . . . 1.0 110.474 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.67 28.67 2.73 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.51 -15.08 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 1.0 110.469 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -136.34 -9.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.636 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -78.39 -40.11 1.76 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.938 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.6 Cg_endo -86.94 25.07 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.444 2.096 . . . . 1.0 112.2 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.12 6.26 4.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -144.79 -40.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.512 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' ' SD ' ' A' ' 36' ' ' MET . 51.0 m-85 -76.6 26.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.492 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.457 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.0 mmt -136.66 -50.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.28 7.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.555 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.4 t -138.26 -54.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.603 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.59 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.364 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -85.55 64.22 8.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 1.0 110.064 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.9 tp -164.43 -39.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.272 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.38 17.87 58.1 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.716 0.293 . . . . 1.0 110.654 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 44.16 1.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.65 -11.66 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 1.0 110.567 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 pp -138.15 -10.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.632 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -72.72 -41.15 7.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.2 Cg_endo -87.49 25.14 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.504 2.136 . . . . 1.0 112.219 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.68 -48.58 1.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' C ' ' N ' ' A' ' 36' ' ' MET . 1.0 OUTLIER -103.75 -51.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.615 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -46.71 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.447 ' N ' ' C ' ' A' ' 34' ' ' ILE . 2.8 mtp -77.44 -55.69 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.564 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -52.03 -13.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.486 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.4 t -103.21 -47.24 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -49.73 -11.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.676 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 38' ' ' VAL . 2.9 mt -133.2 40.16 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.523 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -164.85 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.25 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.2 -1.98 30.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 1.0 110.589 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.831 0.348 . . . . 1.0 110.498 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 35.13 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 -15.08 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.688 0.28 . . . . 1.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.24 -20.56 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -74.87 -34.73 1.81 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.526 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.9 Cg_endo -88.24 26.54 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.282 1.988 . . . . 1.0 112.01 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.54 -3.39 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.657 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.59 -61.16 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.572 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 39' ' ' PHE . 1.9 m-85 -49.1 -29.78 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.3 mmt -74.8 -23.97 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.662 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -85.03 -6.12 59.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.59 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.86 -67.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.656 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 3.6 t80 -40.75 -48.8 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.655 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 ' SD ' ' A' ' 36' ' ' MET . 4.5 mt -103.39 60.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.533 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -165.29 -62.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.34 10.16 2.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.904 -0.879 . . . . 1.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.455 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 1.0 110.589 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.734 0.302 . . . . 1.0 110.573 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.04 23.72 1.6 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.74 6.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 1.0 110.583 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.42 -28.0 7.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.53 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -81.92 -36.14 0.77 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.361 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.1 Cg_endo -87.35 10.12 3.65 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.274 1.983 . . . . 1.0 112.09 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.1 -2.76 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.595 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.5 -42.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.75 31.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.554 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.428 ' H ' ' C ' ' A' ' 34' ' ' ILE . 18.4 mmt -136.53 -59.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mt -83.82 17.54 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.63 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.17 -11.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.63 14.12 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.34 38.89 3.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.517 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.69 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 43' ' ' THR . . . -94.4 23.55 31.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.41 HG22 ' C ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 1.0 110.398 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.778 0.323 . . . . 1.0 110.647 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.31 41.77 0.75 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 -12.34 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 1.0 110.586 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.586 ' O ' HD11 ' A' ' 34' ' ' ILE . 1.7 mp -113.03 -31.22 6.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.522 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.607 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -78.9 -36.26 1.15 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.377 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.2 Cg_endo -87.2 25.87 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.299 1.999 . . . . 1.0 112.162 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.96 11.52 3.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.583 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -140.0 -40.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.5 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -73.07 10.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.583 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ILE . 7.1 mmt -103.04 -64.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.23 -17.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.632 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.47 ' C ' ' N ' ' A' ' 40' ' ' LEU . 50.7 t -90.04 -57.28 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.09 -15.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.533 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 38' ' ' VAL . 60.5 mt -118.94 41.71 2.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.4 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.37 -44.79 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.2 -10.23 82.77 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 1.0 110.38 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.748 0.309 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.86 36.43 0.23 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.01 -3.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 1.0 110.532 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.41 -19.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.582 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -78.59 -41.17 1.8 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 64.1 Cg_endo -86.91 -16.92 3.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.426 2.084 . . . . 1.0 112.21 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -1.37 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -136.47 -51.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.443 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -53.03 -31.79 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.51 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 32' ' ' PRO . 11.9 mmt -60.61 -59.25 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.553 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mp -46.4 -22.25 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.558 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' LEU . 3.7 t -93.38 -50.46 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.552 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.32 -15.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.1 mt -124.85 37.45 4.4 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.358 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' VAL . 14.7 tp -168.57 -62.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.35 -13.39 43.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 121.132 -0.227 . . . . 1.0 110.773 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.831 0.348 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.96 41.87 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.06 -1.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.704 0.288 . . . . 1.0 110.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.34 -30.3 2.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.617 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -75.44 -34.52 1.61 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.4 Cg_endo -88.0 26.36 0.59 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.265 1.977 . . . . 1.0 112.167 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.48 -2.21 3.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.708 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.9 -33.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.571 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -95.76 25.76 4.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.1 mmt -131.16 -19.77 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.511 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -125.26 19.6 8.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.74 -43.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -54.9 -14.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.666 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -140.64 17.92 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.595 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 tp -138.55 -41.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.251 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.96 2.28 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 1.0 110.607 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.732 0.301 . . . . 1.0 110.572 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.58 4.47 3.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 -6.01 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.673 0.273 . . . . 1.0 110.556 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.69 -17.58 13.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.582 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.9 -39.95 3.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 66.4 Cg_endo -86.89 -0.81 7.99 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.454 2.102 . . . . 1.0 112.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.29 11.12 38.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.552 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.7 mt -137.72 -36.53 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.93 2.75 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.8 mmt -101.7 -54.67 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.78 16.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.89 -70.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -46.07 -46.03 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -100.54 50.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -173.54 -64.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.31 -14.02 0.49 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.423 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 1.0 110.607 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.831 0.348 . . . . 1.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.75 37.1 0.14 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.871 . . . . 1.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.64 6.51 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.3 -27.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.608 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -69.99 -41.19 14.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.1 Cg_endo -87.33 22.3 0.94 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.595 2.197 . . . . 1.0 112.226 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.47 -7.89 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.636 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' MET . 45.6 mt -104.59 -45.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.634 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -70.55 9.25 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ILE . 13.0 mmt -97.27 -62.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.53 -9.08 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 40' ' ' LEU . 92.1 t -98.28 -44.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -78.96 30.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.604 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.7 mt -138.9 6.32 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.41 -40.5 4.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.551 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.73 -3.62 50.41 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.616 0.246 . . . . 1.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.826 0.346 . . . . 1.0 110.586 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.36 31.82 8.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 30' ' ' LEU . . . -163.08 -8.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 1.0 110.55 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.402 ' H ' ' H ' ' A' ' 29' ' ' ALA . 25.6 mt -111.52 -30.3 7.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.681 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.57 -37.89 1.7 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.194 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.1 Cg_endo -88.1 -0.27 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.389 2.059 . . . . 1.0 112.119 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.87 6.91 36.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.653 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -140.41 -51.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.585 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.21 -29.8 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.59 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.431 ' C ' ' N ' ' A' ' 38' ' ' VAL . 23.3 mmt -63.59 -60.38 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.446 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.5 mp -46.92 -17.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.537 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.431 ' N ' ' C ' ' A' ' 36' ' ' MET . 6.5 t -97.81 -52.1 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -42.4 -26.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.504 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -115.83 73.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.09 -57.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 10.58 67.86 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 1.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.712 0.292 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.38 40.35 1.11 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.24 -9.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 1.0 110.544 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.51 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.624 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.4 mm -83.86 -36.02 0.63 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.445 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.0 Cg_endo -88.26 10.75 3.3 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.468 2.112 . . . . 1.0 112.266 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.93 -19.8 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.525 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.474 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -105.52 -44.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.627 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' O ' ' SD ' ' A' ' 36' ' ' MET . 30.0 m-85 -74.21 19.77 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.62 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 18.1 mmt -136.49 -50.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.622 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.86 0.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.8 t -137.43 -54.17 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -49.6 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -98.43 56.1 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -175.05 -64.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -17.33 0.88 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.522 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.33 . . . . 1.0 110.518 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.23 32.88 0.16 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.89 -18.01 0.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.717 0.294 . . . . 1.0 110.578 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.442 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 2.6 mp -112.0 -29.69 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.601 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -75.8 -37.81 2.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.19 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.3 Cg_endo -87.6 26.15 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.461 2.108 . . . . 1.0 112.174 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.25 7.82 3.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -145.32 -39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.609 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.493 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.2 m-85 -79.26 26.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.588 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 19.4 mmt -137.34 -67.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.566 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -47.02 -24.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.572 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.61 -51.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.587 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -41.54 -30.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.465 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.93 80.29 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.411 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 43' ' ' THR . 2.0 mt -159.36 -61.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.56 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 43' ' ' THR . . . -75.44 28.41 1.23 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 1.0 110.539 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.859 0.362 . . . . 1.0 110.332 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.666 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . 151.13 -11.1 0.78 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 82.88 34.56 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.852 0.358 . . . . 1.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -110.74 -26.6 9.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.335 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -77.57 -41.01 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.854 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.5 Cg_endo -86.92 24.78 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.475 2.117 . . . . 1.0 112.168 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.8 5.19 5.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -146.26 -55.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.546 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -60.92 -0.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.472 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.9 mmt -96.97 -50.36 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.544 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 37' ' ' LEU . 9.4 mp -78.82 13.21 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.582 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.4 t -141.31 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.564 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.5 -50.49 16.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mt -99.16 49.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.636 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 43' ' ' THR . 14.9 tp -175.19 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.334 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -49.57 -12.49 0.38 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.788 0.328 . . . . 1.0 110.592 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.58 49.21 0.89 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -137.19 -16.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 1.0 110.622 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -136.3 -18.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -68.68 -39.84 16.04 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.95 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.8 Cg_endo -87.11 25.75 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.126 . . . . 1.0 112.192 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.55 -49.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.496 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 pt -101.09 -32.5 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.602 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.504 ' CE2' ' CD1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -79.04 29.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.6 mtp -127.31 -61.13 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.558 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.97 16.74 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.24 -31.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.643 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 35' ' ' TYR . 30.4 t80 -77.82 -34.84 51.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.645 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.53 26.61 10.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.45 -61.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.176 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 -4.86 69.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 121.088 -0.245 . . . . 1.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.819 0.343 . . . . 1.0 110.594 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -157.03 34.68 0.56 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.58 -6.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.665 0.269 . . . . 1.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HD11 ' A' ' 34' ' ' ILE . 1.7 mt -113.19 -26.73 8.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.609 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -85.87 -34.72 0.5 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.597 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.7 Cg_endo -87.68 25.48 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.258 1.972 . . . . 1.0 112.141 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.32 11.17 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.553 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -150.75 -48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.498 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -73.19 12.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.501 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' VAL . 14.5 mmt -129.68 -38.12 1.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.8 mp -55.41 -6.68 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.618 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.96 -53.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.582 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -21.41 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.588 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mt -136.8 54.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 -46.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.15 34.7 4.9 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 1.0 110.53 179.951 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.772 0.32 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.87 45.84 0.86 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.59 -34.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.739 0.304 . . . . 1.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -106.4 -9.61 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.573 -179.994 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.77 -40.06 3.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.49 25.97 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.498 2.132 . . . . 1.0 112.164 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.8 2.59 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.51 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.43 -61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.594 179.918 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.92 -28.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 36' ' ' MET . 2.9 mmm -75.11 -47.3 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -54.76 -7.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.8 OUTLIER -119.72 -51.54 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.494 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -46.13 -17.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.621 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 38' ' ' VAL . 8.7 mt -136.77 52.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.6 tp -169.8 -59.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.29 40.9 2.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 1.0 110.589 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.839 0.352 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.89 31.62 0.61 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.55 5.9 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 1.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.45 -24.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.568 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -73.84 -41.07 5.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 63.3 Cg_endo -87.03 10.24 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.573 2.182 . . . . 1.0 112.251 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.32 3.63 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.564 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.06 -41.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -67.44 4.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' VAL . 20.3 mmt -100.92 -72.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mt -52.09 -9.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' MET . 76.4 t -101.03 -36.47 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.578 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -93.03 33.98 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.597 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -136.92 0.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -112.29 -41.33 3.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.525 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.91 -3.61 44.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 1.0 110.482 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.877 0.37 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.93 20.34 0.87 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' C ' HD22 ' A' ' 30' ' ' LEU . . . -141.78 -5.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 1.0 110.534 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.74 -38.05 5.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.598 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -82.0 -38.04 0.86 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.245 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.7 Cg_endo -87.31 19.4 1.38 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.402 2.068 . . . . 1.0 112.131 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.16 8.28 13.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.49 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.48 -44.0 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.567 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.56 3.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.3 mmt -100.63 -47.63 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.605 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.31 27.86 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -146.58 -18.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 43' ' ' THR . 34.3 t80 -96.23 -2.13 46.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.678 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.84 40.31 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.494 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.87 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.11 20.75 44.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.377 -1.089 . . . . 1.0 110.377 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 1.0 110.344 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -149.4 31.89 1.14 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.82 -9.09 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 1.0 110.497 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -130.85 -16.56 3.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.62 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -78.29 -34.79 1.09 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.395 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.2 Cg_endo -87.72 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.319 2.013 . . . . 1.0 112.16 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.35 10.55 2.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 36' ' ' MET . 14.0 mt -142.93 -44.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 7.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.511 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 34' ' ' ILE . 12.5 mmt -104.68 -55.18 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.561 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.75 18.01 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 179.944 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' C ' ' N ' ' A' ' 40' ' ' LEU . 57.9 t -135.43 -63.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -47.36 -17.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.566 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 38' ' ' VAL . 3.7 mt -135.72 46.4 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.572 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.9 tp -175.17 -62.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.389 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.42 -10.48 2.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 1.0 110.676 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 28' ' ' GLY . 13.6 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.673 0.273 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.665 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . -130.95 -12.97 2.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 81.19 48.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.941 0.4 . . . . 1.0 110.094 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.877 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -129.09 -27.7 2.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.491 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -80.42 -39.05 1.14 Allowed Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.974 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.7 Cg_endo -86.91 25.25 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.362 2.042 . . . . 1.0 112.175 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.5 -0.7 6.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.49 -45.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.592 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.4 27.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.482 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.2 mmt -135.76 -51.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.519 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 41' ' ' LEU . 8.8 mt -59.45 -2.48 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.1 t -140.32 -61.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -64.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.638 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -100.94 63.86 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 37' ' ' LEU . 15.0 tp -163.74 -65.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.46 -23.62 1.37 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 121.2 -0.2 . . . . 1.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.871 0.367 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.58 37.44 0.19 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -137.97 -15.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 1.0 110.561 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -136.83 -15.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.642 179.988 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -79.1 -40.29 1.52 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.1 Cg_endo -86.97 25.29 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.461 2.107 . . . . 1.0 112.203 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.07 6.48 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.497 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -143.96 -42.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 3.3 m-85 -74.94 15.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.528 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 15.1 mmt -132.64 -55.71 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.515 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.98 11.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' GLY . 6.3 t -142.25 -56.86 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.584 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.7 -53.75 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.456 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt -105.0 44.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.314 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -162.88 -55.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.371 -179.875 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -73.23 20.22 1.23 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 1.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 29' ' ' ALA . 10.5 t . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.833 0.349 . . . . 1.0 110.602 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.23 13.23 2.06 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -133.04 -8.79 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 1.0 110.418 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.21 -19.78 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.575 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -91.33 -34.54 0.36 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.673 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.58 13.55 2.61 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.203 1.936 . . . . 1.0 112.403 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' C ' ' SD ' ' A' ' 36' ' ' MET . . . -115.44 6.29 14.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.619 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.6 ' N ' ' SD ' ' A' ' 36' ' ' MET . 1.5 pt -140.15 -26.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -71.47 16.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.622 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -127.21 -67.13 0.85 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.708 -179.944 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mt -47.38 -13.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 1.0 110.689 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.485 ' N ' ' C ' ' A' ' 36' ' ' MET . 21.7 t -102.84 -57.34 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.02 37.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.792 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.9 mt -139.06 -8.44 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.608 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.4 mt -115.77 -41.14 3.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.453 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.54 24.04 3.29 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 C-N-CA 121.12 -0.232 . . . . 1.0 110.583 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 29' ' ' ALA . 52.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 1.0 110.652 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 19.17 1.53 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -114.23 -1.82 13.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 1.0 110.481 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.68 -25.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -66.74 -41.02 35.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.3 Cg_endo -87.18 16.16 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.549 2.166 . . . . 1.0 112.19 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.79 -36.87 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.549 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.594 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.1 mm -89.36 -31.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.387 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -71.71 13.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.489 ' C ' ' H ' ' A' ' 38' ' ' VAL . 28.7 mmm -117.59 -52.61 2.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.434 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.73 12.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.425 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.1 t -134.69 -43.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.469 -179.936 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -63.09 -30.31 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.504 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mt -101.74 52.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.75 -43.94 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.59 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 -16.81 80.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 1.0 110.481 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.8 0.333 . . . . 1.0 110.603 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.51 29.7 2.47 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.54 -7.22 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 1.0 110.493 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -20.18 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -69.57 -39.94 13.04 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 69.5 Cg_endo -87.0 2.48 6.98 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.384 2.056 . . . . 1.0 112.28 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.68 -1.04 57.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.625 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.21 -57.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.69 179.962 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 3.4 m-85 -43.22 -31.59 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.495 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.51 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.5 mmt -71.52 -33.62 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 34' ' ' ILE . 6.6 mt -74.24 -4.26 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.668 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.95 -67.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.692 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' TYR . 9.7 t80 -40.89 -50.05 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.605 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.51 HD12 ' SD ' ' A' ' 36' ' ' MET . 4.6 mt -102.56 61.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.488 -179.957 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -170.47 -61.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.265 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.49 27.49 1.05 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 1.0 110.53 179.991 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.044 0.449 . . . . 1.0 110.164 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . 127.81 10.02 3.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.38 -1.088 . . . . 1.0 110.38 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 80.31 13.23 0.9 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.026 0.441 . . . . 1.0 109.988 -179.548 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 30' ' ' LEU . 3.8 mm? -65.74 -27.86 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.23 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 31' ' ' ILE . 1.6 mp -75.29 -59.68 1.27 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.242 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 11.5 Cg_endo -54.86 -13.55 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.732 1.621 . . . . 1.0 111.949 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.85 -3.67 54.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.745 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.98 -53.81 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.543 -179.974 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -42.55 -30.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 mmt -78.45 -32.77 48.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.667 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.6 mt -68.43 -3.53 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.705 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -59.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.629 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 41' ' ' LEU . 62.7 t80 -44.99 -64.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.42 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.9 41.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.508 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 39' ' ' PHE . 31.6 tp -153.95 -40.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.526 -179.84 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.3 -13.29 76.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.834 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.0 110.636 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.744 0.307 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.07 21.32 3.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.7 -6.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 1.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 31' ' ' ILE . 3.9 mt -102.73 -25.53 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.458 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.721 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -93.21 -42.89 0.33 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.266 179.982 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.9 Cg_endo -83.54 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.793 1.662 . . . . 1.0 112.459 -179.13 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.09 -1.31 7.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.322 179.798 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -148.79 -61.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.544 -179.919 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -42.35 -26.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.616 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.404 ' C ' ' N ' ' A' ' 38' ' ' VAL . 1.9 mtp -74.41 -55.85 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.422 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.9 mp -48.61 -19.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.582 179.911 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' A' ' 36' ' ' MET . 2.2 t -97.76 -49.25 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.56 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -47.31 -43.13 22.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.84 52.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -166.87 -62.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.355 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.78 -15.54 4.8 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.336 . . . . 1.0 110.555 -179.943 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.79 0.329 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.1 24.85 0.33 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' C ' HD22 ' A' ' 30' ' ' LEU . . . -143.54 -5.87 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 1.0 110.601 -179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.869 HD22 ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -108.57 -29.84 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.291 179.96 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -91.63 -37.93 0.37 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.201 -179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.9 Cg_endo -88.41 12.15 2.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.392 2.061 . . . . 1.0 112.203 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.2 -5.11 44.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.612 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.868 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -132.74 -46.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.444 179.912 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -54.87 -52.68 62.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.508 179.781 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.2 mmt -41.34 -54.65 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.03 -38.61 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.951 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 40' ' ' LEU . 1.6 t -83.25 -37.51 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.35 179.537 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.34 19.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.692 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 38' ' ' VAL . 11.3 mt -128.48 34.95 4.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 42' ' ' GLY . 1.9 pp -174.05 -42.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.729 179.806 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 41' ' ' LEU . . . -83.7 14.55 41.34 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 179.756 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 1.0 110.416 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.807 0.337 . . . . 1.0 110.582 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.64 24.39 1.82 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.94 12.18 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 1.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -153.08 -19.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.58 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -82.65 -41.28 0.9 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.799 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 70.9 Cg_endo -87.33 24.99 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.58 2.187 . . . . 1.0 112.184 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 5.08 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.533 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.03 -41.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -75.6 26.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.481 ' H ' ' C ' ' A' ' 34' ' ' ILE . 20.7 mmt -135.02 -50.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.588 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.91 8.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.431 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 36' ' ' MET . 4.3 t -137.44 -54.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.548 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.71 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.472 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -85.24 65.43 9.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.947 0.403 . . . . 1.0 110.11 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -168.59 -47.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.367 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 11.97 56.58 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 1.0 110.702 -179.976 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 29' ' ' ALA . 5.8 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 1.0 110.407 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.64 16.24 1.91 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -135.39 -9.52 2.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.733 0.301 . . . . 1.0 110.519 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.5 mt -112.84 -27.01 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.554 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.59 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -72.89 -37.23 3.89 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.258 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.8 Cg_endo -87.36 23.41 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.384 2.056 . . . . 1.0 112.236 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.61 -21.49 4.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.689 -179.957 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 36' ' ' MET . 33.3 mt -104.46 -43.66 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.483 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -75.48 24.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.561 179.957 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 34' ' ' ILE . 24.7 mmt -111.85 -40.43 4.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.562 179.989 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.77 -35.64 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.571 -179.912 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 40' ' ' LEU . 9.6 t -78.39 -54.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.554 -179.84 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -44.8 -18.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 1.5 mt -123.41 39.75 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' VAL . 15.1 tp -166.33 -62.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.313 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.45 -8.88 47.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.328 . . . . 1.0 110.625 -179.96 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . -145.27 11.91 1.81 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.08 -1.208 . . . . 1.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 69.35 45.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.104 0.478 . . . . 1.0 109.979 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 30' ' ' LEU . 3.4 mm? -83.3 -42.91 16.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.421 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 33' ' ' ALA . 1.5 mp -68.8 -50.63 22.91 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.568 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 57.3 Cg_endo -72.84 29.97 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.593 1.529 . . . . 1.0 112.023 179.98 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . -136.07 3.67 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.488 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -38.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.564 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 42.3 m-85 -82.09 25.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.7 mmt -137.44 -52.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.563 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -68.9 8.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.566 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.3 t -140.3 -52.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.77 -54.71 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.431 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -104.49 45.58 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.423 179.806 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -163.73 -55.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.427 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -71.62 15.91 1.51 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 1.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 50.79 69.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.9 -68.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.598 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 45.36 58.46 5.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.58 109.49 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.26 -78.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 1.0 110.574 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -139.15 47.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -139.04 44.14 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 5.4 m120 -155.83 109.71 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.593 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.0 t80 44.88 20.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.619 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 9' ' ' ASN . 28.6 m-85 -96.22 70.8 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.01 -78.46 0.31 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -171.47 -85.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 1.0 110.555 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 2.8 t0 74.39 17.65 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.587 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 50.42 98.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.55 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.5 -35.8 17.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.02 17.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.582 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.479 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 1.9 tp10 -45.59 -62.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.607 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER 49.56 21.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.525 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.34 15.65 2.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.567 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -100.98 -28.44 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.623 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.67 18.58 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.588 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -125.38 -19.26 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.616 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 p-90 -53.83 -8.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.447 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -135.56 1.17 2.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.59 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 40.24 83.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.711 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -139.51 5.72 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.54 34.65 1.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.643 ' C ' HD23 ' A' ' 30' ' ' LEU . . . -137.87 -20.11 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 1.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.752 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.39 -17.66 13.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.489 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.28 -39.69 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.166 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.5 Cg_endo -87.86 25.03 0.67 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.555 2.17 . . . . 1.0 112.291 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.85 6.75 5.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.534 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.734 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -139.66 -44.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.543 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.28 8.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.489 ' H ' ' C ' ' A' ' 34' ' ' ILE . 10.4 mmt -101.58 -63.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.58 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.2 15.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 36' ' ' MET . 88.9 t -130.92 -68.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.482 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -41.88 -43.51 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.567 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -103.89 52.83 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.542 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.1 tp -159.55 -62.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.95 9.93 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -163.97 -56.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 1.0 110.573 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 43' ' ' THR . 1.3 p 58.41 3.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.587 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 89.49 7.25 69.56 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -100.88 -9.47 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 1.0 110.564 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 51' ' ' TRP . . . -92.11 -34.01 7.41 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.18 26.2 7.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 1.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' O ' HG22 ' A' ' 52' ' ' THR . 54.0 t -137.87 -35.54 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.577 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.2 tp -96.49 -59.3 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.599 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -41.75 -27.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.617 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 15.2 t -56.59 -42.19 78.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.581 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.529 ' N ' HG23 ' A' ' 52' ' ' THR . 21.1 t -47.99 -42.35 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.25 14.62 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 52' ' ' THR . 2.6 ttp180 -135.38 -34.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.14 -12.42 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -52.18 -31.52 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.544 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.5 79.18 0.08 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -41.75 -34.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 1.0 110.556 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.613 ' CD2' ' H ' ' A' ' 61' ' ' HIS . 2.1 p-80 -67.41 -93.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.613 ' H ' ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -154.54 113.09 3.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.638 ' CD2' ' H ' ' A' ' 63' ' ' HIS . 40.1 p-80 -83.67 -127.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.544 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.638 ' H ' ' CD2' ' A' ' 62' ' ' HIS . 13.7 t-80 43.44 42.22 3.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.005 -0.997 . . . . 1.0 110.592 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -84.85 -127.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -144.16 -89.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.26 81.19 1.41 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.27 131.07 10.45 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 10.9 p-10 -173.97 -37.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 1.0 110.575 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 61.57 53.46 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -149.94 54.45 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' C ' ' N ' ' A' ' 11' ' ' TYR . 2.0 m-80 -155.8 116.69 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.547 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.506 ' CD1' ' OD2' ' A' ' 14' ' ' ASP . 6.4 t80 44.78 19.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.571 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' N ' ' C ' ' A' ' 9' ' ' ASN . 20.5 m-85 -98.66 89.57 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.546 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 145.95 -57.7 0.51 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 175.38 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 1.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' OD2' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER 47.19 16.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.518 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.449 ' N ' ' C ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -79.24 -17.36 54.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.547 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -82.33 57.75 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.546 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 p -149.07 -47.12 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 42.93 -155.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.62 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER 73.4 32.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.574 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -50.39 -11.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.468 ' H ' ' C ' ' A' ' 19' ' ' CYS . 5.2 m-85 -47.56 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -165.72 30.1 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.579 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.72 13.07 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -95.7 5.58 51.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -146.11 16.0 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.547 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 28' ' ' GLY . 28.6 t -144.56 -99.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 m -73.23 44.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.522 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -174.92 38.61 0.11 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.1 -4.49 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.334 . . . . 1.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 -18.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.544 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.9 mm -80.77 -35.58 0.84 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.454 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.87 7.83 4.42 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.403 2.068 . . . . 1.0 112.196 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.31 -0.05 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.669 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.61 -35.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -82.46 30.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.613 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.9 mmt -134.21 -62.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 41' ' ' LEU . 15.2 mt -71.9 13.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.52 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.2 t -137.43 -28.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.512 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.02 27.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 38' ' ' VAL . 1.2 pp -173.66 13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 37' ' ' LEU . 96.1 mt -131.34 -48.46 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.442 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.61 42.63 1.87 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 45' ' ' GLY . 3.8 t -162.11 -26.97 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.328 . . . . 1.0 110.486 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 44' ' ' THR . 1.5 t -71.13 40.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.638 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 80.37 28.33 48.77 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -134.89 1.26 3.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 1.0 110.564 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.565 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -105.0 -40.33 2.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.683 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.48 21.59 11.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.765 0.317 . . . . 1.0 110.467 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.71 -38.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.545 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.69 -66.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.566 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -50.06 -28.31 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.554 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -66.25 -29.79 70.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.51 -22.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -0.86 36.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -100.67 -40.86 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.63 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -23.15 67.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -61.72 -35.33 77.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.56 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.78 99.84 0.2 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.4 -24.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 1.0 110.528 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.405 ' C ' ' CG ' ' A' ' 61' ' ' HIS . 1.8 p-80 -75.64 17.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.433 ' H ' ' C ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER 56.23 105.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.564 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -84.34 48.08 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.528 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -147.33 93.59 2.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.595 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 35.4 mp0 -137.97 56.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -81.4 -37.04 28.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.551 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -148.51 65.83 0.4 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.91 89.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 4' ' ' GLY . 1.1 t70 73.03 37.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 1.0 110.578 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -147.28 41.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.55 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.0 41.31 3.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.541 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.415 ' C ' ' N ' ' A' ' 11' ' ' TYR . 53.7 t-20 -138.57 -120.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.608 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -47.27 -19.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.5 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' N ' ' C ' ' A' ' 9' ' ' ASN . 96.4 m-85 -73.88 56.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.67 -65.79 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.08 82.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 1.0 110.514 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.35 30.91 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 58.68 78.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.491 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' A' ' 17' ' ' SER . 4.2 mp0 -87.37 58.22 4.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.633 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 1.8 p 80.11 -19.71 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.388 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.1 tp10 41.36 -164.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.8 OUTLIER 76.7 3.95 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.614 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -98.42 21.12 11.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.624 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.448 ' C ' HG23 ' A' ' 22' ' ' THR . 0.2 OUTLIER -83.76 22.83 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.568 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 ' C ' ' A' ' 21' ' ' TYR . 2.0 p 62.39 41.49 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.578 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.07 10.35 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.546 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.545 ' NE1' ' NZ ' ' A' ' 25' ' ' LYS . 21.9 p-90 -98.56 4.1 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' NZ ' ' NE1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -151.15 16.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.561 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -55.12 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 m -73.92 55.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.606 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.82 34.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.58 17.51 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 1.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.02 -21.61 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -76.4 -35.88 1.65 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.3 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.8 Cg_endo -88.43 3.66 5.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.429 2.086 . . . . 1.0 112.283 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.58 5.05 36.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.825 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 mt -137.22 -35.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -86.45 22.19 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.572 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.3 mmt -136.06 -61.94 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.55 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 41' ' ' LEU . 39.3 mt -60.6 -17.98 50.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -99.24 -51.2 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.611 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -43.5 -46.09 6.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.432 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.76 69.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.468 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -142.28 -58.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.452 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.61 14.62 50.75 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -159.94 -49.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 1.0 110.554 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 42.98 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.575 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 102.5 -31.75 8.36 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -69.18 -4.62 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 1.0 110.594 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.89 -13.81 60.29 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.45 21.32 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.08 -42.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.522 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.06 -44.81 5.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.413 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.423 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -61.38 -24.54 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.57 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -76.22 -29.55 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.496 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 55' ' ' ARG . 58.0 t -54.28 -62.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -73.01 39.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.467 ' H ' ' C ' ' A' ' 53' ' ' VAL . 5.3 ttt180 -148.91 -47.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.544 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -20.77 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.616 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -60.58 -22.05 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.546 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.39 69.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 11.7 m170 41.94 71.02 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 1.0 110.507 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 27.2 p80 40.57 35.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.706 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m170 54.51 105.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.566 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -146.33 104.67 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.531 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -96.29 87.14 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.53 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -100.87 68.73 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -96.82 -5.91 37.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.585 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.45 -138.66 3.68 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.74 108.52 3.55 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -90.7 21.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.805 0.336 . . . . 1.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 5.5 p90 -148.1 56.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.568 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.61 45.61 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.577 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.53 -71.89 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.621 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.481 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 72.2 t80 -146.8 9.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.4 p90 38.8 40.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.664 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -165.15 -56.9 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 163.47 -22.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.673 0.273 . . . . 1.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLN . 11.9 t70 66.68 60.28 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.397 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -40.69 91.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.587 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.66 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -78.25 14.74 1.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.545 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 m -138.38 -49.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.595 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -80.13 61.86 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.599 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -99.41 -9.81 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.519 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.0 -0.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.625 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.482 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -49.58 -53.55 23.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.561 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.84 15.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.57 10.48 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.629 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -84.73 4.11 34.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -151.58 15.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.65 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.62 13.18 2.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.01 29.83 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.515 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.44 34.09 0.83 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.83 -31.89 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 1.0 110.657 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.2 -1.82 21.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.548 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.696 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.28 -39.65 0.41 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.293 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.19 24.16 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 1.0 112.145 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.22 5.15 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.568 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 36' ' ' MET . 29.1 pt -131.67 -31.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.666 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 16.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.472 ' C ' ' H ' ' A' ' 38' ' ' VAL . 19.4 mmm -117.2 -57.99 2.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.2 mt -72.48 13.52 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.591 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.6 t -137.9 -21.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.54 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.472 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 44.5 t80 -91.49 26.77 2.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mt -138.5 -6.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -126.59 -50.16 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.493 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.98 -7.69 0.83 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.6 HG23 ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -135.39 -105.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.413 -0.218 . . . . 1.0 110.413 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.6 ' H ' HG23 ' A' ' 43' ' ' THR . 4.5 t 33.27 48.87 0.18 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.98 -0.555 . . . . 1.0 111.234 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 104.16 -50.03 0.89 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 43' ' ' THR . 54.2 m-20 -51.93 -10.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 1.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -92.41 -34.86 6.82 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.1 mt -82.09 17.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 1.0 110.476 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -137.21 -34.86 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.03 -59.12 1.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.694 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -62.02 -19.65 63.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.523 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -73.71 -31.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.18 -36.1 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.42 16.58 14.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.523 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -129.43 -40.24 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.371 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -8.85 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -54.48 -33.02 59.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.579 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.71 85.22 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.66 -22.38 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 1.0 110.576 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -139.75 -36.39 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.537 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -71.94 42.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.557 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -47.4 -86.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.527 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -156.48 117.44 3.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.613 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.545 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.76 30.18 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.406 ' O ' ' OD2' ' A' ' 8' ' ' ASP . 2.7 mt-10 49.28 58.32 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.582 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.81 -71.03 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 42.79 -120.57 2.61 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.851 -0.899 . . . . 1.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.31 13.72 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 1.0 110.567 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -139.02 43.16 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.533 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD2' ' O ' ' A' ' 3' ' ' GLU . 31.4 t0 -147.14 55.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.605 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.2 -30.65 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.543 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 8.2 t80 -83.81 -11.91 56.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.571 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -63.43 77.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.564 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' TYR . . . 153.66 -76.12 0.22 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -161.68 -37.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 1.0 110.634 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 4.6 t0 75.18 14.19 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 48.71 90.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.561 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -66.49 -19.57 65.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.616 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.92 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 20' ' ' GLU . 5.1 pt-20 -69.99 -167.73 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.619 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 54.49 8.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 18' ' ' GLU . 3.6 tt0 -95.8 60.52 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -138.58 12.89 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.589 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 76.56 37.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.522 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.85 17.46 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -101.13 6.34 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.54 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.68 16.18 1.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.593 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 27' ' ' SER . 1.1 p -137.97 -53.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.541 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -101.05 14.05 33.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.545 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.43 40.04 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -142.36 -15.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 1.0 110.542 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -137.77 -17.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.621 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 4.0 mm -80.24 -35.62 0.91 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.459 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.4 Cg_endo -87.9 24.29 0.72 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.393 2.062 . . . . 1.0 112.282 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.07 1.69 6.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.521 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -36.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.516 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.81 2.85 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.576 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.6 mmt -101.61 -56.23 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.551 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.77 13.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.537 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -137.15 -74.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.502 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -42.69 -40.38 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -102.19 43.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.597 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -163.5 -67.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.382 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.02 -15.19 0.34 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.703 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -138.3 -95.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.119 -0.232 . . . . 1.0 110.537 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.703 ' H ' HG23 ' A' ' 43' ' ' THR . 4.7 t 33.59 48.73 0.21 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.226 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 104.7 -46.89 1.12 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.921 -0.871 . . . . 1.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' THR . 1.5 m-20 -74.88 23.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 1.0 110.559 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.565 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -138.11 -33.27 0.2 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -99.49 33.32 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 1.0 110.615 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 45' ' ' GLY . 97.6 t -126.7 -60.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.724 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.88 -36.6 6.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.572 ' CZ2' ' CE1' ' A' ' 54' ' ' PHE . 76.2 t-105 -78.61 11.85 2.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.454 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -96.76 -26.46 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.534 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.88 -62.01 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.558 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.572 ' CE1' ' CZ2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -53.6 -26.67 22.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.584 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -86.28 -38.14 17.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.564 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -48.43 -22.0 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.573 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -68.02 -31.78 71.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.566 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . 138.01 115.21 1.33 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -7.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 1.0 110.605 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.417 ' H ' ' C ' ' A' ' 58' ' ' GLY . 22.2 m170 -89.49 -0.96 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 47.85 88.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -102.21 91.34 4.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -159.29 79.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.558 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.094 -0.955 . . . . 1.0 110.543 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -51.19 -69.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.643 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -164.71 23.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.552 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.99 116.34 0.7 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.08 77.15 2.06 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.05 14.69 28.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.807 0.337 . . . . 1.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -153.76 48.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.602 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -149.54 44.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.636 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 11' ' ' TYR . 19.8 t-20 -154.47 115.78 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.57 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 t80 44.29 20.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.576 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' ASN . 2.2 m-85 -144.31 111.64 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.555 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.7 -42.47 1.98 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.7 30.75 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 1.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -137.64 4.07 2.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.546 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 5.9 p30 -149.86 56.32 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.519 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 16' ' ' GLN . 1.5 mp0 -70.05 -49.65 49.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.588 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 m -157.01 20.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.599 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.453 ' C ' ' H ' ' A' ' 20' ' ' GLU . 4.7 mt-10 -152.16 -178.44 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.578 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER 62.87 -0.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.587 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 18' ' ' GLU . 2.5 tt0 -83.24 43.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.549 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -149.42 95.3 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.568 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.425 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 72.1 p 47.84 31.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -124.66 -19.82 5.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.594 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -53.71 -8.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.445 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -135.97 1.82 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.652 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.2 p 40.07 66.61 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.768 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.433 ' C ' ' HZ3' ' A' ' 25' ' ' LYS . 10.7 p -146.8 21.82 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.611 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' N ' ' HZ3' ' A' ' 25' ' ' LYS . . . -153.42 33.98 0.77 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.73 -11.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 1.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -1.41 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.591 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.73 -38.88 1.82 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.48 4.6 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.37 2.047 . . . . 1.0 112.202 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.97 3.95 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.549 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 36' ' ' MET . 2.3 mt -140.13 -41.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.446 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.6 m-85 -75.99 26.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.579 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.8 mmt -136.92 -51.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.54 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.22 16.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.549 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' MET . 22.0 t -137.01 -56.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -42.2 -53.36 4.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mt -95.41 60.07 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.573 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -171.11 -62.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.367 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.52 -6.37 1.05 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.537 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -143.47 -91.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 1.0 110.594 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.537 ' H ' HG23 ' A' ' 43' ' ' THR . 1.0 OUTLIER 54.11 7.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.565 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 85.38 27.13 33.92 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 3.22 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 1.0 110.581 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.596 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -104.63 -23.05 8.1 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.752 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -115.35 14.56 16.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.777 0.322 . . . . 1.0 110.56 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -132.1 -34.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.609 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.0 tt -101.9 -67.64 0.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.574 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' O ' ' CD2' ' A' ' 51' ' ' TRP . 5.6 t-105 -51.03 -33.43 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.64 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -60.31 -20.55 59.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.522 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 96.2 t -60.13 -29.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.548 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.45 14.46 31.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.403 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.29 -54.44 3.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.63 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -62.74 -34.41 77.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.62 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -76.23 -21.74 56.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' A' ' 60' ' ' HIS . . . 179.72 92.18 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -19.4 62.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.0 110.626 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.538 ' CG ' ' H ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -74.03 -116.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.568 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.538 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 6.1 p-80 179.31 83.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 62' ' ' HIS . 55.1 t-80 -96.7 10.75 37.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.542 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' HIS . 21.6 t-80 45.92 97.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.618 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.541 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.46 101.53 13.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.515 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -44.02 -56.94 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.565 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.15 -120.71 4.68 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.71 -157.8 7.36 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.33 -43.58 7.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 1.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 t80 56.73 46.5 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.634 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -148.22 56.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' TYR . 46.4 t30 -151.36 70.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.609 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER 41.08 21.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.736 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.2 OUTLIER 43.58 40.46 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.573 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.4 31.43 0.62 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.3 -81.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 1.0 110.583 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.7 t0 70.07 33.37 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.614 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -139.41 55.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.56 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.48 ' CD ' ' H ' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -82.66 -21.09 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.591 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -163.14 50.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.531 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -101.32 -56.55 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.588 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -101.68 -9.75 20.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.565 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -83.28 17.04 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.573 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.455 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -82.1 2.05 33.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.583 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 77.27 41.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.591 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 19.17 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.557 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -97.93 -8.09 28.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.591 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -101.45 10.79 40.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.566 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 28' ' ' GLY . 8.0 m -161.7 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 57.9 7.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.549 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -150.92 38.94 0.84 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.66 -29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 1.0 110.528 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -107.76 -12.64 15.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.587 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.98 -36.06 3.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.315 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.14 25.8 0.65 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.307 2.005 . . . . 1.0 112.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.74 2.12 4.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.558 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -142.83 -44.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.635 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.8 m-85 -79.75 26.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.582 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 17.4 mmt -137.43 -58.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.02 8.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' A' ' 36' ' ' MET . 17.2 t -137.62 -53.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -53.1 -39.68 63.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 mt -101.48 42.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.496 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -159.21 -65.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.8 -13.85 0.34 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.642 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -139.43 -100.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.527 0.203 . . . . 1.0 110.493 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.642 ' H ' HG23 ' A' ' 43' ' ' THR . 4.7 t 33.43 47.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.202 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 101.96 -47.32 1.17 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' THR . 1.2 m-20 -60.19 -5.56 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 1.0 110.498 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -103.64 -61.63 0.69 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -77.55 44.19 0.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 1.0 110.548 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 45' ' ' GLY . 25.2 t -138.34 -48.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.584 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 pp -101.68 -26.05 13.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.591 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.32 -18.54 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.606 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -70.73 -28.87 65.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.553 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t -61.51 -47.89 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -8.29 34.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.568 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -100.82 -47.03 4.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.574 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -47.71 -19.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -53.57 -22.8 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.575 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 142.26 53.6 0.04 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.931 -0.868 . . . . 1.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 14.7 m170 47.6 67.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 1.0 110.536 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 20.9 p80 40.96 25.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.658 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.482 ' C ' ' H ' ' A' ' 63' ' ' HIS . 1.5 t-160 -148.28 104.41 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.635 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 8.2 m80 -75.14 33.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.529 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 30.6 p80 40.68 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.721 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.558 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtp . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.19 147.12 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.585 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -99.81 23.19 10.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.8 -60.02 0.65 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.5 -167.51 29.15 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.3 -33.43 10.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.815 0.34 . . . . 1.0 110.579 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -141.89 45.2 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.514 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -122.24 41.18 3.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.598 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 11' ' ' TYR . 84.3 m-20 -138.06 -82.44 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.581 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -72.99 14.67 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.624 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 9' ' ' ASN . 39.6 m-85 -147.48 86.33 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 149.67 -47.62 0.62 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 176.46 77.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 1.0 110.564 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.75 -62.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.616 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -179.23 69.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.576 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -89.05 12.89 14.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.614 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.8 OUTLIER 82.7 50.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.247 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 3.8 tt0 -130.72 58.89 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.479 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 71.29 -5.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.475 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -84.69 50.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.513 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -155.43 54.85 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.423 HG22 ' HZ1' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 69.61 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.555 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -159.44 20.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.589 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -101.47 -18.29 16.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.586 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' HZ1' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER -100.83 16.12 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.577 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 28' ' ' GLY . 34.0 t -165.21 -80.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.567 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 t -73.13 38.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.579 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -144.75 24.85 1.96 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.37 -0.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 1.0 110.483 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.78 -17.38 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.06 -36.7 4.33 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.235 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.3 Cg_endo -87.47 25.64 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.316 2.011 . . . . 1.0 112.169 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.56 -49.7 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.598 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -99.25 -31.87 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.67 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.551 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.474 ' C ' ' H ' ' A' ' 38' ' ' VAL . 3.2 mtp -136.44 -54.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.52 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.89 2.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 36' ' ' MET . 2.8 t -137.38 -23.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.471 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 41.9 t80 -88.97 37.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.537 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 44' ' ' THR . 2.3 mt -136.59 -9.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.54 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.2 mt -112.15 -41.96 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.07 39.5 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -137.93 -100.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.558 0.218 . . . . 1.0 110.486 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.626 ' H ' HG23 ' A' ' 43' ' ' THR . 4.9 t 33.72 37.92 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.211 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 141.63 -62.77 0.52 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 43' ' ' THR . 8.0 p-10 -75.84 10.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 1.0 110.527 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.26 3.98 51.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.83 7.01 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 1.0 110.554 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 45' ' ' GLY . 92.9 t -95.72 -54.87 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.543 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -23.44 14.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.576 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.502 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 2.5 t-105 -77.25 -13.94 59.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.589 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.7 -20.41 64.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 t -79.71 -29.79 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.586 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -1.45 58.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -101.21 -49.11 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.551 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -51.22 -18.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -54.22 -38.07 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.554 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 170.67 63.52 0.04 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.1 m170 56.92 -79.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.798 0.332 . . . . 1.0 110.713 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 m-70 -98.79 -75.45 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.507 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -161.64 100.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.527 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -145.17 112.04 5.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.553 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.78 72.37 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.53 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.7 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 68.24 1.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.604 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.76 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.07 134.21 1.64 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.02 77.58 0.1 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 3.9 m-20 -139.74 31.41 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 1.0 110.549 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 6' ' ' ASP . 48.7 m-85 -161.96 57.03 0.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -138.64 41.71 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.539 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.42 ' O ' ' CE2' ' A' ' 11' ' ' TYR . 71.3 m-80 -102.4 -73.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.522 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.452 ' C ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 m-85 -93.63 0.98 56.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.479 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.452 ' CD2' ' C ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER 48.13 41.0 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.611 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.07 31.15 0.46 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.07 75.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 1.0 110.613 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.35 -40.46 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.538 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -78.33 104.08 8.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' O ' ' CB ' ' A' ' 17' ' ' SER . 6.5 mt-30 -93.58 50.23 1.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.561 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 79.51 19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.464 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -50.15 157.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.504 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.5 t 76.94 -15.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.565 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 18' ' ' GLU . 9.6 tt0 41.67 22.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 27.8 m-85 55.31 64.44 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.496 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 6.5 p 53.38 40.79 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.647 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.32 2.52 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.338 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -81.86 5.28 19.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.508 ' CD ' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.12 0.34 3.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 t -99.57 -48.36 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -86.33 29.53 0.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.59 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.0 14.65 3.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.879 -0.889 . . . . 1.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.29 3.43 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.277 . . . . 1.0 110.613 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.75 -30.68 6.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.675 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -77.96 -35.98 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.369 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 76.1 Cg_endo -88.74 26.09 0.59 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.413 2.076 . . . . 1.0 112.217 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.44 13.75 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' C ' ' H ' ' A' ' 36' ' ' MET . 10.1 mt -145.51 -46.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.12 4.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.588 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.3 mmt -97.83 -60.38 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.569 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -56.39 -5.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.52 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' MET . 55.8 t -101.82 -56.06 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.451 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -41.83 -41.11 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.63 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mt -103.18 48.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.646 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' THR . 16.7 tp -166.64 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.75 13.85 2.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.616 HG23 ' N ' ' A' ' 44' ' ' THR . 8.9 t -171.19 -48.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 1.0 110.7 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER 50.68 10.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.497 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.686 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 91.76 -10.59 74.24 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -76.66 -11.28 59.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 1.0 110.514 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.832 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -88.18 -15.36 60.85 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.832 HD23 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -118.93 19.47 13.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 1.0 110.483 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 45' ' ' GLY . 45.3 t -117.55 -57.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.809 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.26 -35.93 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.81 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -76.59 -42.24 43.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.519 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -45.85 -21.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.485 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' A' ' 51' ' ' TRP . 53.9 t -72.26 -50.47 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.588 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -67.59 -12.42 60.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -101.69 -35.33 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.599 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -50.76 -41.16 56.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.594 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -58.06 -17.99 21.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.55 76.6 0.21 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.0 110.609 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.567 ' CE1' ' CB ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -150.57 -54.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.568 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.567 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 1.5 t-80 -171.24 104.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.6 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -67.68 -47.92 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.563 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 42.22 61.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.517 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.586 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mmm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.56 116.35 17.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.588 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -95.69 19.12 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.39 -77.31 0.33 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 7' ' ' PHE . . . 159.16 -97.62 0.16 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.68 -17.11 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 1.0 110.507 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 5' ' ' GLY . 4.3 m-85 62.72 42.25 8.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.566 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -153.81 58.4 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.595 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.37 -16.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -146.18 -9.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.42 76.37 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 137.82 -79.58 0.3 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 174.66 71.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 1.0 110.595 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -72.7 -52.18 16.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.527 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 17' ' ' SER . 0.9 OUTLIER -172.08 54.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.549 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -67.41 6.75 0.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.588 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 80.62 45.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.488 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 2.4 tt0 -69.89 -165.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 23.1 m 56.82 43.26 25.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.561 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 22' ' ' THR . 2.2 mm-40 -85.66 10.44 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.523 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER 60.93 1.12 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.572 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 20' ' ' GLU . 63.9 p -150.89 14.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.51 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' C ' ' N ' ' A' ' 25' ' ' LYS . 48.1 t0 -134.15 -39.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -47.6 -15.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.371 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -133.95 0.67 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.38 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 23' ' ' ASP . 1.3 m 38.32 61.59 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.935 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.88 34.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.53 24.44 0.58 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.22 -13.11 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.72 0.295 . . . . 1.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.44 ' C ' HD13 ' A' ' 31' ' ' ILE . 1.6 mp -127.51 -1.96 6.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.678 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.45 -39.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.215 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.2 Cg_endo -87.14 7.94 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.444 2.096 . . . . 1.0 112.159 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.39 4.31 41.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.86 -39.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.28 30.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.576 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.5 mmt -133.96 -58.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.543 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.85 20.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.547 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -139.3 -48.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -49.26 -45.66 45.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.5 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -102.55 62.92 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -137.29 -63.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.533 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.82 -8.34 0.58 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.667 HG23 ' H ' ' A' ' 44' ' ' THR . 1.3 t -135.97 -108.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.56 0.219 . . . . 1.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.667 ' H ' HG23 ' A' ' 43' ' ' THR . 4.8 t 33.7 40.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.22 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.61 27.03 5.91 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -133.88 -32.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 1.0 110.631 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.35 -3.28 69.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.58 34.96 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 1.0 110.492 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.17 -53.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.602 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.98 -25.8 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.609 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.421 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -73.74 -25.73 60.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.519 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 53' ' ' VAL . 15.4 t -67.65 -37.73 82.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.481 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.436 ' N ' HG23 ' A' ' 52' ' ' THR . 60.4 t -47.73 -61.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.596 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -72.77 54.65 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -163.21 -48.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -15.97 55.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -62.6 -35.04 78.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.548 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 155.56 58.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 56.01 -80.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 1.0 110.643 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 58' ' ' GLY . 7.5 m170 -99.83 -74.62 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -157.41 106.54 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.551 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -64.26 -18.81 64.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.563 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.494 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 2.0 t-80 -134.45 -147.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.133 0.492 . . . . 1.0 110.404 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.494 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 17.5 m-70 . . . . . 0 C--N 1.322 -0.609 0 CA-C-O 118.056 -0.973 . . . . 1.0 110.572 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' C ' ' H ' ' A' ' 3' ' ' GLU . 7.4 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.86 40.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.61 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 1' ' ' MET . 2.7 pt-20 -82.07 -14.61 55.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.543 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.72 -108.53 0.25 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.29 -79.53 0.07 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 7' ' ' PHE . 1.4 p-10 -101.31 -77.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.882 0.373 . . . . 1.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 57.8 m-85 54.53 42.84 31.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.625 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 t0 54.38 48.18 21.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.526 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.443 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 48.22 13.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.631 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' N ' ' C ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -137.77 95.97 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.8 -53.43 0.72 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.3 19.92 16.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 1.0 110.595 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -1.4 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.553 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 3.6 p-10 -144.97 70.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.56 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -41.5 16.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.567 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 p -91.47 12.82 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.539 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -138.17 94.6 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.594 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' TYR . 2.0 p -138.97 7.8 2.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -72.0 13.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.576 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -75.53 23.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.528 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.604 ' CG2' ' HZ1' ' A' ' 25' ' ' LYS . 0.2 OUTLIER 76.37 36.37 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.579 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.59 19.42 2.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.584 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -99.26 7.58 45.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.604 ' HZ1' ' CG2' ' A' ' 22' ' ' THR . 0.1 OUTLIER -139.27 13.01 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.579 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 28' ' ' GLY . 64.9 m -137.7 -89.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 p -76.19 26.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.57 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -137.67 28.67 2.73 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.51 -15.08 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 1.0 110.469 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -136.34 -9.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.636 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -78.39 -40.11 1.76 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.938 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.6 Cg_endo -86.94 25.07 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.444 2.096 . . . . 1.0 112.2 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.12 6.26 4.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -144.79 -40.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.512 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' ' SD ' ' A' ' 36' ' ' MET . 51.0 m-85 -76.6 26.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.492 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.457 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.0 mmt -136.66 -50.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.28 7.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.555 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.4 t -138.26 -54.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.603 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.59 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.364 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -85.55 64.22 8.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 1.0 110.064 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.9 tp -164.43 -39.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.272 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.38 17.87 58.1 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.653 HG23 ' N ' ' A' ' 44' ' ' THR . 8.9 t -173.04 -52.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.716 0.293 . . . . 1.0 110.654 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.653 ' N ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER 42.64 21.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.522 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 103.83 -32.73 7.23 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.566 ' ND2' ' O ' ' A' ' 43' ' ' THR . 12.2 p30 -66.23 -6.62 14.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 1.0 110.544 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.52 -14.6 59.71 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.81 45.93 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.585 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 45' ' ' GLY . 38.9 t -134.04 -64.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.403 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -56.91 -5.04 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.62 ' CH2' ' NE ' ' A' ' 55' ' ' ARG . 2.6 m95 -64.83 1.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.519 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.529 HG23 HG23 ' A' ' 53' ' ' VAL . 13.1 t -121.39 24.64 9.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.463 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 HG23 ' A' ' 52' ' ' THR . 83.6 t -152.95 -44.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.92 13.96 31.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.647 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' NE ' ' CH2' ' A' ' 51' ' ' TRP . 4.8 tpt180 -134.73 -35.02 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.477 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -23.48 66.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 12.92 36.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.561 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.0 -56.96 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.444 ' O ' ' CG ' ' A' ' 60' ' ' HIS . 23.2 m170 54.24 36.1 24.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.66 0.267 . . . . 1.0 110.541 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.726 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 51.2 p-80 38.46 94.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.0 m170 45.23 74.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -60.81 -64.53 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.528 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -146.81 93.63 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.575 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' OXT' ' CG ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.583 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -63.75 137.28 58.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.599 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -89.39 -44.18 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.74 -83.01 0.56 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.439 ' C ' ' N ' ' A' ' 7' ' ' PHE . . . -171.88 -46.14 0.04 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 47.89 16.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 1.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' N ' ' C ' ' A' ' 5' ' ' GLY . 13.6 t80 -152.36 44.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.571 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.39 41.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.507 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -101.36 -89.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.482 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 1.1 t80 -88.43 1.4 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.482 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.5 p90 38.72 40.4 0.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.83 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -165.9 -65.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 170.85 -37.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 1.0 110.555 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 t0 74.3 24.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.51 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 17' ' ' SER . 27.2 m120 -142.68 18.06 2.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.565 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -72.43 13.47 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.534 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -100.92 -50.17 3.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.615 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 41.82 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.57 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' TYR . 6.3 t -168.18 60.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.58 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 21' ' ' TYR . 3.6 tp10 -72.06 43.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' CYS . 31.2 m-85 54.63 108.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.515 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.3 -2.5 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.597 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 35.1 t0 -105.74 27.72 8.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -101.25 -4.52 26.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -137.91 10.91 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.541 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -98.14 -62.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.536 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.37 19.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.538 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -138.03 44.16 1.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.65 -11.66 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 1.0 110.567 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 pp -138.15 -10.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.632 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -72.72 -41.15 7.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.2 Cg_endo -87.49 25.14 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.504 2.136 . . . . 1.0 112.219 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.68 -48.58 1.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' C ' ' N ' ' A' ' 36' ' ' MET . 1.0 OUTLIER -103.75 -51.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.615 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -46.71 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.447 ' N ' ' C ' ' A' ' 34' ' ' ILE . 2.8 mtp -77.44 -55.69 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.564 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -52.03 -13.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.486 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.4 t -103.21 -47.24 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -49.73 -11.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.676 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 38' ' ' VAL . 2.9 mt -133.2 40.16 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.523 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -164.85 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.25 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.2 -1.98 30.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.532 ' HB ' HD21 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -144.62 -59.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 1.0 110.589 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.446 HG23 ' C ' ' A' ' 43' ' ' THR . 1.2 p 57.19 4.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.605 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 93.32 13.81 55.13 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.473 ' C ' ' ND2' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -103.92 -18.72 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.402 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -102.84 -16.01 22.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.926 -0.869 . . . . 1.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -96.89 20.22 11.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.737 0.303 . . . . 1.0 110.458 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 2.3 t -103.46 -64.13 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.752 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -112.61 -36.69 5.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.704 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.527 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 21.7 t-105 -67.14 -9.15 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.421 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -61.62 -30.67 70.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.568 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 55' ' ' ARG . 6.0 t -72.03 -45.88 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.556 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.39 13.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 53' ' ' VAL . 40.3 ttt-85 -137.56 -35.15 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.712 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -52.13 -12.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.607 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' N ' ' C ' ' A' ' 55' ' ' ARG . 8.8 mmtp -69.3 -15.71 63.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . 161.06 105.49 0.2 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.4 ' ND1' ' O ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -58.52 -4.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 1.0 110.571 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 58' ' ' GLY . 42.3 m-70 -81.07 -92.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.561 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 98.9 m-70 -155.45 73.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -70.69 61.96 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.585 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -97.48 42.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.598 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 m170 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.06 -0.971 . . . . 1.0 110.609 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 54.44 93.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.587 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.14 14.25 32.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.558 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.02 -131.94 0.39 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.25 92.52 0.12 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -145.89 -57.29 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 1.0 110.488 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER 63.91 44.68 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.547 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -121.84 41.29 3.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -137.9 -74.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.557 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.472 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 24.1 m-85 -98.42 -18.48 18.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.532 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.4 p90 38.7 40.74 0.43 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.859 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.7 -53.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.491 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . -98.35 34.96 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.44 21.69 13.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.592 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.42 46.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.656 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 13' ' ' ALA . 2.1 mt-30 -131.54 34.73 3.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' GLU . 21.7 m -137.91 -43.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.535 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.444 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER 45.28 96.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.648 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 95.2 m -155.73 20.09 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.507 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -98.87 38.18 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.59 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.74 -64.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.55 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -158.82 34.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.11 17.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.565 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 24' ' ' TRP . 20.5 p-90 -99.5 -20.97 16.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.595 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -100.81 14.89 30.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.512 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 28' ' ' GLY . 0.6 OUTLIER -147.93 -74.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.572 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t -75.56 27.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.498 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -137.79 35.13 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 -15.08 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.688 0.28 . . . . 1.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.24 -20.56 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -74.87 -34.73 1.81 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.526 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.9 Cg_endo -88.24 26.54 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.282 1.988 . . . . 1.0 112.01 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.54 -3.39 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.657 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.59 -61.16 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.572 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 39' ' ' PHE . 1.9 m-85 -49.1 -29.78 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.3 mmt -74.8 -23.97 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.662 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -85.03 -6.12 59.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.59 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.86 -67.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.656 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 3.6 t80 -40.75 -48.8 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.655 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 ' SD ' ' A' ' 36' ' ' MET . 4.5 mt -103.39 60.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.533 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -165.29 -62.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.34 10.16 2.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.904 -0.879 . . . . 1.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.496 ' C ' HG23 ' A' ' 44' ' ' THR . 0.2 OUTLIER -162.66 -64.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 1.0 110.589 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.496 HG23 ' C ' ' A' ' 43' ' ' THR . 1.8 p 63.84 -2.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.52 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 82.04 27.67 44.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -134.53 0.77 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 1.0 110.582 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -104.11 -40.56 2.25 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -99.29 21.35 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 1.0 110.446 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.56 -42.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.591 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 53' ' ' VAL . 38.7 tp -97.56 -68.74 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.453 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -46.0 -26.37 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.572 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -68.52 -35.31 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 50' ' ' LEU . 64.7 t -52.04 -69.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.574 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -72.0 59.56 0.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.01 -66.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.643 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -14.6 24.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.639 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -51.6 -38.61 55.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.566 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 154.78 31.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.511 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 9.7 m80 62.58 -71.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 1.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 58' ' ' GLY . 29.5 m170 -69.65 1.46 4.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 31.6 m170 50.21 90.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.566 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -154.09 55.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -99.65 89.61 4.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.502 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.524 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ttm . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.44 -5.82 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.577 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 59.46 17.55 6.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.534 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.84 126.56 1.01 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.73 91.45 0.08 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -148.31 12.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 1.0 110.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 18.4 p90 -160.52 62.56 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.504 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -156.87 60.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.571 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.513 ' O ' ' CE1' ' A' ' 11' ' ' TYR . 20.8 p30 -101.94 -108.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.412 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.485 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 46.0 m-85 -65.6 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.474 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER 59.22 41.76 19.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.606 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.619 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 166.31 -62.58 0.22 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 165.58 -63.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 1.0 110.612 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.82 51.05 6.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.569 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.08 -1.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.614 ' NE2' ' N ' ' A' ' 17' ' ' SER . 1.2 pm0 -49.22 -21.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.614 ' N ' ' NE2' ' A' ' 16' ' ' GLN . 1.9 m -167.68 64.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.586 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.474 ' C ' ' H ' ' A' ' 21' ' ' TYR . 67.5 m 55.83 14.92 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -64.05 2.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.508 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -75.17 31.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.515 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 20' ' ' GLU . 2.5 p 61.64 44.56 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.573 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 7.8 p-10 -137.77 5.14 2.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.54 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -92.36 4.32 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.529 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -152.13 16.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.567 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 28' ' ' GLY . 6.9 t -138.68 -93.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.2 m -76.11 30.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -147.04 23.72 1.6 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.74 6.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 1.0 110.583 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.42 -28.0 7.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.53 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -81.92 -36.14 0.77 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.361 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.1 Cg_endo -87.35 10.12 3.65 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.274 1.983 . . . . 1.0 112.09 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.1 -2.76 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.595 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.5 -42.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.75 31.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.554 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.428 ' H ' ' C ' ' A' ' 34' ' ' ILE . 18.4 mmt -136.53 -59.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mt -83.82 17.54 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.63 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.17 -11.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.63 14.12 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.34 38.89 3.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.517 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.69 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 43' ' ' THR . . . -94.4 23.55 31.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -169.12 -84.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 1.0 110.398 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 0.6 OUTLIER 49.79 10.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.663 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.542 ' O ' HG21 ' A' ' 49' ' ' VAL . . . 74.55 27.11 66.02 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' A' ' 44' ' ' THR . 57.5 p30 -138.76 4.98 2.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 1.0 110.551 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.646 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -106.6 -38.61 2.2 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.742 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -103.5 19.7 19.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 1.0 110.606 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 45' ' ' GLY . 61.3 t -102.71 -64.34 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.697 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -110.64 -35.94 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 43.2 t-105 -68.66 -7.95 37.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.499 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -63.53 -36.78 84.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' ARG . 12.4 t -61.16 -71.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.559 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -42.58 -21.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.604 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.1 tpt180 -82.67 -53.47 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.573 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -63.03 -36.03 82.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.639 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -50.81 -37.14 40.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.535 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.5 86.52 0.1 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.4 -10.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 1.0 110.612 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.0 -75.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.614 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -171.45 118.13 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.62 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -100.76 -65.85 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -135.75 -147.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.137 0.494 . . . . 1.0 110.452 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.566 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' C ' ' H ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 4' ' ' GLY . 5.6 tp10 65.0 -0.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 1' ' ' MET . 20.3 mp0 54.03 12.28 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.587 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 2' ' ' GLU . . . 45.06 88.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.54 17.88 49.22 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -33.14 10.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 1.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.432 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 36.1 t80 -125.67 42.85 3.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.423 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.69 46.25 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.575 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' TYR . 25.2 m120 -149.12 -57.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.62 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -73.56 14.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.642 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.449 ' H ' ' C ' ' A' ' 9' ' ' ASN . 77.9 m-85 -137.84 94.41 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.84 30.97 37.15 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 9' ' ' ASN . . . -174.49 73.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 1.0 110.575 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 12.5 p-10 -163.75 59.9 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.583 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 2.0 m-20 52.29 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.582 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.74 44.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.623 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 t -96.84 -1.67 45.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.01 94.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.626 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 p -141.77 15.69 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.595 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.29 56.94 3.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.595 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.19 -37.22 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.578 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -139.12 12.03 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.567 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -138.23 26.37 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -100.22 -12.76 19.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.501 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.83 11.23 39.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.564 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 28' ' ' GLY . 30.9 t -142.36 -86.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.568 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.66 18.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -151.31 41.77 0.75 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 -12.34 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 1.0 110.586 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' O ' HD11 ' A' ' 34' ' ' ILE . 1.7 mp -113.03 -31.22 6.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.522 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.607 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -78.9 -36.26 1.15 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.377 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.2 Cg_endo -87.2 25.87 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.299 1.999 . . . . 1.0 112.162 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.96 11.52 3.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.583 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -140.0 -40.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.5 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -73.07 10.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.583 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ILE . 7.1 mmt -103.04 -64.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.23 -17.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.632 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' C ' ' N ' ' A' ' 40' ' ' LEU . 50.7 t -90.04 -57.28 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.09 -15.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.533 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 38' ' ' VAL . 60.5 mt -118.94 41.71 2.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.4 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.37 -44.79 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.2 -10.23 82.77 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -133.94 -52.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 1.0 110.38 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 40.26 22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.804 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 98.81 31.24 6.4 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' THR . 44.9 m-80 -136.36 -34.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 1.0 110.507 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.75 -2.19 90.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.5 mt -95.12 -26.48 16.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.578 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 51' ' ' TRP . 4.5 t -74.63 -58.57 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.675 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.71 9.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.643 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.458 ' H ' ' C ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -85.86 -8.54 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 52' ' ' THR . 4.9 t -103.6 22.37 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.572 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.27 -55.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.538 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.02 47.03 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.547 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -145.9 -59.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.721 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.5 -48.74 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.614 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -62.15 -26.11 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.338 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 61' ' ' HIS . . . 135.66 107.25 0.88 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.415 ' CE1' ' ND1' ' A' ' 60' ' ' HIS . 3.5 p80 -41.2 -27.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 1.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.462 ' O ' ' CB ' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -81.25 -44.04 18.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.53 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' HIS . 5.7 t-80 78.22 41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.644 ' CG ' ' H ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -66.21 -112.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.488 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.644 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 6.6 m80 -113.02 -146.61 0.41 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.14 0.495 . . . . 1.0 110.462 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.491 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.14 111.42 5.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -42.53 -41.93 3.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.556 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.59 -83.91 0.24 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.98 -57.33 0.17 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 69.27 14.82 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.313 . . . . 1.0 110.52 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 t80 64.74 43.07 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.593 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.24 56.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 11' ' ' TYR . 3.0 t30 -158.7 120.34 3.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.58 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.4 t80 45.36 17.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.609 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.473 ' N ' ' C ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -103.57 92.06 4.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.471 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 101.65 -68.63 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.931 -0.868 . . . . 1.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 164.38 85.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.313 . . . . 1.0 110.551 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -99.83 -57.92 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.594 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -175.33 97.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.599 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.33 -29.78 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 p -178.51 56.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 4.9 mt-10 -154.37 -176.71 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.549 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 1.1 t 78.32 -15.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.578 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -97.91 3.09 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.585 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.509 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 68.9 t80 -149.36 14.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.624 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.494 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 3.0 p -137.69 22.03 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.599 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -128.53 -8.63 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.686 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -66.22 -8.84 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HZ3' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -132.25 -3.08 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.575 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 t 40.12 60.55 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.761 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -150.78 34.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.497 ' N ' ' HZ3' ' A' ' 25' ' ' LYS . . . -166.86 36.43 0.23 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.01 -3.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 1.0 110.532 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.41 -19.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.582 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -78.59 -41.17 1.8 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 64.1 Cg_endo -86.91 -16.92 3.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.426 2.084 . . . . 1.0 112.21 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -1.37 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -136.47 -51.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.443 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -53.03 -31.79 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.51 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 32' ' ' PRO . 11.9 mmt -60.61 -59.25 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.553 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mp -46.4 -22.25 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.558 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' LEU . 3.7 t -93.38 -50.46 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.552 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.32 -15.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.1 mt -124.85 37.45 4.4 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.358 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' VAL . 14.7 tp -168.57 -62.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.35 -13.39 43.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 45' ' ' GLY . 5.5 t -150.17 -44.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.132 -0.227 . . . . 1.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER 33.02 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.304 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -45.02 -62.26 3.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.56 -2.16 8.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 1.0 110.127 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.85 -23.52 32.73 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.6 41.64 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 1.0 110.605 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 45' ' ' GLY . 38.5 t -135.05 -61.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.538 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -101.39 -15.82 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.56 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -81.63 -32.02 32.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.537 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -49.27 -33.25 12.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 t -57.36 -55.98 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.499 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -79.46 47.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.555 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -152.87 -49.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.561 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -20.96 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.586 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -48.66 -20.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -170.19 30.77 0.14 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.48 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 1.0 110.668 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 24.6 m80 -139.22 -44.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.603 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 0.6 OUTLIER 170.2 130.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.479 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.64 -97.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 44.31 43.58 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.039 -0.982 . . . . 1.0 110.589 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -140.13 -34.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.594 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -166.4 115.83 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.557 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.35 -127.26 1.04 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.45 85.66 0.04 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -165.38 34.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -154.11 56.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.574 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -155.26 53.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.521 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -138.2 -62.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.604 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -77.18 3.81 11.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.578 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -76.45 68.13 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.587 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.33 -80.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -163.27 72.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 1.0 110.513 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.54 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 2.7 p-10 -86.93 -43.48 12.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.547 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -178.29 98.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.577 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -92.96 20.75 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.569 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 1.7 p 79.67 25.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.449 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.2 tt0 -70.24 155.32 40.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.595 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 69.19 -8.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.542 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 18' ' ' GLU . 10.7 tt0 -82.49 61.07 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.583 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -138.48 -66.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.593 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m -164.72 34.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.579 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 19' ' ' CYS . 19.8 p30 -139.73 12.45 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.557 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -101.06 5.32 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -150.26 16.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.585 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 27' ' ' SER . 11.8 t -155.99 -108.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.597 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 46.67 18.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.594 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 26' ' ' SER . . . -167.96 41.87 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.06 -1.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.704 0.288 . . . . 1.0 110.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.34 -30.3 2.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -75.44 -34.52 1.61 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.4 Cg_endo -88.0 26.36 0.59 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.265 1.977 . . . . 1.0 112.167 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.48 -2.21 3.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.708 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.9 -33.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.571 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -95.76 25.76 4.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.1 mmt -131.16 -19.77 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.511 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -125.26 19.6 8.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.74 -43.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -54.9 -14.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.666 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -140.64 17.92 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.595 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 tp -138.55 -41.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.251 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.96 2.28 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' GLY . 14.9 t -170.52 -31.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 1.0 110.607 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.417 ' H ' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -42.55 -21.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.56 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 137.8 33.43 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -137.76 21.94 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 1.0 110.499 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.3 2.91 3.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.15 14.07 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.694 0.283 . . . . 1.0 110.569 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 53' ' ' VAL . 59.5 t -132.28 -33.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.491 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 tp -98.14 -49.23 4.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.356 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CH2' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -62.25 -12.99 23.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.495 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 t -96.17 -15.29 22.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.639 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 49' ' ' VAL . 42.5 t -72.57 -51.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.728 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.52 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 1.8 p90 -79.35 21.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.668 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.602 ' NH1' ' CH2' ' A' ' 51' ' ' TRP . 0.4 OUTLIER -123.96 -49.03 1.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.549 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -18.67 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.679 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -72.88 -19.12 61.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.579 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 158.68 94.5 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.487 ' CD2' ' HE ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -41.07 -23.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.78 0.324 . . . . 1.0 110.573 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -138.71 5.95 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.531 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 63.1 128.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.54 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -147.45 111.88 5.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.55 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.536 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 1.3 t-80 -134.57 -147.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 1.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 20.2 p-80 . . . . . 0 C--N 1.321 -0.64 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 73.82 -46.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.576 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 55.29 100.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.607 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.18 0.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 44.94 35.35 4.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.14 -65.25 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 1.0 110.567 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 53.35 41.82 32.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.49 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -122.19 41.14 3.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 11' ' ' TYR . 1.2 m120 -157.59 111.88 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.565 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 43.68 23.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.592 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' ASN . 1.9 m-85 -139.59 103.69 4.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.616 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 -34.72 2.01 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' ND2' ' A' ' 15' ' ' ASN . . . -178.51 -82.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.8 0.334 . . . . 1.0 110.535 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 49.99 24.59 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.546 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 11.4 p30 -142.81 59.44 1.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -62.36 -48.71 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.62 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.22 6.79 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.575 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -84.76 87.33 7.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.557 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p -178.19 57.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.0 -9.21 28.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.574 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -42.14 -66.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.588 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -146.43 12.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.59 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.6 15.92 27.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.614 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -91.35 4.22 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.524 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -151.87 15.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.579 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 -48.86 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.593 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.8 p -86.19 28.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.572 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.58 4.47 3.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 -6.01 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.673 0.273 . . . . 1.0 110.556 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.69 -17.58 13.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.582 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.9 -39.95 3.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 66.4 Cg_endo -86.89 -0.81 7.99 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.454 2.102 . . . . 1.0 112.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.29 11.12 38.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.552 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.7 mt -137.72 -36.53 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.93 2.75 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.8 mmt -101.7 -54.67 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.78 16.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.89 -70.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -46.07 -46.03 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -100.54 50.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -173.54 -64.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.31 -14.02 0.49 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -138.09 -98.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 1.0 110.607 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.563 ' H ' HG23 ' A' ' 43' ' ' THR . 1.3 p 58.66 3.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.621 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 136.83 -25.66 3.06 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.02 -12.93 52.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 1.0 110.559 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -88.37 -9.89 69.0 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.742 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -116.66 -6.69 11.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.749 0.309 . . . . 1.0 110.462 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.63 -45.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.639 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tt -93.16 -65.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.612 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.426 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 1.1 t-105 -44.74 -37.21 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.601 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -55.97 -33.61 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.598 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.08 -38.03 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.593 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -84.44 9.26 13.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.545 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.86 -68.6 0.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.519 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -53.96 -30.15 45.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -89.56 -9.73 48.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.82 97.7 0.17 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.611 ' CG ' ' N ' ' A' ' 60' ' ' HIS . 19.7 p-80 -171.81 -48.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 1.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.611 ' N ' ' CG ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -101.61 -14.13 17.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.581 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.538 ' CG ' ' H ' ' A' ' 62' ' ' HIS . 4.7 t-80 -108.64 -148.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.563 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.538 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 26.1 t-80 44.1 95.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.537 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 64' ' ' HIS . 6.4 p-80 -110.35 -146.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.165 0.507 . . . . 1.0 110.514 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.549 ' N ' ' CG ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -85.01 14.52 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.508 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 42.55 65.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.538 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.01 92.19 0.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.81 96.38 0.26 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.02 -34.18 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 1.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 54.81 44.41 28.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.569 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.46 49.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.521 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.71 49.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.566 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' CD2' ' OD1' ' A' ' 14' ' ' ASP . 6.2 t80 43.18 29.96 0.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER 49.24 42.54 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.607 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 165.21 -64.19 0.23 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 163.64 -39.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 1.0 110.542 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.494 ' OD1' ' CD2' ' A' ' 10' ' ' TYR . 1.3 t70 76.86 -14.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.543 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 13' ' ' ALA . 7.8 m120 -92.53 75.39 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.528 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.66 -42.88 6.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.593 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 t -157.11 54.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.6 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -102.02 -21.94 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.578 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' C ' ' H ' ' A' ' 21' ' ' TYR . 6.2 t -165.39 65.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.436 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' C ' ' CG ' ' A' ' 21' ' ' TYR . 19.4 mt-10 -71.5 40.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 69.35 -62.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.652 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.76 35.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.473 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 -5.61 4.5 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.62 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -65.43 -9.3 24.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.479 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -130.81 -3.72 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.54 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.8 p 40.22 72.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.654 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.8 p -158.82 25.08 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.614 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.75 37.1 0.14 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.871 . . . . 1.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.64 6.51 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.3 -27.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.608 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -69.99 -41.19 14.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.1 Cg_endo -87.33 22.3 0.94 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.595 2.197 . . . . 1.0 112.226 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.47 -7.89 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.636 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' MET . 45.6 mt -104.59 -45.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.634 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -70.55 9.25 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ILE . 13.0 mmt -97.27 -62.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.53 -9.08 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 40' ' ' LEU . 92.1 t -98.28 -44.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -78.96 30.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.604 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.7 mt -138.9 6.32 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.41 -40.5 4.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.551 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.73 -3.62 50.41 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.657 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -137.66 -99.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.616 0.246 . . . . 1.0 110.565 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.657 ' H ' HG23 ' A' ' 43' ' ' THR . 4.6 t 33.48 49.01 0.21 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.3 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 104.87 -46.74 1.14 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' THR . 67.9 m-80 -75.12 23.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.816 0.341 . . . . 1.0 110.562 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -136.41 -34.32 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.688 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -96.86 15.49 21.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.338 . . . . 1.0 110.475 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.92 -34.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD13 ' C ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -100.47 -75.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.315 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -48.79 -24.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 1.0 110.664 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 t -71.68 -29.19 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.7 t -50.66 -41.48 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.628 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.86 1.61 46.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.88 -44.57 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.599 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -28.76 69.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.61 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -54.45 -37.24 64.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.564 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.61 36.83 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 5.5 m80 54.32 64.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 1.0 110.616 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 21.0 p80 40.93 25.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.718 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 59' ' ' HIS . 33.1 m170 54.72 107.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -53.18 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.563 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.519 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 1.5 t-80 -134.91 -147.32 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.181 0.515 . . . . 1.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.519 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 50.9 m-70 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.48 -79.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.566 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -153.34 95.4 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.18 -121.96 1.31 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' CD2' ' A' ' 7' ' ' PHE . . . 94.72 72.5 1.16 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t70 65.42 54.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 1.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' GLY . 66.7 m-85 -148.58 41.83 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.579 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -157.01 60.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.479 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -138.37 -45.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.526 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CZ ' ' CE1' ' A' ' 11' ' ' TYR . 45.0 p90 -98.4 15.22 25.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.575 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.535 ' CE1' ' CZ ' ' A' ' 10' ' ' TYR . 42.1 m-85 -89.18 55.84 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.569 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -172.64 -70.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 175.41 73.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 1.0 110.616 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.28 -69.63 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -164.78 50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.594 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.43 ' CD ' ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -69.95 -16.72 63.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.61 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 174.13 73.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 20' ' ' GLU . 14.6 tt0 -87.59 130.8 34.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.499 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t 65.19 -3.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.514 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 18' ' ' GLU . 44.7 mt-10 -99.46 19.76 15.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.589 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.71 25.26 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.583 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p 58.69 42.54 20.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.641 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -138.13 5.04 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 45.8 p-90 -75.02 -25.67 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -100.47 5.15 44.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 28' ' ' GLY . 62.4 m -100.22 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 0.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -101.36 31.82 8.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 30' ' ' LEU . . . -163.08 -8.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 1.0 110.55 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.402 ' H ' ' H ' ' A' ' 29' ' ' ALA . 25.6 mt -111.52 -30.3 7.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.681 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.57 -37.89 1.7 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.194 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.1 Cg_endo -88.1 -0.27 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.389 2.059 . . . . 1.0 112.119 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.87 6.91 36.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.653 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -140.41 -51.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.585 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.21 -29.8 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.59 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.431 ' C ' ' N ' ' A' ' 38' ' ' VAL . 23.3 mmt -63.59 -60.38 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.446 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.5 mp -46.92 -17.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.537 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.431 ' N ' ' C ' ' A' ' 36' ' ' MET . 6.5 t -97.81 -52.1 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -42.4 -26.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.504 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -115.83 73.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.09 -57.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 10.58 67.86 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -139.2 -73.87 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 1.0 110.542 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER 41.65 22.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.56 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 102.76 29.24 5.94 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' THR . 66.2 m-80 -130.71 -30.91 1.81 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 1.0 110.583 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.784 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -88.71 -11.7 65.44 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.784 HD23 ' C ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -125.94 31.88 5.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.824 0.345 . . . . 1.0 110.346 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.42 -54.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.594 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -101.8 -23.66 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.461 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.535 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -78.4 -10.79 59.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.523 HG23 ' N ' ' A' ' 53' ' ' VAL . 10.5 t -89.18 -42.81 11.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.704 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' N ' HG23 ' A' ' 52' ' ' THR . 55.6 t -49.01 -24.36 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.922 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -101.12 -21.1 15.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' C ' ' N ' ' A' ' 57' ' ' LYS . 2.0 tpt180 -88.24 -51.98 5.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.606 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.94 -15.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.699 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 55' ' ' ARG . 15.6 mtpp -64.23 -36.74 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.569 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . 134.02 64.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 22.3 p80 40.54 73.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 1.0 110.804 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 44.42 29.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.651 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.431 ' CG ' ' H ' ' A' ' 62' ' ' HIS . 1.5 t-80 -142.35 -150.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.072 0.463 . . . . 1.0 110.421 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.431 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 65.4 m-70 -141.96 97.61 3.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.46 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.416 ' O ' ' OXT' ' A' ' 64' ' ' HIS . 7.5 t-160 -154.86 95.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.416 ' OXT' ' O ' ' A' ' 63' ' ' HIS . 3.6 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.929 -1.034 . . . . 1.0 110.564 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' GLU . 3.0 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER 49.12 99.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.504 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.78 -58.35 2.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.87 -57.34 0.65 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.01 -118.24 11.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.32 40.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 11' ' ' TYR . 4.1 t80 72.24 43.42 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -147.57 49.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.595 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -140.42 -100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.588 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.52 -20.23 65.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.519 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD2' ' CZ ' ' A' ' 7' ' ' PHE . 10.1 m-85 -74.92 77.58 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.478 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.583 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 143.08 -76.62 0.3 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.806 -0.918 . . . . 1.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 168.28 122.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.347 . . . . 1.0 110.621 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -133.52 -73.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.501 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 17' ' ' SER . 63.0 m-20 -84.66 -99.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.586 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER 19.36 48.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.07 0.856 . . . . 1.0 112.202 179.864 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ASN . 8.3 t -158.1 -64.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.566 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 42.73 50.97 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.546 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.43 6.07 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.43 64.22 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.416 ' O ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -140.0 -66.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.619 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 2.0 m -168.23 39.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.544 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -143.29 11.77 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.41 ' NE1' ' NZ ' ' A' ' 25' ' ' LYS . 20.0 p-90 -101.59 5.09 41.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.567 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -150.11 16.37 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.58 -179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 m -137.92 -39.27 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.591 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 p -80.04 23.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.38 40.35 1.11 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.24 -9.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 1.0 110.544 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.51 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.624 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.4 mm -83.86 -36.02 0.63 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.445 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.0 Cg_endo -88.26 10.75 3.3 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.468 2.112 . . . . 1.0 112.266 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.93 -19.8 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.525 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -105.52 -44.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.627 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' O ' ' SD ' ' A' ' 36' ' ' MET . 30.0 m-85 -74.21 19.77 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.62 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 18.1 mmt -136.49 -50.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.622 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.86 0.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.8 t -137.43 -54.17 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -49.6 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -98.43 56.1 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -175.05 -64.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -17.33 0.88 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.71 HG23 ' H ' ' A' ' 44' ' ' THR . 0.8 OUTLIER -138.07 -103.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.522 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.71 ' H ' HG23 ' A' ' 43' ' ' THR . 1.7 p 62.64 -1.05 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 88.83 25.64 29.11 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -137.43 3.95 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.78 0.324 . . . . 1.0 110.534 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.836 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -105.0 -19.24 10.99 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.836 HD23 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -122.0 15.77 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.687 0.279 . . . . 1.0 110.453 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.23 -62.05 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.52 -36.36 10.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.441 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 27.2 t-105 -69.97 -15.57 63.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.467 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.457 ' OG1' ' CE ' ' A' ' 56' ' ' LYS . 2.6 t -78.81 -24.79 44.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.637 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.08 5.52 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.436 ' O ' ' NE2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -138.48 3.39 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.642 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 59' ' ' HIS . 3.2 tmt_? -101.72 -59.42 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' CE ' ' OG1' ' A' ' 52' ' ' THR . 21.5 mtmt -53.91 -45.71 71.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.595 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -52.89 -30.37 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.618 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . -101.06 -68.37 0.83 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER 71.62 -40.57 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 1.0 110.577 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -78.34 11.46 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 66.06 126.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.548 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.436 ' NE2' ' O ' ' A' ' 54' ' ' PHE . 43.0 m-70 -83.0 78.73 9.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.506 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -89.61 84.51 6.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.589 179.935 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -138.04 8.46 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.563 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -140.4 63.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.22 -5.04 32.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.65 164.52 31.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -101.39 -78.12 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 1.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 t80 56.98 43.28 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.578 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -157.67 52.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.564 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -138.98 -20.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.553 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.488 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 t80 -153.21 0.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.617 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 14.9 p90 38.56 40.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.785 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.54 -50.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . 179.23 -58.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.585 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 4.9 t0 77.64 6.07 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.579 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 51.2 102.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.56 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.09 10.39 26.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.591 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 19' ' ' CYS . 5.0 m -134.66 0.38 2.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.633 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -57.74 -7.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 2.0 t -171.1 47.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.582 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -138.72 21.29 2.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.545 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 -52.03 3.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.6 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 p -140.15 31.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.86 3.51 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.568 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -81.58 5.87 16.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.39 16.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.591 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.48 ' OG ' ' N ' ' A' ' 27' ' ' SER . 91.2 p -144.93 -109.17 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.48 ' N ' ' OG ' ' A' ' 26' ' ' SER . 25.8 t -72.08 42.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.518 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -170.23 32.88 0.16 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.89 -18.01 0.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.717 0.294 . . . . 1.0 110.578 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.442 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 2.6 mp -112.0 -29.69 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.601 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -75.8 -37.81 2.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.19 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.3 Cg_endo -87.6 26.15 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.461 2.108 . . . . 1.0 112.174 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.25 7.82 3.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -145.32 -39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.609 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.2 m-85 -79.26 26.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.588 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 19.4 mmt -137.34 -67.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.566 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -47.02 -24.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.572 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.61 -51.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.587 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -41.54 -30.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.465 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.93 80.29 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.411 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 43' ' ' THR . 2.0 mt -159.36 -61.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.56 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 43' ' ' THR . . . -75.44 28.41 1.23 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.559 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -173.47 -86.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 1.0 110.539 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.559 ' H ' HG23 ' A' ' 43' ' ' THR . 0.6 OUTLIER 49.9 11.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.58 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 78.47 3.16 86.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -100.55 -20.92 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 1.0 110.531 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 46' ' ' ASN . . . -91.07 -35.07 7.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 50' ' ' LEU . 3.1 mt -89.98 -145.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 1.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.659 ' O ' HG22 ' A' ' 52' ' ' THR . 2.8 t 62.64 -71.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.642 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 48' ' ' LEU . 1.2 pp -59.08 -4.06 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.7 -45.59 58.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.381 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 49' ' ' VAL . 11.3 t -45.5 -12.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.289 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 51' ' ' TRP . 50.8 t -87.04 -31.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 51' ' ' TRP . 67.1 m-85 -124.09 4.81 8.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.869 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 51' ' ' TRP . 2.4 tpt180 -90.33 -41.52 11.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 1.0 110.674 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 58' ' ' GLY . 3.5 mmtt -78.92 -52.69 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.463 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -62.63 0.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.557 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 56' ' ' LYS . . . 167.61 97.9 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -41.62 -28.24 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 1.0 110.528 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.511 ' CG ' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -138.7 -57.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' N ' ' CG ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER 165.05 108.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.367 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.526 ' CG ' ' H ' ' A' ' 63' ' ' HIS . 1.4 t-80 -101.0 -138.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.582 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.526 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 2.1 m-70 -140.16 93.74 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.58 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.557 -179.997 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.23 71.54 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.534 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.43 86.77 5.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.55 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.13 -5.38 65.72 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.17 -144.11 2.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 t0 71.93 28.74 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 1.0 110.546 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 65.52 58.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.426 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -165.98 66.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.434 ' H ' ' HA ' ' A' ' 13' ' ' ALA . 4.2 m120 -73.43 -34.86 65.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.403 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -152.09 -49.86 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -139.24 30.4 2.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.354 0.597 . . . . 1.0 110.489 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 117.24 27.08 2.76 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 86.4 93.89 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.998 0.428 . . . . 1.0 110.254 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -13.29 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 1.0 110.554 -179.633 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 17' ' ' SER . 38.4 t-20 -150.37 96.79 2.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.452 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' O ' ' CB ' ' A' ' 17' ' ' SER . 5.5 mt-30 -74.77 22.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.599 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 80.56 43.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.335 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.497 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 5.4 tt0 -100.56 131.88 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.525 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 71.71 -8.41 1.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.579 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 18' ' ' GLU . 5.9 tt0 -80.69 45.82 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.578 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -102.17 -75.44 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.543 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.577 HG23 ' HZ1' ' A' ' 25' ' ' LYS . 2.1 m -166.69 28.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.511 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -141.07 28.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.48 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 19' ' ' CYS . 9.2 p-90 -128.83 1.63 5.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.486 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HZ1' HG23 ' A' ' 22' ' ' THR . 0.0 OUTLIER -151.8 19.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.521 179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 28' ' ' GLY . 12.7 t -166.67 25.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.608 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.0 m -72.27 14.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.332 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.666 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . 151.13 -11.1 0.78 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 82.88 34.56 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.852 0.358 . . . . 1.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -110.74 -26.6 9.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.335 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -77.57 -41.01 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.854 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.5 Cg_endo -86.92 24.78 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.475 2.117 . . . . 1.0 112.168 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.8 5.19 5.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -146.26 -55.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.546 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -60.92 -0.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.472 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.9 mmt -96.97 -50.36 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.544 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.4 mp -78.82 13.21 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.582 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.4 t -141.31 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.564 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.5 -50.49 16.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mt -99.16 49.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.636 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 43' ' ' THR . 14.9 tp -175.19 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.334 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -49.57 -12.49 0.38 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.776 HG23 ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -138.09 -98.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.776 ' H ' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER 52.45 9.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.54 -179.981 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 83.53 26.55 42.44 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' C ' ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -134.77 1.16 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 1.0 110.59 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.78 3.63 42.1 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.23 3.03 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.37 . . . . 1.0 110.623 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.72 -58.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.573 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 pp -95.66 -34.32 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -55.46 -16.83 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.481 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 t -81.66 -17.74 47.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.548 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.96 -21.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.514 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.84 15.54 26.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.6 -71.8 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.687 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -33.49 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.69 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -60.15 -31.98 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.526 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.03 98.12 0.17 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -17.15 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 1.0 110.558 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -71.03 -86.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.515 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -175.09 92.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.616 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.521 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 15.8 p80 41.6 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.7 t-160 -70.41 66.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.572 179.991 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' O ' ' A' ' 2' ' ' GLU . 2.6 mmt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . 12.0 tp10 58.77 117.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.55 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -75.4 -85.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.529 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 -61.02 0.81 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.76 105.81 1.32 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -160.68 27.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 1.0 110.612 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -162.73 51.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.545 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -144.17 54.44 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.529 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' TYR . 6.7 p-10 -118.97 43.6 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.563 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.473 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 57.8 t80 48.2 12.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.801 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 39.89 36.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.711 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.66 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 40.27 22.4 0.04 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 162.43 79.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 1.0 110.573 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.435 ' CG ' ' CE1' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.78 19.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.59 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m120 69.93 125.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.591 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.78 -38.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.609 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -158.06 39.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -139.11 -17.61 1.04 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p -171.86 57.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.563 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -101.6 31.92 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.575 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -101.6 -81.5 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.575 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.32 29.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.519 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.15 -11.51 5.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.546 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -60.84 -8.48 3.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.49 -0.84 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.55 179.809 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.3 p 40.04 79.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.666 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t -137.95 -35.43 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.592 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.58 49.21 0.89 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -137.19 -16.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 1.0 110.622 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -136.3 -18.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -68.68 -39.84 16.04 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.95 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.8 Cg_endo -87.11 25.75 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.126 . . . . 1.0 112.192 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.55 -49.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.496 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 pt -101.09 -32.5 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.602 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.504 ' CE2' ' CD1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -79.04 29.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.6 mtp -127.31 -61.13 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.558 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.97 16.74 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.24 -31.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.643 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 35' ' ' TYR . 30.4 t80 -77.82 -34.84 51.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.645 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.53 26.61 10.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.45 -61.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.176 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 -4.86 69.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -138.12 -61.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.088 -0.245 . . . . 1.0 110.65 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER 32.62 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.661 0.601 . . . . 1.0 111.301 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -143.62 17.53 2.23 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.77 21.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 1.0 110.012 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' TRP . . . -147.29 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.039 -0.825 . . . . 1.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -48.59 -13.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 1.0 110.217 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.482 ' N ' ' C ' ' A' ' 47' ' ' GLY . 79.7 t -82.04 -60.03 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.824 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -101.39 -36.51 8.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.692 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' GLY . 42.6 t-105 -60.3 -1.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.446 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 50' ' ' LEU . 3.3 t -94.05 -31.33 14.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.67 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -72.74 -60.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.594 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -55.71 -14.56 2.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.624 -179.905 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 57' ' ' LYS . 2.2 ttm180 -98.1 -38.61 9.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.607 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -54.47 -7.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.62 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 55' ' ' ARG . 36.8 mmtm -78.67 -31.34 46.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.609 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.91 85.53 0.06 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.014 -0.834 . . . . 1.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.43 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -61.74 -12.37 16.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 1.0 110.636 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -98.26 -14.06 20.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.551 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 34.7 m80 50.71 41.63 26.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.58 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -7.59 26.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.56 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -147.14 99.65 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.633 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.554 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -101.43 -29.29 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -139.89 -100.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.579 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.49 -67.18 0.5 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.98 -74.56 0.29 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 -67.86 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 1.0 110.516 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.7 38.92 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 10.4 t70 56.13 50.44 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.546 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -118.09 49.48 1.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.358 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 48.45 27.29 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.4 33.99 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 1.0 110.337 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 44.7 65.58 1.71 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 169.49 115.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.774 0.321 . . . . 1.0 110.605 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 16' ' ' GLN . 27.2 t0 -168.8 45.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m120 56.52 5.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.58 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.619 ' NE2' ' N ' ' A' ' 17' ' ' SER . 1.2 pm0 -55.71 -22.78 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.599 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.619 ' N ' ' NE2' ' A' ' 16' ' ' GLN . 14.5 t -177.27 31.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.606 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -159.12 109.85 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.546 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.49 -71.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.569 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -82.78 51.66 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' O ' ' OG1' ' A' ' 22' ' ' THR . 71.3 m-85 -151.11 54.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.532 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 3.2 p 60.63 42.58 13.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 25' ' ' LYS . 1.1 t70 -124.65 -19.48 5.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.574 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -53.76 -8.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.743 ' HZ3' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -135.27 0.86 2.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.5 p 40.16 62.2 1.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.565 ' C ' ' HZ3' ' A' ' 25' ' ' LYS . 9.2 p -152.6 27.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.743 ' N ' ' HZ3' ' A' ' 25' ' ' LYS . . . -157.03 34.68 0.56 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.58 -6.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.665 0.269 . . . . 1.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HD11 ' A' ' 34' ' ' ILE . 1.7 mt -113.19 -26.73 8.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.609 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -85.87 -34.72 0.5 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.597 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.7 Cg_endo -87.68 25.48 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.258 1.972 . . . . 1.0 112.141 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.32 11.17 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.553 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -150.75 -48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.498 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -73.19 12.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.501 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' VAL . 14.5 mmt -129.68 -38.12 1.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 37' ' ' LEU . 10.8 mp -55.41 -6.68 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.618 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.96 -53.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.582 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -21.41 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.588 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mt -136.8 54.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 -46.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.15 34.7 4.9 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' GLY . 3.6 t -167.65 -30.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 1.0 110.53 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -41.91 -22.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 154.92 -0.54 0.17 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -1.1 4.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 1.0 110.52 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.92 48.34 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.12 23.8 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 1.0 110.539 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.9 t -137.87 -38.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.615 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.9 tt -101.34 -52.76 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.57 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.486 ' O ' ' CD2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -45.89 -16.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.594 179.992 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 50' ' ' LEU . 8.3 t -62.24 -35.77 79.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 50' ' ' LEU . 20.9 t -51.17 -32.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.575 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.71 15.77 6.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.59 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 58' ' ' GLY . 39.7 ttt-85 -135.56 -35.97 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' C ' ' N ' ' A' ' 58' ' ' GLY . 4.2 mtmt -51.6 -42.64 62.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.596 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -54.26 -10.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.511 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 55' ' ' ARG . . . -172.19 112.08 0.42 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.513 ' CG ' ' N ' ' A' ' 60' ' ' HIS . 10.6 p-80 -172.22 -41.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 1.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.513 ' N ' ' CG ' ' A' ' 59' ' ' HIS . 59.5 m80 -157.1 44.48 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.612 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 42.24 76.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.576 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -154.42 115.19 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.598 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 1.3 t-80 -134.7 -147.29 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.495 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.598 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.541 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtp . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 49.8 66.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.607 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -101.38 3.74 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.23 43.53 1.9 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.53 169.0 21.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -87.26 -3.51 59.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.674 0.273 . . . . 1.0 110.572 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 4.1 t80 81.41 72.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 1.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 t70 65.3 61.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.587 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.414 ' H ' ' HA ' ' A' ' 13' ' ' ALA . 3.0 t30 -86.43 -46.32 10.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.41 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -135.93 -76.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.504 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.8 27.61 7.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 1.0 110.458 179.891 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.664 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 123.42 -6.97 9.14 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.319 -0.855 . . . . 1.0 111.208 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 164.27 -35.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.006 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.5 t70 79.74 69.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 1.0 110.51 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' SER . 2.2 p-10 -42.02 100.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.618 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -77.14 34.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.628 179.952 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 79.93 39.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.444 -179.913 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.06 21.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.578 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' H ' ' C ' ' A' ' 17' ' ' SER . 5.5 t -156.19 56.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.38 23.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.543 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 55.31 84.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.655 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.69 27.92 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.655 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.33 13.67 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.585 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -87.66 -16.53 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.546 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.81 11.01 40.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.563 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.4 p -138.54 -64.95 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.542 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.1 t -77.91 15.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.574 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.87 45.84 0.86 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.59 -34.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.739 0.304 . . . . 1.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -106.4 -9.61 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.573 -179.994 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.77 -40.06 3.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.49 25.97 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.498 2.132 . . . . 1.0 112.164 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.8 2.59 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.51 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.43 -61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.594 179.918 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.92 -28.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 36' ' ' MET . 2.9 mmm -75.11 -47.3 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -54.76 -7.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.8 OUTLIER -119.72 -51.54 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.494 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -46.13 -17.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.621 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 38' ' ' VAL . 8.7 mt -136.77 52.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 16.6 tp -169.8 -59.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' CA ' HD21 ' A' ' 46' ' ' ASN . . . -97.29 40.9 2.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.496 ' N ' HD21 ' A' ' 46' ' ' ASN . 1.5 t -171.55 -23.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 1.0 110.589 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -41.55 -36.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.58 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . -161.41 -3.07 0.05 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 41' ' ' LEU . 7.5 p30 -101.58 18.96 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.739 0.304 . . . . 1.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.73 3.88 3.24 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.25 55.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 1.0 110.574 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 72.8 t -142.46 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 pp -97.68 -26.4 14.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -15.06 58.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.575 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 49' ' ' VAL . 13.3 t -80.41 -19.91 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.535 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.0 t -66.08 -64.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.625 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -53.46 -16.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.566 -179.971 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -84.51 -46.31 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.514 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -47.8 -28.49 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.609 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -55.16 -14.14 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.519 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.04 90.15 0.07 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -23.44 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 1.0 110.59 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 61' ' ' HIS . 13.6 p80 -91.76 -37.13 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.621 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 60' ' ' HIS . 9.7 t-160 -89.48 41.83 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.521 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -56.13 -5.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.566 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.482 ' H ' ' C ' ' A' ' 61' ' ' HIS . 10.8 t-80 42.8 78.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.583 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 p80 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.572 -179.989 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -61.38 103.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.551 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -88.55 -97.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.28 -68.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.72 179.72 3.54 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.27 -64.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 1.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 56.37 41.83 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.598 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -141.11 42.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.608 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 11' ' ' TYR . 46.4 t30 -153.5 82.45 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.558 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.479 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 1.2 t80 43.51 21.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.611 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.5 p90 38.76 40.28 0.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.591 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -169.27 -58.4 0.03 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 167.21 -24.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 1.0 110.607 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.9 t70 78.37 -0.66 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.499 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -90.13 58.3 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.548 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.7 mp0 -98.91 59.99 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.582 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 80.98 54.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.149 0.5 . . . . 1.0 110.318 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.07 108.68 5.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.478 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 t 65.2 64.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.762 -0.458 . . . . 1.0 109.762 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' THR . 1.8 tp10 -69.3 58.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.63 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' THR . 17.6 m-85 58.99 -69.66 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.237 179.514 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . 29.8 p -157.81 56.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.1 -35.55 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.616 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' HB3' ' H ' ' A' ' 20' ' ' GLU . 3.7 p-90 -61.74 -30.95 71.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.811 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' CD ' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -70.69 3.85 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.898 -179.682 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -137.55 -77.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.604 179.962 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.64 8.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.596 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -155.89 31.62 0.61 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.55 5.9 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 1.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.45 -24.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.568 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -73.84 -41.07 5.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 63.3 Cg_endo -87.03 10.24 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.573 2.182 . . . . 1.0 112.251 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.32 3.63 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.564 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.06 -41.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -67.44 4.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' VAL . 20.3 mmt -100.92 -72.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mt -52.09 -9.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' MET . 76.4 t -101.03 -36.47 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.578 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -93.03 33.98 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.597 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.2 mt -136.92 0.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.535 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -112.29 -41.33 3.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.525 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.91 -3.61 44.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.625 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -137.46 -100.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 1.0 110.482 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.625 ' H ' HG23 ' A' ' 43' ' ' THR . 4.8 t 33.54 44.35 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 108.15 -49.41 0.86 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -71.08 10.53 0.54 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.914 0.387 . . . . 1.0 110.62 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -96.61 -5.85 58.67 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.17 -10.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 1.0 110.572 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.68 -46.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.556 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tt -95.76 -57.21 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.576 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -45.19 -36.77 4.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.471 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 8.9 t -57.62 -36.51 71.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.519 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -52.15 -48.48 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.586 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.1 -11.85 59.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.642 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.424 HH21 ' CB ' ' A' ' 59' ' ' HIS . 9.1 ttm180 -99.08 -33.63 10.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.592 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -55.08 -21.29 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.571 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -88.86 -11.81 43.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.525 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.41 93.02 2.22 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.424 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -54.76 -18.13 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 1.0 110.556 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' HIS . 4.1 p80 -95.67 -21.35 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.554 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' HIS . 1.4 t-80 60.39 125.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -74.71 -37.59 62.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.513 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 44.4 41.8 4.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.586 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.941 -1.028 . . . . 1.0 110.578 179.998 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.5 mtp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.64 114.0 20.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.534 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.18 -33.35 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.541 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.9 133.56 5.67 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.89 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.25 -46.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.707 0.289 . . . . 1.0 110.511 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 t80 61.5 43.32 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -140.58 42.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.581 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 11' ' ' TYR . 4.8 t-20 -157.48 108.25 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.469 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER 69.02 -38.47 0.4 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.089 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER 38.63 93.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.855 0.36 . . . . 1.0 110.826 179.902 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.53 -64.23 0.43 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.009 -0.836 . . . . 1.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -165.33 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 1.0 110.52 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.32 -0.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.626 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 13' ' ' ALA . 45.6 m-80 -148.98 77.67 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.572 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -101.73 -39.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.679 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -90.72 -3.69 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.58 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -102.19 10.55 39.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -157.8 -36.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.552 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' C ' ' CG ' ' A' ' 21' ' ' TYR . 4.3 tt0 41.81 28.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.435 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 20' ' ' GLU . 1.2 m-85 71.74 -59.48 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 ' HG1' ' C ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -166.87 40.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.579 -179.892 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.83 -1.73 3.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.6 p-90 -70.31 -10.59 59.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.604 ' HZ3' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -134.0 0.38 3.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.609 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.4 p 39.8 79.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.604 ' C ' ' HZ3' ' A' ' 25' ' ' LYS . 3.4 t -161.84 21.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.621 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.93 20.34 0.87 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' C ' HD22 ' A' ' 30' ' ' LEU . . . -141.78 -5.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 1.0 110.534 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.74 -38.05 5.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.598 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -82.0 -38.04 0.86 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.245 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.7 Cg_endo -87.31 19.4 1.38 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.402 2.068 . . . . 1.0 112.131 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.16 8.28 13.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.49 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.48 -44.0 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.567 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.56 3.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.3 mmt -100.63 -47.63 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.605 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.31 27.86 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -146.58 -18.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 43' ' ' THR . 34.3 t80 -96.23 -2.13 46.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.678 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.84 40.31 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.494 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.87 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.11 20.75 44.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.377 -1.089 . . . . 1.0 110.377 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -163.96 -83.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 1.0 110.344 -179.749 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.52 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER 42.85 19.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 60.57 12.12 25.15 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -127.89 -6.05 5.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 1.0 110.396 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.827 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -88.5 -30.79 14.89 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.827 HD23 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -119.08 22.85 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.703 0.287 . . . . 1.0 110.511 179.911 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 52' ' ' THR . 96.4 t -128.58 -55.06 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.622 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.9 tt -95.87 -49.97 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.517 ' CE3' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -18.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.595 179.904 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 50' ' ' LEU . 3.5 t -79.29 19.02 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.2 t -124.89 -29.94 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.504 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.492 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -102.81 -5.07 24.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.492 179.943 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -102.41 -43.59 5.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.623 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.47 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.529 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -58.93 -14.67 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.579 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.29 -107.13 0.72 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 72.82 -53.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 1.0 110.551 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -62.28 -25.59 67.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.554 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 48.91 89.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -99.89 70.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.583 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 56.8 t60 -99.86 84.72 2.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 m80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.61 179.966 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 69.03 117.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.529 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.6 mp0 -93.35 -64.89 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.87 -81.59 0.04 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.17 -50.21 0.75 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 7' ' ' PHE . 1.2 p-10 -100.87 -78.95 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 1.0 110.539 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.486 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 12.1 t80 65.57 58.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.613 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t70 53.12 45.28 29.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.546 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' TYR . 41.6 m-20 -136.78 109.01 7.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.478 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.0 t80 47.76 13.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.643 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' ASN . 14.4 m-85 -154.89 117.07 4.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.558 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 -29.26 11.6 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -160.2 -43.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 1.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 2.1 t70 78.48 -1.1 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.592 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER 60.53 125.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.52 179.973 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.49 -34.78 10.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 t -162.0 32.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.07 -47.91 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.555 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 21' ' ' TYR . 4.3 t 65.92 46.79 2.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.77 15.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.594 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.36 -9.75 19.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.604 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.507 ' OG1' ' CZ ' ' A' ' 21' ' ' TYR . 9.0 m -152.29 -36.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.721 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -87.47 23.3 1.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -90.41 -0.9 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.535 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -136.3 18.32 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 28' ' ' GLY . 27.3 t -135.75 -106.88 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -75.18 30.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -149.4 31.89 1.14 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.82 -9.09 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 1.0 110.497 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -130.85 -16.56 3.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.62 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -78.29 -34.79 1.09 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.395 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.2 Cg_endo -87.72 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.319 2.013 . . . . 1.0 112.16 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.35 10.55 2.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 36' ' ' MET . 14.0 mt -142.93 -44.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 7.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.511 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 34' ' ' ILE . 12.5 mmt -104.68 -55.18 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.561 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.75 18.01 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 179.944 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' C ' ' N ' ' A' ' 40' ' ' LEU . 57.9 t -135.43 -63.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -47.36 -17.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.566 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 38' ' ' VAL . 3.7 mt -135.72 46.4 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.572 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.9 tp -175.17 -62.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.389 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.42 -10.48 2.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.763 HG23 ' H ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -146.35 -101.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 1.0 110.676 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.763 ' H ' HG23 ' A' ' 43' ' ' THR . 1.7 p 64.44 -3.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.572 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 96.72 5.4 58.73 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 43' ' ' THR . 6.3 p30 -96.15 -42.11 8.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.319 . . . . 1.0 110.236 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.703 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -74.17 -16.33 79.72 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.708 -1.357 . . . . 1.0 109.708 179.284 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.729 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -108.52 -169.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.386 -0.407 . . . . 1.0 109.982 179.517 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 52' ' ' THR . 1.5 t 62.1 -70.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.675 179.737 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' VAL . 3.1 tt -66.86 -37.66 84.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.606 ' CE2' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -41.09 -32.1 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.95 -179.573 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 49' ' ' VAL . 3.1 t -70.86 11.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.605 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' LEU . 60.2 t -126.3 -19.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.99 -2.0 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.526 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.606 ' NH1' ' CE2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -103.0 -70.93 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.652 -179.895 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -48.49 79.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 1.0 110.577 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -81.43 -11.56 59.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.625 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.47 -93.02 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.35 6.6 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.797 0.332 . . . . 1.0 110.538 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.04 -34.06 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.603 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.13 103.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.614 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.59 27.43 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.62 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.495 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -89.59 43.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.66 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.506 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 1.4 t60 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.579 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.49 53.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.549 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.74 80.82 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.575 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.51 -134.21 1.08 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -165.84 -4.22 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER 172.82 76.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.386 0.612 . . . . 1.0 109.775 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -154.65 59.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.541 -179.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -148.45 53.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' TYR . 40.8 m-20 -137.39 50.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.588 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' C ' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER 41.54 20.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.708 179.903 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.2 OUTLIER 42.59 40.23 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.622 179.841 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 40.49 28.79 0.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 163.51 101.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 1.0 110.623 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.74 31.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.523 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 16' ' ' GLN . 20.9 p30 -141.3 -31.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.651 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.475 ' N ' ' OD1' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -87.82 18.86 3.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.558 179.961 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' GLU . 10.1 t -147.24 -37.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.547 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 17' ' ' SER . 1.2 tp10 44.0 99.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.019 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -107.66 9.84 29.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.517 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 21' ' ' TYR . 24.6 tt0 45.91 15.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.479 ' C ' HG23 ' A' ' 22' ' ' THR . 2.5 t80 73.7 40.77 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.479 HG23 ' C ' ' A' ' 21' ' ' TYR . 1.8 p 63.64 47.24 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.492 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -134.95 1.91 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.493 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -84.44 4.64 30.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.602 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -150.62 18.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.571 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.8 p -160.65 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.64 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 28' ' ' GLY . 13.6 p 63.27 -68.83 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.579 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.665 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . -130.95 -12.97 2.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 81.19 48.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.941 0.4 . . . . 1.0 110.094 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.877 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -129.09 -27.7 2.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.491 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -80.42 -39.05 1.14 Allowed Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.974 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.7 Cg_endo -86.91 25.25 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.362 2.042 . . . . 1.0 112.175 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.5 -0.7 6.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.49 -45.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.592 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.4 27.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.482 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.2 mmt -135.76 -51.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.519 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 41' ' ' LEU . 8.8 mt -59.45 -2.48 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.1 t -140.32 -61.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -64.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.638 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -100.94 63.86 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 37' ' ' LEU . 15.0 tp -163.74 -65.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.46 -23.62 1.37 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -135.78 -97.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.2 -0.2 . . . . 1.0 110.65 179.894 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.796 ' H ' HG23 ' A' ' 43' ' ' THR . 6.1 t 36.01 32.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.481 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 77.68 -14.53 9.58 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' THR . 7.7 m-20 -60.8 -4.35 0.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 1.0 110.538 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -91.88 -15.13 55.27 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.85 26.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 1.0 110.544 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.725 ' O ' HG23 ' A' ' 53' ' ' VAL . 90.9 t -138.31 -35.83 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 52' ' ' THR . 2.0 tp -98.43 -56.75 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -53.34 -9.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.534 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 50' ' ' LEU . 4.2 t -102.3 -24.16 13.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.602 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 49' ' ' VAL . 38.9 t -66.23 -31.31 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.587 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.519 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -99.28 15.92 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 -179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -128.5 -48.84 1.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -56.78 -33.1 66.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.585 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 2.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.568 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 56' ' ' LYS . . . -146.03 -61.71 0.02 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.91 -63.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 1.0 110.555 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -143.01 9.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.606 -179.969 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.48 114.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.594 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -44.39 -26.77 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.6 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.617 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 3.8 t-80 -117.68 -146.87 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.441 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 117.968 -1.015 . . . . 1.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.426 ' C ' ' N ' ' A' ' 4' ' ' GLY . 3.3 tt0 50.65 89.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.561 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 4.7 pm0 -50.07 -15.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.606 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 2' ' ' GLU . . . 103.9 69.85 0.8 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.15 145.07 24.14 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.3 t0 48.3 33.4 3.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 1.0 110.463 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -158.21 53.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.494 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 10' ' ' TYR . 60.8 m-20 -128.15 40.87 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.491 -179.91 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.8 t-20 79.17 -28.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.0 109.895 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CE1' ' OE1' ' A' ' 16' ' ' GLN . 72.4 m-85 -89.95 -3.74 57.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.641 -0.708 . . . . 1.0 109.445 178.953 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 14.9 p90 38.18 40.71 0.34 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.848 179.985 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.42 -69.44 0.52 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.52 -36.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.814 0.34 . . . . 1.0 110.545 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 10.0 t0 64.88 2.52 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.59 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 t30 46.47 94.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.482 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' OE1' ' CE1' ' A' ' 10' ' ' TYR . 1.7 mt-30 -102.68 -47.76 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.618 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 p -130.76 -31.05 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.676 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 45.77 -148.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.535 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.48 11.11 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.78 12.41 28.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.53 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.416 ' O ' ' OG1' ' A' ' 22' ' ' THR . 24.4 m-85 -67.8 -84.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.533 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 2.4 m -167.98 43.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.56 6.73 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.554 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -101.66 3.29 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.605 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.52 9.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.634 179.99 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 27' ' ' SER . 0.1 OUTLIER -134.2 -73.58 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.559 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.431 ' N ' ' OG ' ' A' ' 26' ' ' SER . 83.7 p -85.87 41.2 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.549 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.58 37.44 0.19 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -137.97 -15.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 1.0 110.561 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -136.83 -15.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.642 179.988 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -79.1 -40.29 1.52 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.1 Cg_endo -86.97 25.29 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.461 2.107 . . . . 1.0 112.203 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.07 6.48 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.497 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -143.96 -42.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 3.3 m-85 -74.94 15.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.528 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 15.1 mmt -132.64 -55.71 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.515 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.98 11.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' GLY . 6.3 t -142.25 -56.86 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.584 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.7 -53.75 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.456 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt -105.0 44.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.314 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -162.88 -55.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.371 -179.875 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -73.23 20.22 1.23 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -170.69 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 1.0 110.571 -179.99 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.522 ' H ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER 50.14 11.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.551 179.985 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' N ' ' C ' ' A' ' 43' ' ' THR . . . 75.44 7.0 82.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.92 -0.54 36.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 1.0 110.54 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.538 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -97.99 -43.4 2.84 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -98.38 29.07 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 1.0 110.512 -179.978 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.45 ' C ' HG22 ' A' ' 52' ' ' THR . 21.9 t -141.49 -47.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.7 tp -97.14 -67.79 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.604 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.62 ' CZ3' ' NE2' ' A' ' 61' ' ' HIS . 46.7 t-105 -44.52 -21.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 49' ' ' VAL . 14.5 t -83.29 25.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.593 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 50' ' ' LEU . 95.0 t -113.6 -57.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.605 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -78.61 -1.16 32.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.58 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -100.11 -40.87 7.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.467 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -85.29 -45.76 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.05 1.11 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.536 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.0 79.2 0.3 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -18.98 9.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 1.0 110.57 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -96.95 -29.9 13.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.631 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.62 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 50.9 t-80 59.46 62.19 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.58 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -82.49 60.11 4.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -156.6 76.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.591 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.568 -179.994 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.381 -0.599 . . . . 1.0 109.381 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 55.85 104.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.559 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.64 -97.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.623 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.74 -96.28 0.2 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 45.09 94.1 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -138.91 28.53 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.0 110.617 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -138.9 47.49 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.567 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -120.68 41.68 3.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -139.52 -53.81 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.596 -179.961 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.82 -29.32 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.553 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.81 58.0 2.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.538 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.4 -37.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -175.98 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 1.0 110.522 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.95 5.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.539 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 13' ' ' ALA . 5.0 t30 -164.95 49.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -31.69 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m 179.91 69.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.52 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.5 tt0 -100.16 60.13 1.04 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 1.4 t 76.12 -11.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.507 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -99.18 50.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.494 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -132.8 -30.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.61 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -166.41 -33.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.722 -179.994 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.63 6.23 7.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.566 -179.975 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -68.5 -12.63 61.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -134.7 1.17 3.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.589 179.953 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.1 t 39.74 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 29' ' ' ALA . 10.5 t -165.05 -38.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.602 -179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.23 13.23 2.06 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -133.04 -8.79 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 1.0 110.418 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.21 -19.78 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.575 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -91.33 -34.54 0.36 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.673 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.58 13.55 2.61 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.203 1.936 . . . . 1.0 112.403 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' C ' ' SD ' ' A' ' 36' ' ' MET . . . -115.44 6.29 14.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.619 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.6 ' N ' ' SD ' ' A' ' 36' ' ' MET . 1.5 pt -140.15 -26.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -71.47 16.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -127.21 -67.13 0.85 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.708 -179.944 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mt -47.38 -13.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 1.0 110.689 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.485 ' N ' ' C ' ' A' ' 36' ' ' MET . 21.7 t -102.84 -57.34 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.02 37.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.792 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.9 mt -139.06 -8.44 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.608 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.4 mt -115.77 -41.14 3.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.453 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.54 24.04 3.29 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -166.53 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.12 -0.232 . . . . 1.0 110.583 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.513 ' H ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER 31.6 67.38 0.14 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.27 -179.998 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 102.35 -59.09 0.57 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 -179.967 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -58.8 -9.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 1.0 110.586 -179.985 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.654 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -95.35 -24.63 15.85 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.753 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -104.38 23.18 13.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 1.0 110.478 -179.943 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 45' ' ' GLY . 69.4 t -106.49 -64.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.716 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -109.76 -35.91 6.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.659 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.515 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 74.5 t-105 -72.63 7.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.492 -179.958 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 50' ' ' LEU . 9.3 t -84.25 -16.85 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.503 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -80.01 -35.86 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.583 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -86.67 4.4 40.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' NH2' ' O ' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -101.59 -64.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.54 -179.948 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -54.49 -33.69 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.559 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -96.58 -5.89 38.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.538 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.31 75.38 0.19 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.006 -0.837 . . . . 1.0 111.006 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -28.52 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 1.0 110.596 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 25.7 m170 -76.23 -120.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.572 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' HIS . 1.2 p-80 -179.09 56.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.58 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 61' ' ' HIS . 27.8 t-80 43.96 94.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.623 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.494 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 1.6 t-80 -134.59 -147.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 1.0 110.415 -180.0 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.494 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.61 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.1 67.62 5.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.551 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 5' ' ' GLY . 11.6 mt-10 -69.92 -76.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.57 3.98 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 3' ' ' GLU . . . 141.65 142.32 4.07 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.25 -61.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.318 . . . . 1.0 110.547 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 54.52 42.99 30.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.99 61.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' TYR . 2.9 m-20 -166.17 130.74 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' A' ' 11' ' ' TYR . 5.6 t80 68.43 -36.18 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.118 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER 41.14 39.88 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 1.0 110.687 179.688 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.03 -46.25 3.6 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.96 -90.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 1.0 110.512 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.5 t0 55.4 32.17 18.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.595 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -90.93 11.95 21.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' O ' ' CB ' ' A' ' 17' ' ' SER . 8.5 mm100 -91.56 4.3 52.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.542 -179.938 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER 164.5 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.584 179.973 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 42.03 35.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.509 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.562 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -141.07 19.31 2.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.592 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 21' ' ' TYR . 8.1 pt-20 36.42 25.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.0 t80 80.68 42.71 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.85 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' CYS . 12.0 p 53.8 29.85 10.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.35 -4.85 26.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.312 179.827 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.46 -9.79 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.383 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.629 ' NZ ' ' H ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -136.03 1.77 2.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.624 179.892 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.2 t 39.87 94.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.808 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.516 ' OG ' ' NZ ' ' A' ' 25' ' ' LYS . 52.8 p -162.94 -35.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.629 ' H ' ' NZ ' ' A' ' 25' ' ' LYS . . . -73.52 19.17 1.53 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -114.23 -1.82 13.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 1.0 110.481 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.68 -25.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -66.74 -41.02 35.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.3 Cg_endo -87.18 16.16 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.549 2.166 . . . . 1.0 112.19 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.79 -36.87 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.549 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.594 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.1 mm -89.36 -31.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.387 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -71.71 13.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.489 ' C ' ' H ' ' A' ' 38' ' ' VAL . 28.7 mmm -117.59 -52.61 2.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.434 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.73 12.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.425 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.1 t -134.69 -43.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.469 -179.936 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -63.09 -30.31 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.504 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mt -101.74 52.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.75 -43.94 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.59 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 -16.81 80.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -139.04 -47.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 1.0 110.481 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.401 HG23 ' C ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 46.8 22.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.549 179.896 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 -12.23 52.7 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 43' ' ' THR . 8.5 m120 -88.2 3.15 50.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 1.0 110.604 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -105.15 -39.7 2.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.696 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.19 30.58 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 1.0 110.604 -179.996 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.517 ' C ' HG22 ' A' ' 52' ' ' THR . 95.4 t -141.1 -48.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.572 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.716 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.7 tt -98.32 -65.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.633 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.401 ' C ' ' H ' ' A' ' 53' ' ' VAL . 56.2 t-105 -46.6 -19.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.55 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.517 HG22 ' C ' ' A' ' 49' ' ' VAL . 9.9 t -79.06 20.29 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.585 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 50' ' ' LEU . 99.2 t -101.75 -64.57 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -83.62 57.27 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.471 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -161.95 -49.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -73.82 -22.57 59.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -70.75 -7.17 42.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.559 -179.985 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.78 96.12 0.11 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -24.05 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 1.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -134.07 -60.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.363 -179.924 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' CG ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER 173.46 112.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.593 179.793 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 63' ' ' HIS . 10.6 p80 -97.71 -137.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.585 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.524 ' N ' ' CG ' ' A' ' 62' ' ' HIS . 20.6 m-70 -151.6 116.2 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.576 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.579 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 64.46 122.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -99.17 -58.64 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.597 179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.57 51.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.78 -157.84 28.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -138.2 -35.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.731 0.3 . . . . 1.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 11.0 p90 -138.7 50.75 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.555 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.63 62.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' C ' ' CG ' ' A' ' 10' ' ' TYR . 70.7 m-20 -161.01 51.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.241 179.91 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLY . 18.2 p90 36.05 41.82 0.14 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.327 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -34.59 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.259 179.617 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' TYR . . . 40.3 53.38 3.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.98 105.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 1.0 110.524 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 1.9 p-10 -175.62 54.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.511 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.507 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 43.9 t-20 -161.71 -113.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.486 179.926 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' NE2' ' H ' ' A' ' 15' ' ' ASN . 6.7 pm0 28.27 51.51 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.714 0.634 . . . . 1.0 111.613 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 82.19 44.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.184 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ASN . 4.5 tt0 -76.85 144.62 38.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.522 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.0 p -173.71 60.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.614 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -129.36 13.4 6.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.513 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.69 -39.85 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.613 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 24.88 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.511 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -136.96 5.06 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -83.36 6.63 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -143.14 17.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.593 -179.976 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 28' ' ' GLY . 2.8 p -145.93 -93.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.583 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -73.57 16.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -139.51 29.7 2.47 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.54 -7.22 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 1.0 110.493 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -20.18 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -69.57 -39.94 13.04 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 69.5 Cg_endo -87.0 2.48 6.98 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.384 2.056 . . . . 1.0 112.28 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.68 -1.04 57.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.625 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.21 -57.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.69 179.962 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 3.4 m-85 -43.22 -31.59 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.495 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.51 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.5 mmt -71.52 -33.62 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 34' ' ' ILE . 6.6 mt -74.24 -4.26 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.668 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.95 -67.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.692 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' TYR . 9.7 t80 -40.89 -50.05 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.605 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.51 HD12 ' SD ' ' A' ' 36' ' ' MET . 4.6 mt -102.56 61.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.488 -179.957 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -170.47 -61.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.265 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.49 27.49 1.05 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -166.49 -90.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 1.0 110.53 179.991 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.497 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER 41.3 22.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.661 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.858 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 135.1 -62.83 0.61 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.93 -15.21 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 1.0 110.677 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.596 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -94.72 -26.46 13.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.902 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.717 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -101.08 15.92 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.72 0.295 . . . . 1.0 110.602 -179.878 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 45' ' ' GLY . 93.3 t -101.9 -60.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.591 -179.969 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 52' ' ' THR . 2.0 pp -62.61 -4.46 2.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.541 -179.982 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.11 16.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.507 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.483 ' H ' ' C ' ' A' ' 50' ' ' LEU . 5.8 t -136.26 14.08 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.445 -179.974 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 52' ' ' THR . 37.3 t -140.65 -35.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.544 179.932 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.86 -9.53 18.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -101.95 -41.37 6.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.628 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -52.64 -35.39 54.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.593 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -68.37 -5.97 21.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.607 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -136.41 -106.37 0.81 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 68.04 -66.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.729 0.299 . . . . 1.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 58' ' ' GLY . 52.4 m80 -142.09 9.47 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.63 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' HIS . 7.4 m80 63.82 98.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 51.79 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.936 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.1 t-80 -136.09 -147.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.22 0.533 . . . . 1.0 110.397 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.54 -179.988 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -99.58 -65.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -170.31 125.33 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.555 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.29 -83.2 0.17 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.86 53.16 6.44 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.17 -16.14 59.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 1.0 110.531 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -138.06 42.19 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.596 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -142.72 45.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.592 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 11' ' ' TYR . 1.1 m-20 -162.38 110.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.421 179.997 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.468 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER 68.91 -38.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.118 179.669 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER 39.38 94.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 1.0 110.861 179.881 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.85 -64.15 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.78 -87.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.776 0.322 . . . . 1.0 110.496 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 t70 69.61 35.99 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.62 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -100.36 52.43 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -23.51 38.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.552 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -173.67 27.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.531 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -90.58 96.69 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.624 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.2 t -173.56 -64.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.606 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -91.72 18.72 7.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.593 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -150.05 46.65 0.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.531 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.5 m -158.77 -36.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.643 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.63 26.67 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.573 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -104.91 1.98 29.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.545 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -137.97 19.31 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.584 -179.974 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 28' ' ' GLY . 58.3 m -149.3 -82.26 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.51 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t 50.73 11.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.044 0.449 . . . . 1.0 110.164 -179.656 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . 127.81 10.02 3.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.38 -1.088 . . . . 1.0 110.38 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 80.31 13.23 0.9 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.026 0.441 . . . . 1.0 109.988 -179.548 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 30' ' ' LEU . 3.8 mm? -65.74 -27.86 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.23 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 31' ' ' ILE . 1.6 mp -75.29 -59.68 1.27 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.242 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 11.5 Cg_endo -54.86 -13.55 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.732 1.621 . . . . 1.0 111.949 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.85 -3.67 54.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.745 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.98 -53.81 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.543 -179.974 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -42.55 -30.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 mmt -78.45 -32.77 48.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.667 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.6 mt -68.43 -3.53 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.705 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -59.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.629 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 41' ' ' LEU . 62.7 t80 -44.99 -64.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.42 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.9 41.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.508 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 39' ' ' PHE . 31.6 tp -153.95 -40.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.526 -179.84 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.3 -13.29 76.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.834 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -138.27 -46.78 0.52 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.0 110.636 -179.921 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 41.72 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 76.77 -7.38 34.33 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.026 -0.829 . . . . 1.0 111.026 179.907 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -101.6 6.69 42.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 1.0 110.644 179.978 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -102.63 -45.78 1.61 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.36 27.4 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 1.0 110.499 -179.983 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 4.9 t -141.66 -46.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.565 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tt -93.56 -63.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -53.14 -32.84 49.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -57.16 -30.69 64.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.568 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -53.72 -54.66 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -93.93 62.34 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.603 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -167.36 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.46 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -17.25 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.536 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -57.9 -38.89 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.545 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 138.0 67.69 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 45.17 18.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.575 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 t-80 44.4 38.1 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.553 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.432 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -138.51 41.92 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.546 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -95.71 -52.89 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.555 179.978 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 30.6 p80 40.67 41.07 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.752 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.04 9.25 10.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.527 -179.944 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -169.66 -52.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.573 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.55 75.94 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.65 -155.97 2.03 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.27 9.62 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 1.0 110.574 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -143.18 42.62 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.549 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -148.68 50.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.51 -55.66 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.621 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.02 10.97 14.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.573 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.57 84.25 7.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.588 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.66 68.34 0.85 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -177.97 -87.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.31 . . . . 1.0 110.604 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t0 52.0 10.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.608 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 13' ' ' ALA . 1.1 m-80 46.77 95.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.586 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.39 -43.87 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.523 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -166.6 37.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.574 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' C ' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -70.11 169.71 12.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.577 -179.964 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m 47.29 18.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.621 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 18' ' ' GLU . 6.2 mm-40 -136.88 22.71 3.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 22' ' ' THR . 1.7 m-85 -97.27 11.12 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.551 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.434 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 76.55 31.08 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.567 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 p30 -140.59 19.32 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -93.75 -21.1 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.575 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 12.58 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.612 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 28' ' ' GLY . 51.4 m -135.81 -63.78 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.553 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 p -71.65 13.24 0.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.538 -179.97 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -134.07 21.32 3.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.7 -6.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 1.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 31' ' ' ILE . 3.9 mt -102.73 -25.53 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.458 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.721 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -93.21 -42.89 0.33 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.266 179.982 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.9 Cg_endo -83.54 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.793 1.662 . . . . 1.0 112.459 -179.13 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.09 -1.31 7.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.322 179.798 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -148.79 -61.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.544 -179.919 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.536 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -42.35 -26.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.616 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.404 ' C ' ' N ' ' A' ' 38' ' ' VAL . 1.9 mtp -74.41 -55.85 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.422 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 37' ' ' LEU . 10.9 mp -48.61 -19.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.582 179.911 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' A' ' 36' ' ' MET . 2.2 t -97.76 -49.25 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.56 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -47.31 -43.13 22.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.84 52.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -166.87 -62.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.355 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.78 -15.54 4.8 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.494 ' C ' HG23 ' A' ' 44' ' ' THR . 0.1 OUTLIER -139.12 -88.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.336 . . . . 1.0 110.555 -179.943 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.494 HG23 ' C ' ' A' ' 43' ' ' THR . 1.7 p 64.17 -2.78 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.566 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 84.32 28.72 32.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.22 7.5 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.58 15.55 6.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.999 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.1 16.65 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 1.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -143.9 -41.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.461 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 50' ' ' LEU . 40.6 tp -94.33 -40.38 9.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.337 -179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -73.5 -30.11 62.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.263 179.796 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.613 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 9.2 t -82.23 33.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.556 -179.991 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 49' ' ' VAL . 2.5 t -129.4 -6.19 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.284 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.93 12.04 3.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.473 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.574 ' HE ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -124.42 -20.95 5.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -103.06 -16.32 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.578 179.918 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -52.35 -32.07 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.627 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -135.33 -17.38 0.87 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.526 ' NE2' ' O ' ' A' ' 56' ' ' LYS . 10.8 m80 65.22 -68.64 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 1.0 110.533 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 58' ' ' GLY . 42.0 m80 -142.35 22.02 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 m80 51.78 101.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 41.63 90.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.581 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 75.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.595 -179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.608 179.995 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.463 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER -63.43 -13.39 39.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.596 -179.993 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -74.44 52.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.536 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.35 57.33 0.62 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.55 -118.59 3.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.63 7.18 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.347 . . . . 1.0 110.539 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 t80 62.63 42.3 8.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.559 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -149.17 53.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.594 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -142.72 -42.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.54 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.454 ' HB2' ' H ' ' A' ' 13' ' ' ALA . 20.3 m-85 -101.12 8.84 42.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.519 -179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 40.7 40.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 97.42 41.53 3.41 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 82.18 -28.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.765 0.317 . . . . 1.0 110.277 -179.904 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 59.58 2.14 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.732 179.654 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 13' ' ' ALA . 10.2 m120 -138.38 78.0 1.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.51 52.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.36 -45.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.557 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 20' ' ' GLU . 21.3 tt0 41.74 56.36 3.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.605 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.8 -8.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.518 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 18' ' ' GLU . 1.8 tp10 -58.62 -22.11 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.555 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -101.31 13.0 36.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -142.18 11.0 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.605 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.04 16.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.573 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -96.04 -5.56 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -100.98 7.48 43.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.574 -179.978 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.6 t -141.08 -67.36 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.545 179.939 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.4 p -77.01 52.16 0.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.604 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.1 24.85 0.33 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' C ' HD22 ' A' ' 30' ' ' LEU . . . -143.54 -5.87 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 1.0 110.601 -179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.869 HD22 ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -108.57 -29.84 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.291 179.96 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -91.63 -37.93 0.37 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.201 -179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.9 Cg_endo -88.41 12.15 2.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.392 2.061 . . . . 1.0 112.203 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.2 -5.11 44.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.612 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.868 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -132.74 -46.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.444 179.912 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -54.87 -52.68 62.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.508 179.781 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.2 mmt -41.34 -54.65 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.03 -38.61 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.951 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 40' ' ' LEU . 1.6 t -83.25 -37.51 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.35 179.537 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.34 19.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.692 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 38' ' ' VAL . 11.3 mt -128.48 34.95 4.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 42' ' ' GLY . 1.9 pp -174.05 -42.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.729 179.806 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 41' ' ' LEU . . . -83.7 14.55 41.34 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 179.756 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -157.85 -85.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 1.0 110.416 -179.857 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.524 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER 41.04 22.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.572 179.808 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.877 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 136.23 -65.21 0.57 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -46.3 -24.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 1.0 110.563 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.579 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -87.94 -27.76 25.36 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.684 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -100.61 13.84 33.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 1.0 110.614 -179.947 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 45' ' ' GLY . 92.6 t -101.82 -61.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.601 -179.924 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.2 -0.52 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.475 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.4 ' CH2' ' CZ ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -80.51 -0.05 35.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.552 -179.962 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 49' ' ' VAL . 6.0 t -113.81 27.69 9.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.551 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.83 -42.99 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.613 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -103.96 6.91 36.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.605 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.491 ' HE ' ' CD2' ' A' ' 59' ' ' HIS . 11.3 tpt180 -102.43 -63.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.584 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.57 -34.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.557 -179.917 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -62.96 -30.33 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . -175.59 96.52 0.11 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.491 ' CD2' ' HE ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -57.68 -6.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.312 . . . . 1.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.44 ' H ' ' C ' ' A' ' 58' ' ' GLY . 30.3 m-70 -143.37 -55.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' HIS . 35.5 m80 -146.64 113.6 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.58 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.483 ' ND1' ' N ' ' A' ' 62' ' ' HIS . 1.3 m-70 -58.32 79.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.586 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 61' ' ' HIS . 39.5 t-80 43.67 94.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.55 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.403 -0.592 . . . . 1.0 109.403 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 53.22 96.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.567 179.959 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -66.26 -62.34 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.583 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.5 33.29 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.91 -116.81 1.62 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.32 -44.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 1.0 110.592 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER 54.82 43.23 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.531 179.968 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -115.34 39.3 2.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.553 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -139.51 63.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.6 t80 43.93 39.28 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.639 -179.95 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.53 110.01 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.634 -179.977 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.51 0.96 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.877 -0.889 . . . . 1.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -171.95 -54.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 1.0 110.517 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 t70 59.52 51.36 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.497 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.488 HD22 ' HG3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER 62.53 127.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.568 179.945 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.66 -45.45 2.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.581 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.66 -22.06 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.79 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HG3' HD22 ' A' ' 15' ' ' ASN . 7.2 tt0 49.15 49.99 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 1.0 110.606 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -36.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.522 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.5 51.92 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.547 179.941 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.48 ' C ' ' NZ ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -144.94 20.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.598 179.997 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.575 ' HA ' ' HZ3' ' A' ' 25' ' ' LYS . 1.4 m -169.35 -33.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.543 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.3 10.43 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.788 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.69 ' HE1' ' NZ ' ' A' ' 25' ' ' LYS . 43.7 p-90 -97.47 -16.95 19.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.455 179.776 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.69 ' NZ ' ' HE1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -121.55 -30.36 4.23 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.411 179.406 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -40.75 -61.57 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.706 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t -87.23 41.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.582 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.64 24.39 1.82 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.94 12.18 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 1.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -153.08 -19.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.58 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -82.65 -41.28 0.9 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.799 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 70.9 Cg_endo -87.33 24.99 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.58 2.187 . . . . 1.0 112.184 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 5.08 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.533 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.03 -41.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -75.6 26.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.481 ' H ' ' C ' ' A' ' 34' ' ' ILE . 20.7 mmt -135.02 -50.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.588 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.91 8.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.431 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 36' ' ' MET . 4.3 t -137.44 -54.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.548 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.71 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.472 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -85.24 65.43 9.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.947 0.403 . . . . 1.0 110.11 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -168.59 -47.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.367 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 11.97 56.58 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.653 HG23 ' N ' ' A' ' 44' ' ' THR . 8.6 t -172.91 -52.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 1.0 110.702 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.653 ' N ' HG23 ' A' ' 43' ' ' THR . 1.4 p 57.05 4.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.561 -179.928 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 103.53 -14.61 53.93 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -0.72 57.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 1.0 110.545 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.08 -8.31 63.28 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.66 20.29 2.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.776 0.322 . . . . 1.0 110.597 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.686 ' O ' HG12 ' A' ' 49' ' ' VAL . 96.7 t -138.31 5.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 tp -133.31 -61.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.427 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -68.22 -8.82 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.424 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -92.08 -9.37 42.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.603 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.09 -43.56 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -84.1 0.85 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.659 -179.998 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.616 ' NH1' ' NE2' ' A' ' 59' ' ' HIS . 61.4 ttt-85 -100.58 -46.18 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.598 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -21.8 62.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.505 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 13.13 35.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.572 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -152.08 -62.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' NE2' ' NH1' ' A' ' 55' ' ' ARG . 0.3 OUTLIER 67.19 -67.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 1.0 110.627 -179.953 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLY . 92.4 m-70 -141.74 -36.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.542 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' O ' ' A' ' 63' ' ' HIS . 14.4 t-160 -98.27 82.47 2.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.577 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -44.7 -40.67 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.597 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.448 ' O ' ' NE2' ' A' ' 61' ' ' HIS . 9.7 m-70 -88.94 81.9 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.511 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.041 -0.98 . . . . 1.0 110.558 -179.978 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 51.5 68.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.559 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -70.83 -8.7 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.16 -84.26 1.49 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.1 14.91 2.23 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -87.29 13.15 10.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.333 . . . . 1.0 110.622 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 53.62 41.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.596 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.48 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 6.3 t70 -154.91 47.67 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.502 179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.07 -17.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.598 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -154.03 9.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -93.2 75.11 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.36 56.91 6.0 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 15' ' ' ASN . . . -171.72 -53.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 1.0 110.547 179.964 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 47.32 16.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.583 -179.989 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 8' ' ' ASP . 27.3 m-20 48.2 96.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.594 -179.969 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -54.45 45.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.572 179.994 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 m -169.74 26.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.595 179.982 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -158.29 120.87 3.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 20' ' ' GLU . 24.0 p -165.57 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.492 179.945 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.454 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 3.6 mm-40 -80.76 11.95 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.512 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.5 8.2 1.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.585 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.67 12.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.427 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.464 ' C ' ' N ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -94.92 -37.45 11.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.65 -179.975 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -48.48 -14.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.409 -179.924 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' N ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -132.17 -1.97 3.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.393 179.687 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.31 107.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 29' ' ' ALA . 5.8 t -173.26 -41.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.407 179.897 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.64 16.24 1.91 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -135.39 -9.52 2.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.733 0.301 . . . . 1.0 110.519 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.5 mt -112.84 -27.01 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.554 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.59 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -72.89 -37.23 3.89 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.258 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.8 Cg_endo -87.36 23.41 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.384 2.056 . . . . 1.0 112.236 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.61 -21.49 4.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.689 -179.957 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 36' ' ' MET . 33.3 mt -104.46 -43.66 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.483 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -75.48 24.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.561 179.957 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 34' ' ' ILE . 24.7 mmt -111.85 -40.43 4.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.562 179.989 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.77 -35.64 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.571 -179.912 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 40' ' ' LEU . 9.6 t -78.39 -54.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.554 -179.84 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -44.8 -18.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 1.5 mt -123.41 39.75 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' VAL . 15.1 tp -166.33 -62.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.313 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.45 -8.88 47.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.634 HG23 ' N ' ' A' ' 44' ' ' THR . 9.9 t -144.64 -49.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.328 . . . . 1.0 110.625 -179.96 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.634 ' N ' HG23 ' A' ' 43' ' ' THR . 1.7 p 62.58 -0.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 81.34 20.15 65.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.98 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.82 -3.6 10.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.836 0.35 . . . . 1.0 110.468 179.945 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.26 -33.28 10.76 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -104.05 -115.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.661 0.267 . . . . 1.0 110.547 179.892 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.447 ' H ' ' CG ' ' A' ' 48' ' ' LEU . 58.7 t 55.58 -81.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.04 0.448 . . . . 1.0 110.514 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' LEU . 10.6 mt -48.95 -27.76 3.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.849 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.592 ' CH2' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -41.6 -39.33 1.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.639 179.94 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -73.58 18.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.3 t -138.2 -24.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.538 179.941 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -126.17 31.68 5.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.493 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.592 ' NH1' ' CH2' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -139.12 -59.34 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.51 179.957 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -29.75 58.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.562 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -49.03 -27.96 3.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.543 179.964 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.13 82.75 0.04 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -31.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.728 0.299 . . . . 1.0 110.583 179.997 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.556 ' ND1' ' N ' ' A' ' 61' ' ' HIS . 14.4 p80 -56.51 -35.07 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.556 ' N ' ' ND1' ' A' ' 60' ' ' HIS . 19.9 m-70 46.14 62.93 2.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.562 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -154.86 83.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.528 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.6 102.82 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.555 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.607 179.965 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 . . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 1' ' ' MET . 14.3 mt-10 60.41 142.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.524 179.981 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.54 -98.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.495 -179.992 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.22 -108.86 0.21 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . 55.96 19.78 23.95 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER 60.83 3.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 1.0 110.608 179.962 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' A' ' 6' ' ' ASP . 23.5 p90 40.65 34.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.39 47.72 1.68 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.613 -0.722 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -162.21 -75.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.605 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.48 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 t80 -144.92 25.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.581 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.1 p90 38.58 40.84 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.69 -68.66 0.08 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -174.01 -96.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 1.0 110.598 -179.989 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.413 ' OD2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 t0 72.26 22.8 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.51 179.955 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -164.3 66.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.59 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -19.95 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.587 179.944 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m 168.4 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.585 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.98 135.41 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.52 179.979 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 175.87 73.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.573 -179.99 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.14 9.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.166 179.76 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 19' ' ' CYS . 3.4 m-85 66.93 92.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.559 179.853 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 m 51.21 25.36 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.398 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.86 15.34 2.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -129.84 -0.96 4.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.278 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -154.72 19.15 0.46 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.431 179.611 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 28' ' ' GLY . 77.4 p -113.33 -108.67 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.6 -69.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 1.0 109.953 -179.664 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 26' ' ' SER . . . -145.27 11.91 1.81 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.08 -1.208 . . . . 1.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 69.35 45.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.104 0.478 . . . . 1.0 109.979 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 30' ' ' LEU . 3.4 mm? -83.3 -42.91 16.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.421 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 33' ' ' ALA . 1.5 mp -68.8 -50.63 22.91 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.568 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 57.3 Cg_endo -72.84 29.97 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.593 1.529 . . . . 1.0 112.023 179.98 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . -136.07 3.67 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.488 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -38.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.564 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 42.3 m-85 -82.09 25.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.7 mmt -137.44 -52.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.563 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -68.9 8.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.566 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.3 t -140.3 -52.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.77 -54.71 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.431 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.41 ' C ' HG22 ' A' ' 44' ' ' THR . 3.4 mt -104.49 45.58 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.423 179.806 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -163.73 -55.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.427 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -71.62 15.91 1.51 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -168.44 -83.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 1.0 110.599 -179.983 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.481 ' H ' HG23 ' A' ' 43' ' ' THR . 1.0 OUTLIER 54.33 7.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.564 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 81.55 21.91 61.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -133.83 11.01 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.802 0.334 . . . . 1.0 110.432 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.8 17.9 4.89 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.72 21.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.683 0.278 . . . . 1.0 110.519 -179.977 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.85 -51.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -101.57 -17.8 16.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.62 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -86.68 -11.32 51.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.618 179.913 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 6.4 t -84.64 -27.24 27.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.572 179.959 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -68.66 -23.66 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.9 15.57 23.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.553 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 57' ' ' LYS . 12.6 ttm180 -135.88 -46.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' CG ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -58.86 -5.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.596 179.945 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -100.95 -10.64 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.569 -179.983 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.48 86.89 0.07 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.05 -16.19 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 1.0 110.576 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -59.64 -114.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -138.06 89.14 2.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 101.96 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 2.0 t-80 -134.46 -147.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 1.0 110.415 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 10.8 t-160 . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.553 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.776 0.322 . . . . 1.0 110.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.54 34.65 1.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.643 ' C ' HD23 ' A' ' 30' ' ' LEU . . . -137.87 -20.11 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 1.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.752 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.39 -17.66 13.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.489 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.28 -39.69 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.166 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.5 Cg_endo -87.86 25.03 0.67 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.555 2.17 . . . . 1.0 112.291 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.85 6.75 5.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.534 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.734 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -139.66 -44.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.543 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.28 8.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.489 ' H ' ' C ' ' A' ' 34' ' ' ILE . 10.4 mmt -101.58 -63.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.58 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.2 15.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 36' ' ' MET . 88.9 t -130.92 -68.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.482 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -41.88 -43.51 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.567 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -103.89 52.83 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.542 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.1 tp -159.55 -62.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.95 9.93 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 1.0 110.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.735 0.302 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.92 38.61 0.11 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.1 -4.49 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.334 . . . . 1.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 -18.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.544 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.9 mm -80.77 -35.58 0.84 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.454 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.87 7.83 4.42 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.403 2.068 . . . . 1.0 112.196 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.31 -0.05 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.669 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.61 -35.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -82.46 30.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.613 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.9 mmt -134.21 -62.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 41' ' ' LEU . 15.2 mt -71.9 13.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.52 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.2 t -137.43 -28.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.512 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.02 27.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 38' ' ' VAL . 1.2 pp -173.66 13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 37' ' ' LEU . 96.1 mt -131.34 -48.46 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.442 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.61 42.63 1.87 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.328 . . . . 1.0 110.486 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.821 0.343 . . . . 1.0 110.606 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.82 34.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.58 17.51 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 1.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.02 -21.61 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -76.4 -35.88 1.65 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.3 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.8 Cg_endo -88.43 3.66 5.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.429 2.086 . . . . 1.0 112.283 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.58 5.05 36.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.825 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 mt -137.22 -35.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -86.45 22.19 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.572 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.3 mmt -136.06 -61.94 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.55 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 41' ' ' LEU . 39.3 mt -60.6 -17.98 50.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -99.24 -51.2 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.611 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -43.5 -46.09 6.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.432 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.76 69.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.468 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -142.28 -58.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.452 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.61 14.62 50.75 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 1.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.812 0.339 . . . . 1.0 110.515 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.44 34.09 0.83 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.83 -31.89 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 1.0 110.657 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.2 -1.82 21.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.548 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.696 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.28 -39.65 0.41 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.293 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.19 24.16 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 1.0 112.145 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.22 5.15 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.568 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 36' ' ' MET . 29.1 pt -131.67 -31.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.666 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 16.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.472 ' C ' ' H ' ' A' ' 38' ' ' VAL . 19.4 mmm -117.2 -57.99 2.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.2 mt -72.48 13.52 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.591 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.6 t -137.9 -21.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.54 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.472 ' CD2' ' O ' ' A' ' 39' ' ' PHE . 44.5 t80 -91.49 26.77 2.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mt -138.5 -6.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -126.59 -50.16 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.493 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.98 -7.69 0.83 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 110.413 -0.218 . . . . 1.0 110.413 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.757 0.313 . . . . 1.0 110.545 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.43 40.04 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -142.36 -15.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 1.0 110.542 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -137.77 -17.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.621 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 4.0 mm -80.24 -35.62 0.91 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.459 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.4 Cg_endo -87.9 24.29 0.72 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.393 2.062 . . . . 1.0 112.282 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.07 1.69 6.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.521 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -36.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.516 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.81 2.85 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.576 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.6 mmt -101.61 -56.23 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.551 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.77 13.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.537 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -137.15 -74.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.502 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -42.69 -40.38 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -102.19 43.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.597 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.449 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -163.5 -67.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.382 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.02 -15.19 0.34 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.449 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 C-N-CA 121.119 -0.232 . . . . 1.0 110.537 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 1.0 110.611 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.42 33.98 0.77 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.73 -11.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 1.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -1.41 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.591 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.73 -38.88 1.82 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.48 4.6 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.37 2.047 . . . . 1.0 112.202 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.97 3.95 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.549 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 36' ' ' MET . 2.3 mt -140.13 -41.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.446 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.6 m-85 -75.99 26.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.579 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.8 mmt -136.92 -51.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.54 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.22 16.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.549 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' MET . 22.0 t -137.01 -56.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -42.2 -53.36 4.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mt -95.41 60.07 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.573 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -171.11 -62.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.367 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.52 -6.37 1.05 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 1.0 110.594 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.92 38.94 0.84 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.66 -29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 1.0 110.528 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -107.76 -12.64 15.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.587 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.98 -36.06 3.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.315 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.14 25.8 0.65 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.307 2.005 . . . . 1.0 112.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.74 2.12 4.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.558 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -142.83 -44.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.635 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.8 m-85 -79.75 26.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.582 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 17.4 mmt -137.43 -58.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.02 8.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' A' ' 36' ' ' MET . 17.2 t -137.62 -53.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -53.1 -39.68 63.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 mt -101.48 42.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.496 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -159.21 -65.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.8 -13.85 0.34 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.527 0.203 . . . . 1.0 110.493 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.821 0.343 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.75 24.85 1.96 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.37 -0.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 1.0 110.483 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.78 -17.38 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.604 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.06 -36.7 4.33 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.235 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.3 Cg_endo -87.47 25.64 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.316 2.011 . . . . 1.0 112.169 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.56 -49.7 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.598 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -99.25 -31.87 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.67 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.551 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.474 ' C ' ' H ' ' A' ' 38' ' ' VAL . 3.2 mtp -136.44 -54.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.52 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.89 2.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 36' ' ' MET . 2.8 t -137.38 -23.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 39' ' ' PHE . 41.9 t80 -88.97 37.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.537 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -136.59 -9.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.2 mt -112.15 -41.96 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.07 39.5 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.558 0.218 . . . . 1.0 110.486 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.784 0.326 . . . . 1.0 110.59 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.0 14.65 3.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.879 -0.889 . . . . 1.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.29 3.43 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.277 . . . . 1.0 110.613 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.75 -30.68 6.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.675 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -77.96 -35.98 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.369 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 76.1 Cg_endo -88.74 26.09 0.59 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.413 2.076 . . . . 1.0 112.217 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.44 13.75 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' C ' ' H ' ' A' ' 36' ' ' MET . 10.1 mt -145.51 -46.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.12 4.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.588 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.3 mmt -97.83 -60.38 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.569 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -56.39 -5.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.52 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' MET . 55.8 t -101.82 -56.06 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.451 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -41.83 -41.11 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.63 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mt -103.18 48.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.646 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' THR . 16.7 tp -166.64 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.75 13.85 2.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' LEU . 8.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 1.0 110.7 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.816 0.341 . . . . 1.0 110.511 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.53 24.44 0.58 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.22 -13.11 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.72 0.295 . . . . 1.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.44 ' C ' HD13 ' A' ' 31' ' ' ILE . 1.6 mp -127.51 -1.96 6.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.678 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.45 -39.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.215 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.2 Cg_endo -87.14 7.94 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.444 2.096 . . . . 1.0 112.159 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.39 4.31 41.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.86 -39.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.28 30.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.576 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.5 mmt -133.96 -58.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.543 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.85 20.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.547 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -139.3 -48.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -49.26 -45.66 45.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.5 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -102.55 62.92 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -137.29 -63.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.533 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.82 -8.34 0.58 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 41' ' ' LEU . 1.3 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.56 0.219 . . . . 1.0 110.474 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.796 0.331 . . . . 1.0 110.57 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.67 28.67 2.73 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.51 -15.08 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 1.0 110.469 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -136.34 -9.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.636 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -78.39 -40.11 1.76 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.938 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.6 Cg_endo -86.94 25.07 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.444 2.096 . . . . 1.0 112.2 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.12 6.26 4.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -144.79 -40.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.512 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' ' SD ' ' A' ' 36' ' ' MET . 51.0 m-85 -76.6 26.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.492 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.457 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.0 mmt -136.66 -50.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.28 7.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.555 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.4 t -138.26 -54.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.603 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.59 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.364 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -85.55 64.22 8.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 1.0 110.064 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.9 tp -164.43 -39.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.272 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.38 17.87 58.1 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.716 0.293 . . . . 1.0 110.654 -179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 44.16 1.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.65 -11.66 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 1.0 110.567 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 pp -138.15 -10.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.632 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -72.72 -41.15 7.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.2 Cg_endo -87.49 25.14 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.504 2.136 . . . . 1.0 112.219 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.68 -48.58 1.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' C ' ' N ' ' A' ' 36' ' ' MET . 1.0 OUTLIER -103.75 -51.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.615 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -46.71 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.447 ' N ' ' C ' ' A' ' 34' ' ' ILE . 2.8 mtp -77.44 -55.69 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.564 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -52.03 -13.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.486 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.4 t -103.21 -47.24 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -49.73 -11.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.676 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 38' ' ' VAL . 2.9 mt -133.2 40.16 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.523 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -164.85 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.25 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.2 -1.98 30.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 1.0 110.589 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.831 0.348 . . . . 1.0 110.498 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.79 35.13 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 -15.08 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.688 0.28 . . . . 1.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.24 -20.56 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -74.87 -34.73 1.81 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.526 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.9 Cg_endo -88.24 26.54 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.282 1.988 . . . . 1.0 112.01 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.54 -3.39 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.657 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.59 -61.16 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.572 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 39' ' ' PHE . 1.9 m-85 -49.1 -29.78 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.3 mmt -74.8 -23.97 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.662 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -85.03 -6.12 59.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.59 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.86 -67.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.656 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 3.6 t80 -40.75 -48.8 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.655 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 ' SD ' ' A' ' 36' ' ' MET . 4.5 mt -103.39 60.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.533 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -165.29 -62.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.34 10.16 2.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.904 -0.879 . . . . 1.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.455 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 1.0 110.589 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.734 0.302 . . . . 1.0 110.573 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.04 23.72 1.6 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.74 6.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 1.0 110.583 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.42 -28.0 7.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.53 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -81.92 -36.14 0.77 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.361 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.1 Cg_endo -87.35 10.12 3.65 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.274 1.983 . . . . 1.0 112.09 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.1 -2.76 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.595 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.5 -42.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.75 31.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.554 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.428 ' H ' ' C ' ' A' ' 34' ' ' ILE . 18.4 mmt -136.53 -59.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mt -83.82 17.54 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.63 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.17 -11.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.63 14.12 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.34 38.89 3.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.517 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.69 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 43' ' ' THR . . . -94.4 23.55 31.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.41 HG22 ' C ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 1.0 110.398 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.778 0.323 . . . . 1.0 110.647 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.31 41.77 0.75 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 -12.34 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 1.0 110.586 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.586 ' O ' HD11 ' A' ' 34' ' ' ILE . 1.7 mp -113.03 -31.22 6.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.522 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.607 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -78.9 -36.26 1.15 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.377 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.2 Cg_endo -87.2 25.87 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.299 1.999 . . . . 1.0 112.162 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.96 11.52 3.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.583 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -140.0 -40.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.5 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -73.07 10.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.583 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ILE . 7.1 mmt -103.04 -64.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.23 -17.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.632 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.47 ' C ' ' N ' ' A' ' 40' ' ' LEU . 50.7 t -90.04 -57.28 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.09 -15.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.533 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 38' ' ' VAL . 60.5 mt -118.94 41.71 2.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.4 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.37 -44.79 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.2 -10.23 82.77 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 1.0 110.38 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.748 0.309 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.86 36.43 0.23 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.01 -3.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 1.0 110.532 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.41 -19.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.582 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -78.59 -41.17 1.8 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 64.1 Cg_endo -86.91 -16.92 3.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.426 2.084 . . . . 1.0 112.21 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -1.37 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -136.47 -51.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.443 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -53.03 -31.79 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.51 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 32' ' ' PRO . 11.9 mmt -60.61 -59.25 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.553 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mp -46.4 -22.25 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.558 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' LEU . 3.7 t -93.38 -50.46 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.552 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.32 -15.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.1 mt -124.85 37.45 4.4 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.358 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' VAL . 14.7 tp -168.57 -62.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.35 -13.39 43.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 121.132 -0.227 . . . . 1.0 110.773 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.831 0.348 . . . . 1.0 110.594 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.96 41.87 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.06 -1.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.704 0.288 . . . . 1.0 110.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.34 -30.3 2.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.617 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -75.44 -34.52 1.61 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.4 Cg_endo -88.0 26.36 0.59 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.265 1.977 . . . . 1.0 112.167 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.48 -2.21 3.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.708 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.9 -33.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.571 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -95.76 25.76 4.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.1 mmt -131.16 -19.77 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.511 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -125.26 19.6 8.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.74 -43.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -54.9 -14.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.666 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -140.64 17.92 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.595 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 tp -138.55 -41.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.251 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.96 2.28 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 1.0 110.607 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.732 0.301 . . . . 1.0 110.572 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.58 4.47 3.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 -6.01 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.673 0.273 . . . . 1.0 110.556 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.69 -17.58 13.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.582 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.9 -39.95 3.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 66.4 Cg_endo -86.89 -0.81 7.99 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.454 2.102 . . . . 1.0 112.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.29 11.12 38.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.552 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.7 mt -137.72 -36.53 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.93 2.75 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.8 mmt -101.7 -54.67 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.78 16.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.89 -70.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -46.07 -46.03 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -100.54 50.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -173.54 -64.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.31 -14.02 0.49 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.423 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 1.0 110.607 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.831 0.348 . . . . 1.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.75 37.1 0.14 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.871 . . . . 1.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.64 6.51 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.3 -27.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.608 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -69.99 -41.19 14.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.1 Cg_endo -87.33 22.3 0.94 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.595 2.197 . . . . 1.0 112.226 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.47 -7.89 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.636 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' MET . 45.6 mt -104.59 -45.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.634 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -70.55 9.25 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ILE . 13.0 mmt -97.27 -62.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.53 -9.08 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 40' ' ' LEU . 92.1 t -98.28 -44.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -78.96 30.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.604 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.7 mt -138.9 6.32 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.41 -40.5 4.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.551 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.73 -3.62 50.41 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.616 0.246 . . . . 1.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.826 0.346 . . . . 1.0 110.586 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.36 31.82 8.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 30' ' ' LEU . . . -163.08 -8.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 1.0 110.55 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.402 ' H ' ' H ' ' A' ' 29' ' ' ALA . 25.6 mt -111.52 -30.3 7.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.681 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.57 -37.89 1.7 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.194 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.1 Cg_endo -88.1 -0.27 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.389 2.059 . . . . 1.0 112.119 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.87 6.91 36.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.653 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -140.41 -51.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.585 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.21 -29.8 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.59 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.431 ' C ' ' N ' ' A' ' 38' ' ' VAL . 23.3 mmt -63.59 -60.38 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.446 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.5 mp -46.92 -17.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.537 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.431 ' N ' ' C ' ' A' ' 36' ' ' MET . 6.5 t -97.81 -52.1 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -42.4 -26.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.504 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -115.83 73.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.09 -57.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 10.58 67.86 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 1.0 110.542 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.712 0.292 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.38 40.35 1.11 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.24 -9.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 1.0 110.544 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.51 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.624 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.4 mm -83.86 -36.02 0.63 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.445 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.0 Cg_endo -88.26 10.75 3.3 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.468 2.112 . . . . 1.0 112.266 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.93 -19.8 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.525 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.474 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -105.52 -44.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.627 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' O ' ' SD ' ' A' ' 36' ' ' MET . 30.0 m-85 -74.21 19.77 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.62 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 18.1 mmt -136.49 -50.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.622 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.86 0.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.8 t -137.43 -54.17 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -49.6 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -98.43 56.1 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -175.05 -64.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -17.33 0.88 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.406 ' N ' ' C ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.522 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.33 . . . . 1.0 110.518 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -170.23 32.88 0.16 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.89 -18.01 0.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.717 0.294 . . . . 1.0 110.578 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.442 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 2.6 mp -112.0 -29.69 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.601 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -75.8 -37.81 2.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.19 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.3 Cg_endo -87.6 26.15 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.461 2.108 . . . . 1.0 112.174 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.25 7.82 3.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -145.32 -39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.609 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.493 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.2 m-85 -79.26 26.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.588 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 19.4 mmt -137.34 -67.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.566 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -47.02 -24.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.572 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.61 -51.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.587 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -41.54 -30.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.465 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.93 80.29 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.411 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 43' ' ' THR . 2.0 mt -159.36 -61.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.56 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 43' ' ' THR . . . -75.44 28.41 1.23 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 1.0 110.539 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.0 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.859 0.362 . . . . 1.0 110.332 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.666 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . 151.13 -11.1 0.78 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 82.88 34.56 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.852 0.358 . . . . 1.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -110.74 -26.6 9.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.335 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -77.57 -41.01 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.854 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.5 Cg_endo -86.92 24.78 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.475 2.117 . . . . 1.0 112.168 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.8 5.19 5.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -146.26 -55.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.546 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -60.92 -0.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.472 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.9 mmt -96.97 -50.36 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.544 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 37' ' ' LEU . 9.4 mp -78.82 13.21 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.582 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.4 t -141.31 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.564 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.5 -50.49 16.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mt -99.16 49.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.636 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 43' ' ' THR . 14.9 tp -175.19 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.334 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -49.57 -12.49 0.38 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.788 0.328 . . . . 1.0 110.592 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.58 49.21 0.89 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -137.19 -16.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 1.0 110.622 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -136.3 -18.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -68.68 -39.84 16.04 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.95 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.8 Cg_endo -87.11 25.75 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.126 . . . . 1.0 112.192 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.55 -49.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.496 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 pt -101.09 -32.5 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.602 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.504 ' CE2' ' CD1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -79.04 29.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.6 mtp -127.31 -61.13 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.558 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.97 16.74 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.24 -31.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.643 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 35' ' ' TYR . 30.4 t80 -77.82 -34.84 51.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.645 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.53 26.61 10.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.45 -61.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.176 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 -4.86 69.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 C-N-CA 121.088 -0.245 . . . . 1.0 110.65 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.819 0.343 . . . . 1.0 110.594 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -157.03 34.68 0.56 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.58 -6.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.665 0.269 . . . . 1.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HD11 ' A' ' 34' ' ' ILE . 1.7 mt -113.19 -26.73 8.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.609 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -85.87 -34.72 0.5 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.597 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.7 Cg_endo -87.68 25.48 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.258 1.972 . . . . 1.0 112.141 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.32 11.17 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.553 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -150.75 -48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.498 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -73.19 12.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.501 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' VAL . 14.5 mmt -129.68 -38.12 1.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.8 mp -55.41 -6.68 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.618 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.96 -53.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.582 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -21.41 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.588 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mt -136.8 54.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 -46.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.15 34.7 4.9 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 1.0 110.53 179.951 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.772 0.32 . . . . 1.0 110.574 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.87 45.84 0.86 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.59 -34.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.739 0.304 . . . . 1.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -106.4 -9.61 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.573 -179.994 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.77 -40.06 3.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.49 25.97 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.498 2.132 . . . . 1.0 112.164 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.8 2.59 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.51 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.43 -61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.594 179.918 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.92 -28.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 36' ' ' MET . 2.9 mmm -75.11 -47.3 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -54.76 -7.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.8 OUTLIER -119.72 -51.54 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.494 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -46.13 -17.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.621 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 38' ' ' VAL . 8.7 mt -136.77 52.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.6 tp -169.8 -59.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.29 40.9 2.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 1.0 110.589 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.839 0.352 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.89 31.62 0.61 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.55 5.9 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 1.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.45 -24.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.568 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -73.84 -41.07 5.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 63.3 Cg_endo -87.03 10.24 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.573 2.182 . . . . 1.0 112.251 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.32 3.63 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.564 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.06 -41.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -67.44 4.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' VAL . 20.3 mmt -100.92 -72.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mt -52.09 -9.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' MET . 76.4 t -101.03 -36.47 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.578 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -93.03 33.98 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.597 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -136.92 0.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.535 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -112.29 -41.33 3.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.525 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.91 -3.61 44.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 1.0 110.482 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.877 0.37 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.93 20.34 0.87 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' C ' HD22 ' A' ' 30' ' ' LEU . . . -141.78 -5.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 1.0 110.534 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.74 -38.05 5.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.598 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -82.0 -38.04 0.86 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.245 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.7 Cg_endo -87.31 19.4 1.38 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.402 2.068 . . . . 1.0 112.131 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.16 8.28 13.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.49 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.48 -44.0 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.567 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.56 3.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.3 mmt -100.63 -47.63 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.605 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.31 27.86 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -146.58 -18.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 43' ' ' THR . 34.3 t80 -96.23 -2.13 46.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.678 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.84 40.31 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.494 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.87 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.11 20.75 44.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.377 -1.089 . . . . 1.0 110.377 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 39' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 1.0 110.344 -179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -149.4 31.89 1.14 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.82 -9.09 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 1.0 110.497 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -130.85 -16.56 3.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.62 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -78.29 -34.79 1.09 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.395 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.2 Cg_endo -87.72 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.319 2.013 . . . . 1.0 112.16 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.35 10.55 2.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 36' ' ' MET . 14.0 mt -142.93 -44.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 7.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.511 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 34' ' ' ILE . 12.5 mmt -104.68 -55.18 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.561 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.75 18.01 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 179.944 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' C ' ' N ' ' A' ' 40' ' ' LEU . 57.9 t -135.43 -63.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -47.36 -17.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.566 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 38' ' ' VAL . 3.7 mt -135.72 46.4 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.572 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.9 tp -175.17 -62.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.389 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.42 -10.48 2.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 1.0 110.676 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 28' ' ' GLY . 13.6 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.673 0.273 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.665 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . -130.95 -12.97 2.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 81.19 48.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.941 0.4 . . . . 1.0 110.094 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.877 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -129.09 -27.7 2.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.491 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -80.42 -39.05 1.14 Allowed Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.974 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.7 Cg_endo -86.91 25.25 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.362 2.042 . . . . 1.0 112.175 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.5 -0.7 6.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.49 -45.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.592 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.4 27.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.482 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.2 mmt -135.76 -51.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.519 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 41' ' ' LEU . 8.8 mt -59.45 -2.48 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.1 t -140.32 -61.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -64.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.638 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -100.94 63.86 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 37' ' ' LEU . 15.0 tp -163.74 -65.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.46 -23.62 1.37 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 121.2 -0.2 . . . . 1.0 110.65 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.871 0.367 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.58 37.44 0.19 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -137.97 -15.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 1.0 110.561 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -136.83 -15.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.642 179.988 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -79.1 -40.29 1.52 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.1 Cg_endo -86.97 25.29 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.461 2.107 . . . . 1.0 112.203 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.07 6.48 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.497 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -143.96 -42.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 3.3 m-85 -74.94 15.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.528 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 15.1 mmt -132.64 -55.71 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.515 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.98 11.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' GLY . 6.3 t -142.25 -56.86 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.584 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.7 -53.75 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.456 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt -105.0 44.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.314 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -162.88 -55.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.371 -179.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -73.23 20.22 1.23 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 1.0 110.571 -179.99 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 29' ' ' ALA . 10.5 t . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.833 0.349 . . . . 1.0 110.602 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.23 13.23 2.06 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -133.04 -8.79 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 1.0 110.418 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.21 -19.78 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.575 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -91.33 -34.54 0.36 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.673 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.58 13.55 2.61 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.203 1.936 . . . . 1.0 112.403 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' C ' ' SD ' ' A' ' 36' ' ' MET . . . -115.44 6.29 14.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.619 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.6 ' N ' ' SD ' ' A' ' 36' ' ' MET . 1.5 pt -140.15 -26.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -71.47 16.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.622 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -127.21 -67.13 0.85 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.708 -179.944 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mt -47.38 -13.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 1.0 110.689 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.485 ' N ' ' C ' ' A' ' 36' ' ' MET . 21.7 t -102.84 -57.34 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.02 37.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.792 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.9 mt -139.06 -8.44 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.608 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.4 mt -115.77 -41.14 3.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.453 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.54 24.04 3.29 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 C-N-CA 121.12 -0.232 . . . . 1.0 110.583 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 29' ' ' ALA . 52.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 1.0 110.652 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 19.17 1.53 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -114.23 -1.82 13.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 1.0 110.481 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.68 -25.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -66.74 -41.02 35.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.3 Cg_endo -87.18 16.16 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.549 2.166 . . . . 1.0 112.19 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.79 -36.87 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.549 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.594 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.1 mm -89.36 -31.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.387 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -71.71 13.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.489 ' C ' ' H ' ' A' ' 38' ' ' VAL . 28.7 mmm -117.59 -52.61 2.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.434 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.73 12.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.425 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.1 t -134.69 -43.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.469 -179.936 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -63.09 -30.31 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.504 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mt -101.74 52.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.75 -43.94 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.59 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 -16.81 80.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 1.0 110.481 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.8 0.333 . . . . 1.0 110.603 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -139.51 29.7 2.47 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.54 -7.22 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 1.0 110.493 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -20.18 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -69.57 -39.94 13.04 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 69.5 Cg_endo -87.0 2.48 6.98 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.384 2.056 . . . . 1.0 112.28 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.68 -1.04 57.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.625 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.21 -57.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.69 179.962 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 3.4 m-85 -43.22 -31.59 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.495 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.51 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.5 mmt -71.52 -33.62 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 34' ' ' ILE . 6.6 mt -74.24 -4.26 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.668 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.95 -67.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.692 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' TYR . 9.7 t80 -40.89 -50.05 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.605 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.51 HD12 ' SD ' ' A' ' 36' ' ' MET . 4.6 mt -102.56 61.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.488 -179.957 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -170.47 -61.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.265 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.49 27.49 1.05 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 1.0 110.53 179.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.044 0.449 . . . . 1.0 110.164 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . 127.81 10.02 3.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.38 -1.088 . . . . 1.0 110.38 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 80.31 13.23 0.9 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.026 0.441 . . . . 1.0 109.988 -179.548 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 30' ' ' LEU . 3.8 mm? -65.74 -27.86 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.23 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 31' ' ' ILE . 1.6 mp -75.29 -59.68 1.27 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.242 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 11.5 Cg_endo -54.86 -13.55 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.732 1.621 . . . . 1.0 111.949 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.85 -3.67 54.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.745 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.98 -53.81 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.543 -179.974 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -42.55 -30.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 mmt -78.45 -32.77 48.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.667 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.6 mt -68.43 -3.53 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.705 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -59.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.629 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 41' ' ' LEU . 62.7 t80 -44.99 -64.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.42 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.9 41.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.508 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 39' ' ' PHE . 31.6 tp -153.95 -40.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.526 -179.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.3 -13.29 76.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.834 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.0 110.636 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.744 0.307 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.07 21.32 3.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.7 -6.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 1.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 31' ' ' ILE . 3.9 mt -102.73 -25.53 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.458 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.721 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -93.21 -42.89 0.33 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.266 179.982 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.9 Cg_endo -83.54 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.793 1.662 . . . . 1.0 112.459 -179.13 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.09 -1.31 7.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.322 179.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -148.79 -61.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.544 -179.919 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -42.35 -26.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.616 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.404 ' C ' ' N ' ' A' ' 38' ' ' VAL . 1.9 mtp -74.41 -55.85 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.422 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.9 mp -48.61 -19.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.582 179.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' A' ' 36' ' ' MET . 2.2 t -97.76 -49.25 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.56 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -47.31 -43.13 22.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.84 52.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -166.87 -62.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.355 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.78 -15.54 4.8 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.336 . . . . 1.0 110.555 -179.943 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.79 0.329 . . . . 1.0 110.604 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.1 24.85 0.33 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' C ' HD22 ' A' ' 30' ' ' LEU . . . -143.54 -5.87 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 1.0 110.601 -179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.869 HD22 ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -108.57 -29.84 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.291 179.96 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -91.63 -37.93 0.37 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.201 -179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.9 Cg_endo -88.41 12.15 2.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.392 2.061 . . . . 1.0 112.203 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.2 -5.11 44.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.612 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.868 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -132.74 -46.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.444 179.912 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -54.87 -52.68 62.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.508 179.781 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.2 mmt -41.34 -54.65 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.03 -38.61 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.951 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 40' ' ' LEU . 1.6 t -83.25 -37.51 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.35 179.537 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.34 19.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.692 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 38' ' ' VAL . 11.3 mt -128.48 34.95 4.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 42' ' ' GLY . 1.9 pp -174.05 -42.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.729 179.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 41' ' ' LEU . . . -83.7 14.55 41.34 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 179.756 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 1.0 110.416 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.807 0.337 . . . . 1.0 110.582 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.64 24.39 1.82 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.94 12.18 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 1.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -153.08 -19.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.58 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -82.65 -41.28 0.9 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.799 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 70.9 Cg_endo -87.33 24.99 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.58 2.187 . . . . 1.0 112.184 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 5.08 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.533 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.03 -41.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -75.6 26.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.481 ' H ' ' C ' ' A' ' 34' ' ' ILE . 20.7 mmt -135.02 -50.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.588 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.91 8.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.431 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 36' ' ' MET . 4.3 t -137.44 -54.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.548 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.71 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.472 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -85.24 65.43 9.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.947 0.403 . . . . 1.0 110.11 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -168.59 -47.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.367 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 11.97 56.58 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 1.0 110.702 -179.976 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 29' ' ' ALA . 5.8 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 1.0 110.407 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.64 16.24 1.91 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -135.39 -9.52 2.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.733 0.301 . . . . 1.0 110.519 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.5 mt -112.84 -27.01 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.554 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.59 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -72.89 -37.23 3.89 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.258 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.8 Cg_endo -87.36 23.41 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.384 2.056 . . . . 1.0 112.236 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.61 -21.49 4.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.689 -179.957 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 36' ' ' MET . 33.3 mt -104.46 -43.66 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.483 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -75.48 24.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.561 179.957 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 34' ' ' ILE . 24.7 mmt -111.85 -40.43 4.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.562 179.989 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.77 -35.64 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.571 -179.912 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 40' ' ' LEU . 9.6 t -78.39 -54.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.554 -179.84 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -44.8 -18.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 1.5 mt -123.41 39.75 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' VAL . 15.1 tp -166.33 -62.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.313 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.45 -8.88 47.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.328 . . . . 1.0 110.625 -179.96 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . -145.27 11.91 1.81 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.08 -1.208 . . . . 1.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 69.35 45.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.104 0.478 . . . . 1.0 109.979 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 30' ' ' LEU . 3.4 mm? -83.3 -42.91 16.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.421 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 33' ' ' ALA . 1.5 mp -68.8 -50.63 22.91 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.568 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 57.3 Cg_endo -72.84 29.97 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.593 1.529 . . . . 1.0 112.023 179.98 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . -136.07 3.67 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.488 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -38.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.564 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 42.3 m-85 -82.09 25.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.7 mmt -137.44 -52.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.563 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -68.9 8.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.566 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.3 t -140.3 -52.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.77 -54.71 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.431 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -104.49 45.58 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.423 179.806 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -163.73 -55.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.427 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -71.62 15.91 1.51 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 1.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 50.79 69.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.582 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -55.9 -68.35 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.598 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 45.36 58.46 5.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.58 109.49 3.17 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.26 -78.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 1.0 110.574 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -139.15 47.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 19.4 t0 -139.04 44.14 2.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.522 ' O ' ' CD2' ' A' ' 11' ' ' TYR . 10.4 m-80 -155.83 109.71 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.593 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.0 t80 44.88 20.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.619 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 9' ' ' ASN . 28.6 m-85 -96.22 70.8 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.01 -78.46 0.31 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -171.47 -85.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.789 0.328 . . . . 1.0 110.555 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 2.8 t0 74.39 17.65 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.587 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 50.42 98.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.55 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -87.5 -35.8 17.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.02 17.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.582 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.479 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 1.9 tp10 -45.59 -62.44 1.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.607 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.8 OUTLIER 49.56 21.74 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.525 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.34 15.65 2.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.567 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -100.98 -28.44 12.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.623 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.67 18.58 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.588 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -125.38 -19.26 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.616 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.2 p-90 -53.83 -8.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.447 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -135.56 1.17 2.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.59 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 77.6 p 40.24 83.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.711 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.1 m -139.51 5.72 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.54 34.65 1.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.643 ' C ' HD23 ' A' ' 30' ' ' LEU . . . -137.87 -20.11 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.736 0.303 . . . . 1.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.752 ' N ' HD23 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -110.39 -17.66 13.42 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.489 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.28 -39.69 0.41 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.166 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.5 Cg_endo -87.86 25.03 0.67 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.555 2.17 . . . . 1.0 112.291 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.85 6.75 5.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.534 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.734 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -139.66 -44.45 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.543 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -68.28 8.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.489 ' H ' ' C ' ' A' ' 34' ' ' ILE . 10.4 mmt -101.58 -63.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.58 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.2 15.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 36' ' ' MET . 88.9 t -130.92 -68.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.482 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -41.88 -43.51 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.567 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -103.89 52.83 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.542 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.1 tp -159.55 -62.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.344 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.95 9.93 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -163.97 -56.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 1.0 110.573 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 43' ' ' THR . 1.3 p 58.41 3.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.587 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 89.49 7.25 69.56 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.674 HD22 ' N ' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -100.88 -9.47 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 1.0 110.564 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 51' ' ' TRP . . . -92.11 -34.01 7.41 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.18 26.2 7.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 1.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' O ' HG22 ' A' ' 52' ' ' THR . 54.0 t -137.87 -35.54 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.577 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.2 tp -96.49 -59.3 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.599 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -41.75 -27.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.617 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 15.2 t -56.59 -42.19 78.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.581 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.529 ' N ' HG23 ' A' ' 52' ' ' THR . 21.1 t -47.99 -42.35 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.558 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.25 14.62 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 52' ' ' THR . 2.6 ttp180 -135.38 -34.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.558 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.14 -12.42 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -52.18 -31.52 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.544 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.5 79.18 0.08 OUTLIER Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -41.75 -34.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 1.0 110.556 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.613 ' CD2' ' H ' ' A' ' 61' ' ' HIS . 2.1 p-80 -67.41 -93.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.528 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.613 ' H ' ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -154.54 113.09 3.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.587 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.638 ' CD2' ' H ' ' A' ' 63' ' ' HIS . 40.1 p-80 -83.67 -127.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.544 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.638 ' H ' ' CD2' ' A' ' 62' ' ' HIS . 13.7 t-80 43.44 42.22 3.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.555 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.005 -0.997 . . . . 1.0 110.592 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -84.85 -127.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.578 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -144.16 -89.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.26 81.19 1.41 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.27 131.07 10.45 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 10.9 p-10 -173.97 -37.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 1.0 110.575 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 61.57 53.46 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -149.94 54.45 0.93 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' C ' ' N ' ' A' ' 11' ' ' TYR . 2.0 m-80 -155.8 116.69 3.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.547 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.506 ' CD1' ' OD2' ' A' ' 14' ' ' ASP . 6.4 t80 44.78 19.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.571 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' N ' ' C ' ' A' ' 9' ' ' ASN . 20.5 m-85 -98.66 89.57 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.546 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 145.95 -57.7 0.51 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 175.38 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 1.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' OD2' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER 47.19 16.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.518 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.449 ' N ' ' C ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -79.24 -17.36 54.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.547 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.693 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -82.33 57.75 3.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.546 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 p -149.07 -47.12 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 42.93 -155.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.62 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER 73.4 32.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.574 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -50.39 -11.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.526 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.468 ' H ' ' C ' ' A' ' 19' ' ' CYS . 5.2 m-85 -47.56 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.573 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -165.72 30.1 0.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.579 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.72 13.07 2.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.2 p-90 -95.7 5.58 51.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -146.11 16.0 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.547 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 28' ' ' GLY . 28.6 t -144.56 -99.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.551 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 m -73.23 44.54 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.522 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -174.92 38.61 0.11 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.858 -0.897 . . . . 1.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.1 -4.49 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.334 . . . . 1.0 110.504 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 -18.08 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.544 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.9 mm -80.77 -35.58 0.84 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.454 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.87 7.83 4.42 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.403 2.068 . . . . 1.0 112.196 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.31 -0.05 39.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.669 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.61 -35.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.472 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -82.46 30.69 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.613 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.9 mmt -134.21 -62.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.092 -0.503 . . . . 1.0 110.509 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 41' ' ' LEU . 15.2 mt -71.9 13.77 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.52 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.2 t -137.43 -28.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.512 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -75.02 27.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.651 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 38' ' ' VAL . 1.2 pp -173.66 13.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.574 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 37' ' ' LEU . 96.1 mt -131.34 -48.46 0.99 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.442 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.61 42.63 1.87 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 45' ' ' GLY . 3.8 t -162.11 -26.97 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.328 . . . . 1.0 110.486 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 44' ' ' THR . 1.5 t -71.13 40.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.638 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 80.37 28.33 48.77 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -134.89 1.26 3.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.738 0.304 . . . . 1.0 110.564 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.565 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -105.0 -40.33 2.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.683 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.48 21.59 11.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.765 0.317 . . . . 1.0 110.467 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.7 t -136.71 -38.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.545 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.69 -66.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.566 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.6 t-105 -50.06 -28.31 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.554 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -66.25 -29.79 70.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.51 -22.0 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.568 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -0.86 36.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.52 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -100.67 -40.86 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.63 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -23.15 67.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.574 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.9 mmtm -61.72 -35.33 77.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.56 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.78 99.84 0.2 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.4 -24.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 1.0 110.528 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.444 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 1.8 p-80 -75.64 17.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.444 ' CD2' ' C ' ' A' ' 60' ' ' HIS . 1.7 m-70 56.23 105.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.564 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -84.34 48.08 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -147.33 93.59 2.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.595 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 35.4 mp0 -137.97 56.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -81.4 -37.04 28.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.551 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -148.51 65.83 0.4 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.91 89.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 4' ' ' GLY . 1.1 t70 73.03 37.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 1.0 110.578 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -147.28 41.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.55 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.0 41.31 3.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.541 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.415 ' C ' ' N ' ' A' ' 11' ' ' TYR . 53.7 t-20 -138.57 -120.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.608 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -47.27 -19.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.5 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' N ' ' C ' ' A' ' 9' ' ' ASN . 96.4 m-85 -73.88 56.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.573 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.67 -65.79 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.914 -0.875 . . . . 1.0 110.914 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.08 82.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 1.0 110.514 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.636 ' N ' HE22 ' A' ' 16' ' ' GLN . 1.3 t70 -101.35 30.91 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.556 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 58.68 78.19 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.491 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.636 HE22 ' N ' ' A' ' 14' ' ' ASP . 10.9 mp0 -87.37 58.22 4.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.633 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 1.8 p 80.11 -19.71 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.388 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.1 tp10 41.36 -164.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.8 OUTLIER 76.7 3.95 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.614 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -98.42 21.12 11.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.624 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.448 ' C ' HG23 ' A' ' 22' ' ' THR . 0.2 OUTLIER -83.76 22.83 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.568 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 ' C ' ' A' ' 21' ' ' TYR . 2.0 p 62.39 41.49 9.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.578 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.07 10.35 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.546 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.545 ' NE1' ' NZ ' ' A' ' 25' ' ' LYS . 21.9 p-90 -98.56 4.1 48.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' NZ ' ' NE1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -151.15 16.31 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.561 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.53 -55.12 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.524 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.5 m -73.92 55.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.606 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.82 34.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.58 17.51 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 1.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -136.02 -21.61 1.42 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.625 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -76.4 -35.88 1.65 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.3 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.8 Cg_endo -88.43 3.66 5.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.429 2.086 . . . . 1.0 112.283 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.58 5.05 36.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.825 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.0 mt -137.22 -35.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -86.45 22.19 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.572 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.3 mmt -136.06 -61.94 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.55 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 41' ' ' LEU . 39.3 mt -60.6 -17.98 50.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.585 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.2 t -99.24 -51.2 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.611 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -43.5 -46.09 6.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.432 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp -105.76 69.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.468 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -142.28 -58.41 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.452 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.61 14.62 50.75 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -159.94 -49.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 1.0 110.554 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 42.98 22.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.575 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 102.5 -31.75 8.36 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -69.18 -4.62 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 1.0 110.594 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.89 -13.81 60.29 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.45 21.32 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -139.08 -42.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.522 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.5 tp -100.06 -44.81 5.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.413 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.423 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -61.38 -24.54 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.57 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.0 t -76.22 -29.55 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.496 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 55' ' ' ARG . 58.0 t -54.28 -62.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.603 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -73.01 39.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.559 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.467 ' H ' ' C ' ' A' ' 53' ' ' VAL . 5.3 ttt180 -148.91 -47.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.544 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -20.77 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.616 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -60.58 -22.05 63.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.546 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.39 69.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 11.7 m170 41.94 71.02 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 1.0 110.507 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 27.2 p80 40.57 35.9 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.706 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.3 m170 54.51 105.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.566 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -146.33 104.67 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.531 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -96.29 87.14 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.445 ' CD2' ' C ' ' A' ' 64' ' ' HIS . 3.2 t-160 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.53 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -100.87 68.73 1.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -96.82 -5.91 37.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.585 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.45 -138.66 3.68 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.74 108.52 3.55 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -90.7 21.16 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.805 0.336 . . . . 1.0 110.527 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 5.5 p90 -148.1 56.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.568 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -138.61 45.61 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.577 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.53 -71.89 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.621 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.481 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 72.2 t80 -146.8 9.37 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.481 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.4 p90 38.8 40.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.835 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.664 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -165.15 -56.9 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 163.47 -22.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.673 0.273 . . . . 1.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 16' ' ' GLN . 11.9 t70 66.68 60.28 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.397 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -40.69 91.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.587 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.66 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -78.25 14.74 1.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.545 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 m -138.38 -49.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.595 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -80.13 61.86 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.599 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -99.41 -9.81 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.519 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.0 -0.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.625 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.482 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -49.58 -53.55 23.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.561 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.84 15.08 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.545 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.57 10.48 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.629 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.0 p-90 -84.73 4.11 34.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.547 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -151.58 15.09 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.65 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.62 13.18 2.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.01 29.83 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.515 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.44 34.09 0.83 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.83 -31.89 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 1.0 110.657 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.2 -1.82 21.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.548 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.696 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.28 -39.65 0.41 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.293 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.6 Cg_endo -87.19 24.16 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.567 2.178 . . . . 1.0 112.145 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.22 5.15 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.568 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 36' ' ' MET . 29.1 pt -131.67 -31.21 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.666 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 16.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.507 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.472 ' C ' ' H ' ' A' ' 38' ' ' VAL . 19.4 mmm -117.2 -57.99 2.1 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.2 mt -72.48 13.52 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.591 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.6 t -137.9 -21.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.54 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.472 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 44.5 t80 -91.49 26.77 2.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mt -138.5 -6.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -126.59 -50.16 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.493 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.98 -7.69 0.83 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.6 HG23 ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -135.39 -105.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.413 -0.218 . . . . 1.0 110.413 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.6 ' H ' HG23 ' A' ' 43' ' ' THR . 4.5 t 33.27 48.87 0.18 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.98 -0.555 . . . . 1.0 111.234 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 104.16 -50.03 0.89 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 43' ' ' THR . 54.2 m-20 -51.93 -10.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 1.0 110.554 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -92.41 -34.86 6.82 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.1 mt -82.09 17.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 1.0 110.476 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -137.21 -34.86 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.03 -59.12 1.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.694 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -62.02 -19.65 63.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.523 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -73.71 -31.01 63.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.616 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.18 -36.1 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.696 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.42 16.58 14.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.523 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -129.43 -40.24 1.44 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.371 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -8.85 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -54.48 -33.02 59.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.579 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.71 85.22 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.66 -22.38 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 1.0 110.576 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 62' ' ' HIS . 0.2 OUTLIER -139.75 -36.39 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.537 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -71.94 42.25 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.557 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -47.4 -86.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.527 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -156.48 117.44 3.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.613 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.545 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -99.76 30.18 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.406 ' O ' ' OD2' ' A' ' 8' ' ' ASP . 2.7 mt-10 49.28 58.32 5.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.582 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.81 -71.03 0.02 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 42.79 -120.57 2.61 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.851 -0.899 . . . . 1.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.31 13.72 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 1.0 110.567 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -139.02 43.16 2.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.533 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.406 ' OD2' ' O ' ' A' ' 3' ' ' GLU . 31.4 t0 -147.14 55.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.605 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.2 -30.65 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.543 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 8.2 t80 -83.81 -11.91 56.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.571 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -63.43 77.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.564 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' TYR . . . 153.66 -76.12 0.22 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -161.68 -37.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 1.0 110.634 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 4.6 t0 75.18 14.19 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 48.71 90.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.561 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.769 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -66.49 -19.57 65.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.616 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.92 -30.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 20' ' ' GLU . 5.1 pt-20 -69.99 -167.73 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.619 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 54.49 8.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 18' ' ' GLU . 3.6 tt0 -95.8 60.52 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -138.58 12.89 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.589 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 76.56 37.82 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.522 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.85 17.46 2.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -101.13 6.34 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.54 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.68 16.18 1.61 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.593 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 27' ' ' SER . 1.1 p -137.97 -53.31 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.541 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -101.05 14.05 33.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.545 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.43 40.04 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -142.36 -15.38 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 1.0 110.542 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -137.77 -17.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.498 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.621 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 4.0 mm -80.24 -35.62 0.91 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.459 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.4 Cg_endo -87.9 24.29 0.72 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.393 2.062 . . . . 1.0 112.282 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.07 1.69 6.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.521 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.13 -36.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.516 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.81 2.85 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.576 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.6 mmt -101.61 -56.23 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.551 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.77 13.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.537 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -137.15 -74.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.502 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -42.69 -40.38 2.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -102.19 43.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.597 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -163.5 -67.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.382 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.02 -15.19 0.34 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.703 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -138.3 -95.85 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.119 -0.232 . . . . 1.0 110.537 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.703 ' H ' HG23 ' A' ' 43' ' ' THR . 4.7 t 33.59 48.73 0.21 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.226 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 104.7 -46.89 1.12 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.921 -0.871 . . . . 1.0 110.921 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 43' ' ' THR . 1.5 m-20 -74.88 23.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 1.0 110.559 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.565 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -138.11 -33.27 0.2 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -99.49 33.32 2.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 1.0 110.615 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 45' ' ' GLY . 97.6 t -126.7 -60.6 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.724 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.88 -36.6 6.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.783 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.572 ' CZ2' ' CE1' ' A' ' 54' ' ' PHE . 76.2 t-105 -78.61 11.85 2.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.454 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 t -96.76 -26.46 15.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.534 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.88 -62.01 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.558 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.572 ' CE1' ' CZ2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -53.6 -26.67 22.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.584 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -86.28 -38.14 17.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.564 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -48.43 -22.0 0.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.573 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -68.02 -31.78 71.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 1.0 110.566 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . 138.01 115.21 1.33 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.429 ' NE2' ' CE1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -57.41 -7.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.33 . . . . 1.0 110.605 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' ' NE2' ' A' ' 59' ' ' HIS . 41.5 m-70 -89.49 -0.96 57.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.577 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 47.85 88.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -102.21 91.34 4.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -159.29 79.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.558 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.094 -0.955 . . . . 1.0 110.543 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -51.19 -69.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.643 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -164.71 23.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.552 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.99 116.34 0.7 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.08 77.15 2.06 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.05 14.69 28.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.807 0.337 . . . . 1.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -153.76 48.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.602 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -149.54 44.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.636 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 11' ' ' TYR . 19.8 t-20 -154.47 115.78 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.57 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 t80 44.29 20.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.576 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' ASN . 2.2 m-85 -144.31 111.64 5.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.555 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.7 -42.47 1.98 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.7 30.75 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 1.0 110.563 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -137.64 4.07 2.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.546 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.568 ' N ' ' NE2' ' A' ' 16' ' ' GLN . 5.9 p30 -149.86 56.32 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.519 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.568 ' NE2' ' N ' ' A' ' 15' ' ' ASN . 2.7 mp0 -70.05 -49.65 49.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.588 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 m -157.01 20.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.599 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.453 ' C ' ' H ' ' A' ' 20' ' ' GLU . 4.7 mt-10 -152.16 -178.44 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.578 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER 62.87 -0.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.587 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 18' ' ' GLU . 2.5 tt0 -83.24 43.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.549 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -149.42 95.3 2.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.568 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.425 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 72.1 p 47.84 31.42 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -124.66 -19.82 5.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.594 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -53.71 -8.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.445 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -135.97 1.82 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.652 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.2 p 40.07 66.61 0.58 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.768 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.433 ' C ' ' HZ3' ' A' ' 25' ' ' LYS . 10.7 p -146.8 21.82 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.611 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' N ' ' HZ3' ' A' ' 25' ' ' LYS . . . -153.42 33.98 0.77 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.73 -11.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 1.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -1.41 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.615 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.591 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.73 -38.88 1.82 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.48 4.6 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.37 2.047 . . . . 1.0 112.202 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.97 3.95 44.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.549 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 36' ' ' MET . 2.3 mt -140.13 -41.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.51 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.446 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.6 m-85 -75.99 26.27 0.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.579 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.8 mmt -136.92 -51.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.54 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.1 mt -77.22 16.43 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.549 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 36' ' ' MET . 22.0 t -137.01 -56.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -42.2 -53.36 4.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.606 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mt -95.41 60.07 2.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.573 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -171.11 -62.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.367 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.52 -6.37 1.05 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.537 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -143.47 -91.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 1.0 110.594 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.537 ' H ' HG23 ' A' ' 43' ' ' THR . 1.0 OUTLIER 54.11 7.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.565 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 85.38 27.13 33.92 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 3.22 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.766 0.317 . . . . 1.0 110.581 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.596 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -104.63 -23.05 8.1 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.752 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -115.35 14.56 16.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.777 0.322 . . . . 1.0 110.56 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -132.1 -34.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.609 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.0 tt -101.9 -67.64 0.86 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.574 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.435 ' O ' ' CD2' ' A' ' 51' ' ' TRP . 5.6 t-105 -51.03 -33.43 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.64 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -60.31 -20.55 59.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.623 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.522 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 96.2 t -60.13 -29.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.548 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.45 14.46 31.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.403 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -98.29 -54.44 3.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.63 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -62.74 -34.41 77.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.62 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -76.23 -21.74 56.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.72 92.18 0.08 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -19.4 62.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.0 110.626 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.538 ' CG ' ' H ' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -74.03 -116.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.568 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.538 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 6.1 p-80 179.31 83.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.555 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 62' ' ' HIS . 79.0 t60 -96.7 10.75 37.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.542 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' HIS . 21.6 t-80 45.92 97.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.618 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.541 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.46 101.53 13.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.515 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -44.02 -56.94 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.565 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.15 -120.71 4.68 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.71 -157.8 7.36 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.926 -0.87 . . . . 1.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.33 -43.58 7.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 1.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 t80 56.73 46.5 19.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.634 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -148.22 56.1 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.599 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' TYR . 46.4 t30 -151.36 70.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.609 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.441 ' C ' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER 41.08 21.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.736 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.2 OUTLIER 43.58 40.46 2.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.573 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.4 31.43 0.62 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.3 -81.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 1.0 110.583 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.7 t0 70.07 33.37 2.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.614 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -139.41 55.67 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.56 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.48 ' CD ' ' H ' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -82.66 -21.09 35.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.591 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -163.14 50.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.531 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -101.32 -56.55 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.588 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -101.68 -9.75 20.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.565 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -83.28 17.04 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.573 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.455 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -82.1 2.05 33.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.583 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 77.27 41.74 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.591 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.71 19.17 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.557 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -97.93 -8.09 28.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.591 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -101.45 10.79 40.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.566 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 28' ' ' GLY . 8.0 m -161.7 -93.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.585 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 57.9 7.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.549 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -150.92 38.94 0.84 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.66 -29.21 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 1.0 110.528 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -107.76 -12.64 15.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.587 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.98 -36.06 3.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.315 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.4 Cg_endo -87.14 25.8 0.65 Allowed 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.307 2.005 . . . . 1.0 112.114 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.74 2.12 4.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.558 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -142.83 -44.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.635 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.8 m-85 -79.75 26.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.582 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 17.4 mmt -137.43 -58.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.02 8.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' A' ' 36' ' ' MET . 17.2 t -137.62 -53.75 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.55 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -53.1 -39.68 63.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.0 mt -101.48 42.1 1.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.496 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -159.21 -65.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.358 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.8 -13.85 0.34 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.642 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -139.43 -100.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.527 0.203 . . . . 1.0 110.493 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.642 ' H ' HG23 ' A' ' 43' ' ' THR . 4.7 t 33.43 47.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.202 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 101.96 -47.32 1.17 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' THR . 1.2 m-20 -60.19 -5.56 1.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 1.0 110.498 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -103.64 -61.63 0.69 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -77.55 44.19 0.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 1.0 110.548 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 45' ' ' GLY . 25.2 t -138.34 -48.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.584 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 pp -101.68 -26.05 13.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.591 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.32 -18.54 24.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.606 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -70.73 -28.87 65.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.553 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.0 t -61.51 -47.89 91.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.529 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -8.29 34.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.568 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -100.82 -47.03 4.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.574 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -47.71 -19.03 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -53.57 -22.8 9.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.575 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 61' ' ' HIS . . . 142.26 53.6 0.04 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.931 -0.868 . . . . 1.0 110.931 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 14.7 m170 47.6 67.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 1.0 110.536 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 20.9 p80 40.96 25.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.658 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.482 ' C ' ' H ' ' A' ' 63' ' ' HIS . 1.5 t-160 -148.28 104.41 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.635 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 8.2 m80 -75.14 33.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.529 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.522 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 30.6 p80 40.68 41.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.721 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.558 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtp . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.362 -0.607 . . . . 1.0 109.362 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.19 147.12 36.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.585 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -99.81 23.19 10.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.8 -60.02 0.65 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.5 -167.51 29.15 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.3 -33.43 10.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.815 0.34 . . . . 1.0 110.579 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -141.89 45.2 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.514 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.521 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 4.4 p-10 -122.24 41.18 3.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.598 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 8' ' ' ASP . 13.9 m120 -138.06 -82.44 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.581 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 0.6 OUTLIER -72.99 14.67 0.26 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.624 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 9' ' ' ASN . 39.6 m-85 -147.48 86.33 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 149.67 -47.62 0.62 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 176.46 77.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 1.0 110.564 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.75 -62.38 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.616 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.65 ' H ' HE21 ' A' ' 16' ' ' GLN . 0.2 OUTLIER -179.23 69.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.576 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.65 HE21 ' H ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -89.05 12.89 14.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.614 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.8 OUTLIER 82.7 50.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.247 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 3.8 tt0 -130.72 58.89 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.479 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 71.29 -5.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.475 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -84.69 50.57 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.513 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -155.43 54.85 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.536 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.423 HG22 ' HZ1' ' A' ' 25' ' ' LYS . 0.7 OUTLIER 69.61 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.555 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -159.44 20.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.589 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -101.47 -18.29 16.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.586 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' HZ1' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER -100.83 16.12 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.577 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 28' ' ' GLY . 34.0 t -165.21 -80.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.567 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 t -73.13 38.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.579 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -144.75 24.85 1.96 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.37 -0.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 1.0 110.483 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.78 -17.38 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.604 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -72.06 -36.7 4.33 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.235 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.3 Cg_endo -87.47 25.64 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 122.316 2.011 . . . . 1.0 112.169 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.56 -49.7 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.598 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -99.25 -31.87 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.658 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.67 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.551 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.474 ' C ' ' H ' ' A' ' 38' ' ' VAL . 3.2 mtp -136.44 -54.76 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.52 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.89 2.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 36' ' ' MET . 2.8 t -137.38 -23.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.471 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 41.9 t80 -88.97 37.45 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.537 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' O ' ' CG2' ' A' ' 44' ' ' THR . 2.3 mt -136.59 -9.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.54 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.2 mt -112.15 -41.96 3.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.64 -3.07 39.5 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -137.93 -100.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.558 0.218 . . . . 1.0 110.486 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.626 ' H ' HG23 ' A' ' 43' ' ' THR . 4.9 t 33.72 37.92 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.211 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 141.63 -62.77 0.52 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 43' ' ' THR . 8.0 p-10 -75.84 10.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 1.0 110.527 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.26 3.98 51.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.83 7.01 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 1.0 110.554 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 45' ' ' GLY . 92.9 t -95.72 -54.87 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.543 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.27 -23.44 14.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.576 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.502 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 2.5 t-105 -77.25 -13.94 59.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.589 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 t -62.7 -20.41 64.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.4 t -79.71 -29.79 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.586 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -1.45 58.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.624 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -101.21 -49.11 4.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.551 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -51.22 -18.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.557 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -54.22 -38.07 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.554 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 170.67 63.52 0.04 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.1 m170 56.92 -79.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.798 0.332 . . . . 1.0 110.713 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 m-70 -98.79 -75.45 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.507 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -161.64 100.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.527 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -145.17 112.04 5.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.553 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -98.78 72.37 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.53 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.7 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 68.24 1.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.604 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.76 -89.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.07 134.21 1.64 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.011 -0.836 . . . . 1.0 111.011 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.02 77.58 0.1 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 3.9 m-20 -139.74 31.41 2.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 1.0 110.549 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 6' ' ' ASP . 48.7 m-85 -161.96 57.03 0.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -138.64 41.71 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.539 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.42 ' O ' ' CE2' ' A' ' 11' ' ' TYR . 71.3 m-80 -102.4 -73.4 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.522 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.452 ' C ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 m-85 -93.63 0.98 56.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.479 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.452 ' CD2' ' C ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER 48.13 41.0 14.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.611 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 41.07 31.15 0.46 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.07 75.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 1.0 110.613 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.35 -40.46 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.538 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -78.33 104.08 8.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.586 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' O ' ' CB ' ' A' ' 17' ' ' SER . 6.5 mt-30 -93.58 50.23 1.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.561 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 79.51 19.59 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.464 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER -50.15 157.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.504 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.5 t 76.94 -15.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.565 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 18' ' ' GLU . 9.6 tt0 41.67 22.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.623 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' CYS . 27.8 m-85 55.31 64.44 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.496 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 6.5 p 53.38 40.79 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.647 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.32 2.52 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.338 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -81.86 5.28 19.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.508 ' CD ' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.12 0.34 3.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 t -99.57 -48.36 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -86.33 29.53 0.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.59 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.0 14.65 3.8 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.879 -0.889 . . . . 1.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.29 3.43 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.683 0.277 . . . . 1.0 110.613 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.75 -30.68 6.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.675 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -77.96 -35.98 1.3 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.369 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 76.1 Cg_endo -88.74 26.09 0.59 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.413 2.076 . . . . 1.0 112.217 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.44 13.75 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.856 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' C ' ' H ' ' A' ' 36' ' ' MET . 10.1 mt -145.51 -46.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.12 4.41 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.588 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.3 mmt -97.83 -60.38 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.569 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.7 mt -56.39 -5.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.52 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' MET . 55.8 t -101.82 -56.06 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.451 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -41.83 -41.11 2.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.63 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mt -103.18 48.25 0.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.646 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' THR . 16.7 tp -166.64 -59.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.75 13.85 2.9 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.616 HG23 ' N ' ' A' ' 44' ' ' THR . 8.9 t -171.19 -48.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.75 0.31 . . . . 1.0 110.7 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER 50.68 10.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.497 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.686 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 91.76 -10.59 74.24 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.498 ' ND2' ' OG1' ' A' ' 44' ' ' THR . 78.5 m-20 -76.66 -11.28 59.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 1.0 110.514 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.832 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -88.18 -15.36 60.85 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.832 HD23 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -118.93 19.47 13.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.698 0.285 . . . . 1.0 110.483 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 45' ' ' GLY . 45.3 t -117.55 -57.06 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.809 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.26 -35.93 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.81 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.3 OUTLIER -76.59 -42.24 43.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.519 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -45.85 -21.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.485 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' A' ' 51' ' ' TRP . 53.9 t -72.26 -50.47 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.588 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -67.59 -12.42 60.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.543 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -101.69 -35.33 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.599 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -50.76 -41.16 56.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.594 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -58.06 -17.99 21.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.593 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.55 76.6 0.21 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.944 -0.863 . . . . 1.0 110.944 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -31.21 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 1.0 110.609 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -150.57 -54.29 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.568 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' N ' ' CD2' ' A' ' 60' ' ' HIS . 1.5 t-80 -171.24 104.95 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.6 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -67.68 -47.92 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.563 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 42.22 61.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.517 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.586 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mmm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.56 116.35 17.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.588 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -95.69 19.12 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.39 -77.31 0.33 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.999 -0.84 . . . . 1.0 110.999 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 7' ' ' PHE . . . 159.16 -97.62 0.16 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.68 -17.11 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.33 . . . . 1.0 110.507 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.416 ' CE2' ' O ' ' A' ' 5' ' ' GLY . 4.3 m-85 62.72 42.25 8.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.566 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -153.81 58.4 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.595 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.37 -16.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -146.18 -9.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.551 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.42 76.37 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.546 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 137.82 -79.58 0.3 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 174.66 71.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 1.0 110.595 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.511 ' OD1' ' ND2' ' A' ' 15' ' ' ASN . 3.4 t70 -72.7 -52.18 16.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.527 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.511 ' ND2' ' OD1' ' A' ' 14' ' ' ASP . 2.2 p30 -172.08 54.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.549 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -67.41 6.75 0.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.588 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 80.62 45.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.488 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 16' ' ' GLN . 2.4 tt0 -69.89 -165.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.629 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' O ' ' CE1' ' A' ' 21' ' ' TYR . 23.1 m 56.82 43.26 25.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.561 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 22' ' ' THR . 2.2 mm-40 -85.66 10.44 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.523 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER 60.93 1.12 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.572 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 20' ' ' GLU . 63.9 p -150.89 14.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.51 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' C ' ' N ' ' A' ' 25' ' ' LYS . 48.1 t0 -134.15 -39.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.485 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -47.6 -15.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.371 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -133.95 0.67 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.38 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 23' ' ' ASP . 1.3 m 38.32 61.59 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.935 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.88 34.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.53 24.44 0.58 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.757 -0.937 . . . . 1.0 110.757 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.22 -13.11 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.72 0.295 . . . . 1.0 110.54 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.44 ' C ' HD13 ' A' ' 31' ' ' ILE . 1.6 mp -127.51 -1.96 6.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.678 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -90.45 -39.69 0.4 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.215 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.2 Cg_endo -87.14 7.94 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.444 2.096 . . . . 1.0 112.159 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.39 4.31 41.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.86 -39.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -79.28 30.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.576 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.5 mmt -133.96 -58.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.543 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.85 20.03 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.547 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -139.3 -48.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.559 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -49.26 -45.66 45.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.5 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -102.55 62.92 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.527 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -137.29 -63.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.533 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.82 -8.34 0.58 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.667 HG23 ' H ' ' A' ' 44' ' ' THR . 1.3 t -135.97 -108.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.56 0.219 . . . . 1.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.667 ' H ' HG23 ' A' ' 43' ' ' THR . 4.8 t 33.7 40.09 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.22 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.482 ' C ' HD22 ' A' ' 46' ' ' ASN . . . 105.61 27.03 5.91 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.482 HD22 ' C ' ' A' ' 45' ' ' GLY . 1.8 m-80 -133.88 -32.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.761 0.315 . . . . 1.0 110.631 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.35 -3.28 69.6 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.58 34.96 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.292 . . . . 1.0 110.492 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -141.17 -53.19 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.602 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.98 -25.8 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.609 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.421 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -73.74 -25.73 60.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.519 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 53' ' ' VAL . 15.4 t -67.65 -37.73 82.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.481 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.436 ' N ' HG23 ' A' ' 52' ' ' THR . 60.4 t -47.73 -61.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.596 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -72.77 54.65 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.595 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -163.21 -48.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -15.97 55.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -62.6 -35.04 78.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.548 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 155.56 58.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.89 -0.884 . . . . 1.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 56.01 -80.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 1.0 110.643 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 58' ' ' GLY . 7.5 m170 -99.83 -74.62 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.605 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -157.41 106.54 2.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.551 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -64.26 -18.81 64.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.563 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.494 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 2.0 t-80 -134.45 -147.35 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.133 0.492 . . . . 1.0 110.404 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.494 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 17.5 m-70 . . . . . 0 C--N 1.322 -0.609 0 CA-C-O 118.056 -0.973 . . . . 1.0 110.572 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' C ' ' H ' ' A' ' 3' ' ' GLU . 7.4 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.86 40.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.61 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 1' ' ' MET . 2.7 pt-20 -82.07 -14.61 55.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.543 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.72 -108.53 0.25 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.29 -79.53 0.07 OUTLIER Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 7' ' ' PHE . 1.4 p-10 -101.31 -77.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.882 0.373 . . . . 1.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 57.8 m-85 54.53 42.84 31.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.625 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 t0 54.38 48.18 21.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.526 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -136.4 108.84 7.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.443 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 48.22 13.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.631 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' N ' ' C ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -137.77 95.97 3.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.572 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.8 -53.43 0.72 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . -101.3 19.92 16.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 1.0 110.595 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.1 -1.4 39.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.553 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 3.6 p-10 -144.97 70.16 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.56 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' NE2' ' O ' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -84.58 -41.5 16.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.567 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 p -91.47 12.82 19.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.539 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -138.17 94.6 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.594 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' TYR . 2.0 p -138.97 7.8 2.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -72.0 13.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.576 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER -75.53 23.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.528 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.604 ' CG2' ' HZ1' ' A' ' 25' ' ' LYS . 0.2 OUTLIER 76.37 36.37 0.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.579 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.59 19.42 2.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.584 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -99.26 7.58 45.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.604 ' HZ1' ' CG2' ' A' ' 22' ' ' THR . 0.1 OUTLIER -139.27 13.01 2.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.579 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 28' ' ' GLY . 64.9 m -137.7 -89.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 p -76.19 26.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.57 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -137.67 28.67 2.73 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.51 -15.08 1.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.33 . . . . 1.0 110.469 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -136.34 -9.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.636 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.583 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -78.39 -40.11 1.76 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.938 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.6 Cg_endo -86.94 25.07 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.444 2.096 . . . . 1.0 112.2 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.12 6.26 4.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -144.79 -40.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.512 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' O ' ' SD ' ' A' ' 36' ' ' MET . 51.0 m-85 -76.6 26.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.492 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.457 ' H ' ' C ' ' A' ' 34' ' ' ILE . 17.0 mmt -136.66 -50.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.523 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.28 7.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.555 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 36' ' ' MET . 3.4 t -138.26 -54.04 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.603 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.59 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.364 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -85.55 64.22 8.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.009 0.433 . . . . 1.0 110.064 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.9 tp -164.43 -39.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.272 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.38 17.87 58.1 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.653 HG23 ' N ' ' A' ' 44' ' ' THR . 8.9 t -173.04 -52.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.716 0.293 . . . . 1.0 110.654 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.653 ' N ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER 42.64 21.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.522 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 103.83 -32.73 7.23 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -66.23 -6.62 14.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 1.0 110.544 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.52 -14.6 59.71 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.81 45.93 0.85 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.769 0.318 . . . . 1.0 110.585 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 45' ' ' GLY . 38.9 t -134.04 -64.29 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.403 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -56.91 -5.04 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.585 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.62 ' CH2' ' NE ' ' A' ' 55' ' ' ARG . 2.6 m95 -64.83 1.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.519 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.529 HG23 HG23 ' A' ' 53' ' ' VAL . 13.1 t -121.39 24.64 9.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.463 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 HG23 ' A' ' 52' ' ' THR . 83.6 t -152.95 -44.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -103.92 13.96 31.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.647 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' NE ' ' CH2' ' A' ' 51' ' ' TRP . 4.8 tpt180 -134.73 -35.02 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.477 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -23.48 66.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.98 12.92 36.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.561 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.0 -56.96 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.898 -0.881 . . . . 1.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.474 ' C ' ' CD2' ' A' ' 60' ' ' HIS . 23.2 m170 54.24 36.1 24.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.66 0.267 . . . . 1.0 110.541 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' O ' ' ND1' ' A' ' 60' ' ' HIS . 20.6 p80 38.46 94.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.008 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.0 m170 45.23 74.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.577 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -60.81 -64.53 0.92 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.528 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -146.81 93.63 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.575 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.436 ' OXT' ' CG ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.583 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -63.75 137.28 58.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.599 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -89.39 -44.18 10.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.74 -83.01 0.56 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.439 ' C ' ' N ' ' A' ' 7' ' ' PHE . . . -171.88 -46.14 0.04 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 47.89 16.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 1.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' N ' ' C ' ' A' ' 5' ' ' GLY . 13.6 t80 -152.36 44.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.571 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -147.39 41.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.507 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -101.36 -89.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.483 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.482 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 1.1 t80 -88.43 1.4 54.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.482 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.5 p90 38.72 40.4 0.41 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.83 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -165.9 -65.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 170.85 -37.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 1.0 110.555 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.445 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 3.3 t0 74.3 24.6 1.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.51 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 17' ' ' SER . 27.2 m120 -142.68 18.06 2.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.565 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.69 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.1 OUTLIER -72.43 13.47 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.534 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -100.92 -50.17 3.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.615 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 41.82 84.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.57 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' TYR . 6.3 t -168.18 60.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.58 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 21' ' ' TYR . 3.6 tp10 -72.06 43.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' CYS . 31.2 m-85 54.63 108.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.515 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.3 -2.5 2.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.597 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 35.1 t0 -105.74 27.72 8.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 p-90 -101.25 -4.52 26.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.527 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -137.91 10.91 2.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.541 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -98.14 -62.2 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.536 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.37 19.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.538 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -138.03 44.16 1.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.65 -11.66 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 1.0 110.567 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 pp -138.15 -10.82 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.632 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.579 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -72.72 -41.15 7.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.805 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.2 Cg_endo -87.49 25.14 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.504 2.136 . . . . 1.0 112.219 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.68 -48.58 1.91 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' C ' ' N ' ' A' ' 36' ' ' MET . 1.0 OUTLIER -103.75 -51.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.615 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -46.71 -16.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.447 ' N ' ' C ' ' A' ' 34' ' ' ILE . 2.8 mtp -77.44 -55.69 5.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.564 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -52.03 -13.57 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.486 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 40' ' ' LEU . 3.4 t -103.21 -47.24 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -49.73 -11.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.676 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 38' ' ' VAL . 2.9 mt -133.2 40.16 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.523 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -164.85 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.25 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.2 -1.98 30.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.532 ' HB ' HD21 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -144.62 -59.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.793 0.33 . . . . 1.0 110.589 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.446 HG23 ' C ' ' A' ' 43' ' ' THR . 1.2 p 57.19 4.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.605 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 93.32 13.81 55.13 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.473 ' C ' ' ND2' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -103.92 -18.72 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.312 . . . . 1.0 110.402 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -102.84 -16.01 22.81 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.926 -0.869 . . . . 1.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -96.89 20.22 11.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.737 0.303 . . . . 1.0 110.458 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 2.3 t -103.46 -64.13 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.752 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -112.61 -36.69 5.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.704 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.527 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 21.7 t-105 -67.14 -9.15 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.421 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -61.62 -30.67 70.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.568 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 55' ' ' ARG . 6.0 t -72.03 -45.88 61.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.556 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.39 13.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.591 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 53' ' ' VAL . 40.3 ttt-85 -137.56 -35.15 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.712 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -52.13 -12.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.607 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' N ' ' C ' ' A' ' 55' ' ' ARG . 8.8 mmtp -69.3 -15.71 63.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . 161.06 105.49 0.2 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.4 ' ND1' ' O ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -58.52 -4.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 1.0 110.571 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 58' ' ' GLY . 42.3 m-70 -81.07 -92.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.561 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 98.9 m-70 -155.45 73.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -70.69 61.96 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.585 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -97.48 42.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.598 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.7 m170 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.06 -0.971 . . . . 1.0 110.609 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 54.44 93.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.587 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.14 14.25 32.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.558 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.02 -131.94 0.39 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.25 92.52 0.12 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' C ' ' CG ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -145.89 -57.29 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 1.0 110.488 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER 63.91 44.68 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.547 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -121.84 41.29 3.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -137.9 -74.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.557 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.472 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 24.1 m-85 -98.42 -18.48 18.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.532 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.4 p90 38.7 40.74 0.43 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.859 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.7 -53.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.491 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . -98.35 34.96 1.87 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 1.0 110.599 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.44 21.69 13.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.592 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -74.42 46.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.656 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 13' ' ' ALA . 2.1 mt-30 -131.54 34.73 3.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.53 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 18' ' ' GLU . 21.7 m -137.91 -43.5 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.535 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.444 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER 45.28 96.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.648 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 95.2 m -155.73 20.09 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.507 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -98.87 38.18 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.59 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.74 -64.55 1.04 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.55 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 m -158.82 34.95 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.576 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.11 17.28 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.565 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 24' ' ' TRP . 20.5 p-90 -99.5 -20.97 16.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.595 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -100.81 14.89 30.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.512 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 28' ' ' GLY . 0.6 OUTLIER -147.93 -74.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.572 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t -75.56 27.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.498 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -137.79 35.13 2.08 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 -15.08 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.688 0.28 . . . . 1.0 110.392 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.24 -20.56 11.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.612 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -74.87 -34.73 1.81 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.526 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.9 Cg_endo -88.24 26.54 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.282 1.988 . . . . 1.0 112.01 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.54 -3.39 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.657 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -133.59 -61.16 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.572 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 39' ' ' PHE . 1.9 m-85 -49.1 -29.78 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.3 mmt -74.8 -23.97 58.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.662 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -85.03 -6.12 59.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.59 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.86 -67.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.656 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 3.6 t80 -40.75 -48.8 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.655 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD12 ' SD ' ' A' ' 36' ' ' MET . 4.5 mt -103.39 60.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.533 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -165.29 -62.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.302 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.34 10.16 2.84 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.904 -0.879 . . . . 1.0 110.904 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.496 ' C ' HG23 ' A' ' 44' ' ' THR . 0.2 OUTLIER -162.66 -64.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 1.0 110.589 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.496 HG23 ' C ' ' A' ' 43' ' ' THR . 1.8 p 63.84 -2.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.52 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 82.04 27.67 44.35 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -134.53 0.77 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 1.0 110.582 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -104.11 -40.56 2.25 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.856 -0.898 . . . . 1.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -99.29 21.35 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 1.0 110.446 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.7 t -136.56 -42.43 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.591 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 53' ' ' VAL . 38.7 tp -97.56 -68.74 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.453 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -46.0 -26.37 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.572 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -68.52 -35.31 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 50' ' ' LEU . 64.7 t -52.04 -69.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.574 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -72.0 59.56 0.37 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.451 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.01 -66.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.643 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -14.6 24.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.639 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -51.6 -38.61 55.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.566 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 154.78 31.54 0.03 OUTLIER Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.511 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 9.7 m80 62.58 -71.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.333 . . . . 1.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 58' ' ' GLY . 29.5 m170 -69.65 1.46 4.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 31.6 m170 50.21 90.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.566 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -154.09 55.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -99.65 89.61 4.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.502 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.4 t60 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.524 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ttm . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.36 -0.608 . . . . 1.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -86.44 -5.82 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.577 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 59.46 17.55 6.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.534 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.84 126.56 1.01 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.872 -0.891 . . . . 1.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.73 91.45 0.08 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -148.31 12.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 1.0 110.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 18.4 p90 -160.52 62.56 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.504 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -156.87 60.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.571 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.575 ' ND2' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -101.94 -108.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.412 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 46.0 m-85 -65.6 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.474 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER 59.22 41.76 19.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.606 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.619 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 166.31 -62.58 0.22 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 165.58 -63.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.353 . . . . 1.0 110.612 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.82 51.05 6.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.569 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.08 -1.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.558 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.614 ' NE2' ' N ' ' A' ' 17' ' ' SER . 1.2 pm0 -49.22 -21.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.614 ' N ' ' NE2' ' A' ' 16' ' ' GLN . 1.9 m -167.68 64.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.586 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.474 ' C ' ' H ' ' A' ' 21' ' ' TYR . 67.5 m 55.83 14.92 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -64.05 2.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.508 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -75.17 31.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.515 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 20' ' ' GLU . 2.5 p 61.64 44.56 8.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.573 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 7.8 p-10 -137.77 5.14 2.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.54 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -92.36 4.32 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.529 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -152.13 16.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.567 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 28' ' ' GLY . 6.9 t -138.68 -93.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.585 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.2 m -76.11 30.64 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -147.04 23.72 1.6 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.74 6.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 1.0 110.583 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.3 mt -113.42 -28.0 7.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.53 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.605 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.5 mp -81.92 -36.14 0.77 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.361 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 74.1 Cg_endo -87.35 10.12 3.65 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.274 1.983 . . . . 1.0 112.09 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.1 -2.76 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.595 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.5 -42.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -78.75 31.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.554 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.428 ' H ' ' C ' ' A' ' 34' ' ' ILE . 18.4 mmt -136.53 -59.49 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.548 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.7 mt -83.82 17.54 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.63 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.17 -11.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -102.63 14.12 32.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.69 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.34 38.89 3.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.517 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.69 -40.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' C ' HG22 ' A' ' 43' ' ' THR . . . -94.4 23.55 31.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -169.12 -84.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.85 0.357 . . . . 1.0 110.398 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 46' ' ' ASN . 0.6 OUTLIER 49.79 10.87 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.663 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.542 ' O ' HG21 ' A' ' 49' ' ' VAL . . . 74.55 27.11 66.02 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' A' ' 44' ' ' THR . 57.5 p30 -138.76 4.98 2.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.775 0.321 . . . . 1.0 110.551 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.646 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -106.6 -38.61 2.2 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.742 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -103.5 19.7 19.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 1.0 110.606 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 45' ' ' GLY . 61.3 t -102.71 -64.34 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.697 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -110.64 -35.94 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.702 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.519 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 43.2 t-105 -68.66 -7.95 37.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.499 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -63.53 -36.78 84.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.535 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 55' ' ' ARG . 12.4 t -61.16 -71.99 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.559 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -42.58 -21.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.604 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.1 tpt180 -82.67 -53.47 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.573 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -63.03 -36.03 82.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.639 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -50.81 -37.14 40.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.535 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.5 86.52 0.1 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.4 -10.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 1.0 110.612 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.0 -75.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.614 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -171.45 118.13 0.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.62 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -100.76 -65.85 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.626 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -135.75 -147.3 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.137 0.494 . . . . 1.0 110.452 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.566 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' C ' ' H ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 4' ' ' GLY . 5.6 tp10 65.0 -0.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.477 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 1' ' ' MET . 20.3 mp0 54.03 12.28 0.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.587 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 2' ' ' GLU . . . 45.06 88.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.54 17.88 49.22 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -33.14 10.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.714 0.292 . . . . 1.0 110.575 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.432 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 36.1 t80 -125.67 42.85 3.2 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.423 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -150.69 46.25 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.575 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' TYR . 25.2 m120 -149.12 -57.23 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.62 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -73.56 14.47 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.642 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.449 ' H ' ' C ' ' A' ' 9' ' ' ASN . 77.9 m-85 -137.84 94.41 2.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.522 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.84 30.97 37.15 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 9' ' ' ASN . . . -174.49 73.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 1.0 110.575 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 14' ' ' ASP . 12.5 p-10 -163.75 59.9 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.583 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 2.0 m-20 52.29 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.582 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.74 44.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.623 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 t -96.84 -1.67 45.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.01 94.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.626 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.1 p -141.77 15.69 2.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.595 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.29 56.94 3.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.595 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.19 -37.22 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.578 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -139.12 12.03 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.567 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -138.23 26.37 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -100.22 -12.76 19.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.501 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.83 11.23 39.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.564 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 28' ' ' GLY . 30.9 t -142.36 -86.36 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.568 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.66 18.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -151.31 41.77 0.75 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 -12.34 1.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.748 0.309 . . . . 1.0 110.586 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' O ' HD11 ' A' ' 34' ' ' ILE . 1.7 mp -113.03 -31.22 6.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.522 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.607 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -78.9 -36.26 1.15 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.162 -0.472 . . . . 1.0 111.377 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.2 Cg_endo -87.2 25.87 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 122.299 1.999 . . . . 1.0 112.162 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.96 11.52 3.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.583 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -140.0 -40.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.5 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -73.07 10.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.583 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ILE . 7.1 mmt -103.04 -64.47 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mt -50.23 -17.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.632 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' C ' ' N ' ' A' ' 40' ' ' LEU . 50.7 t -90.04 -57.28 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.09 -15.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.533 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' N ' ' C ' ' A' ' 38' ' ' VAL . 60.5 mt -118.94 41.71 2.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.4 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.37 -44.79 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.381 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.2 -10.23 82.77 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -133.94 -52.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.879 0.371 . . . . 1.0 110.38 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 40.26 22.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.804 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 98.81 31.24 6.4 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' THR . 44.9 m-80 -136.36 -34.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 1.0 110.507 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.75 -2.19 90.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 48' ' ' LEU . 2.5 mt -95.12 -26.48 16.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 1.0 110.578 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 51' ' ' TRP . 4.5 t -74.63 -58.57 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.675 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.71 9.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.643 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.458 ' H ' ' C ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -85.86 -8.54 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 52' ' ' THR . 4.9 t -103.6 22.37 14.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.572 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.27 -55.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.538 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -103.02 47.03 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.547 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -145.9 -59.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.721 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.5 -48.74 11.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.614 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -62.15 -26.11 68.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.338 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 61' ' ' HIS . . . 135.66 107.25 0.88 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.618 ' NE2' ' CD2' ' A' ' 60' ' ' HIS . 3.5 p80 -41.2 -27.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 1.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.618 ' CD2' ' NE2' ' A' ' 59' ' ' HIS . 3.6 m-70 -81.25 -44.04 18.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.53 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.462 ' CB ' ' O ' ' A' ' 60' ' ' HIS . 5.7 t-80 78.22 41.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.571 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.644 ' CG ' ' H ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -66.21 -112.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.488 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.644 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 6.6 m80 -113.02 -146.61 0.41 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.14 0.495 . . . . 1.0 110.462 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.491 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.14 111.42 5.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -42.53 -41.93 3.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.556 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.59 -83.91 0.24 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.98 -57.33 0.17 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 69.27 14.82 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.758 0.313 . . . . 1.0 110.52 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 t80 64.74 43.07 4.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.593 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -154.24 56.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 11' ' ' TYR . 3.0 t30 -158.7 120.34 3.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.58 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.4 t80 45.36 17.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.609 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.473 ' N ' ' C ' ' A' ' 9' ' ' ASN . 0.8 OUTLIER -103.57 92.06 4.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.471 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 101.65 -68.63 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.931 -0.868 . . . . 1.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 164.38 85.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.313 . . . . 1.0 110.551 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -99.83 -57.92 2.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.594 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -175.33 97.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.599 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.33 -29.78 30.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.585 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 p -178.51 56.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.574 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 4.9 mt-10 -154.37 -176.71 6.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.549 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.47 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 1.1 t 78.32 -15.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.578 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -97.91 3.09 49.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.585 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.509 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 68.9 t80 -149.36 14.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.624 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.494 ' O ' ' NZ ' ' A' ' 25' ' ' LYS . 3.0 p -137.69 22.03 2.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.599 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -128.53 -8.63 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.686 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -66.22 -8.84 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.499 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HZ3' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -132.25 -3.08 3.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.575 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.6 t 40.12 60.55 1.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.761 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 m -150.78 34.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.497 ' N ' ' HZ3' ' A' ' 25' ' ' LYS . . . -166.86 36.43 0.23 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.01 -3.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 1.0 110.532 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.41 -19.46 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.582 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -78.59 -41.17 1.8 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 64.1 Cg_endo -86.91 -16.92 3.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.426 2.084 . . . . 1.0 112.21 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.07 -1.37 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -136.47 -51.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.443 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -53.03 -31.79 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.51 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.454 ' CG ' ' O ' ' A' ' 32' ' ' PRO . 11.9 mmt -60.61 -59.25 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.553 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 mp -46.4 -22.25 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.558 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 40' ' ' LEU . 3.7 t -93.38 -50.46 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.552 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.32 -15.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.1 mt -124.85 37.45 4.4 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.358 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 38' ' ' VAL . 14.7 tp -168.57 -62.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.35 -13.39 43.39 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.555 ' O ' ' N ' ' A' ' 45' ' ' GLY . 5.5 t -150.17 -44.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.132 -0.227 . . . . 1.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER 33.02 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.304 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -45.02 -62.26 3.1 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.56 -2.16 8.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.989 0.423 . . . . 1.0 110.127 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.85 -23.52 32.73 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.6 41.64 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 1.0 110.605 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 45' ' ' GLY . 38.5 t -135.05 -61.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.538 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -101.39 -15.82 17.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.56 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -81.63 -32.02 32.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.537 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -49.27 -33.25 12.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.571 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.3 t -57.36 -55.98 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.499 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -79.46 47.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.555 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -152.87 -49.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.561 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -20.96 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.586 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -48.66 -20.8 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.571 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -170.19 30.77 0.14 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.48 -79.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 1.0 110.668 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 11.7 m-70 -139.22 -44.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.603 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 0.6 OUTLIER 170.2 130.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.479 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.64 -97.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.55 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 44.31 43.58 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.616 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.039 -0.982 . . . . 1.0 110.589 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.379 -0.6 . . . . 1.0 109.379 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -140.13 -34.38 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.594 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -166.4 115.83 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.557 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.35 -127.26 1.04 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.45 85.66 0.04 OUTLIER Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -165.38 34.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -154.11 56.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.574 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 43.3 t0 -155.26 53.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.521 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 8' ' ' ASP . 8.9 m120 -138.2 -62.9 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.604 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -77.18 3.81 11.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.578 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -76.45 68.13 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.587 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.33 -80.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.976 -0.85 . . . . 1.0 110.976 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -163.27 72.29 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.817 0.341 . . . . 1.0 110.513 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 2.7 p-10 -86.93 -43.48 12.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.547 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -178.29 98.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.577 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -92.96 20.75 6.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.569 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 1.7 p 79.67 25.86 0.39 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.449 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.2 tt0 -70.24 155.32 40.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.595 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 69.19 -8.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.542 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 18' ' ' GLU . 10.7 tt0 -82.49 61.07 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.583 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -138.48 -66.27 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.593 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m -164.72 34.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.579 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 19' ' ' CYS . 19.8 p30 -139.73 12.45 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.557 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -101.06 5.32 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -150.26 16.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.585 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 27' ' ' SER . 11.8 t -155.99 -108.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.597 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 46.67 18.28 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.594 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 26' ' ' SER . . . -167.96 41.87 0.23 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.06 -1.88 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.704 0.288 . . . . 1.0 110.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -127.34 -30.3 2.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -75.44 -34.52 1.61 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.4 Cg_endo -88.0 26.36 0.59 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 122.265 1.977 . . . . 1.0 112.167 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -131.48 -2.21 3.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.708 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.9 -33.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.571 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -95.76 25.76 4.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.1 mmt -131.16 -19.77 2.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.511 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -125.26 19.6 8.2 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.422 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 t -145.74 -43.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -54.9 -14.87 1.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.666 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -140.64 17.92 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.595 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.2 tp -138.55 -41.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.251 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.96 2.28 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' GLY . 14.9 t -170.52 -31.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 1.0 110.607 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.417 ' H ' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -42.55 -21.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.56 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 137.8 33.43 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -137.76 21.94 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.745 0.307 . . . . 1.0 110.499 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.3 2.91 3.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.15 14.07 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.694 0.283 . . . . 1.0 110.569 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 53' ' ' VAL . 59.5 t -132.28 -33.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.491 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.2 tp -98.14 -49.23 4.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.356 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.602 ' CH2' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -62.25 -12.99 23.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.495 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 t -96.17 -15.29 22.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.639 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 49' ' ' VAL . 42.5 t -72.57 -51.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.728 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.52 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 1.8 p90 -79.35 21.05 0.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.668 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.647 ' HE ' ' CE1' ' A' ' 59' ' ' HIS . 0.4 OUTLIER -123.96 -49.03 1.86 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.549 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -18.67 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.679 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -72.88 -19.12 61.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.579 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 158.68 94.5 0.1 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.647 ' CE1' ' HE ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -41.07 -23.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.78 0.324 . . . . 1.0 110.573 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' O ' ' ND1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -138.71 5.95 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.531 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 63.1 128.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.54 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -147.45 111.88 5.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.55 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.536 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 3.9 t-160 -134.57 -147.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 1.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 20.2 p-80 . . . . . 0 C--N 1.321 -0.64 0 CA-C-O 118.014 -0.993 . . . . 1.0 110.544 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 73.82 -46.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.576 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 55.29 100.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.607 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.18 0.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 44.94 35.35 4.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.14 -65.25 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 1.0 110.567 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 53.35 41.82 32.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.49 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -122.19 41.14 3.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.521 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' ' N ' ' A' ' 11' ' ' TYR . 1.2 m120 -157.59 111.88 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.565 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 43.68 23.59 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.592 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' ASN . 1.9 m-85 -139.59 103.69 4.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.616 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.61 -34.72 2.01 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' ND2' ' A' ' 15' ' ' ASN . . . -178.51 -82.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.8 0.334 . . . . 1.0 110.535 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 49.99 24.59 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.546 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 11.4 p30 -142.81 59.44 1.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.567 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -62.36 -48.71 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.62 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.22 6.79 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.575 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -84.76 87.33 7.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.557 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p -178.19 57.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.0 -9.21 28.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.574 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -42.14 -66.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.588 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -146.43 12.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.59 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.6 15.92 27.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.614 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -91.35 4.22 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.524 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -151.87 15.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.579 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.05 -48.86 4.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.593 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.8 p -86.19 28.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.572 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.58 4.47 3.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -99.81 -6.01 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.673 0.273 . . . . 1.0 110.556 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -109.69 -17.58 13.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.577 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.582 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.9 -39.95 3.62 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 66.4 Cg_endo -86.89 -0.81 7.99 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.454 2.102 . . . . 1.0 112.184 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.29 11.12 38.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.552 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.7 mt -137.72 -36.53 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.545 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.93 2.75 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.62 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 10.8 mmt -101.7 -54.67 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.621 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt -76.78 16.18 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.576 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.89 -70.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -46.07 -46.03 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -100.54 50.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -173.54 -64.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.332 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.31 -14.02 0.49 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -138.09 -98.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 1.0 110.607 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.563 ' H ' HG23 ' A' ' 43' ' ' THR . 1.3 p 58.66 3.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.621 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 136.83 -25.66 3.06 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -85.02 -12.93 52.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.813 0.34 . . . . 1.0 110.559 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -88.37 -9.89 69.0 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.742 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -116.66 -6.69 11.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.749 0.309 . . . . 1.0 110.462 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.6 t -103.63 -45.84 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.639 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tt -93.16 -65.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.612 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.426 ' CD1' ' C ' ' A' ' 51' ' ' TRP . 1.1 t-105 -44.74 -37.21 3.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.601 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -55.97 -33.61 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.598 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.08 -38.03 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.593 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -84.44 9.26 13.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.545 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.86 -68.6 0.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.519 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -53.96 -30.15 45.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.549 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -89.56 -9.73 48.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.551 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.82 97.7 0.17 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.665 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 4.6 p80 -171.81 -48.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.83 0.348 . . . . 1.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.665 ' H ' ' CD2' ' A' ' 59' ' ' HIS . 4.8 m170 -101.61 -14.13 17.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.581 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.538 ' CG ' ' H ' ' A' ' 62' ' ' HIS . 4.7 t-80 -108.64 -148.88 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.563 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.538 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 26.1 t-80 44.1 95.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.537 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.549 ' CG ' ' N ' ' A' ' 64' ' ' HIS . 6.4 p-80 -110.35 -146.39 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.165 0.507 . . . . 1.0 110.514 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.549 ' N ' ' CG ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -85.01 14.52 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.508 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 42.55 65.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.538 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.01 92.19 0.2 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.81 96.38 0.26 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -98.02 -34.18 10.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.774 0.321 . . . . 1.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 54.81 44.41 28.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.569 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.46 49.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.521 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -140.71 49.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.566 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' CD2' ' OD1' ' A' ' 14' ' ' ASP . 6.2 t80 43.18 29.96 0.25 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.429 ' CD2' ' C ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER 49.24 42.54 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.607 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 165.21 -64.19 0.23 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 163.64 -39.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 1.0 110.542 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.494 ' OD1' ' CD2' ' A' ' 10' ' ' TYR . 1.3 t70 76.86 -14.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.543 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 13' ' ' ALA . 7.8 m120 -92.53 75.39 5.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.528 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.66 -42.88 6.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.593 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 t -157.11 54.15 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.6 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -102.02 -21.94 14.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.578 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' C ' ' H ' ' A' ' 21' ' ' TYR . 6.2 t -165.39 65.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.436 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' C ' ' CG ' ' A' ' 21' ' ' TYR . 19.4 mt-10 -71.5 40.9 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.462 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 21' ' ' TYR . 0.3 OUTLIER 69.35 -62.43 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.652 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.76 35.5 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.473 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 -5.61 4.5 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.62 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -65.43 -9.3 24.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.479 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -130.81 -3.72 4.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.54 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.8 p 40.22 72.57 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.654 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.8 p -158.82 25.08 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.614 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.75 37.1 0.14 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.871 . . . . 1.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.64 6.51 0.34 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 1.0 110.544 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.3 -27.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.608 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -69.99 -41.19 14.4 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.1 Cg_endo -87.33 22.3 0.94 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.595 2.197 . . . . 1.0 112.226 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.47 -7.89 5.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.636 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 36' ' ' MET . 45.6 mt -104.59 -45.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.634 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -70.55 9.25 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.446 ' H ' ' C ' ' A' ' 34' ' ' ILE . 13.0 mmt -97.27 -62.67 1.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.469 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.53 -9.08 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 40' ' ' LEU . 92.1 t -98.28 -44.26 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -78.96 30.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.604 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.7 mt -138.9 6.32 2.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.562 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.41 -40.5 4.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.551 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.73 -3.62 50.41 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.936 -0.866 . . . . 1.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.657 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -137.66 -99.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.616 0.246 . . . . 1.0 110.565 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.657 ' H ' HG23 ' A' ' 43' ' ' THR . 4.6 t 33.48 49.01 0.21 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.3 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 104.87 -46.74 1.14 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 43' ' ' THR . 67.9 m-80 -75.12 23.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.816 0.341 . . . . 1.0 110.562 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -136.41 -34.32 0.22 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.688 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -96.86 15.49 21.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.338 . . . . 1.0 110.475 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -134.92 -34.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD13 ' C ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -100.47 -75.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.315 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -48.79 -24.2 1.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 1.0 110.664 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 t -71.68 -29.19 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.641 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.7 t -50.66 -41.48 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.628 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.86 1.61 46.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.88 -44.57 5.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.599 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -28.76 69.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.61 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -54.45 -37.24 64.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.564 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.61 36.83 0.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 60' ' ' HIS . 12.5 m-70 54.32 64.66 1.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.793 0.33 . . . . 1.0 110.616 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' A' ' 59' ' ' HIS . 21.0 p80 40.93 25.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.718 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 59' ' ' HIS . 33.1 m170 54.72 107.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.567 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -53.18 -86.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.563 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.519 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 3.0 t-160 -134.91 -147.32 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.181 0.515 . . . . 1.0 110.429 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.519 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 50.9 m-70 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.576 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.48 -79.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.566 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -153.34 95.4 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.526 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.18 -121.96 1.31 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' O ' ' CD2' ' A' ' 7' ' ' PHE . . . 94.72 72.5 1.16 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t70 65.42 54.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.31 . . . . 1.0 110.557 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 5' ' ' GLY . 66.7 m-85 -148.58 41.83 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.579 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -157.01 60.9 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.479 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.37 -45.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.526 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CZ ' ' CE1' ' A' ' 11' ' ' TYR . 45.0 p90 -98.4 15.22 25.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.575 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.535 ' CE1' ' CZ ' ' A' ' 10' ' ' TYR . 42.1 m-85 -89.18 55.84 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.569 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -172.64 -70.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 175.41 73.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 1.0 110.616 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.28 -69.63 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.592 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -164.78 50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.594 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.703 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -69.95 -16.72 63.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.61 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 174.13 73.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.523 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 20' ' ' GLU . 14.6 tt0 -87.59 130.8 34.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.499 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.5 t 65.19 -3.67 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.514 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 18' ' ' GLU . 44.7 mt-10 -99.46 19.76 15.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.589 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.71 25.26 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.583 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p 58.69 42.54 20.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.641 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -138.13 5.04 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.51 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 45.8 p-90 -75.02 -25.67 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -100.47 5.15 44.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 28' ' ' GLY . 62.4 m -100.22 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.552 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.22 0.7 1.27 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -101.36 31.82 8.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' H ' ' H ' ' A' ' 30' ' ' LEU . . . -163.08 -8.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.7 0.286 . . . . 1.0 110.55 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.402 ' H ' ' H ' ' A' ' 29' ' ' ALA . 25.6 mt -111.52 -30.3 7.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.681 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -77.57 -37.89 1.7 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.194 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.1 Cg_endo -88.1 -0.27 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.389 2.059 . . . . 1.0 112.119 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.87 6.91 36.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.653 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -140.41 -51.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.585 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.21 -29.8 34.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.59 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.431 ' C ' ' N ' ' A' ' 38' ' ' VAL . 23.3 mmt -63.59 -60.38 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.446 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.5 mp -46.92 -17.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.537 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.431 ' N ' ' C ' ' A' ' 36' ' ' MET . 6.5 t -97.81 -52.1 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -42.4 -26.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.504 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -115.83 73.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.09 -57.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.07 10.58 67.86 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -139.2 -73.87 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 1.0 110.542 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER 41.65 22.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.56 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 102.76 29.24 5.94 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' THR . 66.2 m-80 -130.71 -30.91 1.81 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.753 0.311 . . . . 1.0 110.583 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.784 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -88.71 -11.7 65.44 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.784 HD23 ' C ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -125.94 31.88 5.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.824 0.345 . . . . 1.0 110.346 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.42 -54.77 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.594 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -101.8 -23.66 14.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.461 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.535 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 0.1 OUTLIER -78.4 -10.79 59.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.523 HG23 ' N ' ' A' ' 53' ' ' VAL . 10.5 t -89.18 -42.81 11.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.704 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' N ' HG23 ' A' ' 52' ' ' THR . 55.6 t -49.01 -24.36 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.922 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -101.12 -21.1 15.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.646 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' C ' ' N ' ' A' ' 57' ' ' LYS . 2.0 tpt180 -88.24 -51.98 5.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.606 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.94 -15.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.699 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 55' ' ' ARG . 15.6 mtpp -64.23 -36.74 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.569 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' O ' ' CG ' ' A' ' 59' ' ' HIS . . . 134.02 64.94 0.07 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 58' ' ' GLY . 22.3 p80 40.54 73.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.906 0.384 . . . . 1.0 110.804 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 44.42 29.41 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.651 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.474 ' CD2' ' H ' ' A' ' 62' ' ' HIS . 2.1 t-160 -142.35 -150.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.072 0.463 . . . . 1.0 110.421 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.474 ' H ' ' CD2' ' A' ' 61' ' ' HIS . 65.4 m-70 -141.96 97.61 3.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.46 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.416 ' O ' ' OXT' ' A' ' 64' ' ' HIS . 7.5 t-160 -154.86 95.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.416 ' OXT' ' O ' ' A' ' 63' ' ' HIS . 3.6 t-80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.929 -1.034 . . . . 1.0 110.564 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' GLU . 3.0 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER 49.12 99.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.504 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.78 -58.35 2.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.87 -57.34 0.65 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.01 -118.24 11.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -155.32 40.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.617 ' CZ ' ' CD2' ' A' ' 11' ' ' TYR . 4.1 t80 72.24 43.42 0.51 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' C ' HD22 ' A' ' 9' ' ' ASN . 64.3 m-20 -147.57 49.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.595 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.476 HD22 ' C ' ' A' ' 8' ' ' ASP . 2.6 m-80 -140.42 -100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.588 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -66.52 -20.23 65.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.519 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD2' ' CZ ' ' A' ' 7' ' ' PHE . 10.1 m-85 -74.92 77.58 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.478 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.583 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 143.08 -76.62 0.3 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.806 -0.918 . . . . 1.0 110.806 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 168.28 122.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.347 . . . . 1.0 110.621 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -133.52 -73.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.501 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.541 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 3.6 m120 -84.66 -99.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.398 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 15' ' ' ASN . 2.5 pp0? 19.36 48.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.07 0.856 . . . . 1.0 112.202 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ASN . 8.3 t -158.1 -64.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.566 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 42.73 50.97 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.546 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -140.43 6.07 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.658 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.43 64.22 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.416 ' O ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -140.0 -66.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.619 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 2.0 m -168.23 39.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.544 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -143.29 11.77 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.598 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.41 ' NE1' ' NZ ' ' A' ' 25' ' ' LYS . 20.0 p-90 -101.59 5.09 41.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.567 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -150.11 16.37 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.58 -179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.2 m -137.92 -39.27 0.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.591 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 p -80.04 23.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.512 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.38 40.35 1.11 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.24 -9.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 1.0 110.544 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.91 -13.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.51 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.624 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 3.4 mm -83.86 -36.02 0.63 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.445 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.0 Cg_endo -88.26 10.75 3.3 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.468 2.112 . . . . 1.0 112.266 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.93 -19.8 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.525 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.7 pt -105.52 -44.71 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.627 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' O ' ' SD ' ' A' ' 36' ' ' MET . 30.0 m-85 -74.21 19.77 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.62 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 18.1 mmt -136.49 -50.68 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.622 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.86 0.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.574 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.8 t -137.43 -54.17 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.29 -49.6 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -98.43 56.1 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' A' ' 43' ' ' THR . 15.0 tp -175.05 -64.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -17.33 0.88 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.936 -0.865 . . . . 1.0 110.936 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.71 HG23 ' H ' ' A' ' 44' ' ' THR . 0.8 OUTLIER -138.07 -103.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.353 . . . . 1.0 110.522 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.71 ' H ' HG23 ' A' ' 43' ' ' THR . 1.7 p 62.64 -1.05 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.569 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' C ' HD22 ' A' ' 46' ' ' ASN . . . 88.83 25.64 29.11 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.473 HD22 ' C ' ' A' ' 45' ' ' GLY . 1.2 m-80 -137.43 3.95 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.78 0.324 . . . . 1.0 110.534 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.836 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -105.0 -19.24 10.99 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.836 HD23 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -122.0 15.77 10.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.687 0.279 . . . . 1.0 110.453 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.8 t -102.23 -62.05 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -96.52 -36.36 10.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.888 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.441 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 27.2 t-105 -69.97 -15.57 63.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.467 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.457 ' OG1' ' CE ' ' A' ' 56' ' ' LYS . 2.6 t -78.81 -24.79 44.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.637 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.08 5.52 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.504 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.436 ' O ' ' NE2' ' A' ' 62' ' ' HIS . 0.8 OUTLIER -138.48 3.39 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.642 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 59' ' ' HIS . 3.2 tmt_? -101.72 -59.42 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' CE ' ' OG1' ' A' ' 52' ' ' THR . 21.5 mtmt -53.91 -45.71 71.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.595 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -52.89 -30.37 33.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.618 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . -101.06 -68.37 0.83 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER 71.62 -40.57 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 1.0 110.577 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -78.34 11.46 2.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 66.06 126.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.548 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.436 ' NE2' ' O ' ' A' ' 54' ' ' PHE . 43.0 m-70 -83.0 78.73 9.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.506 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -89.61 84.51 6.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.589 179.935 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -138.04 8.46 2.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.563 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -140.4 63.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.635 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.22 -5.04 32.51 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.947 -0.861 . . . . 1.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.65 164.52 31.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -101.39 -78.12 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 1.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 t80 56.98 43.28 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.578 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -157.67 52.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.564 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -138.98 -20.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.553 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.488 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 4.3 t80 -153.21 0.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.617 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 14.9 p90 38.56 40.74 0.41 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.785 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.54 -50.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . 179.23 -58.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.763 0.316 . . . . 1.0 110.585 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 4.9 t0 77.64 6.07 2.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.579 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.43 ' ND2' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 51.2 102.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.56 -179.955 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.09 10.39 26.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.591 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 19' ' ' CYS . 5.0 m -134.66 0.38 2.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.633 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -57.74 -7.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 2.0 t -171.1 47.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.582 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -138.72 21.29 2.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.545 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.63 -52.03 3.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.6 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.1 p -140.15 31.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.551 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.86 3.51 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.568 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 18.9 p-90 -81.58 5.87 16.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.539 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.39 16.54 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.591 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.48 ' OG ' ' N ' ' A' ' 27' ' ' SER . 91.2 p -144.93 -109.17 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.48 ' N ' ' OG ' ' A' ' 26' ' ' SER . 25.8 t -72.08 42.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.518 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -170.23 32.88 0.16 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.89 -18.01 0.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.717 0.294 . . . . 1.0 110.578 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.442 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 2.6 mp -112.0 -29.69 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.601 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -75.8 -37.81 2.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.261 -0.427 . . . . 1.0 111.19 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.3 Cg_endo -87.6 26.15 0.62 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.461 2.108 . . . . 1.0 112.174 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.25 7.82 3.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -145.32 -39.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.609 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.493 ' O ' ' SD ' ' A' ' 36' ' ' MET . 45.2 m-85 -79.26 26.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.588 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 19.4 mmt -137.34 -67.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.566 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -47.02 -24.13 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.572 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -95.61 -51.7 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.587 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -41.54 -30.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.465 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.93 80.29 1.33 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.411 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 43' ' ' THR . 2.0 mt -159.36 -61.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.56 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 43' ' ' THR . . . -75.44 28.41 1.23 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.559 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -173.47 -86.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 1.0 110.539 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.559 ' H ' HG23 ' A' ' 43' ' ' THR . 0.6 OUTLIER 49.9 11.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.58 179.993 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 78.47 3.16 86.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.585 ' ND2' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -100.55 -20.92 15.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.793 0.33 . . . . 1.0 110.531 -179.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.585 ' N ' ' ND2' ' A' ' 46' ' ' ASN . . . -91.07 -35.07 7.26 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 50' ' ' LEU . 3.1 mt -89.98 -145.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 1.0 110.513 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.659 ' O ' HG22 ' A' ' 52' ' ' THR . 2.8 t 62.64 -71.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.642 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 48' ' ' LEU . 1.2 pp -59.08 -4.06 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.561 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.529 ' O ' ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.7 -45.59 58.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.381 -179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 49' ' ' VAL . 11.3 t -45.5 -12.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.289 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 51' ' ' TRP . 50.8 t -87.04 -31.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.914 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 51' ' ' TRP . 67.1 m-85 -124.09 4.81 8.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.869 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' NH2' ' CE1' ' A' ' 59' ' ' HIS . 2.4 tpt180 -90.33 -41.52 11.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.854 0.359 . . . . 1.0 110.674 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 58' ' ' GLY . 3.5 mmtt -78.92 -52.69 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.463 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -62.63 0.38 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.557 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 56' ' ' LYS . . . 167.61 97.9 0.12 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.49 ' CE1' ' NH2' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -41.62 -28.24 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.77 0.319 . . . . 1.0 110.528 179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.601 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -138.7 -57.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.601 ' N ' ' CD2' ' A' ' 60' ' ' HIS . 0.7 OUTLIER 165.05 108.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.367 179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.526 ' CG ' ' H ' ' A' ' 63' ' ' HIS . 4.7 t-160 -101.0 -138.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.582 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.526 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 2.1 m-70 -140.16 93.74 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.58 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.557 -179.997 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.23 71.54 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.534 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -92.43 86.77 5.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.55 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.13 -5.38 65.72 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.945 -0.862 . . . . 1.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.17 -144.11 2.79 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 t0 71.93 28.74 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 1.0 110.546 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 65.52 58.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.426 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -165.98 66.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.577 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.513 HD22 ' C ' ' A' ' 15' ' ' ASN . 37.5 m-20 -73.43 -34.86 65.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.403 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -152.09 -49.86 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.891 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -139.24 30.4 2.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.354 0.597 . . . . 1.0 110.489 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 117.24 27.08 2.76 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 86.4 93.89 0.03 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.998 0.428 . . . . 1.0 110.254 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -13.29 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.729 -0.669 . . . . 1.0 110.554 -179.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.513 ' C ' HD22 ' A' ' 9' ' ' ASN . 38.4 t-20 -150.37 96.79 2.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.452 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' O ' ' CB ' ' A' ' 17' ' ' SER . 5.5 mt-30 -74.77 22.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.599 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 80.56 43.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.335 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.497 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 5.4 tt0 -100.56 131.88 46.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.525 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 71.71 -8.41 1.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.579 -179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 18' ' ' GLU . 5.9 tt0 -80.69 45.82 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.578 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -102.17 -75.44 0.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.543 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.577 HG23 ' HZ1' ' A' ' 25' ' ' LYS . 2.1 m -166.69 28.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.511 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -141.07 28.96 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.48 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 19' ' ' CYS . 9.2 p-90 -128.83 1.63 5.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.486 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HZ1' HG23 ' A' ' 22' ' ' THR . 0.0 OUTLIER -151.8 19.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.521 179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 28' ' ' GLY . 12.7 t -166.67 25.64 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.608 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.0 m -72.27 14.57 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.332 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.666 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . 151.13 -11.1 0.78 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 82.88 34.56 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.852 0.358 . . . . 1.0 110.383 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -110.74 -26.6 9.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.335 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -77.57 -41.01 2.23 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.854 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.5 Cg_endo -86.92 24.78 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.475 2.117 . . . . 1.0 112.168 -179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.8 5.19 5.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.542 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -146.26 -55.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.546 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -60.92 -0.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.548 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.472 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.9 mmt -96.97 -50.36 4.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.544 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.4 mp -78.82 13.21 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.582 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.4 t -141.31 -75.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.564 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.5 -50.49 16.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.568 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mt -99.16 49.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.636 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 43' ' ' THR . 14.9 tp -175.19 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.334 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -49.57 -12.49 0.38 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.776 HG23 ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -138.09 -98.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 1.0 110.549 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.776 ' H ' HG23 ' A' ' 43' ' ' THR . 0.8 OUTLIER 52.45 9.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.54 -179.981 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 83.53 26.55 42.44 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' C ' ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -134.77 1.16 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.783 0.325 . . . . 1.0 110.59 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.78 3.63 42.1 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.23 3.03 2.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.876 0.37 . . . . 1.0 110.623 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.72 -58.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.573 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 pp -95.66 -34.32 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.496 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -55.46 -16.83 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.481 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 t -81.66 -17.74 47.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.548 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.96 -21.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.514 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.84 15.54 26.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.526 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.6 -71.8 0.7 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.687 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -33.49 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.69 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -60.15 -31.98 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.526 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.03 98.12 0.17 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -17.15 21.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 1.0 110.558 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -71.03 -86.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.577 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.515 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -175.09 92.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.616 -179.993 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.521 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 15.8 p80 41.6 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.667 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 61' ' ' HIS . 6.7 t-160 -70.41 66.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.572 179.991 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' O ' ' A' ' 2' ' ' GLU . 2.6 mmt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.399 -0.593 . . . . 1.0 109.399 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . 12.0 tp10 58.77 117.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.55 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -75.4 -85.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.529 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 -61.02 0.81 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.76 105.81 1.32 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -160.68 27.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 1.0 110.612 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -162.73 51.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.545 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -144.17 54.44 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.529 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' TYR . 6.7 p-10 -118.97 43.6 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.563 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.473 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 57.8 t80 48.2 12.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.801 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 39.89 36.99 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.711 179.843 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.66 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 40.27 22.4 0.04 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 162.43 79.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 1.0 110.573 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.435 ' CG ' ' CE1' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -81.78 19.24 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.59 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.553 ' C ' HE21 ' A' ' 16' ' ' GLN . 1.2 m-80 69.93 125.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.591 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.553 HE21 ' C ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.78 -38.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.609 179.933 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -158.06 39.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.503 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -139.11 -17.61 1.04 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.534 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.9 p -171.86 57.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.563 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -101.6 31.92 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.575 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -101.6 -81.5 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.575 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.32 29.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.519 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.15 -11.51 5.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.546 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -60.84 -8.48 3.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.49 -0.84 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.55 179.809 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.3 p 40.04 79.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.666 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t -137.95 -35.43 0.64 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.592 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.58 49.21 0.89 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -137.19 -16.62 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 1.0 110.622 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -136.3 -18.88 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -68.68 -39.84 16.04 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.95 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.8 Cg_endo -87.11 25.75 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.488 2.126 . . . . 1.0 112.192 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -128.55 -49.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.496 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 36' ' ' MET . 1.1 pt -101.09 -32.5 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.602 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.504 ' CE2' ' CD1' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -79.04 29.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.42 ' H ' ' C ' ' A' ' 34' ' ' ILE . 1.6 mtp -127.31 -61.13 1.16 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.558 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.97 16.74 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.24 -31.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.643 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.504 ' CD1' ' CE2' ' A' ' 35' ' ' TYR . 30.4 t80 -77.82 -34.84 51.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.645 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.53 26.61 10.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.498 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.45 -61.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.176 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 -4.86 69.62 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.948 -0.861 . . . . 1.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -138.12 -61.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.088 -0.245 . . . . 1.0 110.65 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 45' ' ' GLY . 0.2 OUTLIER 32.62 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.661 0.601 . . . . 1.0 111.301 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' THR . . . -143.62 17.53 2.23 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.785 -0.926 . . . . 1.0 110.785 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.77 21.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 1.0 110.012 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' TRP . . . -147.29 -55.24 0.02 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.039 -0.825 . . . . 1.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -48.59 -13.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 1.0 110.217 179.923 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.482 ' N ' ' C ' ' A' ' 47' ' ' GLY . 79.7 t -82.04 -60.03 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.824 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -101.39 -36.51 8.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.692 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' GLY . 42.6 t-105 -60.3 -1.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.446 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 50' ' ' LEU . 3.3 t -94.05 -31.33 14.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.67 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 63.0 t -72.74 -60.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.594 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -55.71 -14.56 2.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.624 -179.905 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 57' ' ' LYS . 2.2 ttm180 -98.1 -38.61 9.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.607 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -54.47 -7.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.62 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 55' ' ' ARG . 36.8 mmtm -78.67 -31.34 46.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.609 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.91 85.53 0.06 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.014 -0.834 . . . . 1.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.43 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -61.74 -12.37 16.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 1.0 110.636 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -98.26 -14.06 20.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.551 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 34.7 m80 50.71 41.63 26.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.58 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -7.59 26.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.56 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -147.14 99.65 3.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.633 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 64' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.554 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -101.43 -29.29 12.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.572 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -139.89 -100.69 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.579 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.49 -67.18 0.5 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.909 -0.876 . . . . 1.0 110.909 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.98 -74.56 0.29 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.48 -67.86 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.817 0.341 . . . . 1.0 110.516 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 71.7 38.92 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' OD1' ' OD2' ' A' ' 14' ' ' ASP . 10.4 t70 56.13 50.44 13.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.546 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -118.09 49.48 1.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.358 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 t80 48.45 27.29 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.4 33.99 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.576 0.703 . . . . 1.0 110.337 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 44.7 65.58 1.71 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 169.49 115.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.774 0.321 . . . . 1.0 110.605 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 16' ' ' GLN . 27.2 t0 -168.8 45.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 m120 56.52 5.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.58 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.619 ' NE2' ' N ' ' A' ' 17' ' ' SER . 1.2 pm0 -55.71 -22.78 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.599 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.619 ' N ' ' NE2' ' A' ' 16' ' ' GLN . 14.5 t -177.27 31.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.606 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -159.12 109.85 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.546 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -167.49 -71.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.569 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -82.78 51.66 1.95 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' O ' ' OG1' ' A' ' 22' ' ' THR . 71.3 m-85 -151.11 54.51 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.532 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 3.2 p 60.63 42.58 13.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 25' ' ' LYS . 1.1 t70 -124.65 -19.48 5.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.574 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -53.76 -8.25 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.452 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.743 ' HZ3' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -135.27 0.86 2.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.5 p 40.16 62.2 1.35 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.565 ' C ' ' HZ3' ' A' ' 25' ' ' LYS . 9.2 p -152.6 27.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.594 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.743 ' N ' ' HZ3' ' A' ' 25' ' ' LYS . . . -157.03 34.68 0.56 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.58 -6.34 1.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.665 0.269 . . . . 1.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.553 ' O ' HD11 ' A' ' 34' ' ' ILE . 1.7 mt -113.19 -26.73 8.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.609 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -85.87 -34.72 0.5 Allowed Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.597 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.7 Cg_endo -87.68 25.48 0.65 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.258 1.972 . . . . 1.0 112.141 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.32 11.17 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.553 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -150.75 -48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.498 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' O ' ' SD ' ' A' ' 36' ' ' MET . 33.5 m-85 -73.19 12.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.501 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' VAL . 14.5 mmt -129.68 -38.12 1.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 37' ' ' LEU . 10.8 mp -55.41 -6.68 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.618 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.1 OUTLIER -134.96 -53.72 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.582 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.33 -21.41 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.588 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mt -136.8 54.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.568 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 -46.6 0.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.349 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.15 34.7 4.9 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' GLY . 3.6 t -167.65 -30.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 1.0 110.53 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -41.91 -22.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 154.92 -0.54 0.17 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.442 ' ND2' ' C ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.31 -1.1 4.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 1.0 110.52 -179.972 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.17 -18.92 48.34 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.12 23.8 2.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 1.0 110.539 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.9 t -137.87 -38.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.615 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.9 tt -101.34 -52.76 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.57 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.486 ' O ' ' CD2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -45.89 -16.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.594 179.992 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 50' ' ' LEU . 8.3 t -62.24 -35.77 79.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.512 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 50' ' ' LEU . 20.9 t -51.17 -32.48 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.575 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.71 15.77 6.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.59 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 58' ' ' GLY . 39.7 ttt-85 -135.56 -35.97 0.79 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' C ' ' N ' ' A' ' 58' ' ' GLY . 4.2 mtmt -51.6 -42.64 62.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.596 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -54.26 -10.9 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.511 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 55' ' ' ARG . . . -172.19 112.08 0.42 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.631 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 2.2 p80 -172.22 -41.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 1.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.631 ' H ' ' CD2' ' A' ' 59' ' ' HIS . 80.9 m-70 -157.1 44.48 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.612 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 42.24 76.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.576 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -154.42 115.19 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.598 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 4.8 t-160 -134.7 -147.29 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.495 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.598 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 118.053 -0.975 . . . . 1.0 110.541 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtp . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 49.8 66.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.607 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -101.38 3.74 40.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.506 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.23 43.53 1.9 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.53 169.0 21.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -87.26 -3.51 59.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.674 0.273 . . . . 1.0 110.572 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 4.1 t80 81.41 72.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.284 0.564 . . . . 1.0 110.662 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 t70 65.3 61.56 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.587 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.414 ' H ' ' HA ' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -86.43 -46.32 10.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.41 179.814 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -135.93 -76.42 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.504 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CG ' ' O ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -103.8 27.61 7.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.333 0.587 . . . . 1.0 110.458 179.891 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.664 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 123.42 -6.97 9.14 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.319 -0.855 . . . . 1.0 111.208 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 164.27 -35.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.006 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.5 t70 79.74 69.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.239 0.543 . . . . 1.0 110.51 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' SER . 2.2 p-10 -42.02 100.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.618 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -77.14 34.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.628 179.952 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 79.93 39.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.444 -179.913 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.06 21.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.578 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' H ' ' C ' ' A' ' 17' ' ' SER . 5.5 t -156.19 56.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.589 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.38 23.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.543 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 55.31 84.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.655 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.69 27.92 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.655 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.33 13.67 0.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.585 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -87.66 -16.53 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.546 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.81 11.01 40.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.563 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.4 p -138.54 -64.95 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.542 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.1 t -77.91 15.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.574 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.87 45.84 0.86 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.59 -34.08 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.739 0.304 . . . . 1.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' O ' ' CG1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -106.4 -9.61 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.573 -179.994 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -74.77 -40.06 3.8 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.49 25.97 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.498 2.132 . . . . 1.0 112.164 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.8 2.59 4.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.51 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' CG1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.43 -61.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.594 179.918 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.92 -28.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.584 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 36' ' ' MET . 2.9 mmm -75.11 -47.3 29.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.7 mt -54.76 -7.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' A' ' 36' ' ' MET . 0.8 OUTLIER -119.72 -51.54 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.494 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -46.13 -17.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.621 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' N ' ' C ' ' A' ' 38' ' ' VAL . 8.7 mt -136.77 52.75 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.532 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 16.6 tp -169.8 -59.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' CA ' HD21 ' A' ' 46' ' ' ASN . . . -97.29 40.9 2.42 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.496 ' N ' HD21 ' A' ' 46' ' ' ASN . 1.5 t -171.55 -23.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 1.0 110.589 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -41.55 -36.86 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.58 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' O ' ' CG2' ' A' ' 49' ' ' VAL . . . -161.41 -3.07 0.05 OUTLIER Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 41' ' ' LEU . 7.5 p30 -101.58 18.96 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.739 0.304 . . . . 1.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.73 3.88 3.24 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.25 55.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 1.0 110.574 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 72.8 t -142.46 -64.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 pp -97.68 -26.4 14.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.559 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -15.06 58.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.575 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 49' ' ' VAL . 13.3 t -80.41 -19.91 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.535 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.0 t -66.08 -64.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.625 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -53.46 -16.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.566 -179.971 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -84.51 -46.31 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.514 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -47.8 -28.49 2.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.609 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -55.16 -14.14 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.519 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.04 90.15 0.07 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.412 ' CD2' ' C ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -57.58 -23.44 50.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 1.0 110.59 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 61' ' ' HIS . 13.6 p80 -91.76 -37.13 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.621 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 60' ' ' HIS . 9.7 t-160 -89.48 41.83 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.521 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -56.13 -5.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.566 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.482 ' H ' ' C ' ' A' ' 61' ' ' HIS . 10.8 t-80 42.8 78.17 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.583 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 p80 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.572 -179.989 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -61.38 103.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.551 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -88.55 -97.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.28 -68.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.72 179.72 3.54 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.27 -64.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.806 0.336 . . . . 1.0 110.544 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 56.37 41.83 28.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.598 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -141.11 42.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.608 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 11' ' ' TYR . 46.4 t30 -153.5 82.45 1.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.558 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.479 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 1.2 t80 43.51 21.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.611 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.479 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.5 p90 38.76 40.28 0.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.789 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.591 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -169.27 -58.4 0.03 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 167.21 -24.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 1.0 110.607 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.9 t70 78.37 -0.66 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.499 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.536 ' C ' HD22 ' A' ' 15' ' ' ASN . 0.1 OUTLIER -90.13 58.3 4.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.548 179.966 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 17' ' ' SER . 2.3 mp0 -98.91 59.99 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.582 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 80.98 54.61 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.149 0.5 . . . . 1.0 110.318 -179.88 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -143.07 108.68 5.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.478 -179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 t 65.2 64.51 0.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.762 -0.458 . . . . 1.0 109.762 -179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 22' ' ' THR . 1.8 tp10 -69.3 58.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.63 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' THR . 17.6 m-85 58.99 -69.66 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.237 179.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 20' ' ' GLU . 29.8 p -157.81 56.82 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.089 -0.338 . . . . 1.0 110.089 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.1 -35.55 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.616 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' HB3' ' H ' ' A' ' 20' ' ' GLU . 3.7 p-90 -61.74 -30.95 71.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.811 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.437 ' CD ' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -70.69 3.85 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.898 -179.682 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -137.55 -77.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.604 179.962 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.64 8.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.596 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -155.89 31.62 0.61 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.55 5.9 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 1.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.45 -24.3 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.568 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -73.84 -41.07 5.38 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 63.3 Cg_endo -87.03 10.24 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.573 2.182 . . . . 1.0 112.251 -179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.32 3.63 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.564 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.06 -41.51 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.57 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -67.44 4.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' VAL . 20.3 mmt -100.92 -72.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.586 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 mt -52.09 -9.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.482 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' MET . 76.4 t -101.03 -36.47 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.578 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -93.03 33.98 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.597 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' O ' ' CG2' ' A' ' 44' ' ' THR . 5.2 mt -136.92 0.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.535 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 28.1 mt -112.29 -41.33 3.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.525 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' C ' HD21 ' A' ' 46' ' ' ASN . . . -69.91 -3.61 44.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.625 HG23 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -137.46 -100.2 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 1.0 110.482 -179.975 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.625 ' H ' HG23 ' A' ' 43' ' ' THR . 4.8 t 33.54 44.35 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.256 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . 108.15 -49.41 0.86 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -71.08 10.53 0.54 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.914 0.387 . . . . 1.0 110.62 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -96.61 -5.85 58.67 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.17 -10.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.362 . . . . 1.0 110.572 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.68 -46.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.556 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 tt -95.76 -57.21 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.576 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -45.19 -36.77 4.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.528 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.471 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 8.9 t -57.62 -36.51 71.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.519 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -52.15 -48.48 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.586 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.1 -11.85 59.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.642 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.424 HH21 ' CB ' ' A' ' 59' ' ' HIS . 9.1 ttm180 -99.08 -33.63 10.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.592 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -55.08 -21.29 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.571 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -88.86 -11.81 43.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.525 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.41 93.02 2.22 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.942 -0.863 . . . . 1.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.424 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -54.76 -18.13 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 1.0 110.556 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' HIS . 4.1 p80 -95.67 -21.35 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.554 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' HIS . 1.4 t-80 60.39 125.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.571 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -74.71 -37.59 62.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.513 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 44.4 41.8 4.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.586 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.941 -1.028 . . . . 1.0 110.578 179.998 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.5 mtp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.64 114.0 20.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.534 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -100.18 -33.35 10.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.541 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.9 133.56 5.67 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.57 -176.33 39.89 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.25 -46.01 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.707 0.289 . . . . 1.0 110.511 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 t80 61.5 43.32 10.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.622 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -140.58 42.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.581 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 11' ' ' TYR . 4.8 t-20 -157.48 108.25 2.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.469 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER 69.02 -38.47 0.4 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.089 179.677 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER 38.63 93.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.855 0.36 . . . . 1.0 110.826 179.902 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.53 -64.23 0.43 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.009 -0.836 . . . . 1.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -165.33 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 1.0 110.52 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.32 -0.45 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.626 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 13' ' ' ALA . 27.8 m120 -148.98 77.67 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.572 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.73 -39.72 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.679 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.2 m -90.72 -3.69 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.58 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -102.19 10.55 39.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -157.8 -36.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.552 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' C ' ' CG ' ' A' ' 21' ' ' TYR . 4.3 tt0 41.81 28.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.435 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 20' ' ' GLU . 1.2 m-85 71.74 -59.48 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.721 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 ' HG1' ' C ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -166.87 40.4 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.579 -179.892 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.83 -1.73 3.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.393 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.6 p-90 -70.31 -10.59 59.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.382 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.604 ' HZ3' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -134.0 0.38 3.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.609 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.4 p 39.8 79.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.604 ' C ' ' HZ3' ' A' ' 25' ' ' LYS . 3.4 t -161.84 21.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.621 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.93 20.34 0.87 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.864 -0.894 . . . . 1.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' C ' HD22 ' A' ' 30' ' ' LEU . . . -141.78 -5.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 1.0 110.534 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.854 HD22 ' N ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -107.74 -38.05 5.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.217 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.598 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.3 mp -82.0 -38.04 0.86 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.245 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 67.7 Cg_endo -87.31 19.4 1.38 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.402 2.068 . . . . 1.0 112.131 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.16 8.28 13.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.516 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.49 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -138.48 -44.0 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.567 179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.56 3.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.689 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 34' ' ' ILE . 9.3 mmt -100.63 -47.63 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.605 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.31 27.86 4.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.587 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -146.58 -18.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.52 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 43' ' ' THR . 34.3 t80 -96.23 -2.13 46.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.678 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.84 40.31 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.494 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -173.87 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.11 20.75 44.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.377 -1.089 . . . . 1.0 110.377 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.52 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -163.96 -83.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.768 0.318 . . . . 1.0 110.344 -179.749 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.52 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER 42.85 19.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 60.57 12.12 25.15 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -127.89 -6.05 5.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 1.0 110.396 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.827 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -88.5 -30.79 14.89 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.827 HD23 ' C ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -119.08 22.85 11.68 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.703 0.287 . . . . 1.0 110.511 179.911 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 52' ' ' THR . 96.4 t -128.58 -55.06 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.622 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 52' ' ' THR . 3.9 tt -95.87 -49.97 5.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.538 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.517 ' CE3' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -43.8 -18.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.595 179.904 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 50' ' ' LEU . 3.5 t -79.29 19.02 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.561 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.2 t -124.89 -29.94 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.504 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.492 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -102.81 -5.07 24.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.492 179.943 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -102.41 -43.59 5.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.623 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.47 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.529 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -58.93 -14.67 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.579 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -139.29 -107.13 0.72 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 72.82 -53.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 1.0 110.551 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -62.28 -25.59 67.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.554 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 48.91 89.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -99.89 70.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.583 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 56.8 t60 -99.86 84.72 2.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.526 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 m80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.61 179.966 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 69.03 117.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.529 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.6 mp0 -93.35 -64.89 1.04 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.525 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.87 -81.59 0.04 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.17 -50.21 0.75 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 7' ' ' PHE . 1.2 p-10 -100.87 -78.95 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 1.0 110.539 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.486 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 12.1 t80 65.57 58.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.613 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t70 53.12 45.28 29.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.546 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 11' ' ' TYR . 41.6 m-20 -136.78 109.01 7.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.478 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.0 t80 47.76 13.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.643 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' ASN . 14.4 m-85 -154.89 117.07 4.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.558 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 -29.26 11.6 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' ASP . . . -160.2 -43.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 1.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 2.1 t70 78.48 -1.1 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.592 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER 60.53 125.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.52 179.973 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.49 -34.78 10.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.528 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.3 t -162.0 32.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -64.07 -47.91 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.555 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 21' ' ' TYR . 4.3 t 65.92 46.79 2.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.56 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.77 15.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.594 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -103.36 -9.75 19.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.604 179.969 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.507 ' OG1' ' CZ ' ' A' ' 21' ' ' TYR . 9.0 m -152.29 -36.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.721 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -87.47 23.3 1.94 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -90.41 -0.9 57.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.535 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 22' ' ' THR . 0.0 OUTLIER -136.3 18.32 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.598 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 28' ' ' GLY . 27.3 t -135.75 -106.88 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.504 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -75.18 30.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.512 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -149.4 31.89 1.14 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.82 -9.09 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.736 0.303 . . . . 1.0 110.497 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mp -130.85 -16.56 3.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.469 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.62 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -78.29 -34.79 1.09 Allowed Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.395 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.2 Cg_endo -87.72 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.319 2.013 . . . . 1.0 112.16 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.35 10.55 2.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.668 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 36' ' ' MET . 14.0 mt -142.93 -44.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.596 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.32 7.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.511 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 34' ' ' ILE . 12.5 mmt -104.68 -55.18 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.561 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.75 18.01 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.478 179.944 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' C ' ' N ' ' A' ' 40' ' ' LEU . 57.9 t -135.43 -63.73 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.512 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -47.36 -17.62 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.566 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' N ' ' C ' ' A' ' 38' ' ' VAL . 3.7 mt -135.72 46.4 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.572 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.9 tp -175.17 -62.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.389 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.42 -10.48 2.97 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.763 HG23 ' H ' ' A' ' 44' ' ' THR . 0.9 OUTLIER -146.35 -101.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 1.0 110.676 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.763 ' H ' HG23 ' A' ' 43' ' ' THR . 1.7 p 64.44 -3.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.572 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 96.72 5.4 58.73 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 43' ' ' THR . 6.3 p30 -96.15 -42.11 8.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.771 0.319 . . . . 1.0 110.236 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.703 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -74.17 -16.33 79.72 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.708 -1.357 . . . . 1.0 109.708 179.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.729 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -108.52 -169.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.386 -0.407 . . . . 1.0 109.982 179.517 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 52' ' ' THR . 1.5 t 62.1 -70.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.675 179.737 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 53' ' ' VAL . 3.1 tt -66.86 -37.66 84.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.56 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.606 ' CE2' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -41.09 -32.1 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.95 -179.573 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 49' ' ' VAL . 3.1 t -70.86 11.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.605 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' LEU . 60.2 t -126.3 -19.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.99 -2.0 17.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.526 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.606 ' NH1' ' CE2' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -103.0 -70.93 0.74 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.652 -179.895 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -48.49 79.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 1.0 110.577 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -81.43 -11.56 59.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.625 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.47 -93.02 2.28 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.922 -0.871 . . . . 1.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.35 6.6 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.797 0.332 . . . . 1.0 110.538 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.04 -34.06 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.603 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.13 103.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.614 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -91.59 27.43 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.62 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.495 ' O ' ' CG ' ' A' ' 63' ' ' HIS . 0.4 OUTLIER -89.59 43.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.66 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.506 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 5.7 t-160 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.579 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.49 53.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.549 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -68.74 80.82 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.575 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.51 -134.21 1.08 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' ' OD1' ' A' ' 6' ' ' ASP . . . -165.84 -4.22 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.932 -0.867 . . . . 1.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 5' ' ' GLY . 0.5 OUTLIER 172.82 76.42 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.386 0.612 . . . . 1.0 109.775 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -154.65 59.45 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.778 -0.647 . . . . 1.0 110.541 -179.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -148.45 53.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.537 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 11' ' ' TYR . 40.8 m-20 -137.39 50.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.588 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' C ' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER 41.54 20.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.708 179.903 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.2 OUTLIER 42.59 40.23 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.622 179.841 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 40.49 28.79 0.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 163.51 101.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 1.0 110.623 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.74 31.33 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.523 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.502 ' H ' HE21 ' A' ' 16' ' ' GLN . 20.9 p30 -141.3 -31.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.651 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.703 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -87.82 18.86 3.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.558 179.961 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' GLU . 10.1 t -147.24 -37.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.547 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 17' ' ' SER . 1.2 tp10 44.0 99.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.019 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -107.66 9.84 29.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.517 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 21' ' ' TYR . 24.6 tt0 45.91 15.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.479 ' C ' HG23 ' A' ' 22' ' ' THR . 2.5 t80 73.7 40.77 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.479 HG23 ' C ' ' A' ' 21' ' ' TYR . 1.8 p 63.64 47.24 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.492 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -134.95 1.91 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.493 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -84.44 4.64 30.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.602 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -150.62 18.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.571 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.8 p -160.65 -96.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.64 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 28' ' ' GLY . 13.6 p 63.27 -68.83 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.579 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.665 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . -130.95 -12.97 2.04 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 81.19 48.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.941 0.4 . . . . 1.0 110.094 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.877 ' H ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -129.09 -27.7 2.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.491 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -80.42 -39.05 1.14 Allowed Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.974 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 68.7 Cg_endo -86.91 25.25 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.362 2.042 . . . . 1.0 112.175 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.5 -0.7 6.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.517 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.435 ' C ' ' H ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -141.49 -45.18 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.592 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.4 27.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.482 ' C ' ' H ' ' A' ' 38' ' ' VAL . 17.2 mmt -135.76 -51.53 0.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.519 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 41' ' ' LEU . 8.8 mt -59.45 -2.48 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.569 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' H ' ' C ' ' A' ' 36' ' ' MET . 1.1 t -140.32 -61.17 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.551 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -43.93 -64.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.638 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -100.94 63.86 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.556 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 37' ' ' LEU . 15.0 tp -163.74 -65.31 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -46.46 -23.62 1.37 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 44' ' ' THR . 0.5 OUTLIER -135.78 -97.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.2 -0.2 . . . . 1.0 110.65 179.894 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.796 ' H ' HG23 ' A' ' 43' ' ' THR . 6.1 t 36.01 32.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.481 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 77.68 -14.53 9.58 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -60.8 -4.35 0.96 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 1.0 110.538 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 45' ' ' GLY . . . -91.88 -15.13 55.27 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.85 26.75 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.794 0.331 . . . . 1.0 110.544 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.725 ' O ' HG23 ' A' ' 53' ' ' VAL . 90.9 t -138.31 -35.83 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 52' ' ' THR . 2.0 tp -98.43 -56.75 2.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.512 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -53.34 -9.18 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.534 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 50' ' ' LEU . 4.2 t -102.3 -24.16 13.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.602 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 49' ' ' VAL . 38.9 t -66.23 -31.31 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.587 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.519 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -99.28 15.92 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.596 -179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -128.5 -48.84 1.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -56.78 -33.1 66.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.585 179.983 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 2.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.568 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 56' ' ' LYS . . . -146.03 -61.71 0.02 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.91 -63.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 1.0 110.555 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.499 ' CG ' ' O ' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -143.01 9.12 1.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.606 -179.969 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.48 114.71 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.594 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -44.39 -26.77 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.6 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.617 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 3.8 t-80 -117.68 -146.87 0.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.441 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 117.968 -1.015 . . . . 1.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.426 ' C ' ' N ' ' A' ' 4' ' ' GLY . 3.3 tt0 50.65 89.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.561 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 4.7 pm0 -50.07 -15.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.606 179.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 2' ' ' GLU . . . 103.9 69.85 0.8 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.15 145.07 24.14 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.3 t0 48.3 33.4 3.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 1.0 110.463 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -158.21 53.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.494 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 10' ' ' TYR . 60.8 m-20 -128.15 40.87 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.491 -179.91 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 8' ' ' ASP . 1.8 t-20 79.17 -28.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.083 0.468 . . . . 1.0 109.895 -179.768 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CE1' ' OE1' ' A' ' 16' ' ' GLN . 72.4 m-85 -89.95 -3.74 57.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.641 -0.708 . . . . 1.0 109.445 178.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 14.9 p90 38.18 40.71 0.34 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.848 179.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.42 -69.44 0.52 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.906 -0.878 . . . . 1.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.52 -36.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.814 0.34 . . . . 1.0 110.545 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 14' ' ' ASP . 10.0 t0 64.88 2.52 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.59 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.1 t30 46.47 94.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.482 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' OE1' ' CE1' ' A' ' 10' ' ' TYR . 1.7 mt-30 -102.68 -47.76 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.618 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 p -130.76 -31.05 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.676 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 45.77 -148.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.535 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.48 11.11 2.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.57 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -94.78 12.41 28.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.53 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.416 ' O ' ' OG1' ' A' ' 22' ' ' THR . 24.4 m-85 -67.8 -84.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.533 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 21' ' ' TYR . 2.4 m -167.98 43.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.509 -179.916 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.56 6.73 2.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.554 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -101.66 3.29 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.605 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -144.52 9.79 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.634 179.99 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 27' ' ' SER . 0.1 OUTLIER -134.2 -73.58 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.559 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.431 ' N ' ' OG ' ' A' ' 26' ' ' SER . 83.7 p -85.87 41.2 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.549 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.58 37.44 0.19 Allowed Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -137.97 -15.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.327 . . . . 1.0 110.561 -179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -136.83 -15.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.642 179.988 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.589 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -79.1 -40.29 1.52 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 71.1 Cg_endo -86.97 25.29 0.68 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.461 2.107 . . . . 1.0 112.203 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.07 6.48 5.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.497 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -143.96 -42.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.925 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 3.3 m-85 -74.94 15.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.528 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 15.1 mmt -132.64 -55.71 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.515 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.98 11.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 42' ' ' GLY . 6.3 t -142.25 -56.86 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.584 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -41.7 -53.75 3.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.456 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt -105.0 44.65 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.314 179.823 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -162.88 -55.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.371 -179.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -73.23 20.22 1.23 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -170.69 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 1.0 110.571 -179.99 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.522 ' H ' HG23 ' A' ' 43' ' ' THR . 0.7 OUTLIER 50.14 11.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.551 179.985 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' N ' ' C ' ' A' ' 43' ' ' THR . . . 75.44 7.0 82.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.888 -0.885 . . . . 1.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.92 -0.54 36.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 1.0 110.54 179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.538 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -97.99 -43.4 2.84 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.934 -0.866 . . . . 1.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -98.38 29.07 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 1.0 110.512 -179.978 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.45 ' C ' HG22 ' A' ' 52' ' ' THR . 21.9 t -141.49 -47.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.551 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 53' ' ' VAL . 1.7 tp -97.14 -67.79 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.604 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.62 ' CZ3' ' NE2' ' A' ' 61' ' ' HIS . 46.7 t-105 -44.52 -21.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.601 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 49' ' ' VAL . 14.5 t -83.29 25.97 0.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.593 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 50' ' ' LEU . 95.0 t -113.6 -57.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.605 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -78.61 -1.16 32.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.58 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -100.11 -40.87 7.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.467 -179.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -85.29 -45.76 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.556 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmt -90.05 1.11 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.536 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.0 79.2 0.3 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.875 -0.89 . . . . 1.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -18.98 9.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 1.0 110.57 179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -96.95 -29.9 13.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.631 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.62 ' NE2' ' CZ3' ' A' ' 51' ' ' TRP . 50.9 t-80 59.46 62.19 1.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.58 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -82.49 60.11 4.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -156.6 76.83 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.591 -179.975 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.2 p80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.988 -1.006 . . . . 1.0 110.568 -179.994 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.381 -0.599 . . . . 1.0 109.381 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 55.85 104.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.559 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -99.64 -97.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.623 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.74 -96.28 0.2 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 45.09 94.1 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -138.91 28.53 2.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 1.0 110.617 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -138.9 47.49 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.567 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -120.68 41.68 3.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -139.52 -53.81 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.596 -179.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -99.82 -29.32 12.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.553 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -94.81 58.0 2.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.538 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.4 -37.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.905 -0.878 . . . . 1.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 15' ' ' ASN . . . -175.98 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 1.0 110.522 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.95 5.15 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.539 180.0 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 13' ' ' ALA . 5.0 t30 -164.95 49.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.634 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -65.79 -31.69 72.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.965 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m 179.91 69.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.52 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' CB ' ' A' ' 19' ' ' CYS . 1.5 tt0 -100.16 60.13 1.04 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 1.4 t 76.12 -11.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.507 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -99.18 50.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.494 -179.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -132.8 -30.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.61 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -166.41 -33.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.722 -179.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.63 6.23 7.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.566 -179.975 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -68.5 -12.63 61.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -134.7 1.17 3.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.589 179.953 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.1 t 39.74 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.745 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 29' ' ' ALA . 10.5 t -165.05 -38.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.602 -179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.23 13.23 2.06 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 179.973 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -133.04 -8.79 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 1.0 110.418 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.21 -19.78 11.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.575 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.608 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.6 mp -91.33 -34.54 0.36 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.673 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.6 Cg_endo -87.58 13.55 2.61 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.203 1.936 . . . . 1.0 112.403 -179.776 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' C ' ' SD ' ' A' ' 36' ' ' MET . . . -115.44 6.29 14.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.619 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.6 ' N ' ' SD ' ' A' ' 36' ' ' MET . 1.5 pt -140.15 -26.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.898 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -71.47 16.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -127.21 -67.13 0.85 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.708 -179.944 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 mt -47.38 -13.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.363 . . . . 1.0 110.689 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.485 ' N ' ' C ' ' A' ' 36' ' ' MET . 21.7 t -102.84 -57.34 4.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -72.02 37.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.792 -179.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 38' ' ' VAL . 5.9 mt -139.06 -8.44 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.608 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.4 mt -115.77 -41.14 3.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.453 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.54 24.04 3.29 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -166.53 -89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.12 -0.232 . . . . 1.0 110.583 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.513 ' H ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER 31.6 67.38 0.14 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.27 -179.998 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 102.35 -59.09 0.57 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 -179.967 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -58.8 -9.02 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.806 0.336 . . . . 1.0 110.586 -179.985 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.654 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -95.35 -24.63 15.85 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 -179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.753 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -104.38 23.18 13.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 1.0 110.478 -179.943 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 45' ' ' GLY . 69.4 t -106.49 -64.11 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.716 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 52' ' ' THR . 1.9 pp -109.76 -35.91 6.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.659 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.515 ' CG ' ' O ' ' A' ' 51' ' ' TRP . 74.5 t-105 -72.63 7.75 1.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.492 -179.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 50' ' ' LEU . 9.3 t -84.25 -16.85 41.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.503 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 t -80.01 -35.86 16.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.583 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -86.67 4.4 40.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.579 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' NH2' ' O ' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -101.59 -64.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.54 -179.948 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -54.49 -33.69 60.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.559 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -96.58 -5.89 38.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.538 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.31 75.38 0.19 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.006 -0.837 . . . . 1.0 111.006 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -28.52 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 1.0 110.596 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.504 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 25.7 m170 -76.23 -120.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.572 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' HIS . 1.2 p-80 -179.09 56.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.58 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 61' ' ' HIS . 27.8 t-80 43.96 94.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.623 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.515 ' CD2' ' H ' ' A' ' 64' ' ' HIS . 2.4 t-160 -134.59 -147.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 1.0 110.415 -180.0 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.515 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.61 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.1 67.62 5.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.551 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 5' ' ' GLY . 11.6 mt-10 -69.92 -76.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.03 -3.57 3.98 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.913 -0.875 . . . . 1.0 110.913 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 3' ' ' GLU . . . 141.65 142.32 4.07 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.895 -0.882 . . . . 1.0 110.895 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.25 -61.93 1.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.318 . . . . 1.0 110.547 179.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 54.52 42.99 30.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.596 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.99 61.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' TYR . 2.9 m-20 -166.17 130.74 2.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.31 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' C ' ' CD1' ' A' ' 11' ' ' TYR . 5.6 t80 68.43 -36.18 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.118 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER 41.14 39.88 1.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 1.0 110.687 179.688 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.03 -46.25 3.6 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.96 -90.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 1.0 110.512 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.5 t0 55.4 32.17 18.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.595 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -90.93 11.95 21.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.556 179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' O ' ' CB ' ' A' ' 17' ' ' SER . 25.6 mm-40 -91.56 4.3 52.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.542 -179.938 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.3 OUTLIER 164.5 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.584 179.973 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 42.03 35.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.509 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.562 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -141.07 19.31 2.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.592 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 21' ' ' TYR . 8.1 pt-20 36.42 25.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.173 -179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' A' ' 19' ' ' CYS . 3.0 t80 80.68 42.71 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.85 179.751 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 19' ' ' CYS . 12.0 p 53.8 29.85 10.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.35 -4.85 26.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.312 179.827 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 33.7 p-90 -62.46 -9.79 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.383 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.629 ' NZ ' ' H ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -136.03 1.77 2.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.624 179.892 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.2 t 39.87 94.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.808 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.516 ' OG ' ' NZ ' ' A' ' 25' ' ' LYS . 52.8 p -162.94 -35.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.652 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.629 ' H ' ' NZ ' ' A' ' 25' ' ' LYS . . . -73.52 19.17 1.53 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -114.23 -1.82 13.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.845 0.355 . . . . 1.0 110.481 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.68 -25.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.593 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -66.74 -41.02 35.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 61.3 Cg_endo -87.18 16.16 2.01 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.549 2.166 . . . . 1.0 112.19 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.79 -36.87 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.549 179.95 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.594 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.1 mm -89.36 -31.68 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.387 179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -71.71 13.71 0.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.489 ' C ' ' H ' ' A' ' 38' ' ' VAL . 28.7 mmm -117.59 -52.61 2.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.434 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.4 mt -71.73 12.94 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.425 179.911 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 36' ' ' MET . 21.1 t -134.69 -43.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.469 -179.936 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -63.09 -30.31 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.504 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 mt -101.74 52.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.75 -43.94 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.59 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.24 -16.81 80.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.866 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -139.04 -47.3 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.795 0.331 . . . . 1.0 110.481 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.401 HG23 ' C ' ' A' ' 43' ' ' THR . 0.1 OUTLIER 46.8 22.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.549 179.896 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.55 -12.23 52.7 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 43' ' ' THR . 4.0 m-80 -88.2 3.15 50.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 1.0 110.604 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -105.15 -39.7 2.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.696 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.19 30.58 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 1.0 110.604 -179.996 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.517 ' C ' HG22 ' A' ' 52' ' ' THR . 95.4 t -141.1 -48.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.572 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.716 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.7 tt -98.32 -65.02 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.633 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.401 ' C ' ' H ' ' A' ' 53' ' ' VAL . 56.2 t-105 -46.6 -19.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.55 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.517 HG22 ' C ' ' A' ' 49' ' ' VAL . 9.9 t -79.06 20.29 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.585 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 50' ' ' LEU . 99.2 t -101.75 -64.57 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -83.62 57.27 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.471 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -161.95 -49.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.578 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -73.82 -22.57 59.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' O ' ' CD2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -70.75 -7.17 42.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.559 -179.985 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 162.78 96.12 0.11 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -49.3 -24.05 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 1.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 0.4 OUTLIER -134.07 -60.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.363 -179.924 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' N ' ' CD2' ' A' ' 60' ' ' HIS . 1.9 m-70 173.46 112.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.593 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 63' ' ' HIS . 10.6 p80 -97.71 -137.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.585 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.524 ' N ' ' CG ' ' A' ' 62' ' ' HIS . 20.6 m-70 -151.6 116.2 5.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.576 179.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.985 -1.007 . . . . 1.0 110.579 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 64.46 122.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -99.17 -58.64 1.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.597 179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.57 51.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.78 -157.84 28.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.957 -0.857 . . . . 1.0 110.957 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -138.2 -35.68 0.61 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.731 0.3 . . . . 1.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 11.0 p90 -138.7 50.75 1.84 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.555 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -160.63 62.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.453 ' C ' ' CG ' ' A' ' 10' ' ' TYR . 70.7 m-20 -161.01 51.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.241 179.91 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 12' ' ' GLY . 18.2 p90 36.05 41.82 0.14 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.327 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -34.59 87.95 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.259 179.617 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 10' ' ' TYR . . . 40.3 53.38 3.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.98 105.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 1.0 110.524 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 1.9 p-10 -175.62 54.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.511 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.466 ' CG ' ' N ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER -161.71 -113.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.486 179.926 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.638 ' NE2' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER 28.27 51.51 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.714 0.634 . . . . 1.0 111.613 179.952 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 16' ' ' GLN . 0.7 OUTLIER 82.19 44.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.184 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' ASN . 4.5 tt0 -76.85 144.62 38.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.522 -179.898 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 23.0 p -173.71 60.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.614 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -129.36 13.4 6.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.513 179.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -94.69 -39.85 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.613 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 24.88 2.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.511 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -136.96 5.06 2.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.557 179.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -83.36 6.63 19.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -143.14 17.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.593 -179.976 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 28' ' ' GLY . 2.8 p -145.93 -93.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.583 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -73.57 16.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -139.51 29.7 2.47 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.54 -7.22 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 1.0 110.493 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.93 -20.18 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.591 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.585 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -69.57 -39.94 13.04 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 69.5 Cg_endo -87.0 2.48 6.98 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.384 2.056 . . . . 1.0 112.28 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.68 -1.04 57.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.625 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -138.21 -57.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.69 179.962 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 3.4 m-85 -43.22 -31.59 0.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.495 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.51 ' SD ' HD12 ' A' ' 40' ' ' LEU . 14.5 mmt -71.52 -33.62 69.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.419 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 34' ' ' ILE . 6.6 mt -74.24 -4.26 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.668 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.95 -67.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.692 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 35' ' ' TYR . 9.7 t80 -40.89 -50.05 3.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.605 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.51 HD12 ' SD ' ' A' ' 36' ' ' MET . 4.6 mt -102.56 61.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.488 -179.957 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 43' ' ' THR . 15.0 tp -170.47 -61.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.265 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.49 27.49 1.05 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -166.49 -90.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 1.0 110.53 179.991 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.497 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER 41.3 22.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.661 -179.98 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.858 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 135.1 -62.83 0.61 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.93 -15.21 0.71 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.824 0.345 . . . . 1.0 110.677 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.596 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -94.72 -26.46 13.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.902 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.717 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -101.08 15.92 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.72 0.295 . . . . 1.0 110.602 -179.878 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 45' ' ' GLY . 93.3 t -101.9 -60.8 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.591 -179.969 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 52' ' ' THR . 2.0 pp -62.61 -4.46 2.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.541 -179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.11 16.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.507 179.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.483 ' H ' ' C ' ' A' ' 50' ' ' LEU . 5.8 t -136.26 14.08 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.445 -179.974 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 52' ' ' THR . 37.3 t -140.65 -35.21 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.544 179.932 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -103.86 -9.53 18.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -101.95 -41.37 6.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.628 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -52.64 -35.39 54.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.593 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -68.37 -5.97 21.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.607 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -136.41 -106.37 0.81 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 68.04 -66.15 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.729 0.299 . . . . 1.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 58' ' ' GLY . 88.5 m-70 -142.09 9.47 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.63 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 63' ' ' HIS . 7.4 m80 63.82 98.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 51.79 -82.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.936 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 61' ' ' HIS . 2.1 t-80 -136.09 -147.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.22 0.533 . . . . 1.0 110.397 179.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 9.2 t-160 . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 117.999 -1.0 . . . . 1.0 110.54 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -99.58 -65.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.611 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -170.31 125.33 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.555 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.29 -83.2 0.17 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.86 53.16 6.44 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.17 -16.14 59.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 1.0 110.531 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -138.06 42.19 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.596 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -142.72 45.87 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.592 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 11' ' ' TYR . 1.1 m-20 -162.38 110.38 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.421 179.997 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.468 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER 68.91 -38.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.118 179.669 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER 39.38 94.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 1.0 110.861 179.881 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.85 -64.15 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.78 -87.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.776 0.322 . . . . 1.0 110.496 -179.953 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 t70 69.61 35.99 2.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.62 -179.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -100.36 52.43 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 -23.51 38.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.552 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -173.67 27.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.531 -179.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -90.58 96.69 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.624 179.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.2 t -173.56 -64.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.606 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -91.72 18.72 7.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.593 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -150.05 46.65 0.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.531 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.5 m -158.77 -36.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.643 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.63 26.67 10.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.573 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 23.7 p-90 -104.91 1.98 29.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.545 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -137.97 19.31 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.584 -179.974 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 28' ' ' GLY . 58.3 m -149.3 -82.26 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.51 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t 50.73 11.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.044 0.449 . . . . 1.0 110.164 -179.656 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 29' ' ' ALA . . . 127.81 10.02 3.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.38 -1.088 . . . . 1.0 110.38 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 80.31 13.23 0.9 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.026 0.441 . . . . 1.0 109.988 -179.548 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 30' ' ' LEU . 3.8 mm? -65.74 -27.86 68.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.23 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 31' ' ' ILE . 1.6 mp -75.29 -59.68 1.27 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.242 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 11.5 Cg_endo -54.86 -13.55 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.732 1.621 . . . . 1.0 111.949 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.85 -3.67 54.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.745 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.98 -53.81 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.543 -179.974 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -42.55 -30.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.606 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 mmt -78.45 -32.77 48.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.667 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.6 mt -68.43 -3.53 11.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.705 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.46 -59.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.629 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 41' ' ' LEU . 62.7 t80 -44.99 -64.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.42 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.9 41.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.508 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 39' ' ' PHE . 31.6 tp -153.95 -40.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.526 -179.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.3 -13.29 76.99 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.834 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -138.27 -46.78 0.52 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.0 110.636 -179.921 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 41.72 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 43' ' ' THR . . . 76.77 -7.38 34.33 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.026 -0.829 . . . . 1.0 111.026 179.907 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -101.6 6.69 42.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 1.0 110.644 179.978 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -102.63 -45.78 1.61 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.873 -0.891 . . . . 1.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -99.36 27.4 5.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.768 0.318 . . . . 1.0 110.499 -179.983 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 4.9 t -141.66 -46.5 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.565 -179.997 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tt -93.56 -63.56 1.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.4 t-105 -53.14 -32.84 49.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -57.16 -30.69 64.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.568 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -53.72 -54.66 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.602 179.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -93.93 62.34 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.603 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.538 ' NH2' ' CD2' ' A' ' 59' ' ' HIS . 1.9 tpm_? -167.36 -43.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.46 179.99 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -17.25 51.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.536 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -57.9 -38.89 76.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.545 179.995 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . 138.0 67.69 0.05 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.959 -0.856 . . . . 1.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.538 ' CD2' ' NH2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER 45.17 18.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.575 179.962 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 t-80 44.4 38.1 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.553 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.432 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -138.51 41.92 2.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.546 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.513 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 0.9 OUTLIER -95.71 -52.89 3.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.555 179.978 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 63' ' ' HIS . 30.6 p80 40.67 41.07 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.752 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.55 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.04 9.25 10.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.527 -179.944 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -169.66 -52.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.573 179.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.01 13.55 75.94 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.919 -0.872 . . . . 1.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.65 -155.97 2.03 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.27 9.62 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 1.0 110.574 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -143.18 42.62 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.549 -179.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -148.68 50.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.577 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -149.51 -55.66 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.621 179.994 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.02 10.97 14.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.573 179.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.57 84.25 7.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.588 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 43.66 68.34 0.85 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' O ' ' NE2' ' A' ' 16' ' ' GLN . . . -177.97 -87.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.31 . . . . 1.0 110.604 179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t0 52.0 10.73 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.608 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 13' ' ' ALA . 1.1 m-80 46.77 95.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.586 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -89.39 -43.87 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.523 -179.943 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -166.6 37.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.574 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' C ' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -70.11 169.71 12.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.577 -179.964 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 40.0 m 47.29 18.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.621 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 18' ' ' GLU . 6.2 mm-40 -136.88 22.71 3.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.595 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 22' ' ' THR . 1.7 m-85 -97.27 11.12 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.551 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.434 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 76.55 31.08 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.567 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 p30 -140.59 19.32 2.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -93.75 -21.1 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.575 179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.32 12.58 34.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.612 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 28' ' ' GLY . 51.4 m -135.81 -63.78 0.65 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.553 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 p -71.65 13.24 0.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.538 -179.97 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 26' ' ' SER . . . -134.07 21.32 3.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.7 -6.41 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 1.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 31' ' ' ILE . 3.9 mt -102.73 -25.53 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.458 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.721 ' N ' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -93.21 -42.89 0.33 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.266 179.982 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.9 Cg_endo -83.54 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.793 1.662 . . . . 1.0 112.459 -179.13 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.09 -1.31 7.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.322 179.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -148.79 -61.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.544 -179.919 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.536 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -42.35 -26.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.616 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.404 ' C ' ' N ' ' A' ' 38' ' ' VAL . 1.9 mtp -74.41 -55.85 5.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.422 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 37' ' ' LEU . 10.9 mp -48.61 -19.03 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.582 179.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' N ' ' C ' ' A' ' 36' ' ' MET . 2.2 t -97.76 -49.25 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.56 -179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -47.31 -43.13 22.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.579 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.84 52.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.0 tp -166.87 -62.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.355 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -53.78 -15.54 4.8 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.494 ' C ' HG23 ' A' ' 44' ' ' THR . 0.1 OUTLIER -139.12 -88.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.336 . . . . 1.0 110.555 -179.943 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.494 HG23 ' C ' ' A' ' 43' ' ' THR . 1.7 p 64.17 -2.78 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.566 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 84.32 28.72 32.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.89 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.22 7.5 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.438 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.58 15.55 6.0 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.999 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.1 16.65 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.751 0.31 . . . . 1.0 110.703 179.989 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -143.9 -41.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.461 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 50' ' ' LEU . 40.6 tp -94.33 -40.38 9.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.337 -179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -73.5 -30.11 62.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.263 179.796 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.613 ' N ' ' CD1' ' A' ' 51' ' ' TRP . 9.2 t -82.23 33.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.556 -179.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 49' ' ' VAL . 2.5 t -129.4 -6.19 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.284 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.93 12.04 3.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.473 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.574 ' HE ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -124.42 -20.95 5.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.809 -179.941 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.526 ' O ' ' NE2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -103.06 -16.32 15.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.578 179.918 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -52.35 -32.07 36.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.627 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -135.33 -17.38 0.87 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.969 -0.852 . . . . 1.0 110.969 -179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.526 ' NE2' ' O ' ' A' ' 56' ' ' LYS . 10.8 m80 65.22 -68.64 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 1.0 110.533 -179.948 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 58' ' ' GLY . 25.7 m-70 -142.35 22.02 2.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 m80 51.78 101.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 41.63 90.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.581 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.585 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 0.1 OUTLIER -68.37 75.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.595 -179.986 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.608 179.995 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.463 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER -63.43 -13.39 39.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.596 -179.993 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -74.44 52.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.536 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.35 57.33 0.62 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.55 -118.59 3.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -138.63 7.18 2.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.83 0.347 . . . . 1.0 110.539 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 t80 62.63 42.3 8.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.559 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -149.17 53.13 0.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.594 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -142.72 -42.03 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.54 -179.984 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.454 ' HB2' ' H ' ' A' ' 13' ' ' ALA . 20.3 m-85 -101.12 8.84 42.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.519 -179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 40.7 40.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 97.42 41.53 3.41 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 82.18 -28.11 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.765 0.317 . . . . 1.0 110.277 -179.904 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 59.58 2.14 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.732 179.654 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 13' ' ' ALA . 10.2 m120 -138.38 78.0 1.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.592 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.51 52.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.36 -45.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.557 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 20' ' ' GLU . 21.3 tt0 41.74 56.36 3.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.605 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.8 -8.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.518 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 18' ' ' GLU . 1.8 tp10 -58.62 -22.11 55.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.555 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -101.31 13.0 36.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.588 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -142.18 11.0 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.605 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.04 16.66 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.573 179.937 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -96.04 -5.56 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.577 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' H ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -100.98 7.48 43.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.574 -179.978 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.6 t -141.08 -67.36 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.545 179.939 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.4 p -77.01 52.16 0.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.604 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.1 24.85 0.33 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' C ' HD22 ' A' ' 30' ' ' LEU . . . -143.54 -5.87 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 1.0 110.601 -179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.869 HD22 ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -108.57 -29.84 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.291 179.96 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.2 mp -91.63 -37.93 0.37 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.201 -179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 72.9 Cg_endo -88.41 12.15 2.88 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.392 2.061 . . . . 1.0 112.203 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.2 -5.11 44.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.612 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.868 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -132.74 -46.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.444 179.912 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -54.87 -52.68 62.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.508 179.781 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.2 mmt -41.34 -54.65 2.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.03 -38.61 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.951 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 40' ' ' LEU . 1.6 t -83.25 -37.51 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.35 179.537 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.34 19.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.692 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 38' ' ' VAL . 11.3 mt -128.48 34.95 4.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.593 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 42' ' ' GLY . 1.9 pp -174.05 -42.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.729 179.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 41' ' ' LEU . . . -83.7 14.55 41.34 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 179.756 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -157.85 -85.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 1.0 110.416 -179.857 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.524 ' H ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER 41.04 22.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.572 179.808 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.877 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 136.23 -65.21 0.57 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -46.3 -24.46 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 1.0 110.563 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.579 ' C ' HD23 ' A' ' 48' ' ' LEU . . . -87.94 -27.76 25.36 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.684 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -100.61 13.84 33.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 1.0 110.614 -179.947 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 45' ' ' GLY . 92.6 t -101.82 -61.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.601 -179.924 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.2 -0.52 10.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.475 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.4 ' CH2' ' CZ ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -80.51 -0.05 35.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.552 -179.962 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 49' ' ' VAL . 6.0 t -113.81 27.69 9.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.551 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.2 t -134.83 -42.99 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.613 179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -103.96 6.91 36.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.605 179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.697 ' HE ' ' CE1' ' A' ' 59' ' ' HIS . 11.3 tpt180 -102.43 -63.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.584 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.57 -34.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.557 -179.917 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -62.96 -30.33 71.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.513 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 60' ' ' HIS . . . -175.59 96.52 0.11 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.927 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.697 ' CE1' ' HE ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -57.68 -6.15 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.312 . . . . 1.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.44 ' H ' ' C ' ' A' ' 58' ' ' GLY . 30.3 m-70 -143.37 -55.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.609 -179.96 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' HIS . 35.5 m80 -146.64 113.6 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.58 179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.483 ' ND1' ' N ' ' A' ' 62' ' ' HIS . 1.3 m-70 -58.32 79.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.586 -179.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 61' ' ' HIS . 39.5 t-80 43.67 94.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.55 179.984 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.403 -0.592 . . . . 1.0 109.403 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 53.22 96.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.567 179.959 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -66.26 -62.34 1.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.583 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 54.76 24.5 33.29 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.91 -116.81 1.62 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.32 -44.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 1.0 110.592 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER 54.82 43.23 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.531 179.968 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -115.34 39.3 2.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.553 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.51 63.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.61 179.96 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.6 t80 43.93 39.28 2.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.639 -179.95 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.53 110.01 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.634 -179.977 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 136.37 -47.51 0.96 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.877 -0.889 . . . . 1.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -171.95 -54.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 1.0 110.517 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 t70 59.52 51.36 6.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.497 -179.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.53 127.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.568 179.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.66 -45.45 2.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.581 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.66 -22.06 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.79 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 49.15 49.99 18.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.893 0.377 . . . . 1.0 110.606 179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 -36.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.522 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -75.5 51.92 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.547 179.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.48 ' C ' ' NZ ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -144.94 20.56 1.62 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.598 179.997 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.575 ' HA ' ' HZ3' ' A' ' 25' ' ' LYS . 1.4 m -169.35 -33.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.543 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -100.3 10.43 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.788 -179.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.69 ' HE1' ' NZ ' ' A' ' 25' ' ' LYS . 43.7 p-90 -97.47 -16.95 19.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.455 179.776 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.69 ' NZ ' ' HE1' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -121.55 -30.36 4.23 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.411 179.406 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -40.75 -61.57 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.706 -179.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.3 t -87.23 41.07 0.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.582 -179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.64 24.39 1.82 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.94 12.18 3.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 1.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' HD11 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -153.08 -19.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.58 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.1 mp -82.65 -41.28 0.9 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.799 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 70.9 Cg_endo -87.33 24.99 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.58 2.187 . . . . 1.0 112.184 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 5.08 5.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.582 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.533 HD11 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -144.03 -41.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -75.6 26.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.481 ' H ' ' C ' ' A' ' 34' ' ' ILE . 20.7 mmt -135.02 -50.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.588 179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.91 8.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.431 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 36' ' ' MET . 4.3 t -137.44 -54.31 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.548 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -41.71 -67.76 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.472 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -85.24 65.43 9.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.947 0.403 . . . . 1.0 110.11 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.6 tp -168.59 -47.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.367 -179.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.33 11.97 56.58 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.653 HG23 ' N ' ' A' ' 44' ' ' THR . 8.6 t -172.91 -52.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 1.0 110.702 -179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.653 ' N ' HG23 ' A' ' 43' ' ' THR . 1.4 p 57.05 4.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.561 -179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 103.53 -14.61 53.93 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.938 -0.865 . . . . 1.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -0.72 57.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.798 0.332 . . . . 1.0 110.545 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.08 -8.31 63.28 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.66 20.29 2.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.776 0.322 . . . . 1.0 110.597 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.686 ' O ' HG12 ' A' ' 49' ' ' VAL . 96.7 t -138.31 5.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.516 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 tp -133.31 -61.97 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.427 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -68.22 -8.82 42.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.424 179.95 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -92.08 -9.37 42.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.603 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.09 -43.56 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' CG ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -84.1 0.85 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.659 -179.998 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.616 ' NH1' ' NE2' ' A' ' 59' ' ' HIS . 61.4 ttt-85 -100.58 -46.18 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.598 -179.992 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -21.8 62.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.505 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 13.13 35.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.572 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 60' ' ' HIS . . . -152.08 -62.82 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' NE2' ' NH1' ' A' ' 55' ' ' ARG . 0.3 OUTLIER 67.19 -67.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 1.0 110.627 -179.953 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 58' ' ' GLY . 92.4 m-70 -141.74 -36.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.542 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.448 ' NE2' ' O ' ' A' ' 63' ' ' HIS . 14.4 t-160 -98.27 82.47 2.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.577 -179.987 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -44.7 -40.67 6.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.597 179.966 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.448 ' O ' ' NE2' ' A' ' 61' ' ' HIS . 9.7 m-70 -88.94 81.9 6.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.511 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.041 -0.98 . . . . 1.0 110.558 -179.978 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 51.5 68.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.559 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -70.83 -8.7 54.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.16 -84.26 1.49 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.908 -0.877 . . . . 1.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.1 14.91 2.23 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.953 -0.859 . . . . 1.0 110.953 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -87.29 13.15 10.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.333 . . . . 1.0 110.622 -179.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 53.62 41.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.596 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -154.91 47.67 0.55 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.502 179.998 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.07 -17.04 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.598 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -154.03 9.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.602 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -93.2 75.11 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.36 56.91 6.0 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.9 -0.88 . . . . 1.0 110.9 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' C ' ' N ' ' A' ' 15' ' ' ASN . . . -171.72 -53.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.747 0.308 . . . . 1.0 110.547 179.964 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 47.32 16.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.583 -179.989 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.447 ' N ' ' C ' ' A' ' 13' ' ' ALA . 9.3 m120 48.2 96.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.594 -179.969 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.497 ' H ' ' NE2' ' A' ' 16' ' ' GLN . 2.2 mp0 -56.36 -54.45 45.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.572 179.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 m -169.74 26.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.595 179.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -158.29 120.87 3.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 20' ' ' GLU . 24.0 p -165.57 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.492 179.945 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.454 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 3.6 mm-40 -80.76 11.95 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.512 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.5 8.2 1.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.585 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.67 12.98 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.427 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.464 ' C ' ' N ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -94.92 -37.45 11.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.65 -179.975 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -48.48 -14.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.409 -179.924 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' N ' ' C ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -132.17 -1.97 3.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.393 179.687 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.31 107.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.876 179.871 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 29' ' ' ALA . 5.8 t -173.26 -41.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.407 179.897 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.64 16.24 1.91 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 27' ' ' SER . . . -135.39 -9.52 2.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.733 0.301 . . . . 1.0 110.519 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.5 mt -112.84 -27.01 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.554 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.59 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 1.4 mp -72.89 -37.23 3.89 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.258 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 31' ' ' ILE . 73.8 Cg_endo -87.36 23.41 0.81 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.384 2.056 . . . . 1.0 112.236 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.61 -21.49 4.46 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.689 -179.957 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 36' ' ' MET . 33.3 mt -104.46 -43.66 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.483 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -75.48 24.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.561 179.957 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 34' ' ' ILE . 24.7 mmt -111.85 -40.43 4.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.562 179.989 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.77 -35.64 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.571 -179.912 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 40' ' ' LEU . 9.6 t -78.39 -54.26 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.554 -179.84 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -44.8 -18.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.603 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 38' ' ' VAL . 1.5 mt -123.41 39.75 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.475 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' VAL . 15.1 tp -166.33 -62.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.313 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.45 -8.88 47.94 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.634 HG23 ' N ' ' A' ' 44' ' ' THR . 9.9 t -144.64 -49.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.328 . . . . 1.0 110.625 -179.96 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.634 ' N ' HG23 ' A' ' 43' ' ' THR . 1.7 p 62.58 -0.67 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.603 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 81.34 20.15 65.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 179.98 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.412 ' ND2' ' OG1' ' A' ' 44' ' ' THR . 0.6 OUTLIER -118.82 -3.6 10.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.836 0.35 . . . . 1.0 110.468 179.945 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.26 -33.28 10.76 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -104.05 -115.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.661 0.267 . . . . 1.0 110.547 179.892 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.447 ' H ' ' CG ' ' A' ' 48' ' ' LEU . 58.7 t 55.58 -81.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.04 0.448 . . . . 1.0 110.514 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' LEU . 10.6 mt -48.95 -27.76 3.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.849 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.592 ' CH2' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -41.6 -39.33 1.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.639 179.94 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -73.58 18.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.719 -179.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' LEU . 45.3 t -138.2 -24.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.538 179.941 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -126.17 31.68 5.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.493 -179.964 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.592 ' NH1' ' CH2' ' A' ' 51' ' ' TRP . 0.5 OUTLIER -139.12 -59.34 0.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.51 179.957 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -29.75 58.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.562 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -49.03 -27.96 3.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.543 179.964 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.13 82.75 0.04 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.891 -0.884 . . . . 1.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.563 ' CD2' ' N ' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -45.23 -31.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.728 0.299 . . . . 1.0 110.583 179.997 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.563 ' N ' ' CD2' ' A' ' 59' ' ' HIS . 14.4 p80 -56.51 -35.07 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.519 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.556 ' N ' ' ND1' ' A' ' 60' ' ' HIS . 19.9 m-70 46.14 62.93 2.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.562 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -154.86 83.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.528 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.6 102.82 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.555 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.607 179.965 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 . . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 1' ' ' MET . 14.3 mt-10 60.41 142.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.524 179.981 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.54 -98.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.495 -179.992 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.22 -108.86 0.21 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.93 -0.868 . . . . 1.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . 55.96 19.78 23.95 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER 60.83 3.71 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.82 0.343 . . . . 1.0 110.608 179.962 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' A' ' 6' ' ' ASP . 23.5 p90 40.65 34.35 0.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -141.39 47.72 1.68 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.613 -0.722 . . . . 1.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -162.21 -75.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.605 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.48 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 2.7 t80 -144.92 25.05 1.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.581 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CG ' ' C ' ' A' ' 10' ' ' TYR . 15.1 p90 38.58 40.84 0.42 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.799 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.69 -68.66 0.08 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -174.01 -96.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 1.0 110.598 -179.989 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.413 ' OD2' ' CE1' ' A' ' 10' ' ' TYR . 2.7 t0 72.26 22.8 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.51 179.955 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -164.3 66.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.59 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -19.95 62.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.587 179.944 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m 168.4 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.585 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -95.98 135.41 37.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.52 179.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 175.87 73.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.573 -179.99 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -70.14 9.16 0.61 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.166 179.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 19' ' ' CYS . 3.4 m-85 66.93 92.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.559 179.853 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 m 51.21 25.36 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.398 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.86 15.34 2.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -129.84 -0.96 4.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.278 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' N ' ' CD ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -154.72 19.15 0.46 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.431 179.611 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 28' ' ' GLY . 77.4 p -113.33 -108.67 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.421 179.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.6 -69.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 1.0 109.953 -179.664 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 26' ' ' SER . . . -145.27 11.91 1.81 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.08 -1.208 . . . . 1.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . 69.35 45.19 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.104 0.478 . . . . 1.0 109.979 -179.511 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 30' ' ' LEU . 3.4 mm? -83.3 -42.91 16.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.421 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 33' ' ' ALA . 1.5 mp -68.8 -50.63 22.91 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.568 -179.837 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 57.3 Cg_endo -72.84 29.97 0.29 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.593 1.529 . . . . 1.0 112.023 179.98 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . -136.07 3.67 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.488 179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.82 -38.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.564 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' O ' ' SD ' ' A' ' 36' ' ' MET . 42.3 m-85 -82.09 25.23 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.564 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 35' ' ' TYR . 16.7 mmt -137.44 -52.27 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.563 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -68.9 8.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.566 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.3 t -140.3 -52.7 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.77 -54.71 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.431 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.41 ' C ' HG22 ' A' ' 44' ' ' THR . 3.4 mt -104.49 45.58 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.423 179.806 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' A' ' 43' ' ' THR . 58.0 tp -163.73 -55.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.427 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' VAL . . . -71.62 15.91 1.51 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.137 -0.785 . . . . 1.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -168.44 -83.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 1.0 110.599 -179.983 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.481 ' H ' HG23 ' A' ' 43' ' ' THR . 1.0 OUTLIER 54.33 7.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.564 179.918 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 43' ' ' THR . . . 81.55 21.91 61.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -133.83 11.01 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.802 0.334 . . . . 1.0 110.432 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.8 17.9 4.89 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.72 21.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.683 0.278 . . . . 1.0 110.519 -179.977 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.85 -51.67 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.578 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 pp -101.57 -17.8 16.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.62 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.507 ' O ' ' CG ' ' A' ' 51' ' ' TRP . 0.0 OUTLIER -86.68 -11.32 51.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.618 179.913 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 6.4 t -84.64 -27.24 27.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.572 179.959 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -68.66 -23.66 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.544 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.9 15.57 23.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.553 179.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.422 ' C ' ' H ' ' A' ' 57' ' ' LYS . 12.6 ttm180 -135.88 -46.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' CG ' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -58.86 -5.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.596 179.945 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -100.95 -10.64 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.569 -179.983 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.48 86.89 0.07 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.05 -16.19 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 1.0 110.576 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -59.64 -114.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.533 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -138.06 89.14 2.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.522 -179.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.72 101.96 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 2.0 t-80 -134.46 -147.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 1.0 110.415 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' A' ' 64' ' ' HIS . 10.8 t-160 . . . . . 0 C--N 1.321 -0.649 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.553 179.991 . . . . . . . . 1 1 . 1 stop_ save_